source_type,source,candidate_id,score,context_snippet
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=1,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=2,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=3,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=4,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=5,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=6,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=7,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=8,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=9,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=10,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=11,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=12,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=13,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=14,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=15,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=16,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=17,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=18,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=19,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=20,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=21,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=22,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=23,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=24,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=25,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=26,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=27,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=28,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=29,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=30,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=31,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=32,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=33,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=34,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=35,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=36,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=37,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=38,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=39,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=40,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=41,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=42,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=43,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=44,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=45,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=46,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=47,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=48,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=49,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=50,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=51,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=52,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=53,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=54,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=55,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=56,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=57,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=58,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=59,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=60,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=61,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=62,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=63,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=64,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=65,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=66,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=67,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=68,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=69,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=70,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=71,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=72,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=73,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=74,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=75,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=76,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=77,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=78,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=79,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=80,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=81,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=82,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=83,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=84,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=85,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=86,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=87,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=88,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=89,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=90,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=91,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=92,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=93,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=94,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=95,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=96,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=97,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=98,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=99,M1-Q03,0.050,
pdf_page,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=100,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=1,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=2,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=3,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=4,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=5,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=6,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=7,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=8,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=9,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=10,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=11,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=12,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=13,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=14,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=15,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=16,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=17,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=18,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=19,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=20,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=21,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=22,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=23,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=24,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=25,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=26,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=27,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=28,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=29,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=30,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=31,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=32,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=33,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=34,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=35,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=36,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=37,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=38,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=39,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=40,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=41,M1-Q03,0.050,
pdf_page,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=42,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=1,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=2,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=3,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=4,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=5,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=6,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=7,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=8,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=9,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=10,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=11,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=12,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=13,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=14,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=15,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=16,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=17,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=18,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=19,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=20,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=21,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=22,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=23,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=24,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=25,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=26,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=27,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=28,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=29,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=30,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=31,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=32,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=33,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=34,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=35,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=36,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=37,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=38,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=39,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=40,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=41,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=42,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=43,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=44,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=45,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=46,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=47,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=48,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=49,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=50,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=51,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=52,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=53,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=54,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=55,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=56,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=57,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=58,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=59,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=60,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=61,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=62,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=63,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=64,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=65,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=66,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=67,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=68,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=69,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=70,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=71,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=72,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=73,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=74,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=75,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=76,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=77,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=78,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=79,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=80,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=81,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=82,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=83,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=84,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=85,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=86,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=87,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=88,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=89,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=90,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=91,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=92,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=93,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=94,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=95,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=96,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=97,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=98,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=99,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=100,M1-Q03,0.050,
pdf_page,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=101,M1-Q03,0.050,
pdf_page,MODULE 3 synthesis#page=1,M1-Q20,0.101,"Module 3: Technology, Learning, and the 
Brain (Complete Summary)  
1. Change of the World: from 3D to 2D  
Based on the work of Susan Greenfield, the fundamental premise for this module is that we 
are living through an unprecedented environmental shift from a ""3D world"" to a ""2D world.""  
The 3D t"
pdf_page,MODULE 3 synthesis#page=2,M1-Q20,0.116,"This is a crucial distinction. A car is a means to an end (getting from A to B). Electricity is a 
means to an end (powering a light).  
In contrast, the digital environment (like a social network) has become an end in itself . It is the 
""place"" where people live, socialise, and build their identit"
pdf_page,MODULE 3 synthesis#page=3,M1-Q20,0.092,"developed superior problem -sol vi ng sk i l l s and measurabl e physi cal  brai n changes 
compared to rats i n ""standard cages.""  
○ Gene- Environment Interaction (Van Dellen et al., 2000):  Mice with the 
Huntington's disease gene raised in an enriched environment developed movement 
problems muc"
pdf_page,MODULE 3 synthesis#page=4,M4-Q09,0.090,"is a curated identity that represents not who we are, but who we want to be  (or who we 
want others to thi nk we are).  
A Kid S c a p e (201 1 ) survey found that 50% of young peopl e (1 1 -18) lie  a b o ut  p e rs o na l d e t a ils  
onl i ne to create i denti ti es that are ""more sex y"" or ""mo"
pdf_page,MODULE 3 synthesis#page=5,M1-Q20,0.105,"○ Full Contact  (in person) and Verbal Contact  (by phone) led to an increase in 
Oxytocin  (the ""bonding"" hormone) and a decrease in Cortisol  (the ""stress"" 
hormone). 
○ Instant Message  (text only) and No Contact  groups showed no increase in 
oxytocin and their cortisol levels remained high. 
● "
pdf_page,MODULE 3 synthesis#page=6,M1-Q20,0.108,"2014): 
● First -Person Shooters (FPS):  Linked to higher arousal during play (""thrill -seeking"" 
model). 
● MMORPGs: Linked to decreased arousal during play (""escapist"" model).  
Videogames and Aggression  
A  l arge body of research expl ores the l i nk between vi ol ent vi deogames and aggressi o"
pdf_page,MODULE 3 synthesis#page=7,M1-Q20,0.112,"to make excellent drone pilots (McKinley et al., 2011). 
5. Effects on Memory and Learning  
T hi s fi nal  secti on expl ores how constant i nformati on access and mul ti taski ng are changi ng 
c o g nit ive  func t io ns  re la t e d  t o  le a rning . 
The ""Google Effect"" (Transactive Memory)  
"
pdf_page,MODULE 3 synthesis#page=8,M1-Q20,0.137,"● Jeong:  This study confirmed that students had better reading comprehension from 
paper books (p - books) . Using CFF (critical flicker/fusion frequency) to measure eye 
fatigue, it also found students had significantly greater  eye fatigue after reading e-
books . 
Media Multitasking and Cognitiv"
pdf_page,MODULE 3_MindChange_part1#page=1,M4-Q07,0.235,"Use of technology and 
networking:
how do they change our brain
"
pdf_page,MODULE 3_MindChange_part1#page=2,M1-Q20,0.199,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_page,MODULE 3_MindChange_part1#page=3,M3-Q15,0.309,"Summary
• Change of the World: from 3D to 2D
• How our brain works and changes
• Effects of the digital world on identity and relationship
• Effects of the digital world on free time and aggressivity
• Effects of the digital world on memory and learning"
pdf_page,MODULE 3_MindChange_part1#page=4,M4-Q18,0.233,"Change of the World: from 3D to 2D
3D world
Tablet
PC
Smartphone
TV"
pdf_page,MODULE 3_MindChange_part1#page=5,M4-Q16,0.222,"Change of the World: from 3D to 2D
3D world
Tablet
PC
Smartphone
TV
• Tech is everywhere
• Facts can be accessed at random
• Actions can be reverse
• Time is short
• 24/7 responsive and productivity"
pdf_page,MODULE 3_MindChange_part1#page=6,M4-Q16,0.213,"Change of the World: from 3D to 2D
This change seems different from previous changes (car, electricity, TV) 
for different reasons: 
1) This change is different of its pervasiveness.
2) The shift from technology as a means to its being an end in and of 
itself"
pdf_page,MODULE 3_MindChange_part1#page=7,M1-Q20,0.160,"Pervasiveness
• In 2011, 71 percent of adult U.S. Internet users bought goods online, and 
the following year a comparable number, 87 percent, of U.K. adults ages 
twenty-five to forty-four were shopping online.
• By 2017, online sales are projected to account for 10 percent of all retail 
sales in "
pdf_page,MODULE 3_MindChange_part1#page=8,M1-Q13,0.214,"Internet sales as a percentage of total retail 
sales (ratio) (%) 
www.ons.gov.uk"
pdf_page,MODULE 3_MindChange_part1#page=9,M1-Q20,0.204,"Pervasiveness
• Study on US adults using social networking sites
• 24% of U.S. adult users of social networking sites reported a curious 
phenomenon in 2012—that they missed out on a key event or 
moment in their lives because they were so absorbed in updating 
their social networking site about tha"
pdf_page,MODULE 3_MindChange_part1#page=10,M4-Q05,0.209,"Pervasiveness
• Work/study
• Communicate with friends
• Find new friends
• Gain information and news
• Shopping
• Spare time
• Alarm
• Maps
• …
Tablet
PC
Smartphone
TV"
pdf_page,MODULE 3_MindChange_part1#page=11,M4-Q07,0.196,"Pervasiveness for who?
3D world 2D world
Different GENERATIONS"
pdf_page,MODULE 3_MindChange_part1#page=12,M1-Q20,0.175,"Digital Native vs Digital Immigrants
• Digital Native: “someone defined by his or her perceived outlook and 
abilities, based on an automatic facility and familiarity with digital 
technologies”
• Digital Immigrants: “have adopted many aspects of the technology, 
but just like those who learn anothe"
pdf_page,MODULE 3_MindChange_part1#page=13,M1-Q20,0.158,"Digital Native vs Digital Immigrants
• Digital Native: the date of birth of the Digital Native seems therefore 
to be uncertain
✓back as the 1960s when the term “computer” entered into common language
✓late 1990 when emails became reality
• Digital Immigrants: “have adopted many aspects of the techn"
pdf_page,MODULE 3_MindChange_part1#page=14,M4-Q16,0.205,"Digital Native vs Digital Immigrants
Irrespective of the date 
of born, parents are most 
likely to be Digital 
Immigrants and their 
children Digital Natives The former are still learning
the enormous potential of
these technologies in
adulthood, while the latter
have known nothing else"
pdf_page,MODULE 3_MindChange_part1#page=15,M3-Q15,0.309,"Summary
• Change of the World: from 3D to 2D
• How our brain works and changes
• Effects of the digital world on identity and relationship
• Effects of the digital world on free time and aggressivity
• Effects of the digital world on memory and learning"
pdf_page,MODULE 3_MindChange_part1#page=16,M4-Q15,0.244,"Brain Changes
3D world 2D world
≠
human brain will adapt to 
whatever environment in 
which it is placed"
pdf_page,MODULE 3_MindChange_part1#page=17,M1-Q20,0.184,"Brain Changes
One leading expert in brain development, 
Bryan Kolb, sums up: “Anything that changes 
your brain, changes who you will be. Your 
brain is produced not just by your genes; it’s 
sculpted by a lifetime of experiences. 
Experience alters brain activity, which 
changes gene expression. An"
pdf_page,MODULE 3_MindChange_part1#page=18,M1-Q13,0.252,"Brain Changes
Let’s see examples of this brain plasticity:
Kolb, B. (2009).
"
pdf_page,MODULE 3_MindChange_part1#page=19,M1-Q20,0.215,"London taxi drivers 
For a rookie driver →2y 
after passing “the 
Knowledge” to become a 
good taxi driver!
Do London Taxi Drivers 
show physical changes in 
their brains as a result of 
the very daily use of their 
working memory?
Maguire et al (2000). Navigation-related structural change in the hi"
pdf_page,MODULE 3_MindChange_part1#page=20,M1-Q20,0.177,"London taxi drivers 
Maguire et al (2000) 
Sagittal section of an MRI scan with the hippocampus
indicated by the red box. (a Right) Coronal section through 
the MRI scan, again with the hippocampi indicated. (b) The 
group results are shown superimposed onto the scan of an 
individual subject select"
pdf_page,MODULE 3_MindChange_part1#page=21,M4-Q22,0.170,"London taxi drivers 
Maguire et al (2000) 
Correlation of volume change with time as a taxi 
driver. (a Left) Sagittal section. (a Right) Coronal 
section. The voxel-based morphometry group 
results are shown superimposed onto the scan of 
an individual subject selected at random. The bar 
to the ri"
pdf_page,MODULE 3_MindChange_part1#page=22,M1-Q20,0.175,"Training dogs and birds
• Changes in the brain as a result of experience were actually first 
shown as long ago as 1783 by the Swiss naturalist Charles Bonnet and 
the Michele Vincenzo Malacarne
• They discovered that training dogs and birds led to an increase in the 
number of folds in a part of th"
pdf_page,MODULE 3_MindChange_part1#page=23,M1-Q20,0.152,"Visual Plasticity
• In the first years of life the brain has windows of opportunity, 
characterized by the exuberant growth of connections between neurons, 
which allows for astonishing possibilities.
• E.g. in infants the visual and auditory compartments of the cortex appear 
to be functionally int"
pdf_page,MODULE 3_MindChange_part1#page=24,M1-Q20,0.149,"Musicians
• Musicians who play string instruments exercise their left hands more than 
their right and, in these players, the section of cortex related to touch is 
accordingly larger for the left hand than the right (right cortex, left hand).
• Study design: 
• Nine musicians (six violinists, two c"
pdf_page,MODULE 3_MindChange_part1#page=25,M4-Q22,0.165,"Musicians
The section of cortex related to touch is accordingly larger for the left hand 
than the right. 
The data indicate that the center of cortical responsivity for tactile stimulation 
of the digits of the left hand was shifted in musicians as compared to that in 
controls. 
Elbert et al., (19"
pdf_page,MODULE 3_MindChange_part1#page=26,M4-Q16,0.177,"Musicians
• Anatomical scans of professional musicians (keyboard players), 
amateur musicians, and nonmusicians showed size differences in a 
range of structures: motor, auditory, and visuo-spatial brain regions
• It’s worth noting that there are strong relationships between 
musician status and pra"
pdf_page,MODULE 3_MindChange_part1#page=27,M1-Q20,0.194,"Training in Math
• Normal human subjects with no particular skill or talent are trained 
from scratch in some standardized experimental tasks
• The training to acquire or practicing to perform a skill, which may lead 
to structural changes in the brain, is called experience-dependent 
structural pla"
pdf_page,MODULE 3_MindChange_part1#page=28,M1-Q20,0.180,"Training in Math
• Twenty-six volunteer mathematicians, who have been working as 
academicians, were enrolled in the study
• Authors assessed the gray and white matter density differences in 
mathematicians and the control subjects. Moreover, the correlation 
between the cortical density and the tim"
pdf_page,MODULE 3_MindChange_part1#page=29,M1-Q20,0.174,"Training in Math
Aydin, K et al., (2007). Increased gray matter density in the parietal cortex of mathematicians: A voxel-based morphometry study. 
American Journal of Neuroradiology 28, no. 10, 1859–1864. 
Fig 2. A, The result of the regression analysis 
testing the correlation between gray matter "
pdf_page,MODULE 3_MindChange_part1#page=30,M1-Q20,0.160,"Training in Math
Aydin, K et al., (2007). Increased gray matter density in the parietal cortex of mathematicians: A voxel-based morphometry study. 
American Journal of Neuroradiology 28, no. 10, 1859–1864. 
Fig 2 B, The gray matter density values 
from the voxels showing the 
maximum correlation on "
pdf_page,MODULE 3_MindChange_part1#page=31,M1-Q20,0.149,"Training in juggling
• Subjects underwent daily training for three months to learn a three-
ball juggling task, where perception and anticipation were key to 
determining upcoming movements accurately. 
• Scans were performed before training, after three months of 
training, and then after another t"
pdf_page,MODULE 3_MindChange_part1#page=32,M1-Q20,0.167,"Training in juggling
• Scans before training →no 
significant regional differences in 
grey matter between jugglers 
and non-jugglers
• Scans after training →the juggler 
group demonstrated a bilateral 
expansion in grey matter in the 
mid-temporal area and in the left 
posterior intraparietal sulcu"
pdf_page,MODULE 3_MindChange_part1#page=33,M4-Q22,0.158,"Studies of enriched environments
• The earliest demonstration of the impact of the outside world was with 
what was eventually to be called an “enriched” environment and dates 
back to the 1940s
• Hebb took some of his lab rats home!! Home rats →superior problem 
solving compared to Lab rats.
• Mark"
pdf_page,MODULE 3_MindChange_part1#page=34,M1-Q20,0.171,"Studies of enriched environments
The study conclusively demonstrated that mice living in such a stimulating environment
developed movement problems much later and with a far more modest degree of impairment. 
Even here, with a disorder linked to a single gene and in the less complex brains of mice, "
pdf_page,MODULE 3_MindChange_part1#page=35,M1-Q12,0.219,"Conclusions
• Our brain is active and can change throughout our lifetime
• Different factors can contribute to these changings
Changing
Time (s)
Environments
Experiences
Deprivations
Life-style"
pdf_page,MODULE 3_MindChange_part1#page=36,M4-Q18,0.192,"Brain Changes
3D world 2D world
≠< →
Considering the abovementioned evidences, it is clear that a decreased 
exposure to 3D world, along with a more exposure to a 2D worlds, will 
change our brain"
pdf_page,MODULE 3_MindChange_part1#page=37,M1-Q20,0.213,"What do we do online? 
Meshi et al., (2015). The Emerging Neuroscience of Social Media. Trends in Cognitive Sciences, Vol.19, No.12 771-782.
http://dx.doi.org/10.1016/j.tics.2015.09.004"
pdf_page,MODULE 3_MindChange_part1#page=38,M4-Q22,0.218,"What do we do online? Which are the 
consequences?
Online activities
Share 
information
Add comments 
Interact with 
“friends”
Biological and psychological 
consequences
1. Change of the concept of identity
2. Change of the concept of privacy
3. Cerebral changes after sharing
4. “Like” effect and “d"
pdf_page,MODULE 3_MindChange_part1#page=39,M3-Q15,0.309,"Summary
• Change of the World: from 3D to 2D
• How our brain works and changes
• Effects of the digital world on identity and relationship
• Effects of the digital world on free time and aggressivity
• Effects of the digital world on memory and learning"
pdf_page,MODULE 3_MindChange_part1#page=40,M4-Q22,0.218,"What do we do online? Which are the 
consequences?
Online activities
Share 
information
Add comments 
Interact with 
“friends”
Biological and psychological 
consequences
1. Change of the concept of identity
2. Change of the concept of privacy
3. Cerebral changes after sharing
4. “Like” effect and “d"
pdf_page,MODULE 3_MindChange_part1#page=41,M1-Q20,0.226,"We share…
• Personal information (true or false)
• We share our identity (real, virtual or desired)
Previous researches on online ID:
1) Focus on the lack of identity →role of anonymity
2) Focus on the possibility to change online ID and on the quality of 
information shared"
pdf_page,MODULE 3_MindChange_part1#page=42,M1-Q20,0.134,"Different “Selves”
True Self: notion introduced by Carl 
Rogers (1951). The true self is based on 
existing characteristics that need not 
necessarily be fully expressed in normal 
social life, perhaps because there are not 
necessarily occasions when they’ll be 
manifest; rather, they are imagined "
pdf_page,MODULE 3_MindChange_part1#page=43,M4-Q22,0.178,"Different “Selves”
• Social networking has now resulted in a new self: the hoped-for, 
possible self displayed on social networking sites.
• Individual's possible selves are thought to be the cognitive link 
between past experiences and future hopes, desires, fears, and 
fantasies. 
• They represent"
pdf_page,MODULE 3_MindChange_part1#page=44,M1-Q20,0.154,"Which self do you share?
Kidscape, a British charity that helps prevent bullying and protects children, 
conducted a survey in which they assessed young people’s cyberlives through an 
online questionnaire.
• N=230 
• Age: 11-18 (from England, Scotland, and Wales)
• Results: one in two (50%) say the"
pdf_page,MODULE 3_MindChange_part1#page=45,M1-Q20,0.200,"Sharing effect
N = 35
Age: 19-34 years
Aim: investigated the intrinsic functional organization of the brain with respect to 
participants’ degree of self-related information sharing 
Methods: 
- resting state functional magnetic resonance imaging 
- self-reported social media use →Participants were "
pdf_page,MODULE 3_MindChange_part1#page=46,M1-Q20,0.194,"Sharing effect
RESULTS:
Connectivity of both the MPFC 
and CP , but not connectivity of the 
cACC, to other brain regions is 
associated with the degree of 
self-related sharing 
→the higher the connectivity the 
higher the degree of self-related 
sharing
Meshi et al., Scientific Report, 2016 
ROI:
"
pdf_page,MODULE 3_MindChange_part1#page=47,M4-Q22,0.161,"Need to share, need to be approved
• Attention and approval from adults are among the strongest rewards 
we experience as we are growing up.
• Infants need a meaningful relationship with a caring and involved 
adult in order to survive and grow. Astonishingly, human growth 
hormone is thought to be "
pdf_page,MODULE 3_MindChange_part1#page=48,M1-Q12,0.178,"Need to share, need to be approved…
• The importance of such recognition does not diminish with age. 
Unlike the real world, Twitter and Facebook can always be relied on to 
provide an almost instant response to even your adult demands for 
attention.
• This in turn may explain why the obsessive soc"
pdf_page,MODULE 3_MindChange_part1#page=49,M1-Q12,0.147,"…despite the loss of privacy
• Many of us take privacy for granted until we feel it is being invaded
• Privacy appears to be a less prized commodity among the younger 
generation of Digital Natives: nearly half of teenagers have given out 
personal information to someone they don’t know, including p"
pdf_page,MODULE 3_MindChange_part1#page=50,M1-Q20,0.211,"Sharing effect
• As a species, we seem to have such a craving for self-disclosure that it 
could be considered a very basic part of the human psyche
• Harvard scientists have actually 
demonstrated that sharing personal 
information about oneself, as on social 
networking sites, activates the reward"
pdf_page,MODULE 3_MindChange_part1#page=51,M1-Q12,0.168,"Sharing effect
• Astonishingly, the participants in this particular experiment were even 
willing to give up monetary rewards for the opportunity to talk about 
themselves
• The results also suggest that the 
existence of a reciprocal cyclical 
feedback for self-disclosure rewards 
and perpetuates t"
pdf_page,MODULE 3_MindChange_part1#page=52,M4-Q22,0.218,"What do we do online? Which are the 
consequences?
Online activities
Share 
information
Add comments 
Interact with 
“friends”
Biological and psychological 
consequences
1. Change of the concept of identity
2. Change of the concept of privacy
3. Cerebral changes after sharing
4. “Like” effect and “d"
pdf_page,MODULE 3_MindChange_part1#page=53,M1-Q20,0.193,"Like effect
• N = 32
• Age = 13-18
Sherman et al., 2016, Psychological Science 
• Aim: investigated a unique way in which adolescent peer influence occurs on 
social media. The authors developed a novel functional MRI (fMRI) paradigm 
to simulate Instagram, a popular social photo-sharing tool, and m"
pdf_page,MODULE 3_MindChange_part1#page=54,M1-Q20,0.142,"Like effect
• Adolescents underwent fMRI 
while viewing photos 
ostensibly submitted to 
Instagram. 
• They were more likely to like 
photos depicted with many 
likes than photos with few 
likes.
• This finding showed the 
influence of virtual peer 
endorsement and held for both 
neutral photos and "
pdf_page,MODULE 3_MindChange_part1#page=55,M1-Q20,0.156,"Like effect
• Viewing photos with many 
(compared with few) likes was 
associated with greater
activity in neural regions 
implicated in reward 
processing, social cognition, 
imitation, and attention. 
• Areas: precuneus, medial 
prefrontal cortex, and 
hippocampus (Mars et al., 
2012; Zaki & Ochsn"
pdf_page,MODULE 3_MindChange_part1#page=56,M1-Q20,0.166,"Like effect
• When participants viewed 
their own photographs or 
neutral photographs 
ostensibly submitted by 
peers, greater activity in 
the visual cortex was 
observed in response to 
photos with many likes 
compared with photos with 
few likes. 
• The increased activation 
suggests that partici"
pdf_page,MODULE 3_MindChange_part1#page=57,M4-Q09,0.218,"Like effect
• Conclusions: Taken together, imaging findings suggest that 
adolescents perceive information online in a qualitatively different 
way when they believe that this information is valued more highly by 
peers.
Sherman et al., 2016, Psychological Science "
pdf_page,MODULE 3_MindChange_part1#page=58,M4-Q16,0.162,"Like effect
• This study replicates the previous one, adding information about 
brain imaging activation stratifying population by age.
• Mobile social media often feature the ability to “Like” content posted 
by others. The present study examined the effect of Likes on youths’ 
neural and behaviora"
pdf_page,MODULE 3_MindChange_part1#page=59,M4-Q22,0.179,"Like effect
• First result: confirmation of previous data
• Participants more often Liked photos that appeared to have received 
many (vs. few) Likes. 
• Popular photos elicited greater activity in multiple brain regions, 
including the nucleus accumbens (Nacc), a hub of the brain’s reward 
circuitr"
pdf_page,MODULE 3_MindChange_part1#page=60,M1-Q20,0.138,"Like effect
Second results:
Nucleus accumbens responsivity 
increased with age for high school but 
not college students
Figure 2. NAcc response to social reward and its relation to age
For participants in the high school cohort, NAcc response to the Popular 
(Many Likes) > Unpopular (Few Likes) con"
pdf_page,MODULE 3_MindChange_part1#page=61,M1-Q20,0.170,"Like effect
Third result:
When viewing images depicting risk-
taking (vs. non-risky photographs), high 
school students, but not college students, 
showed decreased activation of neural 
regions implicated in cognitive control.
Figure 3. Differences in decreased activation for comparison of risky an"
pdf_page,MODULE 3_MindChange_part1#page=62,M1-Q20,0.194,"Conclusions
• Quantifiable Social Endorsement (QSE) plays a significant role in 
influencing how young adults perceive and respond to information on 
social media; in other words, QSE is a mechanism of peer influence, 
and a potential means by which individuals learn about their social 
environment,"
pdf_page,MODULE 3_MindChange_part1#page=63,M1-Q20,0.151,"Conclusions
• While the present study focused specifically on peer influence, it is possible 
that non-peers (e.g., older adults, parents, etc.) might have a similar effect, 
in line with work suggesting overlapping mechanisms between peer and 
parental influence.
• Increased age was associated with"
pdf_page,MODULE 3_MindChange_part1#page=64,M1-Q20,0.205,"Dopamine effect
• If social networking is rewarding and exciting, it is very likely that 
social networking might serve as another trigger for the release of 
dopamine in the brain.
• Specific features of Facebook and other social networking sites 
might make them triggers for dopamine release
Weins"
pdf_page,MODULE 3_MindChange_part1#page=65,M4-Q15,0.175,"Dopamine effect
Weinschenk, S. (November 7, 2009).
Dopamine 
triggers
provide instant 
gratification
offer an anticipatory 
thrill
these sites offer small 
pieces of information
unpredictability
Features of 
Facebook and 
other social 
networking 
sites
DOPAMINE
TRIGGERS"
pdf_page,MODULE 3_MindChange_part1#page=66,M4-Q22,0.224,"What do we do online? Which are the 
consequences?
Online activities
Share 
information
Add comments 
Interact with 
“friends”
Biological and psychological 
consequences
1. Change of the concept of identity
2. Change of the concept of privacy
3. Cerebral changes after sharing
4. “Like” effect and “d"
pdf_page,MODULE 3_MindChange_part1#page=67,M1-Q12,0.135,"Effects of the digital world on relationship
• In 1987, according to one estimate, we spent on average 6 hours per 
day in face-to-face social interaction, and 4 via electronic media. 
• In 2007 the proportion had reversed, with almost 8 hours a day spent 
socializing via electronic media, and only "
pdf_page,MODULE 3_MindChange_part1#page=68,M1-Q12,0.151,"Use of internet for social activities
• In UK: The 64% of internet users (age > 16) also used social 
networking sites  →92% of teenagers (age: 16-19) 
• In USA: 80% of teenagers (age: 12-17) used social networking sites 
(Facebook and Myspace)
Ofcom. (2013). Adults’ media use and attitudes report. "
pdf_page,MODULE 3_MindChange_part1#page=69,M4-Q22,0.240,"Most popular social networks of teenagers in 
the United States from fall 2012 to fall 2019
© Statista 2020"
pdf_page,MODULE 3_MindChange_part1#page=70,M1-Q12,0.129,"How many friends do you have?
• In the United States, 80 percent of online teens ages twelve to seventeen 
use social networking sites, mostly Facebook and MySpace.
• U.S. users have on average 262 friends, a figure higher than the world 
average of roughly 140 friends.
• Twelve-to twenty-four-year-"
pdf_page,MODULE 3_MindChange_part1#page=71,M1-Q20,0.148,"How many friends do you have?
• On an average day, 26 percent of Facebook users “like” a friend’s 
status, 22 percent comment on a friend’s status, while only 15 
percent update their own status.
• So more people spend time interacting with other users’ content 
rather than posting their own
Ofcom. "
pdf_page,MODULE 3_MindChange_part1#page=72,M1-Q20,0.174,"Idea of friendship
• Miller McPherson compare ideas of friendship in 1985 with those in 
2004. 
• McPherson’s team discovered that the 2004 subjects had fewer 
people they could really talk to, with the number of available 
confidants down by about a third. 
• Even more alarming, the proportion of t"
pdf_page,MODULE 3_MindChange_part1#page=73,M1-Q20,0.175,"Social networking and brain
Do social networking map directly onto the 
physical brain?
The size of an individual’s online social network 
is closely linked to certain aspects of physical 
brain structures implicated in social cognition.
Kanai et al. found that variation in the number of 
friends on"
pdf_page,MODULE 3_MindChange_part1#page=74,M4-Q16,0.135,"Social networking and brain
N = 40
Age: 12-30 years
Measures to establish social network extension:
1) Facebook friends
2) Dunbar’s Number (is a suggested cognitive limit to 
the number of people with whom one can 
maintain stable social relationships—relationships 
in which an individual knows who "
pdf_page,MODULE 3_MindChange_part1#page=75,M1-Q20,0.189,"Social networking and brain
Kanai, R., Bahrami, B., Roylance, R., and Rees, G. (2011). Online social network size is reflected in human brain structure.
Proceedings of the Royal Society Biological Sciences 279, no. 1732, 1327–1334. doi:10:1098/rspb.2011:1959.
The gray matter
density of particular
br"
pdf_page,MODULE 3_MindChange_part1#page=76,M1-Q12,0.140,"Changes in communication style
• In 2012, the British communications watchdog Ofcom produced its ninth 
annual Communications Market Report.
• The average person was now sending fifty texts a week
• A staggering 96 percent of young people ages sixteen to twenty-four were 
using instant message (non-"
pdf_page,MODULE 3_MindChange_part1#page=77,M1-Q17,0.176,"Changes in communication style
…the type of emotional support 
that can be provided by these 
forms of communication turns out 
to be very inferior.
Ofcom. (July 18, 2012). The communications market report 2012 
Although Digital Natives may prefer non-
oral communication through text 
messaging or t"
pdf_page,MODULE 3_MindChange_part1#page=78,M4-Q16,0.184,"Changes in 
communication 
style
Speech between trusted individuals is capable of:
• reducing levels of salivary cortisol
• increasing levels of urinary oxytocin
Seltzer, L. J., Prososki, A. R., Ziegler, T. E., and Pollak, S. D. (2012). Instant messages vs. speech: Hormones and why we still need 
to"
pdf_page,MODULE 3_MindChange_part1#page=79,M1-Q20,0.176,"Changes in 
communication 
style
It is not clear, however, whether it is the 
uniquely human grammar, syntax, content 
and/or choice of words that causes these 
physiological changes, or whether the 
prosodic elements of speech, which are 
present in the vocal cues of many other 
species, are respon"
pdf_page,MODULE 3_MindChange_part1#page=80,M1-Q12,0.169,"Changes in 
communication 
style
Researchers at the University of Wisconsin–Madison asked the 
following question: could the content alone of an emotionally 
supportive conversation between a parent and a teenager convey
reassurance, or would the tone of voice and/or physical presence of 
the parent"
pdf_page,MODULE 3_MindChange_part1#page=81,M4-Q15,0.202,"Changes in 
communication 
style
Seltzer, L. J., Prososki, A. R., Ziegler, T. E., and Pollak, S. D. (2012). Instant messages vs. speech: Hormones and why we still need 
to hear each other. Evolution and Human Behavior 33, 42–45. 
No support"
pdf_page,MODULE 3_MindChange_part1#page=82,M4-Q24,0.246,"Changes in 
communication 
style"
pdf_page,MODULE 3_MindChange_part1#page=83,M1-Q12,0.179,"Changes in 
communication 
style
Teenagers who spoke with 
their parents over the phone 
or in person released similar 
amounts of oxytocin and 
showed similar low levels of 
cortisol, indicative of a 
reduction in stress. In 
comparison, those who 
instant-messaged their 
parents released no oxytoc"
pdf_page,MODULE 3_MindChange_part1#page=84,M1-Q12,0.179,"Changes in 
communication 
style
Teenagers who spoke with 
their parents over the phone 
or in person released similar 
amounts of oxytocin and 
showed similar low levels of 
cortisol, indicative of a 
reduction in stress. In 
comparison, those who 
instant-messaged their 
parents released no oxytoc"
pdf_page,MODULE 3_MindChange_part1#page=85,M1-Q20,0.211,"Empathy levels
• Change of communication →reduced interactions →change of 
empathy.
• A survey of fourteen thousand U.S. college students suggests that 
levels of empathy may be declining.
• A huge drop in the curve is related to the last decade, a period that 
corresponds to the increase of social "
pdf_page,MODULE 3_MindChange_part1#page=86,M1-Q20,0.163,"Reduction of face-to-face interactions and 
empaty
• Possible trend: an increase in online relationships and a decrease in 
empathy
• Beyond empathy, excessive Internet use could lead more generally to 
a reduced ability to communicate effectively, as it has been 
associated with a lack of emotional"
pdf_page,MODULE 3_MindChange_part1#page=87,M4-Q16,0.137,"Face processing is 
compromised 
Excessive Internet use is associated with a limited ability to 
communicate effectively socially, which depends largely on the capacity 
for perception of the human face. 
Authors used a passive visual detection paradigm to compare the early 
stages of the processing"
pdf_page,MODULE 3_MindChange_part1#page=88,M4-Q13,0.257,"Face processing is 
compromised 
"
pdf_page,MODULE 3_MindChange_part1#page=89,M1-Q20,0.129,"Face processing is 
compromised 
FIG. 2. Grand averaged ERPs 
elicited by upright faces and
tables at left and right 
occipital-temporal sites (A), 
2D topographic map of N170 
peak amplitude (B), and 
normalized values of the 
N170 face effect in EIUs and 
normal control groups (C).
The P1 and N170"
pdf_page,MODULE 3_MindChange_part1#page=90,M1-Q20,0.158,"Face processing is compromised 
• This impairment could be similar to the impairment of autistic people.
• In the United Kingdom alone, more than half a million people—
around 1 percent of the population—have a form of autism. Autism 
spectrum disorders are characterized by a triad of impairments:
1"
pdf_page,MODULE 3_MindChange_part1#page=91,M4-Q16,0.175,"Face processing is compromised 
• Is there a connection between autistic-like traits and the use of social 
networking?
• Two crucial aspects:
1. autistic people are generally most comfortable in cyberspace: in such a 
world, there is no need to understand what might be going on inside the 
minds of"
pdf_page,MODULE 3_MindChange_part1#page=92,M1-Q20,0.189,"Nacc and 
online 
reputation
• The processing of gains in reputation (positive social feedback related to 
one’s character) occurs in the ventral striatum.
• Furthermore, discovering that others like us, or have provided general 
positive feedback about us, is also processed in the ventral striatum."
pdf_page,MODULE 3_MindChange_part1#page=93,M1-Q12,0.160,"Nacc and online 
reputation
• In today’s world, we can obtain a good reputation in a variety of ways; for 
example, we can be polite to people or behave in a moral manner. We can 
also manage our reputation online via social media websites.
• Aim of the study: authors employed Facebook use as a prox"
pdf_page,MODULE 3_MindChange_part1#page=94,M1-Q20,0.182,"Nacc and online 
reputation
• Authors recruited 31 healthy, right-handed participants (14 males) 
between 19 and 31 years of age
• Participants were told that between Day 1 and Day 2, the recorded video 
interview would be individually observed by 10 anonymous reviewers. 
• The participants were the"
pdf_page,MODULE 3_MindChange_part1#page=95,M4-Q02,0.225,"Nacc and online 
reputation
"
pdf_page,MODULE 3_MindChange_part1#page=96,M1-Q20,0.193,"Nacc and online 
reputation
Results:
1) self-relevant gains in reputation and 
monetary reward are processed in the 
ventral striatum
2) across participants, when responding to 
gains in reputation for the self, compared to 
observing gains for others, reward related 
activity in the left nucleus ac"
pdf_page,MODULE 3_MindChange_part1#page=97,M4-Q16,0.186,"Role of Nacc
In the present study authors combined recorded Facebook usage from 
smartphones with structural brain scans that were obtained from each 
smartphone user at the beginning of the experiment. Here, they focused on 
the nucleus accumbens region that has been highlighted in the study by 
Me"
pdf_page,MODULE 3_MindChange_part1#page=98,M1-Q20,0.190,"Role of Nacc
N =85 participants (46 males)
• Recorded the actual Facebook 
usage on their smartphones over 
the course of five weeks and 
correlated summary measures of 
Facebook use with gray matter 
volume of the nucleus 
accumbens.
"
pdf_page,MODULE 3_MindChange_part1#page=99,M1-Q17,0.249,"Role of Nacc
Fig. 3. Distributions of the tracked Facebook variables from the smartphones of the participants."
pdf_page,MODULE 3_MindChange_part1#page=100,M1-Q12,0.198,"Role of Nacc
Results:
• Lower volumes of the nucleus accumbens were associated with 
higher frequency of Facebook checking in everyday life. 
• There were also associations between accumbens volume and 
Facebook duration. 
• Facebook duration, however, was less reliable than Facebook 
frequency over"
pdf_page,MODULE 3_MindChange_part1#page=101,M4-Q22,0.151,"Role of Nacc
Results:
• Given the cross-sectional design of the present study, it remains to be 
elucidated whether lower volumes of the accumbens constitute a 
factor for increased social media use or whether it results as a 
consequence of higher usage. 
• Interestingly, one recent longitudinal st"
pdf_page,MODULE 3_MindChange_part1#page=102,M1-Q20,0.171,"Role of Nacc
Results:
• In sum, this study gives additional evidence that a) the nucleus accumbens
could be involved in online social media usage and b) that high frequency 
of Facebook checking could be characterized by addictive behavior when 
future work will be able to extend these findings to m"
pdf_page,MODULE 3_MindChange_part2#page=1,M4-Q07,0.235,"Use of technology and 
networking:
how do they change our brain"
pdf_page,MODULE 3_MindChange_part2#page=2,M1-Q20,0.258,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
enlarged ventral 
striatum
AGGRESSION
"
pdf_page,MODULE 3_MindChange_part2#page=3,M3-Q15,0.309,"Summary
• Change of the World: from 3D to 2D
• How our brain works and changes
• Effects of the digital world on identity and relationship
• Effects of the digital world on free time and aggressivity
• Effects of the digital world on memory and learning"
pdf_page,MODULE 3_MindChange_part2#page=4,M1-Q20,0.133,"Time on videogames
• A 2012 study of U.S. adolescents reported that boys between the ages of 
ten and thirteen were playing on average a staggering forty-three hours a 
week (although, admittedly, the number of subjects was fairly small, 184).
• Yet even conservative estimates (from 2009) indicate t"
pdf_page,MODULE 3_MindChange_part2#page=5,M4-Q19,0.214,"Time on videogames
"
pdf_page,MODULE 3_MindChange_part2#page=6,M4-Q21,0.255,"Videogame and the brain
What’s going on in our brain when we play videogames?
"
pdf_page,MODULE 3_MindChange_part2#page=7,M1-Q20,0.178,"Videogame and the brain
• Aviv Weinstein at the Hadassah Medical Organization in Jerusalem 
believes that the craving for online gaming and the craving for 
substance dependence could well share the same neurobiological 
mechanism.
Weinstein, A., and Lejoyeux, M. (2010). Internet addiction or excess"
pdf_page,MODULE 3_MindChange_part2#page=8,M4-Q16,0.157,"Craving hypothesis
• N = 9 abstinent “ecstasy” 
users and 8 control subjects 
• They were scanned at 
baseline and after 
performing on a motorbike 
riding computer game while 
imaging dopamine release in 
vivo with single photon 
emission computed  
tomography (SPECT)
Weinstein, A. M. (2010). Compu"
pdf_page,MODULE 3_MindChange_part2#page=9,M1-Q20,0.183,"Craving hypothesis
• The brain imaging study showed that 
healthy control subjects had reduced 
dopamine D2 receptor occupancy of 
10.5% in the caudate after playing a 
motorbike riding computer game 
compared with baseline levels of 
binding consistent with increased 
release and binding to its rec"
pdf_page,MODULE 3_MindChange_part2#page=10,M1-Q12,0.175,"Craving hypothesis
• For the nonaddicts experiencing the thrill 
of gaming, there was an increase in the 
release of dopamine that “desensitized” 
its receptors.
• But the brains of the Ecstasy addicts told 
a different story. Here chronic use of the 
drug had accustomed the brain to vast 
amounts o"
pdf_page,MODULE 3_MindChange_part2#page=11,M1-Q20,0.181,"Craving hypothesis
• In young gamers, brain imaging shows an enlargement of the area of 
the brain (the ventral striatum) where the neurotransmitter 
dopamine is released. 
• Interestingly enough, a similar feature is also characteristic of the 
brains of pathological gamblers, who suffer from anoth"
pdf_page,MODULE 3_MindChange_part2#page=12,M1-Q20,0.183,"Chicken and eggs dilemma
individuals with brains that happen to have an enlarged 
ventral striatum are predisposed to gaming
excessive gaming has literally left its mark on the brain"
pdf_page,MODULE 3_MindChange_part2#page=13,M4-Q09,0.183,"Chicken and eggs dilemma
• Let’s start with the chicken: that gaming, as with all life 
experiences, leaves its mark on the impressionable, 
plastic brain.
• According to Kuhn et al., the more time spent playing, 
the more pronounced the expansion of the striatum. 
This suggests the former caused th"
pdf_page,MODULE 3_MindChange_part2#page=14,M4-Q16,0.161,"Gaming →mark in the 
brain
• N = 154, 14-years-old
• Division between: frequent and infrequent
• Moreover, they  assessed the Monetary Incentive Delay (MID) task 
during fMRI imaging and a Gambling Task (CGT)
• During the MID task, participants see cues that indicate that they may win or 
not win mo"
pdf_page,MODULE 3_MindChange_part2#page=15,M1-Q20,0.174,"Results:
• higher left striatal grey matter volume when 
comparing frequent against infrequent video 
game players
• higher activity during loses
Conclusion:
• The key finding of higher volume in left ventral 
striatum associated with frequent video game 
playing is in conceptual accordance with 
fi"
pdf_page,MODULE 3_MindChange_part2#page=16,M4-Q16,0.260,"• Considering the CGT task →negative correlation between the gray 
matter volume in the left ventral striatum and the deliberation time in 
the CGT
Gaming →mark in the 
brain"
pdf_page,MODULE 3_MindChange_part2#page=17,M1-Q20,0.201,"• Considering the MID task →frequent compared with infrequent 
video game players showed enhanced activity during feedback of loss 
compared with no loss
Gaming →mark in the 
brain"
pdf_page,MODULE 3_MindChange_part2#page=18,M4-Q09,0.174,"Chicken and eggs dilemma
• Then there’s the egg: the idea that a preexisting brain 
state might predispose individuals to compulsive gaming
• Kirk Erickson at the University of Illinois found a 
correlation between the volume of a key brain area, the 
dorsal striatum, and later training success in a"
pdf_page,MODULE 3_MindChange_part2#page=19,M4-Q09,0.143,"Chicken and eggs dilemma
• Erickson has also described a link, again seen with imaging, 
between activation of the striatum before training and 
subsequent later skill acquisition during gaming. 
• These findings highlight the importance of the striatum, a 
rich source of dopamine, and how this migh"
pdf_page,MODULE 3_MindChange_part2#page=20,M1-Q17,0.190,"Big striatum →more 
videogame
• N = 42 (age 15-28)
• Infrequent players (< 3 hours of video games a week during the 2 
years prior to the study)
• Participants were given instructions about the Space Fortress game 
and then, before game training, completed an MRI session 
• They were then given 20 h"
pdf_page,MODULE 3_MindChange_part2#page=21,M1-Q20,0.169,"Big striatum →more videogame
• The Space Fortress game requires players to navigate their ship with 
precise control using a joystick. 
• The ship moves in an environment, and players can rotate the ship by 
moving the joystick left or right or by applying a thrust by pushing 
forward on the joystic"
pdf_page,MODULE 3_MindChange_part2#page=22,M4-Q07,0.176,"Big striatum →more videogame
RESULTS:
• hippocampal volumes 
did not predict learning 
improvement but 
striatal volumes did.
• The volumes of the 
dorsal striatum
predicted improvement 
in performance. 
• Both ventral and dorsal 
striatal volumes 
predicted early 
acquisition rates.
"
pdf_page,MODULE 3_MindChange_part2#page=23,M1-Q20,0.189,"Striatum: the key area of the dilemma
• Striatum →structure divided into 2 parts: an upper (dorsal) zone and 
a lower (ventral) one. The latter releases more dopamine than the 
former
Drevets et al., (1999). PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum. 
Neu"
pdf_page,MODULE 3_MindChange_part2#page=24,M1-Q20,0.161,"Striatum: the key area of the dilemma
So one way of resolving the 
chicken-and-egg problem 
might be to say that a brain 
predisposed to effective 
sensorimotor coordination, 
with an active dorsal 
striatum, will have a 
predisposition for gaming, 
while it is the games 
themselves that change the "
pdf_page,MODULE 3_MindChange_part2#page=25,M1-Q20,0.181,"Dopamine as crucial contributor 
• A second way to solve the chicken-eggs problem is to 
consider the dopamine.
• Neuroscientists at Hammersmith Hospital in London 
have shown that playing videogames directly results 
in release of this neurotransmitter.
• Raised levels of dopamine are consistently "
pdf_page,MODULE 3_MindChange_part2#page=26,M1-Q20,0.151,"Arousal of different videogames
• One investigation found different 
patterns of arousal in different 
types of gamers. 
• Those who played excessive 
amounts of first-person shooter 
videogames had significantly 
higher levels of arousal during 
gaming, which dropped off 
immediately after gaming. "
pdf_page,MODULE 3_MindChange_part2#page=27,M4-Q22,0.179,"Arousal of different videogames
• MMORPG (Massive[ly] 
Multiplayer Online Role-Playing 
Game) players who gamed 
excessively displayed significant 
decreases in physiological
arousal, which rose again 
immediately after gaming.
• Meanwhile, MMORPG players 
who didn’tplay excessively
showed normal in"
pdf_page,MODULE 3_MindChange_part2#page=28,M1-Q12,0.184,"Arousal of different videogames vs gambling
• These differences in arousal for gamers are comparable to those 
reported in the scientific literature on pathological gambling.
• There are the thrill-seeking, impulsive addicts who take stimulating 
substances or engage in high-risk behaviors; by contr"
pdf_page,MODULE 3_MindChange_part2#page=29,M1-Q12,0.228,"Chicken and eggs complication applies
these disturbances in arousal regulation could be either a cause 
of gaming addiction
Or a consequence of it
"
pdf_page,MODULE 3_MindChange_part2#page=30,M1-Q20,0.189,"Videogames and rewards
• What finally determines an individual’s level of arousal and whether he or 
she becomes addicted to one or another type of videogame?
• How can we solve the dilemma?
• It is impossible to tease out a cause-and-effect sequence of events as the 
brain interacts with the enviro"
pdf_page,MODULE 3_MindChange_part2#page=31,M1-Q20,0.205,"Videogames and rewards
• MMORPGs have been studied because excessive gaming is most 
commonly seen in MMORPGs
• The reward structure built into the game influences the development 
of excessive gaming
• MMORPGs have intricate reward 
systems built into the games, with 
gamers constantly trying to re"
pdf_page,MODULE 3_MindChange_part2#page=32,M4-Q22,0.181,"Videogames and rewards
• Moreover the social interaction with other players appears to be the 
real extra hook.
• Perhaps the appeal is that the player is now not just playing a game 
but playing out an idealized life that is simultaneously exciting and 
safe, both physically and mentally"
pdf_page,MODULE 3_MindChange_part2#page=33,M4-Q18,0.235,"From free time to aggression
A crucial point related to videogames is related to aggression
"
pdf_page,MODULE 3_MindChange_part2#page=34,M1-Q12,0.249,"Is there a link between aggression and 
videogames?
Violent videogames
Especially “realistic” video games
Increase aggression Increase aggression in real life
??? ???"
pdf_page,MODULE 3_MindChange_part2#page=35,M1-Q20,0.136,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• This study tested the hypothesis that 
violent video games are especially likely 
to increase aggression when players 
identify with violent game characters
• N = 112 Dutch adolescent boys with low 
education ability
• were randomly assigned to play a 
real"
pdf_page,MODULE 3_MindChange_part2#page=36,M4-Q22,0.190,"• After the videogame, participants competed with an ostensible 
(pretended) partner on a reaction time task in which the winner could 
blast the loser with loud noise through headphones, which served as 
the measure of aggression.
• Participants were told, wrongly, that high noise levels could caus"
pdf_page,MODULE 3_MindChange_part2#page=37,M1-Q20,0.166,"→MEASURE OF AGGRESSION
VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
Konijn, E. A., Nije Bijvank, M., and Bushman, B. J. (2007). I wish I were a 
warrior: The role of wishful identification in the effects of violent 
videogames on aggression in adolescent boys. Developmental Psychology 
43, no. 4, 1038–1"
pdf_page,MODULE 3_MindChange_part2#page=38,M4-Q09,0.137,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Craig Anderson, professor and chair of psychology at Iowa State 
University and a leading researcher in the field of videogame 
violence, is concerned that while violent games do not cause 
extreme, criminal-level violent behavior, they do enhance low-level"
pdf_page,MODULE 3_MindChange_part2#page=39,M1-Q20,0.183,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• The problem could be the repetition →since we learn...
• More recently, videogame researcher Douglas Gentile has echoed this 
theme, pointing out that “whatever we practice repeatedly affects 
the brain and if we practice aggressive ways of thinking, feelin"
pdf_page,MODULE 3_MindChange_part2#page=40,M1-Q17,0.149,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• This study investigates the hostile 
expectation bias (i.e., tendency to 
perceive hostile intent on the part of 
others).
• N = 136 French college students
• They played either a violent or 
nonviolent game for 20 minutes.
• Afterwards, they read ambiguous"
pdf_page,MODULE 3_MindChange_part2#page=41,M1-Q20,0.129,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Finally, participants were told that they 
would compete with an opponent 
(actually a confederate) on a 25-trial 
computer game in which they had to 
respond to a visual cue faster than their 
partner, with the loser receiving a noise 
blast through a pair"
pdf_page,MODULE 3_MindChange_part2#page=42,M1-Q20,0.174,"• As hypothesized, video game violence 
increased the hostile expectation bias, 
which, in turn, increased aggression.
• Effects were larger for men than 
women. 
• Thus one reason why violent games 
increase aggression is because they 
increase hostile expectations.
VIDEOGAMES, AGGRESSION,
AND RECK"
pdf_page,MODULE 3_MindChange_part2#page=43,M4-Q15,0.261,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Moreover, these effects seem to 
increase and last for several days. 
"
pdf_page,MODULE 3_MindChange_part2#page=44,M1-Q20,0.185,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• The present study investigates 
whether violent games increase 
aggression by inducing stress in 
players. Stress was measured using 
cardiac coherence, defined as the 
synchronization of the rhythm of 
breathing to the rhythm of the heart.
• Authors predic"
pdf_page,MODULE 3_MindChange_part2#page=45,M1-Q13,0.241,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
"
pdf_page,MODULE 3_MindChange_part2#page=46,M1-Q12,0.150,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
As expected, violent video game players had lower 
cardiac coherence levels and higher aggression levels 
than did nonviolent game players. 
This research offers another possible reason why violent 
games can increase aggression—by inducing stress. 
Cardiac c"
pdf_page,MODULE 3_MindChange_part2#page=47,M1-Q12,0.154,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• The change toward a more aggressive disposition as a result of 
videogames does seem to be a definite global phenomenon across 
different cultures.
• A recent longitudinal study designed to explore the long-term effects 
of violent games on the mentality of"
pdf_page,MODULE 3_MindChange_part2#page=48,M1-Q20,0.141,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Although the systematic study of videogames is relatively new, the 
evidence seems strong for a link between playing videogames and an 
aggressive mindset. The most comprehensive meta-analysis to date 
has drawn on 136 papers detailing 381 independent tests"
pdf_page,MODULE 3_MindChange_part2#page=49,M1-Q20,0.130,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Beyond aggressive behavior toward others, violent videogames clearly do 
have a demonstrable effect on the brain and body. 
• Research has linked violent videogames to changes in the fight-or-flight 
system that has evolved to prepare the body for action by"
pdf_page,MODULE 3_MindChange_part2#page=50,M1-Q20,0.174,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• INTRODUCTION of the STUDY: Past research 
shows that violent video game exposure 
increases aggressive thoughts, angry 
feelings, physiological arousal, aggressive 
behaviors, and decreases helpful behaviors. 
Carnagey et al., (2007). The effect of videogam"
pdf_page,MODULE 3_MindChange_part2#page=51,M4-Q09,0.163,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 257 college students
• Divided in 2 groups: violent or nonviolent video games
• They played video games for 20m
• Next, participants watched a 10-min videotape containing scenes of 
real-life violence while heart rate (HR) and galvanic skin response (GS"
pdf_page,MODULE 3_MindChange_part2#page=52,M1-Q20,0.175,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
Carnagey et al., (2007). The effect of videogame violence on physiological desensitization to real-life violence. Journal of 
Experimental Social Psychology 43, no. 3, 489–496 
Participants who previously played a violent video game had 
lower HR while viewin"
pdf_page,MODULE 3_MindChange_part2#page=53,M4-Q09,0.154,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
Carnagey et al., (2007). The effect of videogame violence on physiological desensitization to real-life violence. Journal of 
Experimental Social Psychology 43, no. 3, 489–496 
Participants who previously played a violent video game had 
lower GSR while viewi"
pdf_page,MODULE 3_MindChange_part2#page=54,M4-Q22,0.179,"General Aggression Model
Carnagey et al., (2007). The effect of videogame violence on physiological desensitization to real-life violence. Journal of 
Experimental Social Psychology 43, no. 3, 489–496 
Aggressive behavior is based on the learning,
activation, and application of aggression-related 
k"
pdf_page,MODULE 3_MindChange_part2#page=55,M4-Q15,0.218,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Playing violent videogames has consequences on our behaviors. What 
about our brain?
behaviors
???"
pdf_page,MODULE 3_MindChange_part2#page=56,M1-Q20,0.146,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 13 experienced gamers (18–26 years; average 14 hrs/week playing
• Watching violent scenes caused a change in activity in certain areas of their brains, and 
specifically one particular area, the rostral anterior cingulate. This area is normally active 
"
pdf_page,MODULE 3_MindChange_part2#page=57,M1-Q12,0.180,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 13 experienced gamers (18–26 years; average 14 hrs/week playing
• Gaming was also correlated with the deactivation of the amygdala, a brain region 
normally linked to emotionally charged memory, such that decreased activity in 
this area would lead to t"
pdf_page,MODULE 3_MindChange_part2#page=58,M1-Q20,0.178,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 13 experienced gamers (18–26 years; average 14 hrs/week playing
• The brains of the gamers were therefore less sensitive and less 
emotionally reactive to discrepant actions, such as sudden violence
Mathiak et al., (2006). Toward brain correlates of nat"
pdf_page,MODULE 3_MindChange_part2#page=59,M4-Q09,0.138,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 13 male research participants 
were observed playing a latest-
generation violent video game 
(Tactical Ops: Assault on Terror). 
Weber et al., (2006). Does playing violent videogames induce aggression? Empirical evidence of a functional magnetic 
reson"
pdf_page,MODULE 3_MindChange_part2#page=60,M1-Q20,0.171,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
Results: 
• Areas of the brain linked with emotion and empathy 
(again the rostral cingulate cortex and the amygdala) 
were less active during violent gaming
• The authors suggest that these areas must be 
suppressed during violent gaming, just as they would "
pdf_page,MODULE 3_MindChange_part2#page=61,M4-Q16,0.203,"From aggression to attention
• Could videogames, given their fast-paced and vivid content, be 
affecting attention in a way that is unprecedented and unique 
compared to all the usual, more muted distractions of real life?
• Contrasting results: both positive and negative results…"
pdf_page,MODULE 3_MindChange_part2#page=62,M4-Q09,0.136,"Videogames and attention
• A sample of 1323 middle childhood participants were assessed during 
a 13-month period by parent- and child-reported television and video 
game exposure as well as teacher-reported attention problems.
• Another sample of 210 late adolescent/early adult participants 
provid"
pdf_page,MODULE 3_MindChange_part2#page=63,M4-Q09,0.169,"Videogames and attention
RESULTS:
1) those who had more than two hours of screen time 
(television and videogames combined) per day were 
more likely to be above the norm in showing attention 
problems. 
2) playing games was linked specifically to a greater risk of 
developing attentional problems, "
pdf_page,MODULE 3_MindChange_part2#page=64,M1-Q20,0.160,"Videogames and attention
• N = 3000 children and adolescents tracked 
over 3 years
RESULTS:
• Children who spent more time gaming had 
more attention problems
• Children who were more impulsive or had 
more attention problems subsequently spent 
more time playing videogames
Gentile et al., (2012). V"
pdf_page,MODULE 3_MindChange_part2#page=65,M4-Q22,0.167,"Something good…
• Research shows that gamers make 
excellent drone pilots, and even 
outperform real pilots on certain 
tasks. 
• In the same spirit, scientists at the 
Duke School of Medicine have 
investigated just how effectively 
skilled gamers might eventually 
become highly proficient drone 
p"
pdf_page,MODULE 3_MindChange_part2#page=66,M4-Q16,0.166,"Something good…
• N = 130 individuals (18–
53 years)
• Divided in 2 groups:
• Action video game 
players
• Non video game players
• Task: identify letters in 
specific positions of the 
screen
Appelbaum et al., (2013). Action videogame playing is associated with improved visual sensitivity, but not "
pdf_page,MODULE 3_MindChange_part2#page=67,M1-Q12,0.197,"• The experienced gamers beat 
their rookie counterparts, 
proving that they could 
respond to visual stimuli 
much more quickly
• “Gamers see the world 
differently. They are able to 
extract more information 
from a visual scene,” 
Appelbaum concludes. “They 
need less information to 
arrive at a "
pdf_page,MODULE 3_MindChange_part2#page=68,M1-Q12,0.128,"Screen and visual attention
• They were interested in whether 
learning could improve performance in 
different tasks other than those on 
which the training was focused
• Subjects were aged between 18 and 23 
years. Divided in 2 groups: 
• 5 experiments: 
• experiment 1–4 included only males 
• in "
pdf_page,MODULE 3_MindChange_part2#page=69,M4-Q07,0.239,"Screen and visual attention
the habitual videogame players (VGPs) 
outperformed the rookies (NVGPs)
"
pdf_page,MODULE 3_MindChange_part2#page=70,M4-Q22,0.173,"Screen and visual attention
• Most significant, however, was that in a 
final experiment (experiment 5) the 
nonplayers who had been subsequently 
trained on an action videogame showed 
a marked improvement that transferred 
to skills well beyond the training task
Green and Bavelier (2003). Action v"
pdf_page,MODULE 3_MindChange_part2#page=71,M1-Q20,0.152,"Screen and visual attention
• The evidence is convincing that games can have beneficial, remedial effects 
over a wide range of impairments, including a reversal of cognitive decline 
in the elderly.
• In one study, the researchers trained older adults in a videogame for a total 
of 23.5 hours. They"
pdf_page,MODULE 3_MindChange_part2#page=72,M1-Q20,0.123,"Screen and visual attention
Playing videogames could also potentially have positive effects on more abstract 
aspects of brain function, such as social development and psychological well-being. 
For example:
1. Ability to see details 
2. Fast processing of fast presented information
3. Improved shor"
pdf_page,MODULE 3_MindChange_part2#page=73,M4-Q07,0.241,"Screen and visual attention
"
pdf_page,MODULE 3_MindChange_part2#page=74,M1-Q20,0.155,"Conclusions on attention
• Selective attention →ability to focus on a specific category of stimuli. 
This attention is driven by motivation and leads to reactive control 
(respond to different stimuli presented in the same time)
• Sustained attention →ability to focus for a prolonged period
This att"
pdf_page,MODULE 3_MindChange_part3#page=1,M3-Q15,0.309,"Summary
• Change of the World: from 3D to 2D
• How our brain works and changes
• Effects of the digital world on identity and relationship
• Effects of the digital world on free time and aggressivity
• Effects of the digital world on memory and learning"
pdf_page,MODULE 3_MindChange_part3#page=2,M1-Q20,0.224,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_page,MODULE 3_MindChange_part3#page=3,M4-Q18,0.200,"Search information
"
pdf_page,MODULE 3_MindChange_part3#page=4,M1-Q20,0.193,"Google effect
• The present research explores 
whether having online access 
to search engines and
databases has become a 
primary transactive memory 
source in itself.
• Authors designed 4 different 
experiments:
EXPERIMENT 1
EXPERIMENT 2
EXPERIMENT 3
EXPERIMENT 4"
pdf_page,MODULE 3_MindChange_part3#page=5,M1-Q17,0.184,"Google effect
EXPERIMENT 1:
• participants were tested in two 
within-subject conditions
• they answered either easy or 
hard yes/no trivia questions in 
two blocks. 
PIZZA
SCREEN
Question: Which is the capital of Karnataka?
Modified Stroop test to text RTs
Answer:  …                                "
pdf_page,MODULE 3_MindChange_part3#page=6,M4-Q16,0.181,"Google effect
EXPERIMENT 1:
• Each block was followed by a 
modified Stroop task to test 
reaction times to matched 
computer (e.g. presentation of 
wards such as “screen”, or 
“google”) and everyday terms.
< RTs for naming the color of interested 
words
PIZZA
SCREEN"
pdf_page,MODULE 3_MindChange_part3#page=7,M1-Q12,0.160,"Google effect
EXPERIMENT 1:
• Paired within-subject t tests were 
conducted on color-naming reaction 
times to computer and general words 
after the easy and difficult question 
blocks.
• RESULTS: computer words were more 
accessible then general words when 
participants had encountered a series 
of"
pdf_page,MODULE 3_MindChange_part3#page=8,M1-Q20,0.170,"Google effect
EXPERIMENT 2:
• Authors tested whether people 
remembered information that 
they expected to have later 
access to 
• Participants had to read 40 
statements. 
• Participants divided in 2 groups:
• Half of them were led to believe 
the statements would be saved and 
available to look u"
pdf_page,MODULE 3_MindChange_part3#page=9,M1-Q20,0.170,"Google effect
EXPERIMENT 2:
• RESULTS: Participants apparently 
did not make the effort to 
remember when they thought 
they could later look up the 
trivia statements they had read. 
• CONCLUSIONS: Because search 
engines are continually available 
to us, we may often be in a state 
of not feeling "
pdf_page,MODULE 3_MindChange_part3#page=10,M1-Q20,0.181,"Google effect
EXPERIMENT 3:
• Authors tested memory for where
to find information that one might 
look up online.
• Participants again red and typed in 
statements, this time in three 
within subject conditions:
1/3 questions →“Your entry 
has been saved in a general folder.”
1/3 questions →“Your en"
pdf_page,MODULE 3_MindChange_part3#page=11,M1-Q12,0.178,"Google effect
EXPERIMENT 3:
• Recognition trial: 
Participants had to judge yes or no 
1) whether the statement they were 
now shown was exactly what they 
had read
2) whether the statement had been 
saved or erased, and finally,
3) if the statement had been saved 
to a folder, which folder it had b"
pdf_page,MODULE 3_MindChange_part3#page=12,M1-Q12,0.185,"Google effect
EXPERIMENT 3:
“Was this statement exactly what you 
read?” 
RESULTS: Participants recognized the 
accuracy of a large proportion of 
statements. But for those statements 
they believed had been erased, 
participants had the best memory.
CONCLUSION: believing that one won’t 
have access"
pdf_page,MODULE 3_MindChange_part3#page=13,M4-Q16,0.176,"Google effect
EXPERIMENT 3:
“Was this statement saved or erased?”
RESULTS: Participants accurately 
remembered what they had saved more 
than they accurately remembered what they 
had erased.
CONCLUSION:  believing the information 
was saved externally enhances memory for 
the fact that the informat"
pdf_page,MODULE 3_MindChange_part3#page=14,M1-Q20,0.168,"Google effect
EXPERIMENT 3:
“If the information was saved, what
folder was it saved into?”
RESULTS: Participants did remember more that the information 
was erased than specifically whether the information was 
generally saved or which folder it was saved into.
CONCLUSION: This result is a reminder "
pdf_page,MODULE 3_MindChange_part3#page=15,M1-Q20,0.205,"Google effect
EXPERIMENT 4: 
• Was conducted to see if 
people would recall “where”
to find information more than 
the information itself (“what”)
• Participants believed all trivia 
statements that they typed 
would be saved into one of 
five generic folders
Statement: The capital of Karnataka is B"
pdf_page,MODULE 3_MindChange_part3#page=16,M1-Q12,0.178,"Google effect
EXPERIMENT 4:
RESULTS: 
• When asked to recall the folder names, 
they did so at greater rates than they 
recalled the trivia statements themselves. 
• A deeper analysis revealed that people do 
not necessarily remember where to find 
certain information when they 
remember what it was"
pdf_page,MODULE 3_MindChange_part3#page=17,M1-Q12,0.251,"• The Internet has become a 
primary form of external or 
transactive memory, where 
information is stored 
collectively outside ourselves.
• Google can “affect” memory… 
which kind of memory?
Google effect
"
pdf_page,MODULE 3_MindChange_part3#page=18,M4-Q05,0.221,"Different memories
• Nondeclarative memory (or implicit or procedural memory)
• Declarative (or explicit) memory
• Episodic
• Semantic
"
pdf_page,MODULE 3_MindChange_part3#page=19,M1-Q12,0.169,"Googling
• Using computer search engines to find information on the Internet 
has become a frequent daily activity of people at any age, including 
middle aged and older adults.
• Cross-sectional, exploratory observational study
• N = 24 (age 55-76)
N = 12 →Net Naive group (minimal search 
engine ex"
pdf_page,MODULE 3_MindChange_part3#page=20,M1-Q12,0.205,"•Task: Patterns of brain activation during functional MRI 
scanning were determined while subjects performed 
1. a novel Internet search task
Googling
2.   or a control task of reading text on a 
computer screen formatted to simulate 
the prototypic layout of a printed book
 Read 
this text"
pdf_page,MODULE 3_MindChange_part3#page=21,M1-Q17,0.187,"While the brains of the two groups 
showed similar patterns of 
activation during the text reading 
task…
Googling
Read 
this text
…the activation patterns were 
markedly different during the 
Internet search task"
pdf_page,MODULE 3_MindChange_part3#page=22,M1-Q20,0.224,"• The brain scans of the Net-naive group 
showed an activation pattern similar to that 
of their text reading task.
• Net-savvy group demonstrated significant 
increases in activity in additional regions 
that control decision making, complex 
reasoning, and vision
• After only five days of spending"
pdf_page,MODULE 3_MindChange_part3#page=23,M1-Q12,0.194,"When we search information we organize facts
Connections 
between facts
Highlight 
concepts
Create 
maps
History
Hyperlinks
Key words
VideosAudio"
pdf_page,MODULE 3_MindChange_part3#page=24,M4-Q16,0.187,"Internet 
exploration
• As a type of hypermedia, the Internet combines graphics, 
audio, video, text and hyperlinks in an interactive and 
nonlinear environment. 
• Users must decide how to find information, what 
information to read, which hyperlinks to followand 
when to modify behaviours. 
• Cons"
pdf_page,MODULE 3_MindChange_part3#page=25,M1-Q17,0.169,"Internet 
exploration
• Researchers have identified that learners with low
domain knowledge, on average, have exhibited little or 
no learning gains after studying from hypermedia 
environments, including the Internet
• In general, attention has been regarded as a major 
influence on the information"
pdf_page,MODULE 3_MindChange_part3#page=26,M1-Q20,0.158,"• Eye-gaze was recorded
• Eye-gaze information was used to 
determine the time spent 
attending to relevant information. 
• Based on the time spent viewing 
relevant look zones the following 
two scores were created: 
(a) the duration of time spent 
within the look-zone during 
the initial visit of "
pdf_page,MODULE 3_MindChange_part3#page=27,M1-Q17,0.191,"Internet 
exploration
• N = 84 undergraduate students with high 
and low levels of sustained attention (65 
females and 19 males, with a mean age 
of 20.46 years)
• Students were tasked with navigating 
the Internet for 20 minutes to learn 
about how tropical cyclones form"
pdf_page,MODULE 3_MindChange_part3#page=28,M1-Q12,0.215,"• Students with high level of attention →more frequently guided their 
learning in a linear manner, alternating between search engine results 
and first links. Rarely did these learners select hyperlinks presented 
on the links themselves, and it was these students who performed 
better on the test
"
pdf_page,MODULE 3_MindChange_part3#page=29,M1-Q12,0.166,"• Learners with low levels of sustained attention →typically took advantage 
of the opportunity to jump around between sources of information. While 
they alternated between search engine results and first links, the low-
attending learners engaged in far more exploration of the hyperlinks 
presente"
pdf_page,MODULE 3_MindChange_part3#page=30,M1-Q20,0.189,"Internet exploration 
and generations 
• Such variations in 
performance can be even 
more marked when we look 
across age groups
Google generation
(born after 1993)
Generation Y
(1973<born<1994)
Generation X
(born before 1973)
→Younger generations were faster but less confident about 
the answers"
pdf_page,MODULE 3_MindChange_part3#page=31,M4-Q15,0.203,"Reading
from books to 
screens
 Read 
this text"
pdf_page,MODULE 3_MindChange_part3#page=32,M4-Q16,0.182,"Readings
• The authors explored 
effects of the 
technological interface 
on reading 
comprehension in a 
Norwegian school 
context
• N = 72 tenth graders from 
2 different primary 
schools in Norway.
• Students randomized into 2 groups:
Read 
this text
Read the same text as pdf 
on a computer scree"
pdf_page,MODULE 3_MindChange_part3#page=33,M1-Q12,0.180,"Readings
• Regression analysis was 
carried out to investigate to 
what extent reading 
modality would influence 
the students’ scores on the 
reading comprehension 
measure
• RESULTS: students who 
read texts in print scored 
better on the reading 
comprehension test
• Pedagogical implications?
"
pdf_page,MODULE 3_MindChange_part3#page=34,M4-Q16,0.198,"Readings
• This paper aims to assess the 
usability of electronic books (e-
books) and paper books (p-
books) with objective measures, 
including user comprehension, 
eye fatigue, and perception
• N = 56 sixth-year public school 
students participated in this 
study
"
pdf_page,MODULE 3_MindChange_part3#page=35,M1-Q20,0.187,"Readings
• Eye fatigue →Participants’ eye fatigues were measured by critical 
flicker/fusion frequency (CFF) threshold. 
• CFF is defined as the frequency at which a flickering light is in 
distinguishable from steady, non-flickering light
• CFF is widely used as highly sensitive measurement to eval"
pdf_page,MODULE 3_MindChange_part3#page=36,M4-Q22,0.214,"Readings
This paper was conducted in the 
following order: 
1) pre-CFF measurement, 
2) p-/e-book reading,
3) post-CFF measurement, 
4) quiz and questionnaire. 
5) exit
"
pdf_page,MODULE 3_MindChange_part3#page=37,M1-Q12,0.169,"Readings
RESULTS: 
1) there is a significant “book 
effect” on quiz scores →
compared to e-books, p-books 
appear to enable better 
reading comprehension
2) Regarding eye fatigue, students 
had significantly greater eye 
fatigue after reading e-books 
than after reading p-books. 
3) Students were sa"
pdf_page,MODULE 3_MindChange_part3#page=38,M4-Q16,0.186,"Multitasking
• A distinguishing feature of 
digital technology is the 
temptation and opportunity it 
offers for multitasking
• In a survey of two thousand children between the ages of eight and 
eighteen, the time spent multitasking between more than one 
technology medium in 1999 was 16 percent bu"
pdf_page,MODULE 3_MindChange_part3#page=39,M4-Q16,0.153,"Multitasking
• In a survey of U.S. college 
students, 38 percent said they 
could not go for more than ten 
minutes while studying without 
checking their laptop, 
smartphone, tablet, or e-reader
• Since media multitasking involves, by definition, shifting attention 
between multiple sources, much r"
pdf_page,MODULE 3_MindChange_part3#page=40,M4-Q09,0.187,"Multitasking
• Chronic media multitasking is quickly becoming ubiquitous, 
although processing multiple incoming streams of information is 
considered a challenge for human cognition. 
• A series of experiments addressed whether there are 
systematic differences in information processing styles betw"
pdf_page,MODULE 3_MindChange_part3#page=41,M1-Q20,0.160,"Multitasking
• A trait media multitasking index was developed to identify 
groups of heavy and light media multitaskers. 
• The questionnaire addressed 12 different media forms: 
print media, television, computer-based video (such as 
YouTube or online television episodes), music, nonmusic
audio, vi"
pdf_page,MODULE 3_MindChange_part3#page=42,M1-Q20,0.177,"• The goal was to examine whether there is a relationship between 
chronic media multitasking and cognitive control abilities.
• Different hypothesis →
Multitasking
Positive
Light media multitaskers exhibit 
advantages in cognitive control 
This result would motivate future work to 
establish whethe"
pdf_page,MODULE 3_MindChange_part3#page=43,M4-Q22,0.220,"• Three tests in the study involved the subjects looking at shapes, 
numbers, or letters, but the task was to remember something about 
just some of the images on the screen and to ignore the others.
Multitasking
FILTERING TASK, example for shapes"
pdf_page,MODULE 3_MindChange_part3#page=44,M4-Q22,0.191,"Multitasking
RESULTS: 
Heavy media multitaskers are more 
susceptible to interference from irrelevant 
environmental stimuli
CONCLUSIONS:
the high multitaskers seemed unable to 
ignore the shapes they were told to ignore, 
and were unable to filter out what wasn’t 
important to that particular task."
pdf_page,MODULE 4_1_Neuro_mech-1#page=1,M4-Q05,0.304,"Placebo, nocebo and 
contextual factors:
history, research and clinical practice"
pdf_page,MODULE 4_1_Neuro_mech-1#page=2,M4-Q22,0.288,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_page,MODULE 4_1_Neuro_mech-1#page=3,M1-Q17,0.179,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_page,MODULE 4_1_Neuro_mech-1#page=4,M1-Q20,0.164,"ISCHEMIC PAIN
DAY1   DAY2    DAY3   DAY4    DAY5
15
20
25
30
MOR MOR PLA
+
NAL
Pain tolerance
(minutes)
NALOXONE
 antagonist
OPIOIDS
Placebo analgesia: Study on 
Ischemic Pain 
(Amanzio & Benedetti J Neurosci 1999; 19:484-94
Benedetti et al. J Neurosci  2007; 27:11934-9)
• Day 1 (baseline): no trea"
pdf_page,MODULE 4_1_Neuro_mech-1#page=5,M1-Q20,0.155,"HOT PLATE TEST
Guo et al. (2010) J. Psychopharmacol. 24: 1561-1567
Drug  (US) + blue light (CS)
OPIOIDS
paw
withdrawal
latency
(seconds)
DAY1   DAY2  DAY3 DAY4 DAY5
15
30
MOR MOR PLAMOR MOR
+
NAL
45
MICE
Placebo analgesia: Animal Study (Mice) 
• Mice reveived morphine paired with blue light 
(condit"
pdf_page,MODULE 4_1_Neuro_mech-1#page=6,M4-Q22,0.131,"Benedetti et al. Lancet, 1995; 346:1231. Benedetti et al. Psychopharmacol 2011; 213:791-7
PENTAGASTRIN (CCK agonist) 
MOR MORPLA + PENTAGASTRIN
15
20
25
30
DAY1   DAY2   DAY3   DAY4   DAY5
Pain tolerance
(minutes)
PROGLUMIDE (CCK antagonist)
CCK  (ANTI-OPIOIDS)
3
Proglumide
Placebo
Control
time
10
9"
pdf_page,MODULE 4_1_Neuro_mech-1#page=7,M4-Q22,0.135,"Amanzio & Benedetti J Neurosci 1999;19:484-94 Benedetti et al. Nature Med 2011;17:12828-30
DAY1    DAY2    DAY3    DAY4    DAY5
10
15
20
KET KET PLA + RIM
Pain tolerance
(minutes)
CANNABINOIDS
25
20
+
NAL
DAY1   DAY2   DAY3  DAY4   DAY5
15
Pain tolerance
(minutes)
KET KET PLA
Activation of 
CB1 rece"
pdf_page,MODULE 4_1_Neuro_mech-1#page=8,M1-Q20,0.166,"Placebo analgesia depends on the 
neurotransmitter system engaged during 
preconditioning
• If preconditioned with opioids → blocked with naloxone 
• If preconditioned with cannabinoids → blocked by rimonabant 
→ Past experiences, expectations, and psychosocial context can 
trigger analgesia via the"
pdf_page,MODULE 4_1_Neuro_mech-1#page=9,M4-Q09,0.181,"Psychosocial context
Expectation
Previous experiences 
Benedetti et al. (2011) Nature Med, 17: 1228-1230
CB1
cannabinoid
receptor
 opioid
receptor
Analgesia
Previous exposure
to opioids () 
Previous exposure
to NSAIDs (CB1) 
Memory
ON
Memory
ON
and
 and
"
pdf_page,MODULE 4_1_Neuro_mech-1#page=10,M4-Q22,0.130,"Amanzio & Benedetti J Neurosci 1999 
Benedetti et al. J Neurosci  2007
Benedetti et al. Lancet, 1995
Benedetti et al. Psychopharmacol, 2011
Benedetti et al. Nature Med 2011
Kessner et al., Jama, 2013
CCK
SYSTEM
Nocebo
HYPERALGESIA
Block by anti-CCK 
drugs (e.g. proglumide)
Placebo
OPIOID 
SYSTEM
Opp"
pdf_page,MODULE 4_1_Neuro_mech-1#page=11,M4-Q18,0.266,"Placebo effect and PAIN
• Behavioral Studies
• Pharmacological studies
• Neuroimaging studies
- PET-fMRI
-EEG"
pdf_page,MODULE 4_1_Neuro_mech-1#page=12,M1-Q20,0.197,"Wager et al. 2004 Science 303: 1162-1167.
Zubieta et al. 2005 J. Neurosci. 25: 7754 –7762.Watson et al. 2009 Pain 145: 24-30.
DLPFC
Petrovic et al. 2002 Science 295: 1737-1740.
ACC
Opioid-induced analgesia and placebo analgesia activate the same 
brain areas
PET  AND  fMRI STUDIES
Increased activity"
pdf_page,MODULE 4_1_Neuro_mech-1#page=13,M4-Q22,0.177,"Role of DLPFC in 
Placebo Analgesia 
Key Points:
• Maintains the “placebo effect”: helps sustain the expectation of 
analgesia.
• Reduces pain perception: even when the actual pain intensity is the 
same as baseline.
• Consolidates priors: triggers endogenous analgesic mechanisms 
based on prior dru"
pdf_page,MODULE 4_1_Neuro_mech-1#page=14,M1-Q20,0.259,"Amanzio, Benedetti et al (2011) Hum Brain Mapp
Placebo - Expectation Pain perception (pain matrix)
Activation
Inhibition
DLPFC
rACC
(Rostral Cingulate 
Anterior Cortex)
PAG
(Periaqueductal 
Gray)
Putamen
Insula
Caudate
Thalamus
pCC
(Posterior cingulate 
Cortex)"
pdf_page,MODULE 4_1_Neuro_mech-1#page=15,M4-Q22,0.276,"Krummenacher et al. 2010 Pain 148: 368-374
If the prefrontal area (DLPFC) is inactivated, 
placebo effect is abolished
Analgesia 
expectation
Analgesia 
expectation"
pdf_page,MODULE 4_1_Neuro_mech-1#page=16,M1-Q17,0.229,"Stein et al (2012) Pain 153: 2210-2217
The matter integrity
by fractional anisotropy
in normal subjects
Lower frontal integrity corresponds to a lower 
placebo response"
pdf_page,MODULE 4_1_Neuro_mech-1#page=17,M1-Q12,0.160,"All participants received remifentanil, at a fixed dose. 
The study aimed to test how expectations modulate the effect of a real drug: 
1. No expectancy: patients received remifentanil without knowing its effect
2. Positive expectancy: participants received remifentanil and, therefore they 
expected"
pdf_page,MODULE 4_1_Neuro_mech-1#page=18,M1-Q20,0.197,"Bingel et al. 2011 Science Trans Med, 3: 70ra14
Gollub  and Kong, 2011 Science Trans Med Com
OPEN ADMINISTRATION: 
• Expecting pain relief enhances 
opioid analgesia 
• Brain activity increases in: 
• Dorsolateral prefrontal 
cortex (DLPFC) 
• ACC (anterior cingulate cortex) 
• Striatum (Caudate, pu"
pdf_page,MODULE 4_1_Neuro_mech-1#page=19,M4-Q18,0.266,"Placebo effect and PAIN
• Behavioral Studies
• Pharmacological studies
• Neuroimaging studies
- PET-fMRI
- EEG"
pdf_page,MODULE 4_1_Neuro_mech-1#page=20,M4-Q07,0.185,"Placebo and Event Related Potentials 
(ERPs)
• STUDY 1: LEP
(Laser-Evoked 
Potentials)
• STUDY 2: CNV
(Contingent Negative 
Variation)
EEG
early nociceptive 
processes
anticipation phase 
during pain-task
"
pdf_page,MODULE 4_1_Neuro_mech-1#page=21,M1-Q20,0.186,"Colloca et al. Pain 139 (2009) 306-314
Wager et al. Brain, Behav Imm 20 (2006) 219-230
Watson et al Pain 126 (2006) 115-122
DECREASE IN N2-P2 
complex during placebo 
analgesia
The N2–P2 complex is a component of laser-
evoked potentials (LEPs) that reflects cortical 
processing of painful stimuli, "
pdf_page,MODULE 4_1_Neuro_mech-1#page=22,M1-Q20,0.185,"?
?
ACQUISITION
+
̶
EVALUATION
LESS PAIN
MORE PAIN
< INTENSITY
> INTENSITY +
̶
= INTENSITY
COND + NO VER 
groupCOND + VER group
Carlino et al., EJP, 2015
CONDITIONED ANALGESIA AND THE ROLE OF VERBAL 
INFORMATION
Two conditioning blocks: one cue 
paired with increased pain and the 
other with decreas"
pdf_page,MODULE 4_1_Neuro_mech-1#page=23,M1-Q20,0.162,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_page,MODULE 4_1_Neuro_mech-1#page=24,M1-Q20,0.160,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_page,MODULE 4_1_Neuro_mech-1#page=25,M4-Q22,0.142,"Another study investigates how expectations modulate pain, underlying placebo 
hypoalgesia and nocebo hyperalgesia. 
It is novel in using the Contingent Negative Variation (CNV), an electrophysiological 
marker of cognitive anticipation and motor preparation, to separate sensory and 
motor component"
pdf_page,MODULE 4_1_Neuro_mech-1#page=26,M4-Q22,0.178,"Reaction time recording
Electrical 
shocks
EEG recording
Cue’s 
presentation
ACQUISITION
EVOCATION
COND group
warning
imperative
Piedimonte et al., 2017
Green cue → expected pain reduction (placebo) 
Red cue → expected pain increase (nocebo) 
Measures: 
• RT: reaction time to stop the stimulus 
(if "
pdf_page,MODULE 4_1_Neuro_mech-1#page=27,M4-Q22,0.115,"Se rosso mi aspetto ‘preparazione’ maggiore per stoppare lo stimolo (onda più gonfia)
Se stimoli rosso e verde stessa intensità → se ti ho condizionato dopo il rosso ti prepari a schivare 
come fosse intenso come prima. 
A livello comportamentale i rossi sono più alti dei verdi, invece i tempi di re"
pdf_page,MODULE 4_1_Neuro_mech-1#page=28,M1-Q17,0.179,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System 
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_page,MODULE 4_1_Neuro_mech-1#page=29,M4-Q18,0.304,"MOTOR 
SYSTEM
Placebo effect
(caffeine drink)
Nocebo effect
(sham stimulation)
"
pdf_page,MODULE 4_1_Neuro_mech-1#page=30,M4-Q16,0.148,"PROTOCOL 1:
Expectation 
alone
SESSION 1
Baseline
SESSION 2
Evaluation
PROTOCOL 2:
Expectation + 
conditioning
SESSION 1
Baseline
SESSION 4
Evaluation
SESSION 2 and SESSION 3
Conditioning + Expectation
load to lift
Subjects performed different leg extension 
sessions, to exhaustion, in different day"
pdf_page,MODULE 4_1_Neuro_mech-1#page=31,M4-Q22,0.165,"0,0
1,0
2,0
3,0
4,0
5,0
6,0
7,0
1 2
Work (kJ)
sessions
control
0,0
1,0
2,0
3,0
4,0
5,0
6,0
7,0
1 2
Work (kJ)
sessions
placebo
A
B
p = 0.029
6
8
10
12
14
16
18
20
0 3 6 9 12 15
RPE
extensions
session 1
session 2
6
8
10
12
14
16
18
20
0 3 6 9 12 15
RPE
extensions
session 1
session 2
More work done and"
pdf_page,MODULE 4_1_Neuro_mech-1#page=32,M4-Q22,0.152,"0,0
1,0
2,0
3,0
4,0
5,0
6,0
7,0
1 2 3 4
Work (kJ)
sessions
control
0,0
1,0
2,0
3,0
4,0
5,0
6,0
7,0
1 2 3 4
Work (kJ)
sessions
placebo
p = 0.011
6
8
10
12
14
16
18
20
0 3 6 9 12 15
RPE
extensions
session 1 (baseline)
session 2 (conditioning)
session 3 (conditioning)
session 4 (placebo)
6
8
10
12
14
1"
pdf_page,MODULE 4_1_Neuro_mech-1#page=33,M4-Q22,0.218,"Expectation protocol → patients showed partial 
improvements: they could do more repetitions, but their fatigue 
level did not change.
Conditioning protocol → there was a clear improvement by 
session 4 (final phase), both in subjective (RPE) and 
objective (rep) measures
CONCLUSION
• The placebo ef"
pdf_page,MODULE 4_1_Neuro_mech-1#page=34,M1-Q20,0.162,"1
2
3
4
5
6
7
8
9
S-1 S-2
Work (Kj)
Sessions
Control
1
2
3
4
5
6
7
8
9
S-1 S-2
Work (Kj)
Sessions
Nocebo
6
8
10
12
14
16
18
20
0 3 6 9 12 15 18 21
RPE
Extentions
Control
Baseline
Evaluation
6
8
10
12
14
16
18
20
0 3 6 9 12 15 18 21
RPE
Extentions
Nocebo
Baseline
Evaluation
Pollo et al., 2010
Improve"
pdf_page,MODULE 4_1_Neuro_mech-1#page=35,M1-Q20,0.147,"0
2
4
6
8
1 2 3 4
Work (KJ)
Sessions
Control
0
2
4
6
8
1 2 3 4
Work (KJ)
Sessions
Nocebo
6
8
10
12
14
16
18
20
0 3 6 9 12 15
RPE
Extensions
Control
Baseline
Conditioning + Expectation 1
Conditioning + Expectation 2
Evaluation
6
8
10
12
14
16
18
20
0 3 6 9 12
RPE
Extensions
Nocebo
Baseline
Conditioni"
pdf_page,MODULE 4_1_Neuro_mech-1#page=36,M1-Q12,0.224,"CONCLUSIONS
• The nocebo effect acts on the motor system in 
""physiological"" conditions.
• Expectation alone produces a worsening of 
performance even without preconditioning"
pdf_page,MODULE 4_1_Neuro_mech-1#page=37,M4-Q22,0.169,"First series
(10-min, 60 movements)  
Second series
(10-min, 60 movements)  
Third series
(10-min, 60 movements)  
CONTROL GROUP
PLACEBO  GROUP
A)
B)
administration         → expected effect →“in ten minutes it will 
be effective”
grip handleload
First series
(10-min, 60 movements)  
Second series
("
pdf_page,MODULE 4_1_Neuro_mech-1#page=38,M4-Q18,0.179,"0,00
2,00
4,00
6,00
8,00
10,00
CONTROL GROUP                                PLACEBO GROUP              
***
FIRST               SECOND               THIRD                         FIRST                SECOND              THIRD
SERIES               SERIES SERIES SERIES SERIES SERIES
expected effect
**"
pdf_page,MODULE 4_1_Neuro_mech-1#page=39,M1-Q20,0.122,"C3 Cz C4 
CONTROL  GROUPPLACEBO  GROUP
A)
B)
FIG. 3 AREA (uVs) Amp  (uV)
**
***
**
***
**
**
 **
***
**
First series Second series Third series
-2000    -1500   - 1000   -500         0 
Time windows (ms)
4
3
2
1
0
- 12
- 6
0
-2000    -1500   - 1000   -500        0 
Time windows (ms)
4
3
2
1
0
- 12
-"
pdf_page,MODULE 4_1_Neuro_mech-1#page=40,M1-Q20,0.142,"Conclusions
Inhibitory systemFacilitatory system
•Motor cortex
•Orbitofrontal cortex
•Prefrontal cortex
•Anterior Cingulate cortex
•Limbic system
•Thalamus
•Basal ganglia
•Motor cortex
•Anterior Cingulate cortex
•Medial and posterior insular 
cortex
•Secondary somatosensory cortex
•Thalamus
•Spinal "
pdf_page,MODULE 4_1_Neuro_mech-1#page=41,M1-Q17,0.179,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System 
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_page,MODULE 4_1_Neuro_mech-1#page=42,M1-Q20,0.156,"Goebel et al. (2002) FASEB J. 16: 1869-1873.
ACQUISITION EVOCATION
IMMUNOSUPPRESSION
• Participants received a novel-
tasting beverage paired with the 
immunosuppressive drug 
Cyclosporine A.
• Cyclosporine A normally reduces 
interleukins and interferon-gamma 
levels.
• After administration, in the"
pdf_page,MODULE 4_1_Neuro_mech-1#page=43,M4-Q09,0.205,"Goebel et al. (2002) FASEB J. 16: 1869-1873.
Strawberry 
milk
Cyclosporin A
(immunosuppressant:
reduction of interleukin-2 and interferon)
Placebo
Strawberry 
milk
CONDITIONED GROUP
ACQUISITION EVOCATION
Control group
Conditioned group
Drug group
IMMUNOSUPPRESSION"
pdf_page,MODULE 4_1_Neuro_mech-1#page=44,M4-Q09,0.169,"Water group (water + placebo):
- decreased the subjective symptoms
- attenuated the effects of the skin prick 
test for histamine
Placebo group (novel-tasting drink + 
placebo):
- decreased the subjective symptoms
- attenuated the effects of the skin prick 
test for histamine
- Reduced basophil acti"
pdf_page,MODULE 4_1_Neuro_mech-1#page=45,M4-Q18,0.258,"HORMONAL CHANGES
• Plasma GH 
concentration
• Expectancy does not 
vary GH 
concentration
• Placebo mimics the 
effect of 
sumatriptan (> GH)
Benedetti et al., 2003"
pdf_page,MODULE 4_1_Neuro_mech-1#page=46,M4-Q18,0.254,"HORMONAL CHANGES
• Plasma cortisol 
concentration
• Expectancy does not 
vary cortisol 
concentration
• Placebo mimics the 
effect of sumatriptan 
(< cortisol)
Benedetti et al., 2003
"
pdf_page,MODULE 4_1_Neuro_mech-1#page=47,M1-Q17,0.179,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System 
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_page,MODULE 4_1_Neuro_mech-1#page=48,M1-Q17,0.162,"Parkinson’s Disease (PD)
Bradykinesia
Tremor at 
rest
Rigidity
Postural instability
Freezing
Symptoms due to dopaminergic 
impairment at the level of the 
substance nigra and striatum 
(putamen and caudate):
- From initial nigrostriatal 
degeneration
- Possible degeneration of 
several dopaminergic "
pdf_page,MODULE 4_1_Neuro_mech-1#page=49,M4-Q22,0.126,"PD Treatments
• Drug treatment: L-Dopa
Levodopa, a dopamine precursor, is converted into dopamine by the enzyme dopa-
decarboxylase in dopaminergic neurons. The main problem is that only a small 
fraction (~5–10%) actually reaches the target neurons in the brain that control motor 
symptoms. The res"
pdf_page,MODULE 4_1_Neuro_mech-1#page=50,M4-Q16,0.306,"Placebo effect and PD
• Clinical trials
• Behavioral Studies
• Neuroimaging studies
– PET
– Single neuron recordings
– EEG"
pdf_page,MODULE 4_1_Neuro_mech-1#page=51,M4-Q22,0.190,"Improvements in RCTs
• Improvement in parkinsonian 
symptoms in the placebo 
group in several clinical trials 
(pharmacological and 
surgigical)
Goetz et al., (2002, 2008)
• Pharmacological: placebo vs 
sarizotan comparison 
(serotonergic action) on 
dyskinesias (involuntary 
movements)
• Surgical: "
pdf_page,MODULE 4_1_Neuro_mech-1#page=52,M1-Q12,0.241,"• Surgical trial (McRae et al., 2004):
• No difference between real intervention and placebo 
(""effectiveness of transplantation of human embryonic 
dopamine neurons"")
• Difference based on patient perception:
– Patients who thought they had undergone the real surgery had 
a benefit up to 12 months "
pdf_page,MODULE 4_1_Neuro_mech-1#page=53,M4-Q16,0.190,"• In certain clinical trials, such as those testing surgical 
treatments like embryonic dopaminergic neuron 
transplants, the observed improvement often came from 
the patient’s belief that they were in the treatment group, 
rather than the treatment itself. 
• There was no real difference between t"
pdf_page,MODULE 4_1_Neuro_mech-1#page=54,M4-Q22,0.203,"Improvement in behavioral studies
• The expectation of clinical improvement plays a crucial role
• Typical experimental situation: placebo is administered 
giving the patient positive expectations of improvement
• Bradykinesia is the symptom more sensitive to positive 
expectations, compared to trem"
pdf_page,MODULE 4_1_Neuro_mech-1#page=55,M4-Q09,0.157,"Patients were divided into two 
verbal suggestion groups:
• “Bad” condition: told they 
would perform poorly
• “Good” condition: told they 
would perform well
They were also told that DBS 
would not affect their 
performance. 
Results showed that verbal 
instructions alone could worsen 
or improve m"
pdf_page,MODULE 4_1_Neuro_mech-1#page=56,M4-Q09,0.224,"Pollo et al., 2002; Benedetti et al., 2003
Improvement in behavioral studies"
pdf_page,MODULE 4_1_Neuro_mech-1#page=57,M1-Q20,0.186,"Improvement in PET studies
• First PET study using raclopride
• Raclopride: radiotracer that binds to D2 
and D3, competing with endogenous 
dopamine
• PD patients: knew they could receive 
placebo or apomorphine
De la Fuente-Fernandez et al.  Science  2001"
pdf_page,MODULE 4_1_Neuro_mech-1#page=58,M1-Q17,0.184,"De la Fuente-Fernandez et al.  Science  2001
200% increase in
dopamine =
One dose of
amphetamine
Release of 
endogenous 
dopamine at the 
level of the striatum 
in PD.
Improvement in PET studies
Raclopride binding decreased because endogenous 
dopamine increased, showing that placebo induced 
dopami"
pdf_page,MODULE 4_1_Neuro_mech-1#page=59,M4-Q16,0.208,"• All patients showed a dopamine release BUT 
only half also reported clinical improvement
• These patients (clinically improved): 
increased release of dopamine at the level of 
the dorsal striatum.
De la Fuente-Fernandez et al.  Science  2001
Improvement in PET studies"
pdf_page,MODULE 4_1_Neuro_mech-1#page=60,M1-Q20,0.209,"Improvement in PET studies
• Clinical improvement associated with →
dorsal striatum (caudate and putamen)
• Expectation of beneficial associated with→
ventral striatum (accumbens)"
pdf_page,MODULE 4_1_Neuro_mech-1#page=61,M1-Q20,0.215,"• Double-blind study
• During DBS surgery
• Placebo administered in the operating room 
after several days of preconditioning with 
apomorphine
Improvements in single-neuron 
studies
Benedetti,   Nature Neurosci  2004
"
pdf_page,MODULE 4_1_Neuro_mech-1#page=62,M4-Q22,0.193,"Basal Recording
of the subthalamic nucleus
Experimental registration
of the subthalamic nucleus
placebo
Improvements in single-neuron 
studies
PLACEBO EFFECT
• Reduction of wrist rigidity between pre- and post-treatment
• Increase in the firing rate of the thalamus (in the inhibitory circuit 
of the"
pdf_page,MODULE 4_1_Neuro_mech-1#page=63,M1-Q20,0.229,"• Extension of previous study
• During DBS surgery
• Analysis of thalamic nuclei (VA, anterior 
ventral and anterior ventral lateral VLA) and 
substance nigra
Improvements in single-neuron 
studies
Benedetti,   J Physiol  2009
"
pdf_page,MODULE 4_1_Neuro_mech-1#page=64,M1-Q20,0.207,"Placebo responder: reduction of 
firing rate in the STN associated with 
reduction in the substance nigra and 
increase in the thalamic nuclei
Placebo non-responder
+ +
- -
+ +
increasedecrease
pre –post 
pre
Neuronal firing rate (Hz)
STN
SNr
Th
STN"
pdf_page,MODULE 4_1_Neuro_mech-1#page=65,M4-Q09,0.219,"• N = 42 PD patients (DBS)
• 6 experimental groups
• OUTCOMES:
– Single Neuron Recording (Thalamus)
– Wrist rigidity
Benedetti et al., J Physiol, 2016
Improvements in single-neuron 
studies"
pdf_page,MODULE 4_1_Neuro_mech-1#page=66,M1-Q20,0.129,"This study showed that thalamic activity changes
observed during surgery persisted into the next day and 
depended on how many apomorphine preconditioning 
sessions patients had received.
•Control group: no intervention or placebo → no changes in thalamic 
activity or rigidity.
•Placebo 0: only expe"
pdf_page,MODULE 4_1_Neuro_mech-1#page=67,M4-Q19,0.193,EXPERIMENTAL GROUPS
pdf_page,MODULE 4_1_Neuro_mech-1#page=68,M1-Q20,0.228,"EEG STUDY
It’s my 
standard dose 
of L-dopa
DECEIVE
= HALF DOSE
HALF
= HALF DOSE 
FULL
= FULL DOSE 
It’s my 
standard dose 
of L-dopa
It’s the 50% 
of my dose of 
L-dopa
Carlino et al., Parkinsonisms, 2019"
pdf_page,MODULE 4_1_Neuro_mech-1#page=69,M1-Q20,0.164,"Medication-off condition           Medication-on condition                    
UPDRS
1. Full group (get full dose, told full dose)
2. Half group (get half dose, told half dose)
3. Deceit group (get half dose, told full dose)
Number of 
flexions
Rate of perceived 
exertion
EEG recording
Readiness Pot"
pdf_page,MODULE 4_1_Neuro_mech-1#page=70,M4-Q16,0.219,"0
20
40
60
80
100
-50
0
50
100
% improvement
**
*
Full  Deceit  Half  
% improvement
**
*
Full  Deceit  Half  
UPDRS
(part III)
-50
0
50
100% improvement
***
***
Full  Deceit  Half  
Fatigue
EEG STUDY
Results showed a large difference
between the two half-dose groups: 
those who believedthey receive"
pdf_page,MODULE 4_1_Neuro_mech-1#page=71,M4-Q16,0.225,"Conclusion
Patients’ expectations about treatment can 
significantly enhance its clinical efficacy, even 
when the actual dose is lower."
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=1,M1-Q20,0.185,"Before starting…
If you are interested in taking part in some of our research studies, 
please scan the QR code and fill out the form. 
A member of our research team will get in touch with you (there is no obligation 
to participate if our free slots are not compatible with your schedule).
https://f"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=2,M4-Q22,0.192,"Your next presentation: 
On Thursday (6th November)
Main topics : 
How the doctor-patient relationship shapes the brain
or/and 
How context modulates neural processes
Key words: Contextual factors, Placebo and nocebo 
mechanisms, Neurobiology of trust, Neuroplasticity in 
clinical interaction 
You w"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=3,M4-Q05,0.261,"Placebo, nocebo and 
contextual factors: 
HOW DOES CONTEXT CHANGES OUR BRAIN?
History, research and clinical practice "
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=4,M4-Q22,0.267,"THEORETICAL SUMMARY
• Definitions
• Psychological mechanisms that activate placebo and nocebo effects
• Physiological mechanisms that activate placebo and nocebo effects
• From theory to clinical practice and ethics"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=5,M4-Q22,0.217,"Pharmacological Treatment
masculine noun
A substance capable of causing functional changes in the body by 
means of a chemical or physical action
"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=6,M1-Q17,0.204,"PHARMACOLOGICAL 
TREATMENT
• molecule introduced into the body
• has certain biochemical actions
• has certain biological effects
ex. morphine
pain
μ
μ
First analgesic pathway
Second analgesic pathway"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=7,M4-Q22,0.186,"PHARMACOLOGICAL 
TREATMENT 
• Pharmacodynamics: study of the 
biochemical and physiological 
effects of drugs on the body, and 
their mechanism of action
• Pharmacokinetics:  study of the 
effects that the body's processes 
have on the drug (absorption, 
distribution, metabolism, 
elimination)
pharm"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=8,M4-Q22,0.208,"From pharmacological treatments to other 
treatments
Pharmacological 
treatment 
Surgical 
treatment
Manual therapies
Psychotherapy
"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=9,M4-Q18,0.246,"HOW CAN WE SAY THAT A TREATMENT 
IS EFFECTIVE?
?"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=10,M4-Q07,0.221,"DEFINITIONS
placebo
/pla·cè·bo/
masculine noun
Inert substance, with no specific effects
??
? ? ?
?
?
PLACEBO ?
? ?"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=11,M4-Q22,0.280,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how placebo effect works
• In clinical practice → the aim is to INCREASE the placebo effect
"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=12,M4-Q22,0.307,"PLACEBO in modern science: 3 contexts
• In clinical trials→ the aim is to REDUCE the placebo effect
Placebo administered to quantify the efficacy of an active 
treatment
"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=13,M4-Q16,0.280,"PLACEBO in modern science: 3 contexts
• In clinical trials → REDUCE
PLACEBO
Efficacy"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=14,M4-Q16,0.200,"PLACEBO IN CLINICAL TRIALS
Placebo in modern science: distinguishing 3 contexts
• In clinical trials
→Placebo as a control treatment to evaluate the efficacy of an active treatment
→THE GOAL IS TO FIND TREATMENTS WITH SUPERIOR EFFICACY  
COMPARING TO PLACEBO
"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=15,M4-Q16,0.251,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm)
time
pain
Treatment 
administration
PAIN CONDITION
With the active treatment the 
pain decreases over time"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=16,M4-Q16,0.235,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(flat line)
In this case, is the drug more 
effective than placebo in reducing 
pain?
Time
pain
Treatment 
administration
PAIN CONDITION
Pain remains the same 
over time"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=17,M4-Q16,0.251,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(sine wave)
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Treatment 
administration
PAIN CONDITION"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=18,M4-Q16,0.234,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Administration
treatment
PAIN CONDITION
Both active treatment and 
placebo lead to a decrease of 
pain over t"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=19,M1-Q20,0.201,"FACTORS THAT LEAD TO IMPROVEMENT
When we administer a treatment, this treatment can lead to an 
improvement due to several factors:
1) Specific factors→related to the treatment→active principle 
2) Methodological factors
3) Non-specific factors
1 +/* 2 +/* 3
time
pain
Treatment efficacyActive princi"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=20,M1-Q20,0.194,"METHODOLOGICAL FACTORS: 
NATURAL REMISSION
• Natural remission: happens in a lot of conditions (e.g. Anxiety, 
Depression, Headache...) that have spontaneous fluctuations (natural 
history of a disease, a symptom).
• Natural remission →natural course of a symptom, of a disease, in 
the absence of sp"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=21,M4-Q22,0.169,"METHODOLOGICAL FACTORS: 
REGRESSION to the MEAN
• Statistical phenomenon (non-biological and non-psychological)
• If a variable is extreme at its first measurement, it will tend to be 
closer to the mean at its second measurement.
Example: 
• A medication that lower blood sugar is tested on a patien"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=22,M4-Q22,0.174,"METHODOLOGICAL FACTORS:
BIASES , ambiguity of the symptom, errors
• Hawthorne effect (effect of being observed): people tend to work harder or 
perform better when they feel they are being watched or studied.
• Pleasing the Experimenter: participants may alter their behavior to fit what 
they believ"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=23,M4-Q15,0.217,"Natural History (NH)
Regression to the mean
Bias
NON-SPECIFIC FACTORS
HOW CAN WE SAY THAT A DRUG (treatment) 
is EFFECTIVE?
• To control methodological factors→we administer a PLACEBO
✓ACTIVE ARM: receives the active treatment
✓PLACEBO ARM: receives the placebo treatment
time
Administration
treatmen"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=24,M4-Q16,0.208,"CLINICAL TRIALS
• Gold standard → RCT (Randomized – double blind – placebo 
controlled – Clinical Trial)
• Examples of ""historical"" controlled trials:
1. Mesmerism (Mesmer, commissioned by Benjamin Franklin →
there is no magnetic fluid, it is a matter of imagination or 
spontaneous remission)
2. Hom"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=25,M1-Q12,0.174,"CLINICAL TRIALS
Research conducted to collect data on the safety and efficacy of new 
drugs, new clinical procedures or new medical devices.
They are conducted after the approval by competent authorities and an 
ethics committee.
They are characterized by PHASES (see phases of clinical trials).
Clin"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=26,M4-Q16,0.285,"CLASSIFICATION OF CLINICAL TRIALS
• Method used to allocate participants to groups (treatment or control) 
(randomized or non-randomized)
• Participant and researcher awareness of group allocation (blinding)"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=27,M4-Q16,0.295,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: non-
randomized method"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=28,M4-Q16,0.254,"Informations
about
patients
 RANDOM
CLASSIFICATION OF CLINICAL TRIALS: 
randomized method
Experimenter"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=29,M4-Q16,0.356,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
SINGLE-BLINDING"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=30,M4-Q16,0.373,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
DOUBLE-BLINDING"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=31,M4-Q16,0.247,"CLINICAL TRIALS
GOLD STANDARD:
1) Randomized
2) Double-blind
3) Placebo controlled
Experimenter
RANDOMIZATION"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=32,M4-Q24,0.183,"Clinical trial phases
0. Preclinical phase
1. PHASE I 
2. PHASE II  
3. PHASE III  
4. PHASE IV"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=33,M1-Q17,0.187,"PHASE 0 –Discovery and early 
testing 
• Discovery and selection of molecules
• Laboratory analysis on cells and animals
• Administration of extremely small doses of 
the drug under study to obtain preliminary 
data on the pharmacokinetics of the agent 
• Request for authorization of human trials
• "
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=34,M1-Q20,0.216,"PHASE I –Safety and dosage 
• Typically on humans (volunteers) (20-80 
subjects)
• Typically on healthy subjects (sometimes on 
terminal patients in the absence of other 
treatments)
• It is used to test the pharmacokinetics and 
toxicity
• If the safety of the drug has been confirmed, 
we move on t"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=35,M1-Q17,0.223,"PHASE II –Efficacy
• Testing of the molecule on larger groups (300-
400 subjects).
• Patients who have the pathology for which 
the particular molecule is to be tested are 
recruited
Phase III
If benefits are 
observed"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=36,M1-Q17,0.215,"PHASE III –
Approval phase
• Increasing the number of patients 
(multicenter studies with 2000-3000 patients)
• Approval phase
 If few side effects
and good efficacy
"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=37,M1-Q20,0.203,"PHASE IV –Post-marketing 
surveillance
• MARKET LAUNCH
• Phase that lasts ""forever“
• The recording of side effects continues.
• Ex: Thalidomide, marketed after animal testing 
(late 50s)
→Lancet study
→administration of thalidomide to pregnant mice 
resulted in the birth of broods with severe limb "
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=38,M4-Q07,0.224,"• STANDARD TRIALS (Phase I, II and III):
• If active arm > placebo arm →We proceed with the other phases of 
the trial
VERUM GROUP
(active arm)
PLACEBO GROUP
(placebo arm)"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=39,M4-Q24,0.217,"Gold standard? 
All that glitters is not gold
RCTs Problems"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=40,M4-Q15,0.240,"PLACEBO IN CLINICAL TRIALS: PROBLEMS
We administer the ACTIVE treatment (active arm) and… WE COMPARE WITH PLACEBO
(placebo arm)
pain
Treatment administration
Natural History (NH)
Regression to the mean
Bias
NON-SPECIFIC FACTORS
Treatment efficacy
ACTIVE 
PRINCIPLE
x
"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=41,M4-Q16,0.203,"PLACEBO IN CLINICAL TRIALS: PROBLEMS
One therapy is tested by comparing the ""active treatment arm"" with the 
""placebo arm"".
Unfortunately, this comparison often generates uncertainty for several 
reasons:
• Wrong interpretation (I report a difference that does not exist). 
• Inability to find a diff"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=42,M4-Q22,0.155,"PLACEBO IN CLINICAL TRIALS: PROBLEMS
Clinical trial: postoperative pain
Benedetti F, Amanzio M, Maggi G. Potentiation of placebo analgesia by proglumide. Lancet 1995.
Benedetti F, Carlino E, Piedimonte A. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effec"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=43,M4-Q22,0.163,"PLACEBO IN CLINICAL TRIALS: 
ACTIVE ARM PROBLEMS
Clinical trial: postoperative pain
Benedetti F, Amanzio M, Maggi G. Potentiation of placebo analgesia by proglumide. Lancet 1995.
Benedetti F, Carlino E, Piedimonte A. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Haw"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=44,M4-Q16,0.181,"PLACEBO IN CLINICAL TRIALS: 
ACTIVE ARM PROBLEMS
Clinical trial: postoperative pain
Benedetti F, Amanzio M, Maggi G. Potentiation of placebo analgesia by proglumide. Lancet 1995.
Benedetti F, Carlino E, Piedimonte A. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Haw"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=45,M1-Q17,0.193,"PLACEBO IN CLINICAL TRIALS: 
ACTIVE ARM PROBLEMS
Trial of open vs hidden administration of remifentanil (no placebo!)
Benedetti F, Carlino E, Piedimonte A. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects. Lancet 
Neurology 2016.
Bingel U, Wanigaseker"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=46,M4-Q16,0.213,"PLACEBO IN CLINICAL TRIALS: 
ACTIVE ARM PROBLEMS
• Negative RCTs are increasing over time in different therapeutic areas 
(oncology, chronic and musculoskeletal pain, CNS disorders)
• In the majority of trials (52%), the problem is the absence of a 
difference between the treatment and the placebo→
"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=47,M4-Q22,0.241,"PLACEBO IN CLINICAL TRIALS: 
ACTIVE ARM PROBLEMS
• Is the placebo effect therefore increasing?
• The effect of the psychosocial context that accompanies the 
administration of medical treatment is increasing
Carlino E, Vase L. Can knowledge of Placebo and Nocebo Mechanisms Help Improve Randomized Cl"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=48,M4-Q18,0.260,"PLACEBO EFFECT = CONTEXT EFFECT
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=49,M4-Q18,0.258,"PLACEBO EFFECT = CONTEXT EFFECT
The placebo effect is the effect of the context
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT
PLACEBO"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=50,M4-Q18,0.268,"+ CONTEXT
PLACEBO
Placebo effect Nocebo effect
Placebo effect ≠ placebo response (RCTs)
Inert treatment administered 
within a psychosocial 
setting (context effect)"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=51,M4-Q22,0.205,"Benedetti F, Carlino E, Pollo A. Neuropsychopharmacology 2011;36:339-54
Benedetti F, Carlino E, Pollo A. Neuropsychopharmacology 2011;36:339-54
Clinical trialist
Neurobiologist
Our interest
/TREATMENT
PLACEBO EFFECT"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=52,M1-Q12,0.225,"CONTEXTUAL FACTORS: 
what are they and how have they been studied? 
Testa & Rossettini, 2016, Manual Therapy
Rossettini, Carlino, Testa, 2018, BMC Musculoskeletal Disorders"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=53,M4-Q22,0.136,"CONTEXTUAL FACTORS: 
what are they and how have they been studied?
Therapeutic outcome is influenced by: 
1.PATIENT’S INVIDUAL VARIABLES: 
• Psychological variables: patients who respond well to placebo (responders) 
tend to be less anxious and more optimistic 
• Genetic variables: studies have show"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=54,M4-Q16,0.133,"CONTEXTUAL FACTORS: 
what are they and how have they been studied?
Therapeutic outcome is influenced by: 
2.PHYSIOTHERAPIST: 
• A doctor who presents himself as competent, experienced, polite, 
professional, trustworthy, able to provide a clear diagnosis and a 
clear prognosis and who monitors the p"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=55,M1-Q20,0.138,"→fMRI study on the biological 
effect of holding hands 
→Married women were exposed 
to the threat of an electric 
shock under three conditions: 
→ not holding hands/spouse 
hand/stranger hand 
2
No hand     spouse    unknown
unpleasantness
When they held their spouse’s hand, they reported 
less unp"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=56,M1-Q20,0.146,"Therapeutic outcome is influenced by: 
3.TREATMENT:
• The formulation of a clear diagnosis that explains the symptoms to the 
patient and gives meaning to the disease is in fact a form of treatment 
(Hopayian and Notley, 2014)
• Detailed diagnoses and comprehensive explanations are appreciated by th"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=57,M1-Q20,0.152,"Therapeutic outcome is influenced by: 
4.PATIENT-PHYSIOTHERAPIST RELATIONSHIP:
• Appropriate verbal communication is a prerequisite for a good therapeutic 
relationship (Parson et al., 2007).
• Supportive verbal expressions, active listening, encouragement, empathycorrelate 
with patient satisfactio"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=58,M4-Q18,0.219,"HOW TO GIVE INFORMATION
• IBS patients
• Placebo acupuncture 
Kelley et al., Psychosom Med. 2009
Augmented group:
Treated with an empathetic approach Control group
Limited group:
Treated with a neutral approach
"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=59,M1-Q20,0.203,"Testa & Rossettini, 2016, Manual Therapy
Rossettini, Carlino, Testa, 2018, BMC Musculoskeletal Disorders
CONTEXTUAL FACTORS: 
what are they and how have they been studied?"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=60,M4-Q19,0.198,"TYPES OF CLINICAL TRIAL 
Placebo run-in 
→EXCLUDING PLACEBO 
RESPONDERS
P non-responder
P responder
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Administration of 
a placebo
Placebo administration"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=61,M4-Q16,0.202,"Active run-in →
EXCLUDE SUBJECTS WHO DO NOT 
RESPOND TO THE DRUG
• F responder
• Few side effects
• F non-responder o 
• Marked collateral effect
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Administration of 
a drug
Placebo administration"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=62,M4-Q13,0.240,"CROSS-OVER DESIGN
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Placebo administration
 Placebo administration
Drug administration"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=63,M4-Q22,0.190,"TRIAL BASED ON ASSIGNMENT
(real or perceived)
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Placebo administration
REAL ASSIGNMENT ASSIGNMENT RECEIVED
Drug administration
Placebo administration
""What group 
do you think 
you belong to?""
"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=64,M4-Q18,0.290,"BALANCED DESIGN
GET
TOLD
MEDICATION PLACEBO
ACTIVE 
EFFECT
PLACEBO
EFFECT
BASELINE
MEDICATION
PLACEBO
ACTIVE + 
Placebo"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=65,M4-Q22,0.223,"ETHICAL ISSUES IN THE USE OF PLACEBO
• Use of placebo prohibited dentologically in certain conditions (e.g.
depression, suicide risk, patients with cancer, etc.).
• Without the placebo group, is it possible to evaluate the efficacy of a 
treatment?
• Possible use of trials with two active drugs (Old"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=66,M4-Q22,0.198,"OPEN-HIDDEN
OPEN
 HIDDEN
Enck et al, 2013, Nature 12:191-204.
Benedetti F, Carlino E, Pollo A. 2011 Clin Pharm Ther 90: 651-661.
• Participants know they 
are receiving the 
tratment 
• Allows both 
pharmacological effects 
and 
psychological/placebo 
effects to occur 
• Participants don’t know 
whe"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=67,M4-Q16,0.187,"Colloca and Benedetti, Nature Rev Neurosci 6: 545-552, 2005 
OPEN-HIDDEN
Is metamizol (300 mg) effective in post-
operative pain? 
Double blind
Informed consent ""You will 
receive a dose of metamizole
but you will not know when""
Open group (N=10) Hidden group (N=10)"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=68,M4-Q09,0.188,"OPEN-HIDDEN
-3
0
BUPRENORPHINE
OPEN
-1
-2
PAIN REDUCTION
TRAMADOL
OPEN
KETOROLAC
OPEN
METAMIZOLO
OPEN
HIDDEN HIDDENHIDDEN HIDDEN
EFFECT of the
DRUG
CONTEXT
Benedetti et al. 1995 Lancet 346: 1231;  
Amanzio et al.  2001 Pain 90: 205-15;
Colloca et al. 2004 Lancet Neurol 3: 679-684"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=69,M4-Q05,0.304,"Placebo, nocebo and 
contextual factors:
history, research and clinical practice"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=70,M4-Q22,0.288,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=71,M4-Q22,0.283,"PLACEBO in modern science: SCIENTIFIC 
RESEARCH
• In research→ UNDERSTAND
How does that work:
1) Psychological mechanisms
2) Neurobiological mechanisms
How can it be studied?
How much does it work?
Who does it work on?
On what population?
Under what conditions does it work?"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=72,M1-Q17,0.179,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=73,M4-Q15,0.206,"BEHAVIORAL STUDIES
EEGPHARMACOLOGY
How can it be studied?
fMRI / PET
"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=74,M4-Q22,0.197,"Magnitude of the placebo effect
• Several studies have measured and quantified the magnitude of the 
placebo/nocebo effect induced by contextual factors under different 
conditions.
E.g. Musculoskeletal pain, fibromyalgia, osteoarthritis (effect size > 0.5) 
Rossettini, Carlino, Testa, 2015, BMC Mus"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=75,M4-Q22,0.249,"PSYCHOLOGICAL MECHANISMS
• Theoretical aspects:
– Expectation: Models
• Pierce’s theory →SIGNS 
• Atkinson →EXPECTATIONS + SUBJECTIVE VALUE 
• Khaneman, Tversky →PROSPECT THEORY (loss and gain) 
• Rescorla-Wagner →ASSOCIATIVE LEARNING PROCESS
• ViolEx Model →VIOLATION OF EXPECTATION 
• Bayesian pers"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=76,M4-Q22,0.171,"Expectation
“Placebo interventions, such as sugar pills or saline injections, can be 
vehicles of therapeutic responses, but not by virtue of containing 
medication or internal properties with the power to produce beneficial 
health outcomes. Instead, the placebo intervention—a placebo pill, 
saline"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=77,M1-Q12,0.199,"Expectation: different theories
Colloca & Miller, 2003
Peirce Theory
Atkinson's expectancy-
value 
Kahneman 
and Tversky 
Rescorla-
Wagner's model
Rief model 
(Viol-EX)
Expectations
Bayesian Brain"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=78,M1-Q17,0.174,"Expectation: Peirce's theory
•According to Peirce's theory (1839-1914), when one is in 
front of a sign (index, symbol or icon) we speak of 
""translation"" to identify the process by which it is possible to 
derive meaning from the particular sign. Triadic relation of 
signs, object and interpretant
"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=79,M1-Q12,0.156,"Expectation: Peirce's theory
Signs are anything that elicits an interpretation of an 
object. They are classified into 3 categories:
1. Indexes →signs that are dynamically connected with 
objects and with the senses and memories of the 
individuals to whom they serve as signs. They refer to 
a given"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=80,M4-Q22,0.241,"Expectation: Peirce's theory
•We actively interpret the signs of the objects that surround us
•This interpretation produces changes in our body that add to 
the changes produced by the object itself"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=81,M4-Q16,0.155,"Expectation: Atkinson's expectancy-value 
theory
•Behaviors in stressful situations can be predicted based on the 
interaction between the expectation of being able to cope with 
such situations, borrowed from past experiences, and the 
subjective value of the specific situation (Atkinson and Reitma"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=82,M1-Q20,0.226,"Expectation: Kahneman and Tversky's 
prospect theory
•The idea behind these theories is the balance between loss 
and gain
•In decision-making, potential losses tend to carry greater 
weight than anticipated gains
•In a clinical setting, patient anxiety and concerns about 
treatments may be more rel"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=83,M1-Q20,0.205,"Expectation: Rescorla-Wagner's model
•Expectations develop as a result of an associative learning 
process.
•According to the Rescorla-Wagner model, expectations are 
learned following trials (learning what to expect).
•The strength of expectations is given by the number of trials that 
confirm the "
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=84,M4-Q16,0.190,"Expectation: ViolEx-model
• Rief et al., developed a model that conceptualizes how expectations 
influence different clinical outcomes and explains how the violation 
of expectations leads to behavior change or perseverance
• At the basis of the proposed model there is the interaction between 
EXPEC"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=85,M4-Q22,0.133,"1)
2)
3)4)
5)
6)
ViolEx-model
Rief and Petrie, 2016
When we receive medical treatment:
1) Generalized pre-existing expectations→may amplify the effects 
of the treatment or worsen them (nocebo effects)
2) The interaction between generalized pre-existing expectations 
and the medical context leads to"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=86,M1-Q12,0.167,"ViolEX model
internal model:  
‘if A → B’
Personal experiences
Personality traits
Psychological status
A → B
Expectation 
confirmation
Violation: 
Expectation 
update 
(optimization)
Violation: 
Expectation 
mantained
(cognitive 
immunization) 
A → BX X
Rossettini et al., 2022 (under review)
?"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=87,M4-Q22,0.153,"Rief and Petrie, 2016
tre
7) The development of expectations is determined by at 
least three different factors: 
• previous experience (associative learning)
• social influences (direct or indirect social learning via 
social media)
• cognitive processes specific to the individual patient
8) Finall"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=88,M1-Q12,0.164,"Bayesian Perspective
• Following the Bayesian perspective, our 
brain is a probabilistic machine that 
generates predictions (priors) about 
incoming sensory stimuli.
• When the priors update in relation to 
sensory experiences (sensory input), 
posteriors are generated, i.e. priors updated 
by the "
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=89,M4-Q09,0.193,"Bayesian Perspective
• Prior has different levels of accuracy
• High accuracy → Reliable
• Low accuracy→ Unreliable
PE
Expect A Get B
prior update
prior sensory imput
(Brown et al., 2013;Buchel et al., 2014;Seth and Friston, 2016)
"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=90,M1-Q12,0.182,"Bayesian Perspective
PE
Expect A
A gets closer 
to B
Get B
prior update
A remains 
close to A
Prior with low 
certainty
Prior with high  
certainty
prior sensory imput
posterior
PE
Expect A Get B
minimal prior update
prior sensory imput
posterior
Rossettini et al., 2022 (under review)"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=91,M1-Q20,0.142,"According to Bayesian Perspective and ViolEx model
• Expectation violation followed by update →can be attributed to 
one’s having a prior with low precision which is updated accordingly 
with the newly acquired evidence (i.e., according to this view, the 
patient who is shown that lifting their arm "
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=92,M4-Q09,0.218,"Clinical scenario
Rossettini et al., 2022 (under review)"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=93,M4-Q22,0.310,"PSYCHOLOGICAL MECHANISMS
• Theoretical aspects:
–Expectation: models
–Conditioning:
– Classical
– Operant
– Social
• From theory to practice: placebo effect studies"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=94,M4-Q24,0.259,"Conditioning
• Behavioral psychology: different types of Learning 
"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=95,M4-Q09,0.158,"ACQUISITION PHASE
Sound + food Salivation
(UR)
BEFORE CONDITIONING
Food
(US)
Unconditioned 
Stimulus
Salivation
(UR)
Unconditioned 
Response
Sound
(NS)
Neutral 
Stimulus 
No salivation
(no UR)
Unconditioned 
Response
RECALL PHASE
Sound
(CS)
Conditioned Stimulus
Salivation
(CR)
Conditioned response
S"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=96,M1-Q17,0.170,"CLASSICAL CONDITIONING
ACQUISITION PHASE
co-occurrence of… 
THERAPEUTIC 
BENEFIT
(pain reduction)
RE-RECALL PHASE
Schedlowski et al. (2010) Brain Behav Imm 24: 176-185
Vits et al. (2011) Phil. Trans. R. Soc. B 366: 1799-1807
+
MEDICATION / 
TREATMENT CONTEXT CONTEXT
+ EFFECT EFFECT
Chemotherapy +
 N"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=97,M1-Q20,0.210,"SOCIAL CONDITIONING
Colloca et al., Philos Trans R Soc Lond B Biol Sci, 2011
• Learning mediated by the presence of a social 
context (observational)
–Presence of an ""actor"" who simulates 
improvements or worsening
–In the clinical context→waiting room"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=98,M1-Q17,0.138,"0
1.2
0.6
0 10 70
ORE POST INTERVENTO
Buprenorphine intake/patient (mg)
0.91 mg/patient
0.76 mg/patient
1.15 mg/patient
100% chance of receiving 
a painkiller
20 30 40 50 60
1.0
0.8
0.4
0.2
NATURAL 
HISTORY
50% chance of receiving a 
painkiller
Painkiller 
request
-20.8%
-33.8%
Post-surgery patients"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=99,M4-Q22,0.191,"Role of time expectation
Camerone et al., Psychosom Med, 2021
Temporal expectations play a crucial role in modulating when and how pain is 
perceived
(study with a inert cream) 
• Placebo effects emerge at the expected time and remain stable 
• Nocebo effects emerge at the expected time and increase"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=100,M1-Q12,0.182,"Colloca L, Benedetti F (2009) Pain 144:28–34.
Social Learning vs Classical 
Conditioning vs Expectation
Learning from a model: 
it can be observed that
another subject experiences
a reduction in pain following the activation of two 
electrodes (sham placebo)
NO DIFFERENCE BETWEEN SOCIAL LEARNING
AND"
pdf_page,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=101,M4-Q22,0.184,"Au Yeung et al. (2014) Pain 155:1110–1117.
During the
Acquisition phase, 
the placebo
is always paired with 
the
Pain reduction
During the
Acquisition phase, the placebo
is paired with the
Pain reduction in 62% of trials
The placebo effect does not 
extinguish after partial 
reinforcement
Partial vs"
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=1#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_1_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=3#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_3_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=3#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_3_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=3#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_3_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=7#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_7_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=8#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_8_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=8#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_8_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=8#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_8_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=9#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_9_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=9#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_9_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=10#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_10_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=10#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_10_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=11#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_11_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=11#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_11_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=11#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_11_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=12#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_12_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=12#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_12_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=12#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_12_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=12#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_12_img4.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=12#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_12_img5.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=13#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_13_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=15#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_15_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=15#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_15_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=15#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_15_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=15#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_15_img4.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=15#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_15_img5.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=15#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_15_img6.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=15#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_15_img7.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=15#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_15_img8.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=15#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_15_img9.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=16#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_16_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=16#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_16_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=16#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_16_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=16#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_16_img4.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=16#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_16_img5.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=16#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_16_img6.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=16#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_16_img7.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=16#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_16_img8.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=16#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_16_img9.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=17#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_17_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=17#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_17_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=17#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_17_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=17#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_17_img4.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=17#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_17_img5.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=17#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_17_img6.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=17#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_17_img7.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=17#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_17_img8.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=17#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_17_img9.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=17#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_17_img10.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=17#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_17_img11.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=17#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_17_img12.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=17#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_17_img13.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=17#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_17_img14.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=18#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_18_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=18#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_18_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=18#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_18_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=18#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_18_img4.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=18#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_18_img5.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=18#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_18_img6.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=18#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_18_img7.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=18#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_18_img8.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=18#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_18_img9.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=18#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_18_img10.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=18#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_18_img11.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=18#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_18_img12.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=18#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_18_img13.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=18#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_18_img14.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=19#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_19_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=19#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_19_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=19#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_19_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=19#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_19_img4.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=19#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_19_img5.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=19#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_19_img6.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=19#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_19_img7.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=19#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_19_img8.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=19#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_19_img9.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=19#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_19_img10.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=19#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_19_img11.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=19#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_19_img12.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=19#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_19_img13.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=21#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_21_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=21#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_21_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=23#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_23_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=23#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_23_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=23#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_23_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=25#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_25_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=25#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_25_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=25#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_25_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=26#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_26_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=26#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_26_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=26#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_26_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=26#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_26_img4.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=26#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_26_img5.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=26#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_26_img6.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=39#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_39_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=42#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_42_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=42#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_42_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=42#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_42_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=43#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_43_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=43#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_43_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=43#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_43_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=43#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_43_img4.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=44#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_44_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=44#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_44_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=44#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_44_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=45#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_45_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=45#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_45_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=45#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_45_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=46#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_46_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=53#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_53_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=53#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_53_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=54#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_54_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=55#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_55_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=55#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_55_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=55#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_55_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=56#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_56_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=56#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_56_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=56#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_56_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=56#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_56_img4.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=56#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_56_img5.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=57#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_57_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=57#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_57_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=58#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_58_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=58#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_58_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=59#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_59_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=59#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_59_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=60#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_60_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=60#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_60_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=61#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_61_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=61#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_61_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=61#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_61_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=61#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_61_img4.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=69#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_69_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=74#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_74_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=74#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_74_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=76#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_76_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=77#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_77_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=80#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_80_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=81#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_81_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=81#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_81_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=81#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_81_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=82#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_82_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=84#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_84_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=84#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_84_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=85#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_85_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=86#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_86_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=87#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_87_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=90#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_90_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=90#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_90_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=90#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_90_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=91#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_91_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=92#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_92_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=92#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_92_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=93#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_93_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=93#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_93_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=94#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_94_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=94#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_94_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=95#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_95_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=95#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_95_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=96#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_96_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=96#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_96_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=96#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_96_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=96#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_96_img4.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=97#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_97_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=97#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_97_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=97#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_97_img3.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=98#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_98_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=98#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_98_img2.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=99#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_99_img1.png,,0.000,
pdf_image,MODULE 1_1_6wdx.yFooMSpEweBG.file#page=99#docs\pdf_images\MODULE 1_1_6wdx.yFooMSpEweBG.file\page_99_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=1#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_1_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=3#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_3_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=3#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_3_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=3#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_3_img3.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=4#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_4_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=4#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_4_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=4#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_4_img3.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=4#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_4_img4.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=4#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_4_img5.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=4#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_4_img6.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=4#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_4_img7.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=5#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_5_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=5#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_5_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=5#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_5_img3.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=5#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_5_img4.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=5#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_5_img5.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=5#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_5_img6.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=5#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_5_img7.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=6#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_6_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=6#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_6_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=7#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_7_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=7#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_7_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=7#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_7_img3.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=7#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_7_img4.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=8#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_8_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=8#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_8_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=8#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_8_img3.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=8#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_8_img4.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=8#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_8_img5.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=11#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_11_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=12#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_12_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=13#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_13_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=14#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_14_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=15#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_15_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=17#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_17_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=17#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_17_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=18#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_18_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=19#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_19_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=19#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_19_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=20#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_20_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=21#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_21_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=22#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_22_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=23#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_23_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=23#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_23_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=23#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_23_img3.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=23#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_23_img4.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=23#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_23_img5.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=23#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_23_img6.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=24#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_24_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=24#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_24_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=25#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_25_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=25#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_25_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=26#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_26_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=27#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_27_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=28#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_28_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=29#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_29_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=30#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_30_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=30#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_30_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=31#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_31_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=31#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_31_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=31#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_31_img3.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=31#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_31_img4.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=31#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_31_img5.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=31#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_31_img6.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=31#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_31_img7.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=32#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_32_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=32#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_32_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=34#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_34_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=34#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_34_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=34#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_34_img3.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=35#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_35_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=35#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_35_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=35#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_35_img3.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=36#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_36_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=36#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_36_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=36#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_36_img3.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=37#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_37_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=37#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_37_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=37#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_37_img3.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=38#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_38_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=38#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_38_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=39#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_39_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=40#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_40_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=41#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_41_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=41#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_41_img2.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=42#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_42_img1.png,,0.000,
pdf_image,MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file#page=42#docs\pdf_images\MODULE 1_2_1xn2.Fqv7c8lyq6Fk.file\page_42_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=1#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_1_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=2#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_2_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=2#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_2_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=2#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_2_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=5#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_5_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=5#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_5_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=6#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_6_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=10#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_10_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=11#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_11_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=11#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_11_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=11#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_11_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=12#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_12_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=12#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_12_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=12#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_12_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=13#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_13_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=13#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_13_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=13#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_13_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=13#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_13_img4.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=14#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_14_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=14#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_14_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=14#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_14_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=14#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_14_img4.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=14#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_14_img5.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=15#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_15_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=15#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_15_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=15#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_15_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=15#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_15_img4.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=16#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_16_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=16#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_16_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=16#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_16_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=17#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_17_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=17#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_17_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=18#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_18_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=18#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_18_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=18#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_18_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=19#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_19_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=19#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_19_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=20#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_20_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=20#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_20_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=20#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_20_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=21#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_21_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=21#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_21_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=22#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_22_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=22#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_22_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=23#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_23_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=23#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_23_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=24#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_24_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=27#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_27_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=27#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_27_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=28#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_28_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=28#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_28_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=29#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_29_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=30#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_30_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=30#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_30_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=31#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_31_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=31#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_31_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=31#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_31_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=32#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_32_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=32#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_32_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=33#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_33_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=35#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_35_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=36#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_36_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=37#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_37_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=37#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_37_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=38#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_38_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=38#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_38_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=38#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_38_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=38#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_38_img4.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=39#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_39_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=40#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_40_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=40#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_40_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=41#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_41_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=41#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_41_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=42#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_42_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=42#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_42_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=43#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_43_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=44#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_44_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=47#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_47_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=50#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_50_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=51#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_51_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=51#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_51_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=51#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_51_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=52#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_52_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=52#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_52_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=52#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_52_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=52#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_52_img4.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=52#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_52_img5.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=52#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_52_img6.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=52#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_52_img7.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=52#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_52_img8.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=53#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_53_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=53#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_53_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=53#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_53_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=53#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_53_img4.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=53#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_53_img5.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=54#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_54_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=54#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_54_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=54#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_54_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=55#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_55_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=56#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_56_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=57#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_57_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=57#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_57_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=58#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_58_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=58#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_58_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=59#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_59_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=60#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_60_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=60#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_60_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=61#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_61_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=61#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_61_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=62#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_62_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=62#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_62_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=63#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_63_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=63#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_63_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=64#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_64_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=65#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_65_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=65#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_65_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=66#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_66_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=67#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_67_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=67#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_67_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=67#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_67_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=68#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_68_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=68#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_68_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=69#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_69_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=69#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_69_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=69#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_69_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=70#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_70_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=71#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_71_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=71#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_71_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=72#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_72_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=72#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_72_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=73#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_73_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=73#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_73_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=73#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_73_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=73#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_73_img4.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=73#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_73_img5.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=74#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_74_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=74#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_74_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=75#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_75_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=77#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_77_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=77#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_77_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=78#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_78_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=78#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_78_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=80#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_80_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=81#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_81_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=81#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_81_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=82#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_82_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=82#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_82_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=85#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_85_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=86#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_86_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=86#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_86_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=86#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_86_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=91#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_91_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=92#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_92_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=92#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_92_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=93#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_93_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=93#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_93_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=94#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_94_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=94#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_94_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=94#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_94_img3.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=94#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_94_img4.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=94#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_94_img5.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=94#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_94_img6.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=95#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_95_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=95#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_95_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=96#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_96_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=96#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_96_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=101#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_101_img1.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=101#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_101_img2.png,,0.000,
pdf_image,MODULE 1_3_cp9q.vZHFBn9oMUZP.file#page=101#docs\pdf_images\MODULE 1_3_cp9q.vZHFBn9oMUZP.file\page_101_img3.png,,0.000,
pdf_image,MODULE 3_MindChange_part1#page=1#docs\pdf_images\MODULE 3_MindChange_part1\page_1_img1.png,M4-Q06,0.149,"Use of technology and 
networking:
how do they change our brain
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img1.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img2.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img3.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img4.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img5.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img6.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img7.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img8.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img9.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img10.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img11.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img12.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img13.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img14.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img15.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img16.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=2#docs\pdf_images\MODULE 3_MindChange_part1\page_2_img17.png,M3-Q10,0.140,"Conceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
Share information →we have different selves →privacy?? 
1)
2)
3)
4)
enlarged ventral 
striatum
AGGRESSION
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part1#page=4#docs\pdf_images\MODULE 3_MindChange_part1\page_4_img1.png,M3-Q15,0.183,"Change of the World: from 3D to 2D
3D world
Tablet
PC
Smartphone
TV"
pdf_image,MODULE 3_MindChange_part1#page=4#docs\pdf_images\MODULE 3_MindChange_part1\page_4_img2.png,M3-Q15,0.183,"Change of the World: from 3D to 2D
3D world
Tablet
PC
Smartphone
TV"
pdf_image,MODULE 3_MindChange_part1#page=4#docs\pdf_images\MODULE 3_MindChange_part1\page_4_img3.png,M3-Q15,0.183,"Change of the World: from 3D to 2D
3D world
Tablet
PC
Smartphone
TV"
pdf_image,MODULE 3_MindChange_part1#page=4#docs\pdf_images\MODULE 3_MindChange_part1\page_4_img4.png,M3-Q15,0.183,"Change of the World: from 3D to 2D
3D world
Tablet
PC
Smartphone
TV"
pdf_image,MODULE 3_MindChange_part1#page=4#docs\pdf_images\MODULE 3_MindChange_part1\page_4_img5.png,M3-Q15,0.183,"Change of the World: from 3D to 2D
3D world
Tablet
PC
Smartphone
TV"
pdf_image,MODULE 3_MindChange_part1#page=4#docs\pdf_images\MODULE 3_MindChange_part1\page_4_img6.png,M3-Q15,0.183,"Change of the World: from 3D to 2D
3D world
Tablet
PC
Smartphone
TV"
pdf_image,MODULE 3_MindChange_part1#page=5#docs\pdf_images\MODULE 3_MindChange_part1\page_5_img1.png,M4-Q16,0.137,"Change of the World: from 3D to 2D
3D world
Tablet
PC
Smartphone
TV
• Tech is everywhere
• Facts can be accessed at random
• Actions can be reverse
• Time is short
• 24/7 responsive and productivity"
pdf_image,MODULE 3_MindChange_part1#page=5#docs\pdf_images\MODULE 3_MindChange_part1\page_5_img2.png,M4-Q16,0.137,"Change of the World: from 3D to 2D
3D world
Tablet
PC
Smartphone
TV
• Tech is everywhere
• Facts can be accessed at random
• Actions can be reverse
• Time is short
• 24/7 responsive and productivity"
pdf_image,MODULE 3_MindChange_part1#page=5#docs\pdf_images\MODULE 3_MindChange_part1\page_5_img3.png,M4-Q16,0.137,"Change of the World: from 3D to 2D
3D world
Tablet
PC
Smartphone
TV
• Tech is everywhere
• Facts can be accessed at random
• Actions can be reverse
• Time is short
• 24/7 responsive and productivity"
pdf_image,MODULE 3_MindChange_part1#page=5#docs\pdf_images\MODULE 3_MindChange_part1\page_5_img4.png,M4-Q16,0.137,"Change of the World: from 3D to 2D
3D world
Tablet
PC
Smartphone
TV
• Tech is everywhere
• Facts can be accessed at random
• Actions can be reverse
• Time is short
• 24/7 responsive and productivity"
pdf_image,MODULE 3_MindChange_part1#page=5#docs\pdf_images\MODULE 3_MindChange_part1\page_5_img5.png,M4-Q16,0.137,"Change of the World: from 3D to 2D
3D world
Tablet
PC
Smartphone
TV
• Tech is everywhere
• Facts can be accessed at random
• Actions can be reverse
• Time is short
• 24/7 responsive and productivity"
pdf_image,MODULE 3_MindChange_part1#page=5#docs\pdf_images\MODULE 3_MindChange_part1\page_5_img6.png,M4-Q16,0.137,"Change of the World: from 3D to 2D
3D world
Tablet
PC
Smartphone
TV
• Tech is everywhere
• Facts can be accessed at random
• Actions can be reverse
• Time is short
• 24/7 responsive and productivity"
pdf_image,MODULE 3_MindChange_part1#page=8#docs\pdf_images\MODULE 3_MindChange_part1\page_8_img1.png,M3-Q11,0.140,"Internet sales as a percentage of total retail 
sales (ratio) (%) 
www.ons.gov.uk"
pdf_image,MODULE 3_MindChange_part1#page=10#docs\pdf_images\MODULE 3_MindChange_part1\page_10_img1.png,M4-Q05,0.127,"Pervasiveness
• Work/study
• Communicate with friends
• Find new friends
• Gain information and news
• Shopping
• Spare time
• Alarm
• Maps
• …
Tablet
PC
Smartphone
TV"
pdf_image,MODULE 3_MindChange_part1#page=10#docs\pdf_images\MODULE 3_MindChange_part1\page_10_img2.png,M4-Q05,0.127,"Pervasiveness
• Work/study
• Communicate with friends
• Find new friends
• Gain information and news
• Shopping
• Spare time
• Alarm
• Maps
• …
Tablet
PC
Smartphone
TV"
pdf_image,MODULE 3_MindChange_part1#page=10#docs\pdf_images\MODULE 3_MindChange_part1\page_10_img3.png,M4-Q05,0.127,"Pervasiveness
• Work/study
• Communicate with friends
• Find new friends
• Gain information and news
• Shopping
• Spare time
• Alarm
• Maps
• …
Tablet
PC
Smartphone
TV"
pdf_image,MODULE 3_MindChange_part1#page=10#docs\pdf_images\MODULE 3_MindChange_part1\page_10_img4.png,M4-Q05,0.127,"Pervasiveness
• Work/study
• Communicate with friends
• Find new friends
• Gain information and news
• Shopping
• Spare time
• Alarm
• Maps
• …
Tablet
PC
Smartphone
TV"
pdf_image,MODULE 3_MindChange_part1#page=10#docs\pdf_images\MODULE 3_MindChange_part1\page_10_img5.png,M4-Q05,0.127,"Pervasiveness
• Work/study
• Communicate with friends
• Find new friends
• Gain information and news
• Shopping
• Spare time
• Alarm
• Maps
• …
Tablet
PC
Smartphone
TV"
pdf_image,MODULE 3_MindChange_part1#page=10#docs\pdf_images\MODULE 3_MindChange_part1\page_10_img6.png,M4-Q05,0.127,"Pervasiveness
• Work/study
• Communicate with friends
• Find new friends
• Gain information and news
• Shopping
• Spare time
• Alarm
• Maps
• …
Tablet
PC
Smartphone
TV"
pdf_image,MODULE 3_MindChange_part1#page=11#docs\pdf_images\MODULE 3_MindChange_part1\page_11_img1.png,M3-Q15,0.144,"Pervasiveness for who?
3D world 2D world
Different GENERATIONS"
pdf_image,MODULE 3_MindChange_part1#page=11#docs\pdf_images\MODULE 3_MindChange_part1\page_11_img2.png,M3-Q15,0.144,"Pervasiveness for who?
3D world 2D world
Different GENERATIONS"
pdf_image,MODULE 3_MindChange_part1#page=11#docs\pdf_images\MODULE 3_MindChange_part1\page_11_img3.png,M3-Q15,0.144,"Pervasiveness for who?
3D world 2D world
Different GENERATIONS"
pdf_image,MODULE 3_MindChange_part1#page=11#docs\pdf_images\MODULE 3_MindChange_part1\page_11_img4.png,M3-Q15,0.144,"Pervasiveness for who?
3D world 2D world
Different GENERATIONS"
pdf_image,MODULE 3_MindChange_part1#page=11#docs\pdf_images\MODULE 3_MindChange_part1\page_11_img5.png,M3-Q15,0.144,"Pervasiveness for who?
3D world 2D world
Different GENERATIONS"
pdf_image,MODULE 3_MindChange_part1#page=11#docs\pdf_images\MODULE 3_MindChange_part1\page_11_img6.png,M3-Q15,0.144,"Pervasiveness for who?
3D world 2D world
Different GENERATIONS"
pdf_image,MODULE 3_MindChange_part1#page=14#docs\pdf_images\MODULE 3_MindChange_part1\page_14_img1.png,M3-Q15,0.129,"Digital Native vs Digital Immigrants
Irrespective of the date 
of born, parents are most 
likely to be Digital 
Immigrants and their 
children Digital Natives The former are still learning
the enormous potential of
these technologies in
adulthood, while the latter
have known nothing else"
pdf_image,MODULE 3_MindChange_part1#page=14#docs\pdf_images\MODULE 3_MindChange_part1\page_14_img2.png,M3-Q15,0.129,"Digital Native vs Digital Immigrants
Irrespective of the date 
of born, parents are most 
likely to be Digital 
Immigrants and their 
children Digital Natives The former are still learning
the enormous potential of
these technologies in
adulthood, while the latter
have known nothing else"
pdf_image,MODULE 3_MindChange_part1#page=14#docs\pdf_images\MODULE 3_MindChange_part1\page_14_img3.png,M3-Q15,0.129,"Digital Native vs Digital Immigrants
Irrespective of the date 
of born, parents are most 
likely to be Digital 
Immigrants and their 
children Digital Natives The former are still learning
the enormous potential of
these technologies in
adulthood, while the latter
have known nothing else"
pdf_image,MODULE 3_MindChange_part1#page=16#docs\pdf_images\MODULE 3_MindChange_part1\page_16_img1.png,M4-Q15,0.155,"Brain Changes
3D world 2D world
≠
human brain will adapt to 
whatever environment in 
which it is placed"
pdf_image,MODULE 3_MindChange_part1#page=16#docs\pdf_images\MODULE 3_MindChange_part1\page_16_img2.png,M4-Q15,0.155,"Brain Changes
3D world 2D world
≠
human brain will adapt to 
whatever environment in 
which it is placed"
pdf_image,MODULE 3_MindChange_part1#page=16#docs\pdf_images\MODULE 3_MindChange_part1\page_16_img3.png,M4-Q15,0.155,"Brain Changes
3D world 2D world
≠
human brain will adapt to 
whatever environment in 
which it is placed"
pdf_image,MODULE 3_MindChange_part1#page=16#docs\pdf_images\MODULE 3_MindChange_part1\page_16_img4.png,M4-Q15,0.155,"Brain Changes
3D world 2D world
≠
human brain will adapt to 
whatever environment in 
which it is placed"
pdf_image,MODULE 3_MindChange_part1#page=16#docs\pdf_images\MODULE 3_MindChange_part1\page_16_img5.png,M4-Q15,0.155,"Brain Changes
3D world 2D world
≠
human brain will adapt to 
whatever environment in 
which it is placed"
pdf_image,MODULE 3_MindChange_part1#page=16#docs\pdf_images\MODULE 3_MindChange_part1\page_16_img6.png,M4-Q15,0.155,"Brain Changes
3D world 2D world
≠
human brain will adapt to 
whatever environment in 
which it is placed"
pdf_image,MODULE 3_MindChange_part1#page=16#docs\pdf_images\MODULE 3_MindChange_part1\page_16_img7.png,M4-Q15,0.155,"Brain Changes
3D world 2D world
≠
human brain will adapt to 
whatever environment in 
which it is placed"
pdf_image,MODULE 3_MindChange_part1#page=16#docs\pdf_images\MODULE 3_MindChange_part1\page_16_img8.png,M4-Q15,0.155,"Brain Changes
3D world 2D world
≠
human brain will adapt to 
whatever environment in 
which it is placed"
pdf_image,MODULE 3_MindChange_part1#page=17#docs\pdf_images\MODULE 3_MindChange_part1\page_17_img1.png,M1-Q20,0.107,"Brain Changes
One leading expert in brain development, 
Bryan Kolb, sums up: “Anything that changes 
your brain, changes who you will be. Your 
brain is produced not just by your genes; it’s 
sculpted by a lifetime of experiences. 
Experience alters brain activity, which 
changes gene expression. An"
pdf_image,MODULE 3_MindChange_part1#page=18#docs\pdf_images\MODULE 3_MindChange_part1\page_18_img1.png,M1-Q13,0.162,"Brain Changes
Let’s see examples of this brain plasticity:
Kolb, B. (2009).
"
pdf_image,MODULE 3_MindChange_part1#page=18#docs\pdf_images\MODULE 3_MindChange_part1\page_18_img2.png,M1-Q13,0.162,"Brain Changes
Let’s see examples of this brain plasticity:
Kolb, B. (2009).
"
pdf_image,MODULE 3_MindChange_part1#page=18#docs\pdf_images\MODULE 3_MindChange_part1\page_18_img3.png,M1-Q13,0.162,"Brain Changes
Let’s see examples of this brain plasticity:
Kolb, B. (2009).
"
pdf_image,MODULE 3_MindChange_part1#page=18#docs\pdf_images\MODULE 3_MindChange_part1\page_18_img4.png,M1-Q13,0.162,"Brain Changes
Let’s see examples of this brain plasticity:
Kolb, B. (2009).
"
pdf_image,MODULE 3_MindChange_part1#page=18#docs\pdf_images\MODULE 3_MindChange_part1\page_18_img5.png,M1-Q13,0.162,"Brain Changes
Let’s see examples of this brain plasticity:
Kolb, B. (2009).
"
pdf_image,MODULE 3_MindChange_part1#page=18#docs\pdf_images\MODULE 3_MindChange_part1\page_18_img6.png,M1-Q13,0.162,"Brain Changes
Let’s see examples of this brain plasticity:
Kolb, B. (2009).
"
pdf_image,MODULE 3_MindChange_part1#page=18#docs\pdf_images\MODULE 3_MindChange_part1\page_18_img7.png,M1-Q13,0.162,"Brain Changes
Let’s see examples of this brain plasticity:
Kolb, B. (2009).
"
pdf_image,MODULE 3_MindChange_part1#page=19#docs\pdf_images\MODULE 3_MindChange_part1\page_19_img1.png,M1-Q20,0.132,"London taxi drivers 
For a rookie driver →2y 
after passing “the 
Knowledge” to become a 
good taxi driver!
Do London Taxi Drivers 
show physical changes in 
their brains as a result of 
the very daily use of their 
working memory?
Maguire et al (2000). Navigation-related structural change in the hi"
pdf_image,MODULE 3_MindChange_part1#page=19#docs\pdf_images\MODULE 3_MindChange_part1\page_19_img2.png,M1-Q20,0.132,"London taxi drivers 
For a rookie driver →2y 
after passing “the 
Knowledge” to become a 
good taxi driver!
Do London Taxi Drivers 
show physical changes in 
their brains as a result of 
the very daily use of their 
working memory?
Maguire et al (2000). Navigation-related structural change in the hi"
pdf_image,MODULE 3_MindChange_part1#page=20#docs\pdf_images\MODULE 3_MindChange_part1\page_20_img1.png,M1-Q29,0.105,"London taxi drivers 
Maguire et al (2000) 
Sagittal section of an MRI scan with the hippocampus
indicated by the red box. (a Right) Coronal section through 
the MRI scan, again with the hippocampi indicated. (b) The 
group results are shown superimposed onto the scan of an 
individual subject select"
pdf_image,MODULE 3_MindChange_part1#page=20#docs\pdf_images\MODULE 3_MindChange_part1\page_20_img2.png,M1-Q29,0.105,"London taxi drivers 
Maguire et al (2000) 
Sagittal section of an MRI scan with the hippocampus
indicated by the red box. (a Right) Coronal section through 
the MRI scan, again with the hippocampi indicated. (b) The 
group results are shown superimposed onto the scan of an 
individual subject select"
pdf_image,MODULE 3_MindChange_part1#page=21#docs\pdf_images\MODULE 3_MindChange_part1\page_21_img1.png,M4-Q22,0.096,"London taxi drivers 
Maguire et al (2000) 
Correlation of volume change with time as a taxi 
driver. (a Left) Sagittal section. (a Right) Coronal 
section. The voxel-based morphometry group 
results are shown superimposed onto the scan of 
an individual subject selected at random. The bar 
to the ri"
pdf_image,MODULE 3_MindChange_part1#page=21#docs\pdf_images\MODULE 3_MindChange_part1\page_21_img2.png,M4-Q22,0.096,"London taxi drivers 
Maguire et al (2000) 
Correlation of volume change with time as a taxi 
driver. (a Left) Sagittal section. (a Right) Coronal 
section. The voxel-based morphometry group 
results are shown superimposed onto the scan of 
an individual subject selected at random. The bar 
to the ri"
pdf_image,MODULE 3_MindChange_part1#page=22#docs\pdf_images\MODULE 3_MindChange_part1\page_22_img1.png,M3-Q10,0.104,"Training dogs and birds
• Changes in the brain as a result of experience were actually first 
shown as long ago as 1783 by the Swiss naturalist Charles Bonnet and 
the Michele Vincenzo Malacarne
• They discovered that training dogs and birds led to an increase in the 
number of folds in a part of th"
pdf_image,MODULE 3_MindChange_part1#page=23#docs\pdf_images\MODULE 3_MindChange_part1\page_23_img1.png,M1-Q20,0.081,"Visual Plasticity
• In the first years of life the brain has windows of opportunity, 
characterized by the exuberant growth of connections between neurons, 
which allows for astonishing possibilities.
• E.g. in infants the visual and auditory compartments of the cortex appear 
to be functionally int"
pdf_image,MODULE 3_MindChange_part1#page=24#docs\pdf_images\MODULE 3_MindChange_part1\page_24_img1.png,M1-Q20,0.079,"Musicians
• Musicians who play string instruments exercise their left hands more than 
their right and, in these players, the section of cortex related to touch is 
accordingly larger for the left hand than the right (right cortex, left hand).
• Study design: 
• Nine musicians (six violinists, two c"
pdf_image,MODULE 3_MindChange_part1#page=25#docs\pdf_images\MODULE 3_MindChange_part1\page_25_img1.png,M3-Q10,0.102,"Musicians
The section of cortex related to touch is accordingly larger for the left hand 
than the right. 
The data indicate that the center of cortical responsivity for tactile stimulation 
of the digits of the left hand was shifted in musicians as compared to that in 
controls. 
Elbert et al., (19"
pdf_image,MODULE 3_MindChange_part1#page=25#docs\pdf_images\MODULE 3_MindChange_part1\page_25_img2.png,M3-Q10,0.102,"Musicians
The section of cortex related to touch is accordingly larger for the left hand 
than the right. 
The data indicate that the center of cortical responsivity for tactile stimulation 
of the digits of the left hand was shifted in musicians as compared to that in 
controls. 
Elbert et al., (19"
pdf_image,MODULE 3_MindChange_part1#page=26#docs\pdf_images\MODULE 3_MindChange_part1\page_26_img1.png,M3-Q10,0.112,"Musicians
• Anatomical scans of professional musicians (keyboard players), 
amateur musicians, and nonmusicians showed size differences in a 
range of structures: motor, auditory, and visuo-spatial brain regions
• It’s worth noting that there are strong relationships between 
musician status and pra"
pdf_image,MODULE 3_MindChange_part1#page=27#docs\pdf_images\MODULE 3_MindChange_part1\page_27_img1.png,M1-Q20,0.115,"Training in Math
• Normal human subjects with no particular skill or talent are trained 
from scratch in some standardized experimental tasks
• The training to acquire or practicing to perform a skill, which may lead 
to structural changes in the brain, is called experience-dependent 
structural pla"
pdf_image,MODULE 3_MindChange_part1#page=28#docs\pdf_images\MODULE 3_MindChange_part1\page_28_img1.png,M4-Q11,0.110,"Training in Math
• Twenty-six volunteer mathematicians, who have been working as 
academicians, were enrolled in the study
• Authors assessed the gray and white matter density differences in 
mathematicians and the control subjects. Moreover, the correlation 
between the cortical density and the tim"
pdf_image,MODULE 3_MindChange_part1#page=29#docs\pdf_images\MODULE 3_MindChange_part1\page_29_img1.png,M3-Q10,0.103,"Training in Math
Aydin, K et al., (2007). Increased gray matter density in the parietal cortex of mathematicians: A voxel-based morphometry study. 
American Journal of Neuroradiology 28, no. 10, 1859–1864. 
Fig 2. A, The result of the regression analysis 
testing the correlation between gray matter "
pdf_image,MODULE 3_MindChange_part1#page=29#docs\pdf_images\MODULE 3_MindChange_part1\page_29_img2.png,M3-Q10,0.103,"Training in Math
Aydin, K et al., (2007). Increased gray matter density in the parietal cortex of mathematicians: A voxel-based morphometry study. 
American Journal of Neuroradiology 28, no. 10, 1859–1864. 
Fig 2. A, The result of the regression analysis 
testing the correlation between gray matter "
pdf_image,MODULE 3_MindChange_part1#page=30#docs\pdf_images\MODULE 3_MindChange_part1\page_30_img1.png,M1-Q29,0.100,"Training in Math
Aydin, K et al., (2007). Increased gray matter density in the parietal cortex of mathematicians: A voxel-based morphometry study. 
American Journal of Neuroradiology 28, no. 10, 1859–1864. 
Fig 2 B, The gray matter density values 
from the voxels showing the 
maximum correlation on "
pdf_image,MODULE 3_MindChange_part1#page=30#docs\pdf_images\MODULE 3_MindChange_part1\page_30_img2.png,M1-Q29,0.100,"Training in Math
Aydin, K et al., (2007). Increased gray matter density in the parietal cortex of mathematicians: A voxel-based morphometry study. 
American Journal of Neuroradiology 28, no. 10, 1859–1864. 
Fig 2 B, The gray matter density values 
from the voxels showing the 
maximum correlation on "
pdf_image,MODULE 3_MindChange_part1#page=31#docs\pdf_images\MODULE 3_MindChange_part1\page_31_img1.png,M3-Q10,0.081,"Training in juggling
• Subjects underwent daily training for three months to learn a three-
ball juggling task, where perception and anticipation were key to 
determining upcoming movements accurately. 
• Scans were performed before training, after three months of 
training, and then after another t"
pdf_image,MODULE 3_MindChange_part1#page=32#docs\pdf_images\MODULE 3_MindChange_part1\page_32_img1.png,M1-Q20,0.094,"Training in juggling
• Scans before training →no 
significant regional differences in 
grey matter between jugglers 
and non-jugglers
• Scans after training →the juggler 
group demonstrated a bilateral 
expansion in grey matter in the 
mid-temporal area and in the left 
posterior intraparietal sulcu"
pdf_image,MODULE 3_MindChange_part1#page=33#docs\pdf_images\MODULE 3_MindChange_part1\page_33_img1.png,M3-Q14,0.088,"Studies of enriched environments
• The earliest demonstration of the impact of the outside world was with 
what was eventually to be called an “enriched” environment and dates 
back to the 1940s
• Hebb took some of his lab rats home!! Home rats →superior problem 
solving compared to Lab rats.
• Mark"
pdf_image,MODULE 3_MindChange_part1#page=34#docs\pdf_images\MODULE 3_MindChange_part1\page_34_img1.png,M1-Q20,0.097,"Studies of enriched environments
The study conclusively demonstrated that mice living in such a stimulating environment
developed movement problems much later and with a far more modest degree of impairment. 
Even here, with a disorder linked to a single gene and in the less complex brains of mice, "
pdf_image,MODULE 3_MindChange_part1#page=35#docs\pdf_images\MODULE 3_MindChange_part1\page_35_img1.png,M1-Q12,0.135,"Conclusions
• Our brain is active and can change throughout our lifetime
• Different factors can contribute to these changings
Changing
Time (s)
Environments
Experiences
Deprivations
Life-style"
pdf_image,MODULE 3_MindChange_part1#page=35#docs\pdf_images\MODULE 3_MindChange_part1\page_35_img2.png,M1-Q12,0.135,"Conclusions
• Our brain is active and can change throughout our lifetime
• Different factors can contribute to these changings
Changing
Time (s)
Environments
Experiences
Deprivations
Life-style"
pdf_image,MODULE 3_MindChange_part1#page=35#docs\pdf_images\MODULE 3_MindChange_part1\page_35_img3.png,M1-Q12,0.135,"Conclusions
• Our brain is active and can change throughout our lifetime
• Different factors can contribute to these changings
Changing
Time (s)
Environments
Experiences
Deprivations
Life-style"
pdf_image,MODULE 3_MindChange_part1#page=35#docs\pdf_images\MODULE 3_MindChange_part1\page_35_img4.png,M1-Q12,0.135,"Conclusions
• Our brain is active and can change throughout our lifetime
• Different factors can contribute to these changings
Changing
Time (s)
Environments
Experiences
Deprivations
Life-style"
pdf_image,MODULE 3_MindChange_part1#page=36#docs\pdf_images\MODULE 3_MindChange_part1\page_36_img1.png,M3-Q06,0.132,"Brain Changes
3D world 2D world
≠< →
Considering the abovementioned evidences, it is clear that a decreased 
exposure to 3D world, along with a more exposure to a 2D worlds, will 
change our brain"
pdf_image,MODULE 3_MindChange_part1#page=36#docs\pdf_images\MODULE 3_MindChange_part1\page_36_img2.png,M3-Q06,0.132,"Brain Changes
3D world 2D world
≠< →
Considering the abovementioned evidences, it is clear that a decreased 
exposure to 3D world, along with a more exposure to a 2D worlds, will 
change our brain"
pdf_image,MODULE 3_MindChange_part1#page=36#docs\pdf_images\MODULE 3_MindChange_part1\page_36_img3.png,M3-Q06,0.132,"Brain Changes
3D world 2D world
≠< →
Considering the abovementioned evidences, it is clear that a decreased 
exposure to 3D world, along with a more exposure to a 2D worlds, will 
change our brain"
pdf_image,MODULE 3_MindChange_part1#page=36#docs\pdf_images\MODULE 3_MindChange_part1\page_36_img4.png,M3-Q06,0.132,"Brain Changes
3D world 2D world
≠< →
Considering the abovementioned evidences, it is clear that a decreased 
exposure to 3D world, along with a more exposure to a 2D worlds, will 
change our brain"
pdf_image,MODULE 3_MindChange_part1#page=36#docs\pdf_images\MODULE 3_MindChange_part1\page_36_img5.png,M3-Q06,0.132,"Brain Changes
3D world 2D world
≠< →
Considering the abovementioned evidences, it is clear that a decreased 
exposure to 3D world, along with a more exposure to a 2D worlds, will 
change our brain"
pdf_image,MODULE 3_MindChange_part1#page=36#docs\pdf_images\MODULE 3_MindChange_part1\page_36_img6.png,M3-Q06,0.132,"Brain Changes
3D world 2D world
≠< →
Considering the abovementioned evidences, it is clear that a decreased 
exposure to 3D world, along with a more exposure to a 2D worlds, will 
change our brain"
pdf_image,MODULE 3_MindChange_part1#page=36#docs\pdf_images\MODULE 3_MindChange_part1\page_36_img7.png,M3-Q06,0.132,"Brain Changes
3D world 2D world
≠< →
Considering the abovementioned evidences, it is clear that a decreased 
exposure to 3D world, along with a more exposure to a 2D worlds, will 
change our brain"
pdf_image,MODULE 3_MindChange_part1#page=36#docs\pdf_images\MODULE 3_MindChange_part1\page_36_img8.png,M3-Q06,0.132,"Brain Changes
3D world 2D world
≠< →
Considering the abovementioned evidences, it is clear that a decreased 
exposure to 3D world, along with a more exposure to a 2D worlds, will 
change our brain"
pdf_image,MODULE 3_MindChange_part1#page=37#docs\pdf_images\MODULE 3_MindChange_part1\page_37_img1.png,M1-Q20,0.131,"What do we do online? 
Meshi et al., (2015). The Emerging Neuroscience of Social Media. Trends in Cognitive Sciences, Vol.19, No.12 771-782.
http://dx.doi.org/10.1016/j.tics.2015.09.004"
pdf_image,MODULE 3_MindChange_part1#page=42#docs\pdf_images\MODULE 3_MindChange_part1\page_42_img1.png,M1-Q20,0.067,"Different “Selves”
True Self: notion introduced by Carl 
Rogers (1951). The true self is based on 
existing characteristics that need not 
necessarily be fully expressed in normal 
social life, perhaps because there are not 
necessarily occasions when they’ll be 
manifest; rather, they are imagined "
pdf_image,MODULE 3_MindChange_part1#page=46#docs\pdf_images\MODULE 3_MindChange_part1\page_46_img1.png,M1-Q20,0.115,"Sharing effect
RESULTS:
Connectivity of both the MPFC 
and CP , but not connectivity of the 
cACC, to other brain regions is 
associated with the degree of 
self-related sharing 
→the higher the connectivity the 
higher the degree of self-related 
sharing
Meshi et al., Scientific Report, 2016 
ROI:
"
pdf_image,MODULE 3_MindChange_part1#page=50#docs\pdf_images\MODULE 3_MindChange_part1\page_50_img1.png,M1-Q20,0.129,"Sharing effect
• As a species, we seem to have such a craving for self-disclosure that it 
could be considered a very basic part of the human psyche
• Harvard scientists have actually 
demonstrated that sharing personal 
information about oneself, as on social 
networking sites, activates the reward"
pdf_image,MODULE 3_MindChange_part1#page=50#docs\pdf_images\MODULE 3_MindChange_part1\page_50_img2.png,M1-Q20,0.129,"Sharing effect
• As a species, we seem to have such a craving for self-disclosure that it 
could be considered a very basic part of the human psyche
• Harvard scientists have actually 
demonstrated that sharing personal 
information about oneself, as on social 
networking sites, activates the reward"
pdf_image,MODULE 3_MindChange_part1#page=50#docs\pdf_images\MODULE 3_MindChange_part1\page_50_img3.png,M1-Q20,0.129,"Sharing effect
• As a species, we seem to have such a craving for self-disclosure that it 
could be considered a very basic part of the human psyche
• Harvard scientists have actually 
demonstrated that sharing personal 
information about oneself, as on social 
networking sites, activates the reward"
pdf_image,MODULE 3_MindChange_part1#page=51#docs\pdf_images\MODULE 3_MindChange_part1\page_51_img1.png,M4-Q06,0.097,"Sharing effect
• Astonishingly, the participants in this particular experiment were even 
willing to give up monetary rewards for the opportunity to talk about 
themselves
• The results also suggest that the 
existence of a reciprocal cyclical 
feedback for self-disclosure rewards 
and perpetuates t"
pdf_image,MODULE 3_MindChange_part1#page=51#docs\pdf_images\MODULE 3_MindChange_part1\page_51_img2.png,M4-Q06,0.097,"Sharing effect
• Astonishingly, the participants in this particular experiment were even 
willing to give up monetary rewards for the opportunity to talk about 
themselves
• The results also suggest that the 
existence of a reciprocal cyclical 
feedback for self-disclosure rewards 
and perpetuates t"
pdf_image,MODULE 3_MindChange_part1#page=51#docs\pdf_images\MODULE 3_MindChange_part1\page_51_img3.png,M4-Q06,0.097,"Sharing effect
• Astonishingly, the participants in this particular experiment were even 
willing to give up monetary rewards for the opportunity to talk about 
themselves
• The results also suggest that the 
existence of a reciprocal cyclical 
feedback for self-disclosure rewards 
and perpetuates t"
pdf_image,MODULE 3_MindChange_part1#page=52#docs\pdf_images\MODULE 3_MindChange_part1\page_52_img1.png,M4-Q22,0.135,"What do we do online? Which are the 
consequences?
Online activities
Share 
information
Add comments 
Interact with 
“friends”
Biological and psychological 
consequences
1. Change of the concept of identity
2. Change of the concept of privacy
3. Cerebral changes after sharing
4. “Like” effect and “d"
pdf_image,MODULE 3_MindChange_part1#page=53#docs\pdf_images\MODULE 3_MindChange_part1\page_53_img1.png,M1-Q20,0.115,"Like effect
• N = 32
• Age = 13-18
Sherman et al., 2016, Psychological Science 
• Aim: investigated a unique way in which adolescent peer influence occurs on 
social media. The authors developed a novel functional MRI (fMRI) paradigm 
to simulate Instagram, a popular social photo-sharing tool, and m"
pdf_image,MODULE 3_MindChange_part1#page=54#docs\pdf_images\MODULE 3_MindChange_part1\page_54_img1.png,M1-Q20,0.073,"Like effect
• Adolescents underwent fMRI 
while viewing photos 
ostensibly submitted to 
Instagram. 
• They were more likely to like 
photos depicted with many 
likes than photos with few 
likes.
• This finding showed the 
influence of virtual peer 
endorsement and held for both 
neutral photos and "
pdf_image,MODULE 3_MindChange_part1#page=54#docs\pdf_images\MODULE 3_MindChange_part1\page_54_img2.png,M1-Q20,0.073,"Like effect
• Adolescents underwent fMRI 
while viewing photos 
ostensibly submitted to 
Instagram. 
• They were more likely to like 
photos depicted with many 
likes than photos with few 
likes.
• This finding showed the 
influence of virtual peer 
endorsement and held for both 
neutral photos and "
pdf_image,MODULE 3_MindChange_part1#page=55#docs\pdf_images\MODULE 3_MindChange_part1\page_55_img1.png,M3-Q08,0.086,"Like effect
• Viewing photos with many 
(compared with few) likes was 
associated with greater
activity in neural regions 
implicated in reward 
processing, social cognition, 
imitation, and attention. 
• Areas: precuneus, medial 
prefrontal cortex, and 
hippocampus (Mars et al., 
2012; Zaki & Ochsn"
pdf_image,MODULE 3_MindChange_part1#page=56#docs\pdf_images\MODULE 3_MindChange_part1\page_56_img1.png,M1-Q20,0.093,"Like effect
• When participants viewed 
their own photographs or 
neutral photographs 
ostensibly submitted by 
peers, greater activity in 
the visual cortex was 
observed in response to 
photos with many likes 
compared with photos with 
few likes. 
• The increased activation 
suggests that partici"
pdf_image,MODULE 3_MindChange_part1#page=58#docs\pdf_images\MODULE 3_MindChange_part1\page_58_img1.png,M3-Q10,0.115,"Like effect
• This study replicates the previous one, adding information about 
brain imaging activation stratifying population by age.
• Mobile social media often feature the ability to “Like” content posted 
by others. The present study examined the effect of Likes on youths’ 
neural and behaviora"
pdf_image,MODULE 3_MindChange_part1#page=59#docs\pdf_images\MODULE 3_MindChange_part1\page_59_img1.png,M1-Q29,0.135,"Like effect
• First result: confirmation of previous data
• Participants more often Liked photos that appeared to have received 
many (vs. few) Likes. 
• Popular photos elicited greater activity in multiple brain regions, 
including the nucleus accumbens (Nacc), a hub of the brain’s reward 
circuitr"
pdf_image,MODULE 3_MindChange_part1#page=60#docs\pdf_images\MODULE 3_MindChange_part1\page_60_img1.png,M1-Q20,0.070,"Like effect
Second results:
Nucleus accumbens responsivity 
increased with age for high school but 
not college students
Figure 2. NAcc response to social reward and its relation to age
For participants in the high school cohort, NAcc response to the Popular 
(Many Likes) > Unpopular (Few Likes) con"
pdf_image,MODULE 3_MindChange_part1#page=61#docs\pdf_images\MODULE 3_MindChange_part1\page_61_img1.png,M1-Q20,0.096,"Like effect
Third result:
When viewing images depicting risk-
taking (vs. non-risky photographs), high 
school students, but not college students, 
showed decreased activation of neural 
regions implicated in cognitive control.
Figure 3. Differences in decreased activation for comparison of risky an"
pdf_image,MODULE 3_MindChange_part1#page=69#docs\pdf_images\MODULE 3_MindChange_part1\page_69_img1.png,M4-Q22,0.152,"Most popular social networks of teenagers in 
the United States from fall 2012 to fall 2019
© Statista 2020"
pdf_image,MODULE 3_MindChange_part1#page=73#docs\pdf_images\MODULE 3_MindChange_part1\page_73_img1.png,M1-Q20,0.100,"Social networking and brain
Do social networking map directly onto the 
physical brain?
The size of an individual’s online social network 
is closely linked to certain aspects of physical 
brain structures implicated in social cognition.
Kanai et al. found that variation in the number of 
friends on"
pdf_image,MODULE 3_MindChange_part1#page=73#docs\pdf_images\MODULE 3_MindChange_part1\page_73_img2.png,M1-Q20,0.100,"Social networking and brain
Do social networking map directly onto the 
physical brain?
The size of an individual’s online social network 
is closely linked to certain aspects of physical 
brain structures implicated in social cognition.
Kanai et al. found that variation in the number of 
friends on"
pdf_image,MODULE 3_MindChange_part1#page=74#docs\pdf_images\MODULE 3_MindChange_part1\page_74_img1.png,M1-Q29,0.080,"Social networking and brain
N = 40
Age: 12-30 years
Measures to establish social network extension:
1) Facebook friends
2) Dunbar’s Number (is a suggested cognitive limit to 
the number of people with whom one can 
maintain stable social relationships—relationships 
in which an individual knows who "
pdf_image,MODULE 3_MindChange_part1#page=74#docs\pdf_images\MODULE 3_MindChange_part1\page_74_img2.png,M1-Q29,0.080,"Social networking and brain
N = 40
Age: 12-30 years
Measures to establish social network extension:
1) Facebook friends
2) Dunbar’s Number (is a suggested cognitive limit to 
the number of people with whom one can 
maintain stable social relationships—relationships 
in which an individual knows who "
pdf_image,MODULE 3_MindChange_part1#page=75#docs\pdf_images\MODULE 3_MindChange_part1\page_75_img1.png,M1-Q20,0.111,"Social networking and brain
Kanai, R., Bahrami, B., Roylance, R., and Rees, G. (2011). Online social network size is reflected in human brain structure.
Proceedings of the Royal Society Biological Sciences 279, no. 1732, 1327–1334. doi:10:1098/rspb.2011:1959.
The gray matter
density of particular
br"
pdf_image,MODULE 3_MindChange_part1#page=75#docs\pdf_images\MODULE 3_MindChange_part1\page_75_img2.png,M1-Q20,0.111,"Social networking and brain
Kanai, R., Bahrami, B., Roylance, R., and Rees, G. (2011). Online social network size is reflected in human brain structure.
Proceedings of the Royal Society Biological Sciences 279, no. 1732, 1327–1334. doi:10:1098/rspb.2011:1959.
The gray matter
density of particular
br"
pdf_image,MODULE 3_MindChange_part1#page=77#docs\pdf_images\MODULE 3_MindChange_part1\page_77_img1.png,M4-Q17,0.108,"Changes in communication style
…the type of emotional support 
that can be provided by these 
forms of communication turns out 
to be very inferior.
Ofcom. (July 18, 2012). The communications market report 2012 
Although Digital Natives may prefer non-
oral communication through text 
messaging or t"
pdf_image,MODULE 3_MindChange_part1#page=77#docs\pdf_images\MODULE 3_MindChange_part1\page_77_img2.png,M4-Q17,0.108,"Changes in communication style
…the type of emotional support 
that can be provided by these 
forms of communication turns out 
to be very inferior.
Ofcom. (July 18, 2012). The communications market report 2012 
Although Digital Natives may prefer non-
oral communication through text 
messaging or t"
pdf_image,MODULE 3_MindChange_part1#page=78#docs\pdf_images\MODULE 3_MindChange_part1\page_78_img1.png,M3-Q10,0.121,"Changes in 
communication 
style
Speech between trusted individuals is capable of:
• reducing levels of salivary cortisol
• increasing levels of urinary oxytocin
Seltzer, L. J., Prososki, A. R., Ziegler, T. E., and Pollak, S. D. (2012). Instant messages vs. speech: Hormones and why we still need 
to"
pdf_image,MODULE 3_MindChange_part1#page=79#docs\pdf_images\MODULE 3_MindChange_part1\page_79_img1.png,M3-Q10,0.108,"Changes in 
communication 
style
It is not clear, however, whether it is the 
uniquely human grammar, syntax, content 
and/or choice of words that causes these 
physiological changes, or whether the 
prosodic elements of speech, which are 
present in the vocal cues of many other 
species, are respon"
pdf_image,MODULE 3_MindChange_part1#page=79#docs\pdf_images\MODULE 3_MindChange_part1\page_79_img2.png,M3-Q10,0.108,"Changes in 
communication 
style
It is not clear, however, whether it is the 
uniquely human grammar, syntax, content 
and/or choice of words that causes these 
physiological changes, or whether the 
prosodic elements of speech, which are 
present in the vocal cues of many other 
species, are respon"
pdf_image,MODULE 3_MindChange_part1#page=79#docs\pdf_images\MODULE 3_MindChange_part1\page_79_img3.png,M3-Q10,0.108,"Changes in 
communication 
style
It is not clear, however, whether it is the 
uniquely human grammar, syntax, content 
and/or choice of words that causes these 
physiological changes, or whether the 
prosodic elements of speech, which are 
present in the vocal cues of many other 
species, are respon"
pdf_image,MODULE 3_MindChange_part1#page=80#docs\pdf_images\MODULE 3_MindChange_part1\page_80_img1.png,M3-Q10,0.115,"Changes in 
communication 
style
Researchers at the University of Wisconsin–Madison asked the 
following question: could the content alone of an emotionally 
supportive conversation between a parent and a teenager convey
reassurance, or would the tone of voice and/or physical presence of 
the parent"
pdf_image,MODULE 3_MindChange_part1#page=81#docs\pdf_images\MODULE 3_MindChange_part1\page_81_img1.png,M4-Q15,0.121,"Changes in 
communication 
style
Seltzer, L. J., Prososki, A. R., Ziegler, T. E., and Pollak, S. D. (2012). Instant messages vs. speech: Hormones and why we still need 
to hear each other. Evolution and Human Behavior 33, 42–45. 
No support"
pdf_image,MODULE 3_MindChange_part1#page=81#docs\pdf_images\MODULE 3_MindChange_part1\page_81_img2.png,M4-Q15,0.121,"Changes in 
communication 
style
Seltzer, L. J., Prososki, A. R., Ziegler, T. E., and Pollak, S. D. (2012). Instant messages vs. speech: Hormones and why we still need 
to hear each other. Evolution and Human Behavior 33, 42–45. 
No support"
pdf_image,MODULE 3_MindChange_part1#page=81#docs\pdf_images\MODULE 3_MindChange_part1\page_81_img3.png,M4-Q15,0.121,"Changes in 
communication 
style
Seltzer, L. J., Prososki, A. R., Ziegler, T. E., and Pollak, S. D. (2012). Instant messages vs. speech: Hormones and why we still need 
to hear each other. Evolution and Human Behavior 33, 42–45. 
No support"
pdf_image,MODULE 3_MindChange_part1#page=81#docs\pdf_images\MODULE 3_MindChange_part1\page_81_img4.png,M4-Q15,0.121,"Changes in 
communication 
style
Seltzer, L. J., Prososki, A. R., Ziegler, T. E., and Pollak, S. D. (2012). Instant messages vs. speech: Hormones and why we still need 
to hear each other. Evolution and Human Behavior 33, 42–45. 
No support"
pdf_image,MODULE 3_MindChange_part1#page=82#docs\pdf_images\MODULE 3_MindChange_part1\page_82_img1.png,M3-Q07,0.166,"Changes in 
communication 
style"
pdf_image,MODULE 3_MindChange_part1#page=83#docs\pdf_images\MODULE 3_MindChange_part1\page_83_img1.png,M1-Q12,0.103,"Changes in 
communication 
style
Teenagers who spoke with 
their parents over the phone 
or in person released similar 
amounts of oxytocin and 
showed similar low levels of 
cortisol, indicative of a 
reduction in stress. In 
comparison, those who 
instant-messaged their 
parents released no oxytoc"
pdf_image,MODULE 3_MindChange_part1#page=83#docs\pdf_images\MODULE 3_MindChange_part1\page_83_img2.png,M1-Q12,0.103,"Changes in 
communication 
style
Teenagers who spoke with 
their parents over the phone 
or in person released similar 
amounts of oxytocin and 
showed similar low levels of 
cortisol, indicative of a 
reduction in stress. In 
comparison, those who 
instant-messaged their 
parents released no oxytoc"
pdf_image,MODULE 3_MindChange_part1#page=83#docs\pdf_images\MODULE 3_MindChange_part1\page_83_img3.png,M1-Q12,0.103,"Changes in 
communication 
style
Teenagers who spoke with 
their parents over the phone 
or in person released similar 
amounts of oxytocin and 
showed similar low levels of 
cortisol, indicative of a 
reduction in stress. In 
comparison, those who 
instant-messaged their 
parents released no oxytoc"
pdf_image,MODULE 3_MindChange_part1#page=84#docs\pdf_images\MODULE 3_MindChange_part1\page_84_img1.png,M1-Q12,0.103,"Changes in 
communication 
style
Teenagers who spoke with 
their parents over the phone 
or in person released similar 
amounts of oxytocin and 
showed similar low levels of 
cortisol, indicative of a 
reduction in stress. In 
comparison, those who 
instant-messaged their 
parents released no oxytoc"
pdf_image,MODULE 3_MindChange_part1#page=84#docs\pdf_images\MODULE 3_MindChange_part1\page_84_img2.png,M1-Q12,0.103,"Changes in 
communication 
style
Teenagers who spoke with 
their parents over the phone 
or in person released similar 
amounts of oxytocin and 
showed similar low levels of 
cortisol, indicative of a 
reduction in stress. In 
comparison, those who 
instant-messaged their 
parents released no oxytoc"
pdf_image,MODULE 3_MindChange_part1#page=84#docs\pdf_images\MODULE 3_MindChange_part1\page_84_img3.png,M1-Q12,0.103,"Changes in 
communication 
style
Teenagers who spoke with 
their parents over the phone 
or in person released similar 
amounts of oxytocin and 
showed similar low levels of 
cortisol, indicative of a 
reduction in stress. In 
comparison, those who 
instant-messaged their 
parents released no oxytoc"
pdf_image,MODULE 3_MindChange_part1#page=87#docs\pdf_images\MODULE 3_MindChange_part1\page_87_img1.png,M3-Q10,0.077,"Face processing is 
compromised 
Excessive Internet use is associated with a limited ability to 
communicate effectively socially, which depends largely on the capacity 
for perception of the human face. 
Authors used a passive visual detection paradigm to compare the early 
stages of the processing"
pdf_image,MODULE 3_MindChange_part1#page=88#docs\pdf_images\MODULE 3_MindChange_part1\page_88_img1.png,M1-Q01,0.188,"Face processing is 
compromised 
"
pdf_image,MODULE 3_MindChange_part1#page=88#docs\pdf_images\MODULE 3_MindChange_part1\page_88_img2.png,M1-Q01,0.188,"Face processing is 
compromised 
"
pdf_image,MODULE 3_MindChange_part1#page=89#docs\pdf_images\MODULE 3_MindChange_part1\page_89_img1.png,M1-Q29,0.071,"Face processing is 
compromised 
FIG. 2. Grand averaged ERPs 
elicited by upright faces and
tables at left and right 
occipital-temporal sites (A), 
2D topographic map of N170 
peak amplitude (B), and 
normalized values of the 
N170 face effect in EIUs and 
normal control groups (C).
The P1 and N170"
pdf_image,MODULE 3_MindChange_part1#page=89#docs\pdf_images\MODULE 3_MindChange_part1\page_89_img2.png,M1-Q29,0.071,"Face processing is 
compromised 
FIG. 2. Grand averaged ERPs 
elicited by upright faces and
tables at left and right 
occipital-temporal sites (A), 
2D topographic map of N170 
peak amplitude (B), and 
normalized values of the 
N170 face effect in EIUs and 
normal control groups (C).
The P1 and N170"
pdf_image,MODULE 3_MindChange_part1#page=89#docs\pdf_images\MODULE 3_MindChange_part1\page_89_img3.png,M1-Q29,0.071,"Face processing is 
compromised 
FIG. 2. Grand averaged ERPs 
elicited by upright faces and
tables at left and right 
occipital-temporal sites (A), 
2D topographic map of N170 
peak amplitude (B), and 
normalized values of the 
N170 face effect in EIUs and 
normal control groups (C).
The P1 and N170"
pdf_image,MODULE 3_MindChange_part1#page=92#docs\pdf_images\MODULE 3_MindChange_part1\page_92_img1.png,M3-Q08,0.115,"Nacc and 
online 
reputation
• The processing of gains in reputation (positive social feedback related to 
one’s character) occurs in the ventral striatum.
• Furthermore, discovering that others like us, or have provided general 
positive feedback about us, is also processed in the ventral striatum."
pdf_image,MODULE 3_MindChange_part1#page=93#docs\pdf_images\MODULE 3_MindChange_part1\page_93_img1.png,M1-Q29,0.102,"Nacc and online 
reputation
• In today’s world, we can obtain a good reputation in a variety of ways; for 
example, we can be polite to people or behave in a moral manner. We can 
also manage our reputation online via social media websites.
• Aim of the study: authors employed Facebook use as a prox"
pdf_image,MODULE 3_MindChange_part1#page=94#docs\pdf_images\MODULE 3_MindChange_part1\page_94_img1.png,M3-Q10,0.106,"Nacc and online 
reputation
• Authors recruited 31 healthy, right-handed participants (14 males) 
between 19 and 31 years of age
• Participants were told that between Day 1 and Day 2, the recorded video 
interview would be individually observed by 10 anonymous reviewers. 
• The participants were the"
pdf_image,MODULE 3_MindChange_part1#page=95#docs\pdf_images\MODULE 3_MindChange_part1\page_95_img1.png,M4-Q01,0.140,"Nacc and online 
reputation
"
pdf_image,MODULE 3_MindChange_part1#page=95#docs\pdf_images\MODULE 3_MindChange_part1\page_95_img2.png,M4-Q01,0.140,"Nacc and online 
reputation
"
pdf_image,MODULE 3_MindChange_part1#page=95#docs\pdf_images\MODULE 3_MindChange_part1\page_95_img3.png,M4-Q01,0.140,"Nacc and online 
reputation
"
pdf_image,MODULE 3_MindChange_part1#page=96#docs\pdf_images\MODULE 3_MindChange_part1\page_96_img1.png,M1-Q20,0.114,"Nacc and online 
reputation
Results:
1) self-relevant gains in reputation and 
monetary reward are processed in the 
ventral striatum
2) across participants, when responding to 
gains in reputation for the self, compared to 
observing gains for others, reward related 
activity in the left nucleus ac"
pdf_image,MODULE 3_MindChange_part1#page=97#docs\pdf_images\MODULE 3_MindChange_part1\page_97_img1.png,M3-Q10,0.149,"Role of Nacc
In the present study authors combined recorded Facebook usage from 
smartphones with structural brain scans that were obtained from each 
smartphone user at the beginning of the experiment. Here, they focused on 
the nucleus accumbens region that has been highlighted in the study by 
Me"
pdf_image,MODULE 3_MindChange_part1#page=98#docs\pdf_images\MODULE 3_MindChange_part1\page_98_img1.png,M3-Q14,0.129,"Role of Nacc
N =85 participants (46 males)
• Recorded the actual Facebook 
usage on their smartphones over 
the course of five weeks and 
correlated summary measures of 
Facebook use with gray matter 
volume of the nucleus 
accumbens.
"
pdf_image,MODULE 3_MindChange_part1#page=99#docs\pdf_images\MODULE 3_MindChange_part1\page_99_img1.png,M1-Q32,0.160,"Role of Nacc
Fig. 3. Distributions of the tracked Facebook variables from the smartphones of the participants."
pdf_image,MODULE 3_MindChange_part2#page=2#docs\pdf_images\MODULE 3_MindChange_part2\page_2_img1.png,M3-Q13,0.205,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
enlarged ventral 
striatum
AGGRESSION
"
pdf_image,MODULE 3_MindChange_part2#page=2#docs\pdf_images\MODULE 3_MindChange_part2\page_2_img2.png,M3-Q13,0.205,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
enlarged ventral 
striatum
AGGRESSION
"
pdf_image,MODULE 3_MindChange_part2#page=2#docs\pdf_images\MODULE 3_MindChange_part2\page_2_img3.png,M3-Q13,0.205,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
enlarged ventral 
striatum
AGGRESSION
"
pdf_image,MODULE 3_MindChange_part2#page=2#docs\pdf_images\MODULE 3_MindChange_part2\page_2_img4.png,M3-Q13,0.205,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
enlarged ventral 
striatum
AGGRESSION
"
pdf_image,MODULE 3_MindChange_part2#page=2#docs\pdf_images\MODULE 3_MindChange_part2\page_2_img5.png,M3-Q13,0.205,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
enlarged ventral 
striatum
AGGRESSION
"
pdf_image,MODULE 3_MindChange_part2#page=2#docs\pdf_images\MODULE 3_MindChange_part2\page_2_img6.png,M3-Q13,0.205,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
enlarged ventral 
striatum
AGGRESSION
"
pdf_image,MODULE 3_MindChange_part2#page=2#docs\pdf_images\MODULE 3_MindChange_part2\page_2_img7.png,M3-Q13,0.205,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
enlarged ventral 
striatum
AGGRESSION
"
pdf_image,MODULE 3_MindChange_part2#page=2#docs\pdf_images\MODULE 3_MindChange_part2\page_2_img8.png,M3-Q13,0.205,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
enlarged ventral 
striatum
AGGRESSION
"
pdf_image,MODULE 3_MindChange_part2#page=2#docs\pdf_images\MODULE 3_MindChange_part2\page_2_img9.png,M3-Q13,0.205,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
enlarged ventral 
striatum
AGGRESSION
"
pdf_image,MODULE 3_MindChange_part2#page=2#docs\pdf_images\MODULE 3_MindChange_part2\page_2_img10.png,M3-Q13,0.205,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
enlarged ventral 
striatum
AGGRESSION
"
pdf_image,MODULE 3_MindChange_part2#page=5#docs\pdf_images\MODULE 3_MindChange_part2\page_5_img1.png,M3-Q12,0.188,"Time on videogames
"
pdf_image,MODULE 3_MindChange_part2#page=6#docs\pdf_images\MODULE 3_MindChange_part2\page_6_img1.png,M3-Q12,0.200,"Videogame and the brain
What’s going on in our brain when we play videogames?
"
pdf_image,MODULE 3_MindChange_part2#page=6#docs\pdf_images\MODULE 3_MindChange_part2\page_6_img2.png,M3-Q12,0.200,"Videogame and the brain
What’s going on in our brain when we play videogames?
"
pdf_image,MODULE 3_MindChange_part2#page=6#docs\pdf_images\MODULE 3_MindChange_part2\page_6_img3.png,M3-Q12,0.200,"Videogame and the brain
What’s going on in our brain when we play videogames?
"
pdf_image,MODULE 3_MindChange_part2#page=7#docs\pdf_images\MODULE 3_MindChange_part2\page_7_img1.png,M3-Q10,0.117,"Videogame and the brain
• Aviv Weinstein at the Hadassah Medical Organization in Jerusalem 
believes that the craving for online gaming and the craving for 
substance dependence could well share the same neurobiological 
mechanism.
Weinstein, A., and Lejoyeux, M. (2010). Internet addiction or excess"
pdf_image,MODULE 3_MindChange_part2#page=8#docs\pdf_images\MODULE 3_MindChange_part2\page_8_img1.png,M3-Q10,0.121,"Craving hypothesis
• N = 9 abstinent “ecstasy” 
users and 8 control subjects 
• They were scanned at 
baseline and after 
performing on a motorbike 
riding computer game while 
imaging dopamine release in 
vivo with single photon 
emission computed  
tomography (SPECT)
Weinstein, A. M. (2010). Compu"
pdf_image,MODULE 3_MindChange_part2#page=8#docs\pdf_images\MODULE 3_MindChange_part2\page_8_img2.png,M3-Q10,0.121,"Craving hypothesis
• N = 9 abstinent “ecstasy” 
users and 8 control subjects 
• They were scanned at 
baseline and after 
performing on a motorbike 
riding computer game while 
imaging dopamine release in 
vivo with single photon 
emission computed  
tomography (SPECT)
Weinstein, A. M. (2010). Compu"
pdf_image,MODULE 3_MindChange_part2#page=9#docs\pdf_images\MODULE 3_MindChange_part2\page_9_img1.png,M1-Q29,0.126,"Craving hypothesis
• The brain imaging study showed that 
healthy control subjects had reduced 
dopamine D2 receptor occupancy of 
10.5% in the caudate after playing a 
motorbike riding computer game 
compared with baseline levels of 
binding consistent with increased 
release and binding to its rec"
pdf_image,MODULE 3_MindChange_part2#page=10#docs\pdf_images\MODULE 3_MindChange_part2\page_10_img1.png,M3-Q10,0.102,"Craving hypothesis
• For the nonaddicts experiencing the thrill 
of gaming, there was an increase in the 
release of dopamine that “desensitized” 
its receptors.
• But the brains of the Ecstasy addicts told 
a different story. Here chronic use of the 
drug had accustomed the brain to vast 
amounts o"
pdf_image,MODULE 3_MindChange_part2#page=12#docs\pdf_images\MODULE 3_MindChange_part2\page_12_img1.png,M4-Q23,0.129,"Chicken and eggs dilemma
individuals with brains that happen to have an enlarged 
ventral striatum are predisposed to gaming
excessive gaming has literally left its mark on the brain"
pdf_image,MODULE 3_MindChange_part2#page=12#docs\pdf_images\MODULE 3_MindChange_part2\page_12_img2.png,M4-Q23,0.129,"Chicken and eggs dilemma
individuals with brains that happen to have an enlarged 
ventral striatum are predisposed to gaming
excessive gaming has literally left its mark on the brain"
pdf_image,MODULE 3_MindChange_part2#page=12#docs\pdf_images\MODULE 3_MindChange_part2\page_12_img3.png,M4-Q23,0.129,"Chicken and eggs dilemma
individuals with brains that happen to have an enlarged 
ventral striatum are predisposed to gaming
excessive gaming has literally left its mark on the brain"
pdf_image,MODULE 3_MindChange_part2#page=13#docs\pdf_images\MODULE 3_MindChange_part2\page_13_img1.png,M1-Q29,0.133,"Chicken and eggs dilemma
• Let’s start with the chicken: that gaming, as with all life 
experiences, leaves its mark on the impressionable, 
plastic brain.
• According to Kuhn et al., the more time spent playing, 
the more pronounced the expansion of the striatum. 
This suggests the former caused th"
pdf_image,MODULE 3_MindChange_part2#page=14#docs\pdf_images\MODULE 3_MindChange_part2\page_14_img1.png,M4-Q16,0.089,"Gaming →mark in the 
brain
• N = 154, 14-years-old
• Division between: frequent and infrequent
• Moreover, they  assessed the Monetary Incentive Delay (MID) task 
during fMRI imaging and a Gambling Task (CGT)
• During the MID task, participants see cues that indicate that they may win or 
not win mo"
pdf_image,MODULE 3_MindChange_part2#page=15#docs\pdf_images\MODULE 3_MindChange_part2\page_15_img1.png,M1-Q20,0.099,"Results:
• higher left striatal grey matter volume when 
comparing frequent against infrequent video 
game players
• higher activity during loses
Conclusion:
• The key finding of higher volume in left ventral 
striatum associated with frequent video game 
playing is in conceptual accordance with 
fi"
pdf_image,MODULE 3_MindChange_part2#page=16#docs\pdf_images\MODULE 3_MindChange_part2\page_16_img1.png,M4-Q11,0.200,"• Considering the CGT task →negative correlation between the gray 
matter volume in the left ventral striatum and the deliberation time in 
the CGT
Gaming →mark in the 
brain"
pdf_image,MODULE 3_MindChange_part2#page=17#docs\pdf_images\MODULE 3_MindChange_part2\page_17_img1.png,M1-Q16,0.122,"• Considering the MID task →frequent compared with infrequent 
video game players showed enhanced activity during feedback of loss 
compared with no loss
Gaming →mark in the 
brain"
pdf_image,MODULE 3_MindChange_part2#page=18#docs\pdf_images\MODULE 3_MindChange_part2\page_18_img1.png,M3-Q10,0.121,"Chicken and eggs dilemma
• Then there’s the egg: the idea that a preexisting brain 
state might predispose individuals to compulsive gaming
• Kirk Erickson at the University of Illinois found a 
correlation between the volume of a key brain area, the 
dorsal striatum, and later training success in a"
pdf_image,MODULE 3_MindChange_part2#page=19#docs\pdf_images\MODULE 3_MindChange_part2\page_19_img1.png,M3-Q10,0.081,"Chicken and eggs dilemma
• Erickson has also described a link, again seen with imaging, 
between activation of the striatum before training and 
subsequent later skill acquisition during gaming. 
• These findings highlight the importance of the striatum, a 
rich source of dopamine, and how this migh"
pdf_image,MODULE 3_MindChange_part2#page=20#docs\pdf_images\MODULE 3_MindChange_part2\page_20_img1.png,M4-Q11,0.117,"Big striatum →more 
videogame
• N = 42 (age 15-28)
• Infrequent players (< 3 hours of video games a week during the 2 
years prior to the study)
• Participants were given instructions about the Space Fortress game 
and then, before game training, completed an MRI session 
• They were then given 20 h"
pdf_image,MODULE 3_MindChange_part2#page=22#docs\pdf_images\MODULE 3_MindChange_part2\page_22_img1.png,M3-Q15,0.130,"Big striatum →more videogame
RESULTS:
• hippocampal volumes 
did not predict learning 
improvement but 
striatal volumes did.
• The volumes of the 
dorsal striatum
predicted improvement 
in performance. 
• Both ventral and dorsal 
striatal volumes 
predicted early 
acquisition rates.
"
pdf_image,MODULE 3_MindChange_part2#page=23#docs\pdf_images\MODULE 3_MindChange_part2\page_23_img1.png,M1-Q20,0.112,"Striatum: the key area of the dilemma
• Striatum →structure divided into 2 parts: an upper (dorsal) zone and 
a lower (ventral) one. The latter releases more dopamine than the 
former
Drevets et al., (1999). PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum. 
Neu"
pdf_image,MODULE 3_MindChange_part2#page=23#docs\pdf_images\MODULE 3_MindChange_part2\page_23_img2.png,M1-Q20,0.112,"Striatum: the key area of the dilemma
• Striatum →structure divided into 2 parts: an upper (dorsal) zone and 
a lower (ventral) one. The latter releases more dopamine than the 
former
Drevets et al., (1999). PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum. 
Neu"
pdf_image,MODULE 3_MindChange_part2#page=24#docs\pdf_images\MODULE 3_MindChange_part2\page_24_img1.png,M1-Q29,0.096,"Striatum: the key area of the dilemma
So one way of resolving the 
chicken-and-egg problem 
might be to say that a brain 
predisposed to effective 
sensorimotor coordination, 
with an active dorsal 
striatum, will have a 
predisposition for gaming, 
while it is the games 
themselves that change the "
pdf_image,MODULE 3_MindChange_part2#page=24#docs\pdf_images\MODULE 3_MindChange_part2\page_24_img2.png,M1-Q29,0.096,"Striatum: the key area of the dilemma
So one way of resolving the 
chicken-and-egg problem 
might be to say that a brain 
predisposed to effective 
sensorimotor coordination, 
with an active dorsal 
striatum, will have a 
predisposition for gaming, 
while it is the games 
themselves that change the "
pdf_image,MODULE 3_MindChange_part2#page=24#docs\pdf_images\MODULE 3_MindChange_part2\page_24_img3.png,M1-Q29,0.096,"Striatum: the key area of the dilemma
So one way of resolving the 
chicken-and-egg problem 
might be to say that a brain 
predisposed to effective 
sensorimotor coordination, 
with an active dorsal 
striatum, will have a 
predisposition for gaming, 
while it is the games 
themselves that change the "
pdf_image,MODULE 3_MindChange_part2#page=25#docs\pdf_images\MODULE 3_MindChange_part2\page_25_img1.png,M1-Q20,0.104,"Dopamine as crucial contributor 
• A second way to solve the chicken-eggs problem is to 
consider the dopamine.
• Neuroscientists at Hammersmith Hospital in London 
have shown that playing videogames directly results 
in release of this neurotransmitter.
• Raised levels of dopamine are consistently "
pdf_image,MODULE 3_MindChange_part2#page=26#docs\pdf_images\MODULE 3_MindChange_part2\page_26_img1.png,M3-Q14,0.095,"Arousal of different videogames
• One investigation found different 
patterns of arousal in different 
types of gamers. 
• Those who played excessive 
amounts of first-person shooter 
videogames had significantly 
higher levels of arousal during 
gaming, which dropped off 
immediately after gaming. "
pdf_image,MODULE 3_MindChange_part2#page=27#docs\pdf_images\MODULE 3_MindChange_part2\page_27_img1.png,M4-Q22,0.103,"Arousal of different videogames
• MMORPG (Massive[ly] 
Multiplayer Online Role-Playing 
Game) players who gamed 
excessively displayed significant 
decreases in physiological
arousal, which rose again 
immediately after gaming.
• Meanwhile, MMORPG players 
who didn’tplay excessively
showed normal in"
pdf_image,MODULE 3_MindChange_part2#page=28#docs\pdf_images\MODULE 3_MindChange_part2\page_28_img1.png,M3-Q10,0.131,"Arousal of different videogames vs gambling
• These differences in arousal for gamers are comparable to those 
reported in the scientific literature on pathological gambling.
• There are the thrill-seeking, impulsive addicts who take stimulating 
substances or engage in high-risk behaviors; by contr"
pdf_image,MODULE 3_MindChange_part2#page=28#docs\pdf_images\MODULE 3_MindChange_part2\page_28_img2.png,M3-Q10,0.131,"Arousal of different videogames vs gambling
• These differences in arousal for gamers are comparable to those 
reported in the scientific literature on pathological gambling.
• There are the thrill-seeking, impulsive addicts who take stimulating 
substances or engage in high-risk behaviors; by contr"
pdf_image,MODULE 3_MindChange_part2#page=29#docs\pdf_images\MODULE 3_MindChange_part2\page_29_img1.png,M3-Q14,0.156,"Chicken and eggs complication applies
these disturbances in arousal regulation could be either a cause 
of gaming addiction
Or a consequence of it
"
pdf_image,MODULE 3_MindChange_part2#page=29#docs\pdf_images\MODULE 3_MindChange_part2\page_29_img2.png,M3-Q14,0.156,"Chicken and eggs complication applies
these disturbances in arousal regulation could be either a cause 
of gaming addiction
Or a consequence of it
"
pdf_image,MODULE 3_MindChange_part2#page=29#docs\pdf_images\MODULE 3_MindChange_part2\page_29_img3.png,M3-Q14,0.156,"Chicken and eggs complication applies
these disturbances in arousal regulation could be either a cause 
of gaming addiction
Or a consequence of it
"
pdf_image,MODULE 3_MindChange_part2#page=29#docs\pdf_images\MODULE 3_MindChange_part2\page_29_img4.png,M3-Q14,0.156,"Chicken and eggs complication applies
these disturbances in arousal regulation could be either a cause 
of gaming addiction
Or a consequence of it
"
pdf_image,MODULE 3_MindChange_part2#page=31#docs\pdf_images\MODULE 3_MindChange_part2\page_31_img1.png,M3-Q08,0.125,"Videogames and rewards
• MMORPGs have been studied because excessive gaming is most 
commonly seen in MMORPGs
• The reward structure built into the game influences the development 
of excessive gaming
• MMORPGs have intricate reward 
systems built into the games, with 
gamers constantly trying to re"
pdf_image,MODULE 3_MindChange_part2#page=33#docs\pdf_images\MODULE 3_MindChange_part2\page_33_img1.png,M3-Q11,0.180,"From free time to aggression
A crucial point related to videogames is related to aggression
"
pdf_image,MODULE 3_MindChange_part2#page=33#docs\pdf_images\MODULE 3_MindChange_part2\page_33_img2.png,M3-Q11,0.180,"From free time to aggression
A crucial point related to videogames is related to aggression
"
pdf_image,MODULE 3_MindChange_part2#page=34#docs\pdf_images\MODULE 3_MindChange_part2\page_34_img1.png,M3-Q10,0.192,"Is there a link between aggression and 
videogames?
Violent videogames
Especially “realistic” video games
Increase aggression Increase aggression in real life
??? ???"
pdf_image,MODULE 3_MindChange_part2#page=34#docs\pdf_images\MODULE 3_MindChange_part2\page_34_img2.png,M3-Q10,0.192,"Is there a link between aggression and 
videogames?
Violent videogames
Especially “realistic” video games
Increase aggression Increase aggression in real life
??? ???"
pdf_image,MODULE 3_MindChange_part2#page=34#docs\pdf_images\MODULE 3_MindChange_part2\page_34_img3.png,M3-Q10,0.192,"Is there a link between aggression and 
videogames?
Violent videogames
Especially “realistic” video games
Increase aggression Increase aggression in real life
??? ???"
pdf_image,MODULE 3_MindChange_part2#page=35#docs\pdf_images\MODULE 3_MindChange_part2\page_35_img1.png,M3-Q10,0.080,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• This study tested the hypothesis that 
violent video games are especially likely 
to increase aggression when players 
identify with violent game characters
• N = 112 Dutch adolescent boys with low 
education ability
• were randomly assigned to play a 
real"
pdf_image,MODULE 3_MindChange_part2#page=36#docs\pdf_images\MODULE 3_MindChange_part2\page_36_img1.png,M3-Q08,0.129,"• After the videogame, participants competed with an ostensible 
(pretended) partner on a reaction time task in which the winner could 
blast the loser with loud noise through headphones, which served as 
the measure of aggression.
• Participants were told, wrongly, that high noise levels could caus"
pdf_image,MODULE 3_MindChange_part2#page=36#docs\pdf_images\MODULE 3_MindChange_part2\page_36_img2.png,M3-Q08,0.129,"• After the videogame, participants competed with an ostensible 
(pretended) partner on a reaction time task in which the winner could 
blast the loser with loud noise through headphones, which served as 
the measure of aggression.
• Participants were told, wrongly, that high noise levels could caus"
pdf_image,MODULE 3_MindChange_part2#page=37#docs\pdf_images\MODULE 3_MindChange_part2\page_37_img1.png,M3-Q10,0.096,"→MEASURE OF AGGRESSION
VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
Konijn, E. A., Nije Bijvank, M., and Bushman, B. J. (2007). I wish I were a 
warrior: The role of wishful identification in the effects of violent 
videogames on aggression in adolescent boys. Developmental Psychology 
43, no. 4, 1038–1"
pdf_image,MODULE 3_MindChange_part2#page=37#docs\pdf_images\MODULE 3_MindChange_part2\page_37_img2.png,M3-Q10,0.096,"→MEASURE OF AGGRESSION
VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
Konijn, E. A., Nije Bijvank, M., and Bushman, B. J. (2007). I wish I were a 
warrior: The role of wishful identification in the effects of violent 
videogames on aggression in adolescent boys. Developmental Psychology 
43, no. 4, 1038–1"
pdf_image,MODULE 3_MindChange_part2#page=40#docs\pdf_images\MODULE 3_MindChange_part2\page_40_img1.png,M3-Q10,0.079,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• This study investigates the hostile 
expectation bias (i.e., tendency to 
perceive hostile intent on the part of 
others).
• N = 136 French college students
• They played either a violent or 
nonviolent game for 20 minutes.
• Afterwards, they read ambiguous"
pdf_image,MODULE 3_MindChange_part2#page=40#docs\pdf_images\MODULE 3_MindChange_part2\page_40_img2.png,M3-Q10,0.079,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• This study investigates the hostile 
expectation bias (i.e., tendency to 
perceive hostile intent on the part of 
others).
• N = 136 French college students
• They played either a violent or 
nonviolent game for 20 minutes.
• Afterwards, they read ambiguous"
pdf_image,MODULE 3_MindChange_part2#page=40#docs\pdf_images\MODULE 3_MindChange_part2\page_40_img3.png,M3-Q10,0.079,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• This study investigates the hostile 
expectation bias (i.e., tendency to 
perceive hostile intent on the part of 
others).
• N = 136 French college students
• They played either a violent or 
nonviolent game for 20 minutes.
• Afterwards, they read ambiguous"
pdf_image,MODULE 3_MindChange_part2#page=40#docs\pdf_images\MODULE 3_MindChange_part2\page_40_img4.png,M3-Q10,0.079,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• This study investigates the hostile 
expectation bias (i.e., tendency to 
perceive hostile intent on the part of 
others).
• N = 136 French college students
• They played either a violent or 
nonviolent game for 20 minutes.
• Afterwards, they read ambiguous"
pdf_image,MODULE 3_MindChange_part2#page=40#docs\pdf_images\MODULE 3_MindChange_part2\page_40_img5.png,M3-Q10,0.079,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• This study investigates the hostile 
expectation bias (i.e., tendency to 
perceive hostile intent on the part of 
others).
• N = 136 French college students
• They played either a violent or 
nonviolent game for 20 minutes.
• Afterwards, they read ambiguous"
pdf_image,MODULE 3_MindChange_part2#page=41#docs\pdf_images\MODULE 3_MindChange_part2\page_41_img1.png,M3-Q08,0.063,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Finally, participants were told that they 
would compete with an opponent 
(actually a confederate) on a 25-trial 
computer game in which they had to 
respond to a visual cue faster than their 
partner, with the loser receiving a noise 
blast through a pair"
pdf_image,MODULE 3_MindChange_part2#page=41#docs\pdf_images\MODULE 3_MindChange_part2\page_41_img2.png,M3-Q08,0.063,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Finally, participants were told that they 
would compete with an opponent 
(actually a confederate) on a 25-trial 
computer game in which they had to 
respond to a visual cue faster than their 
partner, with the loser receiving a noise 
blast through a pair"
pdf_image,MODULE 3_MindChange_part2#page=42#docs\pdf_images\MODULE 3_MindChange_part2\page_42_img1.png,M3-Q10,0.102,"• As hypothesized, video game violence 
increased the hostile expectation bias, 
which, in turn, increased aggression.
• Effects were larger for men than 
women. 
• Thus one reason why violent games 
increase aggression is because they 
increase hostile expectations.
VIDEOGAMES, AGGRESSION,
AND RECK"
pdf_image,MODULE 3_MindChange_part2#page=42#docs\pdf_images\MODULE 3_MindChange_part2\page_42_img2.png,M3-Q10,0.102,"• As hypothesized, video game violence 
increased the hostile expectation bias, 
which, in turn, increased aggression.
• Effects were larger for men than 
women. 
• Thus one reason why violent games 
increase aggression is because they 
increase hostile expectations.
VIDEOGAMES, AGGRESSION,
AND RECK"
pdf_image,MODULE 3_MindChange_part2#page=42#docs\pdf_images\MODULE 3_MindChange_part2\page_42_img3.png,M3-Q10,0.102,"• As hypothesized, video game violence 
increased the hostile expectation bias, 
which, in turn, increased aggression.
• Effects were larger for men than 
women. 
• Thus one reason why violent games 
increase aggression is because they 
increase hostile expectations.
VIDEOGAMES, AGGRESSION,
AND RECK"
pdf_image,MODULE 3_MindChange_part2#page=42#docs\pdf_images\MODULE 3_MindChange_part2\page_42_img4.png,M3-Q10,0.102,"• As hypothesized, video game violence 
increased the hostile expectation bias, 
which, in turn, increased aggression.
• Effects were larger for men than 
women. 
• Thus one reason why violent games 
increase aggression is because they 
increase hostile expectations.
VIDEOGAMES, AGGRESSION,
AND RECK"
pdf_image,MODULE 3_MindChange_part2#page=43#docs\pdf_images\MODULE 3_MindChange_part2\page_43_img1.png,M4-Q15,0.169,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Moreover, these effects seem to 
increase and last for several days. 
"
pdf_image,MODULE 3_MindChange_part2#page=43#docs\pdf_images\MODULE 3_MindChange_part2\page_43_img2.png,M4-Q15,0.169,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Moreover, these effects seem to 
increase and last for several days. 
"
pdf_image,MODULE 3_MindChange_part2#page=43#docs\pdf_images\MODULE 3_MindChange_part2\page_43_img3.png,M4-Q15,0.169,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Moreover, these effects seem to 
increase and last for several days. 
"
pdf_image,MODULE 3_MindChange_part2#page=43#docs\pdf_images\MODULE 3_MindChange_part2\page_43_img4.png,M4-Q15,0.169,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Moreover, these effects seem to 
increase and last for several days. 
"
pdf_image,MODULE 3_MindChange_part2#page=43#docs\pdf_images\MODULE 3_MindChange_part2\page_43_img5.png,M4-Q15,0.169,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Moreover, these effects seem to 
increase and last for several days. 
"
pdf_image,MODULE 3_MindChange_part2#page=44#docs\pdf_images\MODULE 3_MindChange_part2\page_44_img1.png,M3-Q10,0.117,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• The present study investigates 
whether violent games increase 
aggression by inducing stress in 
players. Stress was measured using 
cardiac coherence, defined as the 
synchronization of the rhythm of 
breathing to the rhythm of the heart.
• Authors predic"
pdf_image,MODULE 3_MindChange_part2#page=44#docs\pdf_images\MODULE 3_MindChange_part2\page_44_img2.png,M3-Q10,0.117,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• The present study investigates 
whether violent games increase 
aggression by inducing stress in 
players. Stress was measured using 
cardiac coherence, defined as the 
synchronization of the rhythm of 
breathing to the rhythm of the heart.
• Authors predic"
pdf_image,MODULE 3_MindChange_part2#page=44#docs\pdf_images\MODULE 3_MindChange_part2\page_44_img3.png,M3-Q10,0.117,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• The present study investigates 
whether violent games increase 
aggression by inducing stress in 
players. Stress was measured using 
cardiac coherence, defined as the 
synchronization of the rhythm of 
breathing to the rhythm of the heart.
• Authors predic"
pdf_image,MODULE 3_MindChange_part2#page=44#docs\pdf_images\MODULE 3_MindChange_part2\page_44_img4.png,M3-Q10,0.117,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• The present study investigates 
whether violent games increase 
aggression by inducing stress in 
players. Stress was measured using 
cardiac coherence, defined as the 
synchronization of the rhythm of 
breathing to the rhythm of the heart.
• Authors predic"
pdf_image,MODULE 3_MindChange_part2#page=44#docs\pdf_images\MODULE 3_MindChange_part2\page_44_img5.png,M3-Q10,0.117,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• The present study investigates 
whether violent games increase 
aggression by inducing stress in 
players. Stress was measured using 
cardiac coherence, defined as the 
synchronization of the rhythm of 
breathing to the rhythm of the heart.
• Authors predic"
pdf_image,MODULE 3_MindChange_part2#page=44#docs\pdf_images\MODULE 3_MindChange_part2\page_44_img6.png,M3-Q10,0.117,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• The present study investigates 
whether violent games increase 
aggression by inducing stress in 
players. Stress was measured using 
cardiac coherence, defined as the 
synchronization of the rhythm of 
breathing to the rhythm of the heart.
• Authors predic"
pdf_image,MODULE 3_MindChange_part2#page=45#docs\pdf_images\MODULE 3_MindChange_part2\page_45_img1.png,M3-Q11,0.176,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
"
pdf_image,MODULE 3_MindChange_part2#page=45#docs\pdf_images\MODULE 3_MindChange_part2\page_45_img2.png,M3-Q11,0.176,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
"
pdf_image,MODULE 3_MindChange_part2#page=46#docs\pdf_images\MODULE 3_MindChange_part2\page_46_img1.png,M1-Q12,0.080,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
As expected, violent video game players had lower 
cardiac coherence levels and higher aggression levels 
than did nonviolent game players. 
This research offers another possible reason why violent 
games can increase aggression—by inducing stress. 
Cardiac c"
pdf_image,MODULE 3_MindChange_part2#page=46#docs\pdf_images\MODULE 3_MindChange_part2\page_46_img2.png,M1-Q12,0.080,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
As expected, violent video game players had lower 
cardiac coherence levels and higher aggression levels 
than did nonviolent game players. 
This research offers another possible reason why violent 
games can increase aggression—by inducing stress. 
Cardiac c"
pdf_image,MODULE 3_MindChange_part2#page=50#docs\pdf_images\MODULE 3_MindChange_part2\page_50_img1.png,M1-Q20,0.100,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• INTRODUCTION of the STUDY: Past research 
shows that violent video game exposure 
increases aggressive thoughts, angry 
feelings, physiological arousal, aggressive 
behaviors, and decreases helpful behaviors. 
Carnagey et al., (2007). The effect of videogam"
pdf_image,MODULE 3_MindChange_part2#page=51#docs\pdf_images\MODULE 3_MindChange_part2\page_51_img1.png,M3-Q14,0.092,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 257 college students
• Divided in 2 groups: violent or nonviolent video games
• They played video games for 20m
• Next, participants watched a 10-min videotape containing scenes of 
real-life violence while heart rate (HR) and galvanic skin response (GS"
pdf_image,MODULE 3_MindChange_part2#page=52#docs\pdf_images\MODULE 3_MindChange_part2\page_52_img1.png,M3-Q14,0.134,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
Carnagey et al., (2007). The effect of videogame violence on physiological desensitization to real-life violence. Journal of 
Experimental Social Psychology 43, no. 3, 489–496 
Participants who previously played a violent video game had 
lower HR while viewin"
pdf_image,MODULE 3_MindChange_part2#page=52#docs\pdf_images\MODULE 3_MindChange_part2\page_52_img2.png,M3-Q14,0.134,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
Carnagey et al., (2007). The effect of videogame violence on physiological desensitization to real-life violence. Journal of 
Experimental Social Psychology 43, no. 3, 489–496 
Participants who previously played a violent video game had 
lower HR while viewin"
pdf_image,MODULE 3_MindChange_part2#page=53#docs\pdf_images\MODULE 3_MindChange_part2\page_53_img1.png,M3-Q14,0.114,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
Carnagey et al., (2007). The effect of videogame violence on physiological desensitization to real-life violence. Journal of 
Experimental Social Psychology 43, no. 3, 489–496 
Participants who previously played a violent video game had 
lower GSR while viewi"
pdf_image,MODULE 3_MindChange_part2#page=53#docs\pdf_images\MODULE 3_MindChange_part2\page_53_img2.png,M3-Q14,0.114,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
Carnagey et al., (2007). The effect of videogame violence on physiological desensitization to real-life violence. Journal of 
Experimental Social Psychology 43, no. 3, 489–496 
Participants who previously played a violent video game had 
lower GSR while viewi"
pdf_image,MODULE 3_MindChange_part2#page=54#docs\pdf_images\MODULE 3_MindChange_part2\page_54_img1.png,M3-Q14,0.117,"General Aggression Model
Carnagey et al., (2007). The effect of videogame violence on physiological desensitization to real-life violence. Journal of 
Experimental Social Psychology 43, no. 3, 489–496 
Aggressive behavior is based on the learning,
activation, and application of aggression-related 
k"
pdf_image,MODULE 3_MindChange_part2#page=54#docs\pdf_images\MODULE 3_MindChange_part2\page_54_img2.png,M3-Q14,0.117,"General Aggression Model
Carnagey et al., (2007). The effect of videogame violence on physiological desensitization to real-life violence. Journal of 
Experimental Social Psychology 43, no. 3, 489–496 
Aggressive behavior is based on the learning,
activation, and application of aggression-related 
k"
pdf_image,MODULE 3_MindChange_part2#page=55#docs\pdf_images\MODULE 3_MindChange_part2\page_55_img1.png,M3-Q12,0.180,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Playing violent videogames has consequences on our behaviors. What 
about our brain?
behaviors
???"
pdf_image,MODULE 3_MindChange_part2#page=55#docs\pdf_images\MODULE 3_MindChange_part2\page_55_img2.png,M3-Q12,0.180,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Playing violent videogames has consequences on our behaviors. What 
about our brain?
behaviors
???"
pdf_image,MODULE 3_MindChange_part2#page=55#docs\pdf_images\MODULE 3_MindChange_part2\page_55_img3.png,M3-Q12,0.180,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• Playing violent videogames has consequences on our behaviors. What 
about our brain?
behaviors
???"
pdf_image,MODULE 3_MindChange_part2#page=56#docs\pdf_images\MODULE 3_MindChange_part2\page_56_img1.png,M1-Q29,0.079,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 13 experienced gamers (18–26 years; average 14 hrs/week playing
• Watching violent scenes caused a change in activity in certain areas of their brains, and 
specifically one particular area, the rostral anterior cingulate. This area is normally active 
"
pdf_image,MODULE 3_MindChange_part2#page=56#docs\pdf_images\MODULE 3_MindChange_part2\page_56_img2.png,M1-Q29,0.079,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 13 experienced gamers (18–26 years; average 14 hrs/week playing
• Watching violent scenes caused a change in activity in certain areas of their brains, and 
specifically one particular area, the rostral anterior cingulate. This area is normally active 
"
pdf_image,MODULE 3_MindChange_part2#page=56#docs\pdf_images\MODULE 3_MindChange_part2\page_56_img3.png,M1-Q29,0.079,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 13 experienced gamers (18–26 years; average 14 hrs/week playing
• Watching violent scenes caused a change in activity in certain areas of their brains, and 
specifically one particular area, the rostral anterior cingulate. This area is normally active 
"
pdf_image,MODULE 3_MindChange_part2#page=57#docs\pdf_images\MODULE 3_MindChange_part2\page_57_img1.png,M1-Q12,0.104,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 13 experienced gamers (18–26 years; average 14 hrs/week playing
• Gaming was also correlated with the deactivation of the amygdala, a brain region 
normally linked to emotionally charged memory, such that decreased activity in 
this area would lead to t"
pdf_image,MODULE 3_MindChange_part2#page=57#docs\pdf_images\MODULE 3_MindChange_part2\page_57_img2.png,M1-Q12,0.104,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 13 experienced gamers (18–26 years; average 14 hrs/week playing
• Gaming was also correlated with the deactivation of the amygdala, a brain region 
normally linked to emotionally charged memory, such that decreased activity in 
this area would lead to t"
pdf_image,MODULE 3_MindChange_part2#page=57#docs\pdf_images\MODULE 3_MindChange_part2\page_57_img3.png,M1-Q12,0.104,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 13 experienced gamers (18–26 years; average 14 hrs/week playing
• Gaming was also correlated with the deactivation of the amygdala, a brain region 
normally linked to emotionally charged memory, such that decreased activity in 
this area would lead to t"
pdf_image,MODULE 3_MindChange_part2#page=58#docs\pdf_images\MODULE 3_MindChange_part2\page_58_img1.png,M1-Q20,0.103,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 13 experienced gamers (18–26 years; average 14 hrs/week playing
• The brains of the gamers were therefore less sensitive and less 
emotionally reactive to discrepant actions, such as sudden violence
Mathiak et al., (2006). Toward brain correlates of nat"
pdf_image,MODULE 3_MindChange_part2#page=58#docs\pdf_images\MODULE 3_MindChange_part2\page_58_img2.png,M1-Q20,0.103,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 13 experienced gamers (18–26 years; average 14 hrs/week playing
• The brains of the gamers were therefore less sensitive and less 
emotionally reactive to discrepant actions, such as sudden violence
Mathiak et al., (2006). Toward brain correlates of nat"
pdf_image,MODULE 3_MindChange_part2#page=58#docs\pdf_images\MODULE 3_MindChange_part2\page_58_img3.png,M1-Q20,0.103,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 13 experienced gamers (18–26 years; average 14 hrs/week playing
• The brains of the gamers were therefore less sensitive and less 
emotionally reactive to discrepant actions, such as sudden violence
Mathiak et al., (2006). Toward brain correlates of nat"
pdf_image,MODULE 3_MindChange_part2#page=59#docs\pdf_images\MODULE 3_MindChange_part2\page_59_img1.png,M4-Q09,0.070,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 13 male research participants 
were observed playing a latest-
generation violent video game 
(Tactical Ops: Assault on Terror). 
Weber et al., (2006). Does playing violent videogames induce aggression? Empirical evidence of a functional magnetic 
reson"
pdf_image,MODULE 3_MindChange_part2#page=59#docs\pdf_images\MODULE 3_MindChange_part2\page_59_img2.png,M4-Q09,0.070,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
• N = 13 male research participants 
were observed playing a latest-
generation violent video game 
(Tactical Ops: Assault on Terror). 
Weber et al., (2006). Does playing violent videogames induce aggression? Empirical evidence of a functional magnetic 
reson"
pdf_image,MODULE 3_MindChange_part2#page=60#docs\pdf_images\MODULE 3_MindChange_part2\page_60_img1.png,M1-Q20,0.097,"VIDEOGAMES, AGGRESSION,
AND RECKLESSNESS
Results: 
• Areas of the brain linked with emotion and empathy 
(again the rostral cingulate cortex and the amygdala) 
were less active during violent gaming
• The authors suggest that these areas must be 
suppressed during violent gaming, just as they would "
pdf_image,MODULE 3_MindChange_part2#page=64#docs\pdf_images\MODULE 3_MindChange_part2\page_64_img1.png,M3-Q07,0.094,"Videogames and attention
• N = 3000 children and adolescents tracked 
over 3 years
RESULTS:
• Children who spent more time gaming had 
more attention problems
• Children who were more impulsive or had 
more attention problems subsequently spent 
more time playing videogames
Gentile et al., (2012). V"
pdf_image,MODULE 3_MindChange_part2#page=65#docs\pdf_images\MODULE 3_MindChange_part2\page_65_img1.png,M4-Q22,0.094,"Something good…
• Research shows that gamers make 
excellent drone pilots, and even 
outperform real pilots on certain 
tasks. 
• In the same spirit, scientists at the 
Duke School of Medicine have 
investigated just how effectively 
skilled gamers might eventually 
become highly proficient drone 
p"
pdf_image,MODULE 3_MindChange_part2#page=66#docs\pdf_images\MODULE 3_MindChange_part2\page_66_img1.png,M3-Q10,0.113,"Something good…
• N = 130 individuals (18–
53 years)
• Divided in 2 groups:
• Action video game 
players
• Non video game players
• Task: identify letters in 
specific positions of the 
screen
Appelbaum et al., (2013). Action videogame playing is associated with improved visual sensitivity, but not "
pdf_image,MODULE 3_MindChange_part2#page=67#docs\pdf_images\MODULE 3_MindChange_part2\page_67_img1.png,M1-Q12,0.117,"• The experienced gamers beat 
their rookie counterparts, 
proving that they could 
respond to visual stimuli 
much more quickly
• “Gamers see the world 
differently. They are able to 
extract more information 
from a visual scene,” 
Appelbaum concludes. “They 
need less information to 
arrive at a "
pdf_image,MODULE 3_MindChange_part2#page=67#docs\pdf_images\MODULE 3_MindChange_part2\page_67_img2.png,M1-Q12,0.117,"• The experienced gamers beat 
their rookie counterparts, 
proving that they could 
respond to visual stimuli 
much more quickly
• “Gamers see the world 
differently. They are able to 
extract more information 
from a visual scene,” 
Appelbaum concludes. “They 
need less information to 
arrive at a "
pdf_image,MODULE 3_MindChange_part2#page=68#docs\pdf_images\MODULE 3_MindChange_part2\page_68_img1.png,M3-Q10,0.073,"Screen and visual attention
• They were interested in whether 
learning could improve performance in 
different tasks other than those on 
which the training was focused
• Subjects were aged between 18 and 23 
years. Divided in 2 groups: 
• 5 experiments: 
• experiment 1–4 included only males 
• in "
pdf_image,MODULE 3_MindChange_part2#page=69#docs\pdf_images\MODULE 3_MindChange_part2\page_69_img1.png,M4-Q07,0.151,"Screen and visual attention
the habitual videogame players (VGPs) 
outperformed the rookies (NVGPs)
"
pdf_image,MODULE 3_MindChange_part2#page=69#docs\pdf_images\MODULE 3_MindChange_part2\page_69_img2.png,M4-Q07,0.151,"Screen and visual attention
the habitual videogame players (VGPs) 
outperformed the rookies (NVGPs)
"
pdf_image,MODULE 3_MindChange_part2#page=69#docs\pdf_images\MODULE 3_MindChange_part2\page_69_img3.png,M4-Q07,0.151,"Screen and visual attention
the habitual videogame players (VGPs) 
outperformed the rookies (NVGPs)
"
pdf_image,MODULE 3_MindChange_part2#page=70#docs\pdf_images\MODULE 3_MindChange_part2\page_70_img1.png,M3-Q10,0.123,"Screen and visual attention
• Most significant, however, was that in a 
final experiment (experiment 5) the 
nonplayers who had been subsequently 
trained on an action videogame showed 
a marked improvement that transferred 
to skills well beyond the training task
Green and Bavelier (2003). Action v"
pdf_image,MODULE 3_MindChange_part2#page=73#docs\pdf_images\MODULE 3_MindChange_part2\page_73_img1.png,M4-Q07,0.153,"Screen and visual attention
"
pdf_image,MODULE 3_MindChange_part3#page=2#docs\pdf_images\MODULE 3_MindChange_part3\page_2_img1.png,M3-Q16,0.159,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part3#page=2#docs\pdf_images\MODULE 3_MindChange_part3\page_2_img2.png,M3-Q16,0.159,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part3#page=2#docs\pdf_images\MODULE 3_MindChange_part3\page_2_img3.png,M3-Q16,0.159,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part3#page=2#docs\pdf_images\MODULE 3_MindChange_part3\page_2_img4.png,M3-Q16,0.159,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part3#page=2#docs\pdf_images\MODULE 3_MindChange_part3\page_2_img5.png,M3-Q16,0.159,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part3#page=2#docs\pdf_images\MODULE 3_MindChange_part3\page_2_img6.png,M3-Q16,0.159,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part3#page=2#docs\pdf_images\MODULE 3_MindChange_part3\page_2_img7.png,M3-Q16,0.159,"Conceptual mapConceptual map
Change of the world Change of the brain
FREE TIME
LEARNING
1) Memory →google effect
2) Searching
3) Reading
4) Multitasking
"
pdf_image,MODULE 3_MindChange_part3#page=3#docs\pdf_images\MODULE 3_MindChange_part3\page_3_img1.png,M3-Q13,0.149,"Search information
"
pdf_image,MODULE 3_MindChange_part3#page=3#docs\pdf_images\MODULE 3_MindChange_part3\page_3_img2.png,M3-Q13,0.149,"Search information
"
pdf_image,MODULE 3_MindChange_part3#page=3#docs\pdf_images\MODULE 3_MindChange_part3\page_3_img3.png,M3-Q13,0.149,"Search information
"
pdf_image,MODULE 3_MindChange_part3#page=3#docs\pdf_images\MODULE 3_MindChange_part3\page_3_img4.png,M3-Q13,0.149,"Search information
"
pdf_image,MODULE 3_MindChange_part3#page=3#docs\pdf_images\MODULE 3_MindChange_part3\page_3_img5.png,M3-Q13,0.149,"Search information
"
pdf_image,MODULE 3_MindChange_part3#page=4#docs\pdf_images\MODULE 3_MindChange_part3\page_4_img1.png,M3-Q16,0.122,"Google effect
• The present research explores 
whether having online access 
to search engines and
databases has become a 
primary transactive memory 
source in itself.
• Authors designed 4 different 
experiments:
EXPERIMENT 1
EXPERIMENT 2
EXPERIMENT 3
EXPERIMENT 4"
pdf_image,MODULE 3_MindChange_part3#page=5#docs\pdf_images\MODULE 3_MindChange_part3\page_5_img1.png,M3-Q08,0.127,"Google effect
EXPERIMENT 1:
• participants were tested in two 
within-subject conditions
• they answered either easy or 
hard yes/no trivia questions in 
two blocks. 
PIZZA
SCREEN
Question: Which is the capital of Karnataka?
Modified Stroop test to text RTs
Answer:  …                                "
pdf_image,MODULE 3_MindChange_part3#page=5#docs\pdf_images\MODULE 3_MindChange_part3\page_5_img2.png,M3-Q08,0.127,"Google effect
EXPERIMENT 1:
• participants were tested in two 
within-subject conditions
• they answered either easy or 
hard yes/no trivia questions in 
two blocks. 
PIZZA
SCREEN
Question: Which is the capital of Karnataka?
Modified Stroop test to text RTs
Answer:  …                                "
pdf_image,MODULE 3_MindChange_part3#page=5#docs\pdf_images\MODULE 3_MindChange_part3\page_5_img3.png,M3-Q08,0.127,"Google effect
EXPERIMENT 1:
• participants were tested in two 
within-subject conditions
• they answered either easy or 
hard yes/no trivia questions in 
two blocks. 
PIZZA
SCREEN
Question: Which is the capital of Karnataka?
Modified Stroop test to text RTs
Answer:  …                                "
pdf_image,MODULE 3_MindChange_part3#page=5#docs\pdf_images\MODULE 3_MindChange_part3\page_5_img4.png,M3-Q08,0.127,"Google effect
EXPERIMENT 1:
• participants were tested in two 
within-subject conditions
• they answered either easy or 
hard yes/no trivia questions in 
two blocks. 
PIZZA
SCREEN
Question: Which is the capital of Karnataka?
Modified Stroop test to text RTs
Answer:  …                                "
pdf_image,MODULE 3_MindChange_part3#page=5#docs\pdf_images\MODULE 3_MindChange_part3\page_5_img5.png,M3-Q08,0.127,"Google effect
EXPERIMENT 1:
• participants were tested in two 
within-subject conditions
• they answered either easy or 
hard yes/no trivia questions in 
two blocks. 
PIZZA
SCREEN
Question: Which is the capital of Karnataka?
Modified Stroop test to text RTs
Answer:  …                                "
pdf_image,MODULE 3_MindChange_part3#page=6#docs\pdf_images\MODULE 3_MindChange_part3\page_6_img1.png,M3-Q16,0.120,"Google effect
EXPERIMENT 1:
• Each block was followed by a 
modified Stroop task to test 
reaction times to matched 
computer (e.g. presentation of 
wards such as “screen”, or 
“google”) and everyday terms.
< RTs for naming the color of interested 
words
PIZZA
SCREEN"
pdf_image,MODULE 3_MindChange_part3#page=6#docs\pdf_images\MODULE 3_MindChange_part3\page_6_img2.png,M3-Q16,0.120,"Google effect
EXPERIMENT 1:
• Each block was followed by a 
modified Stroop task to test 
reaction times to matched 
computer (e.g. presentation of 
wards such as “screen”, or 
“google”) and everyday terms.
< RTs for naming the color of interested 
words
PIZZA
SCREEN"
pdf_image,MODULE 3_MindChange_part3#page=6#docs\pdf_images\MODULE 3_MindChange_part3\page_6_img3.png,M3-Q16,0.120,"Google effect
EXPERIMENT 1:
• Each block was followed by a 
modified Stroop task to test 
reaction times to matched 
computer (e.g. presentation of 
wards such as “screen”, or 
“google”) and everyday terms.
< RTs for naming the color of interested 
words
PIZZA
SCREEN"
pdf_image,MODULE 3_MindChange_part3#page=7#docs\pdf_images\MODULE 3_MindChange_part3\page_7_img1.png,M3-Q08,0.106,"Google effect
EXPERIMENT 1:
• Paired within-subject t tests were 
conducted on color-naming reaction 
times to computer and general words 
after the easy and difficult question 
blocks.
• RESULTS: computer words were more 
accessible then general words when 
participants had encountered a series 
of"
pdf_image,MODULE 3_MindChange_part3#page=7#docs\pdf_images\MODULE 3_MindChange_part3\page_7_img2.png,M3-Q08,0.106,"Google effect
EXPERIMENT 1:
• Paired within-subject t tests were 
conducted on color-naming reaction 
times to computer and general words 
after the easy and difficult question 
blocks.
• RESULTS: computer words were more 
accessible then general words when 
participants had encountered a series 
of"
pdf_image,MODULE 3_MindChange_part3#page=7#docs\pdf_images\MODULE 3_MindChange_part3\page_7_img3.png,M3-Q08,0.106,"Google effect
EXPERIMENT 1:
• Paired within-subject t tests were 
conducted on color-naming reaction 
times to computer and general words 
after the easy and difficult question 
blocks.
• RESULTS: computer words were more 
accessible then general words when 
participants had encountered a series 
of"
pdf_image,MODULE 3_MindChange_part3#page=8#docs\pdf_images\MODULE 3_MindChange_part3\page_8_img1.png,M1-Q20,0.096,"Google effect
EXPERIMENT 2:
• Authors tested whether people 
remembered information that 
they expected to have later 
access to 
• Participants had to read 40 
statements. 
• Participants divided in 2 groups:
• Half of them were led to believe 
the statements would be saved and 
available to look u"
pdf_image,MODULE 3_MindChange_part3#page=8#docs\pdf_images\MODULE 3_MindChange_part3\page_8_img2.png,M1-Q20,0.096,"Google effect
EXPERIMENT 2:
• Authors tested whether people 
remembered information that 
they expected to have later 
access to 
• Participants had to read 40 
statements. 
• Participants divided in 2 groups:
• Half of them were led to believe 
the statements would be saved and 
available to look u"
pdf_image,MODULE 3_MindChange_part3#page=8#docs\pdf_images\MODULE 3_MindChange_part3\page_8_img3.png,M1-Q20,0.096,"Google effect
EXPERIMENT 2:
• Authors tested whether people 
remembered information that 
they expected to have later 
access to 
• Participants had to read 40 
statements. 
• Participants divided in 2 groups:
• Half of them were led to believe 
the statements would be saved and 
available to look u"
pdf_image,MODULE 3_MindChange_part3#page=9#docs\pdf_images\MODULE 3_MindChange_part3\page_9_img1.png,M1-Q29,0.119,"Google effect
EXPERIMENT 2:
• RESULTS: Participants apparently 
did not make the effort to 
remember when they thought 
they could later look up the 
trivia statements they had read. 
• CONCLUSIONS: Because search 
engines are continually available 
to us, we may often be in a state 
of not feeling "
pdf_image,MODULE 3_MindChange_part3#page=9#docs\pdf_images\MODULE 3_MindChange_part3\page_9_img2.png,M1-Q29,0.119,"Google effect
EXPERIMENT 2:
• RESULTS: Participants apparently 
did not make the effort to 
remember when they thought 
they could later look up the 
trivia statements they had read. 
• CONCLUSIONS: Because search 
engines are continually available 
to us, we may often be in a state 
of not feeling "
pdf_image,MODULE 3_MindChange_part3#page=9#docs\pdf_images\MODULE 3_MindChange_part3\page_9_img3.png,M1-Q29,0.119,"Google effect
EXPERIMENT 2:
• RESULTS: Participants apparently 
did not make the effort to 
remember when they thought 
they could later look up the 
trivia statements they had read. 
• CONCLUSIONS: Because search 
engines are continually available 
to us, we may often be in a state 
of not feeling "
pdf_image,MODULE 3_MindChange_part3#page=10#docs\pdf_images\MODULE 3_MindChange_part3\page_10_img1.png,M4-Q11,0.105,"Google effect
EXPERIMENT 3:
• Authors tested memory for where
to find information that one might 
look up online.
• Participants again red and typed in 
statements, this time in three 
within subject conditions:
1/3 questions →“Your entry 
has been saved in a general folder.”
1/3 questions →“Your en"
pdf_image,MODULE 3_MindChange_part3#page=10#docs\pdf_images\MODULE 3_MindChange_part3\page_10_img2.png,M4-Q11,0.105,"Google effect
EXPERIMENT 3:
• Authors tested memory for where
to find information that one might 
look up online.
• Participants again red and typed in 
statements, this time in three 
within subject conditions:
1/3 questions →“Your entry 
has been saved in a general folder.”
1/3 questions →“Your en"
pdf_image,MODULE 3_MindChange_part3#page=10#docs\pdf_images\MODULE 3_MindChange_part3\page_10_img3.png,M4-Q11,0.105,"Google effect
EXPERIMENT 3:
• Authors tested memory for where
to find information that one might 
look up online.
• Participants again red and typed in 
statements, this time in three 
within subject conditions:
1/3 questions →“Your entry 
has been saved in a general folder.”
1/3 questions →“Your en"
pdf_image,MODULE 3_MindChange_part3#page=10#docs\pdf_images\MODULE 3_MindChange_part3\page_10_img4.png,M4-Q11,0.105,"Google effect
EXPERIMENT 3:
• Authors tested memory for where
to find information that one might 
look up online.
• Participants again red and typed in 
statements, this time in three 
within subject conditions:
1/3 questions →“Your entry 
has been saved in a general folder.”
1/3 questions →“Your en"
pdf_image,MODULE 3_MindChange_part3#page=11#docs\pdf_images\MODULE 3_MindChange_part3\page_11_img1.png,M1-Q12,0.103,"Google effect
EXPERIMENT 3:
• Recognition trial: 
Participants had to judge yes or no 
1) whether the statement they were 
now shown was exactly what they 
had read
2) whether the statement had been 
saved or erased, and finally,
3) if the statement had been saved 
to a folder, which folder it had b"
pdf_image,MODULE 3_MindChange_part3#page=12#docs\pdf_images\MODULE 3_MindChange_part3\page_12_img1.png,M3-Q16,0.111,"Google effect
EXPERIMENT 3:
“Was this statement exactly what you 
read?” 
RESULTS: Participants recognized the 
accuracy of a large proportion of 
statements. But for those statements 
they believed had been erased, 
participants had the best memory.
CONCLUSION: believing that one won’t 
have access"
pdf_image,MODULE 3_MindChange_part3#page=13#docs\pdf_images\MODULE 3_MindChange_part3\page_13_img1.png,M3-Q16,0.117,"Google effect
EXPERIMENT 3:
“Was this statement saved or erased?”
RESULTS: Participants accurately 
remembered what they had saved more 
than they accurately remembered what they 
had erased.
CONCLUSION:  believing the information 
was saved externally enhances memory for 
the fact that the informat"
pdf_image,MODULE 3_MindChange_part3#page=14#docs\pdf_images\MODULE 3_MindChange_part3\page_14_img1.png,M1-Q20,0.094,"Google effect
EXPERIMENT 3:
“If the information was saved, what
folder was it saved into?”
RESULTS: Participants did remember more that the information 
was erased than specifically whether the information was 
generally saved or which folder it was saved into.
CONCLUSION: This result is a reminder "
pdf_image,MODULE 3_MindChange_part3#page=15#docs\pdf_images\MODULE 3_MindChange_part3\page_15_img1.png,M1-Q29,0.125,"Google effect
EXPERIMENT 4: 
• Was conducted to see if 
people would recall “where”
to find information more than 
the information itself (“what”)
• Participants believed all trivia 
statements that they typed 
would be saved into one of 
five generic folders
Statement: The capital of Karnataka is B"
pdf_image,MODULE 3_MindChange_part3#page=15#docs\pdf_images\MODULE 3_MindChange_part3\page_15_img2.png,M1-Q29,0.125,"Google effect
EXPERIMENT 4: 
• Was conducted to see if 
people would recall “where”
to find information more than 
the information itself (“what”)
• Participants believed all trivia 
statements that they typed 
would be saved into one of 
five generic folders
Statement: The capital of Karnataka is B"
pdf_image,MODULE 3_MindChange_part3#page=15#docs\pdf_images\MODULE 3_MindChange_part3\page_15_img3.png,M1-Q29,0.125,"Google effect
EXPERIMENT 4: 
• Was conducted to see if 
people would recall “where”
to find information more than 
the information itself (“what”)
• Participants believed all trivia 
statements that they typed 
would be saved into one of 
five generic folders
Statement: The capital of Karnataka is B"
pdf_image,MODULE 3_MindChange_part3#page=16#docs\pdf_images\MODULE 3_MindChange_part3\page_16_img1.png,M1-Q12,0.102,"Google effect
EXPERIMENT 4:
RESULTS: 
• When asked to recall the folder names, 
they did so at greater rates than they 
recalled the trivia statements themselves. 
• A deeper analysis revealed that people do 
not necessarily remember where to find 
certain information when they 
remember what it was"
pdf_image,MODULE 3_MindChange_part3#page=16#docs\pdf_images\MODULE 3_MindChange_part3\page_16_img2.png,M1-Q12,0.102,"Google effect
EXPERIMENT 4:
RESULTS: 
• When asked to recall the folder names, 
they did so at greater rates than they 
recalled the trivia statements themselves. 
• A deeper analysis revealed that people do 
not necessarily remember where to find 
certain information when they 
remember what it was"
pdf_image,MODULE 3_MindChange_part3#page=16#docs\pdf_images\MODULE 3_MindChange_part3\page_16_img3.png,M1-Q12,0.102,"Google effect
EXPERIMENT 4:
RESULTS: 
• When asked to recall the folder names, 
they did so at greater rates than they 
recalled the trivia statements themselves. 
• A deeper analysis revealed that people do 
not necessarily remember where to find 
certain information when they 
remember what it was"
pdf_image,MODULE 3_MindChange_part3#page=17#docs\pdf_images\MODULE 3_MindChange_part3\page_17_img1.png,M1-Q12,0.161,"• The Internet has become a 
primary form of external or 
transactive memory, where 
information is stored 
collectively outside ourselves.
• Google can “affect” memory… 
which kind of memory?
Google effect
"
pdf_image,MODULE 3_MindChange_part3#page=18#docs\pdf_images\MODULE 3_MindChange_part3\page_18_img1.png,M4-Q05,0.137,"Different memories
• Nondeclarative memory (or implicit or procedural memory)
• Declarative (or explicit) memory
• Episodic
• Semantic
"
pdf_image,MODULE 3_MindChange_part3#page=18#docs\pdf_images\MODULE 3_MindChange_part3\page_18_img2.png,M4-Q05,0.137,"Different memories
• Nondeclarative memory (or implicit or procedural memory)
• Declarative (or explicit) memory
• Episodic
• Semantic
"
pdf_image,MODULE 3_MindChange_part3#page=18#docs\pdf_images\MODULE 3_MindChange_part3\page_18_img3.png,M4-Q05,0.137,"Different memories
• Nondeclarative memory (or implicit or procedural memory)
• Declarative (or explicit) memory
• Episodic
• Semantic
"
pdf_image,MODULE 3_MindChange_part3#page=18#docs\pdf_images\MODULE 3_MindChange_part3\page_18_img4.png,M4-Q05,0.137,"Different memories
• Nondeclarative memory (or implicit or procedural memory)
• Declarative (or explicit) memory
• Episodic
• Semantic
"
pdf_image,MODULE 3_MindChange_part3#page=19#docs\pdf_images\MODULE 3_MindChange_part3\page_19_img1.png,M1-Q16,0.100,"Googling
• Using computer search engines to find information on the Internet 
has become a frequent daily activity of people at any age, including 
middle aged and older adults.
• Cross-sectional, exploratory observational study
• N = 24 (age 55-76)
N = 12 →Net Naive group (minimal search 
engine ex"
pdf_image,MODULE 3_MindChange_part3#page=20#docs\pdf_images\MODULE 3_MindChange_part3\page_20_img1.png,M3-Q10,0.129,"•Task: Patterns of brain activation during functional MRI 
scanning were determined while subjects performed 
1. a novel Internet search task
Googling
2.   or a control task of reading text on a 
computer screen formatted to simulate 
the prototypic layout of a printed book
 Read 
this text"
pdf_image,MODULE 3_MindChange_part3#page=20#docs\pdf_images\MODULE 3_MindChange_part3\page_20_img2.png,M3-Q10,0.129,"•Task: Patterns of brain activation during functional MRI 
scanning were determined while subjects performed 
1. a novel Internet search task
Googling
2.   or a control task of reading text on a 
computer screen formatted to simulate 
the prototypic layout of a printed book
 Read 
this text"
pdf_image,MODULE 3_MindChange_part3#page=20#docs\pdf_images\MODULE 3_MindChange_part3\page_20_img3.png,M3-Q10,0.129,"•Task: Patterns of brain activation during functional MRI 
scanning were determined while subjects performed 
1. a novel Internet search task
Googling
2.   or a control task of reading text on a 
computer screen formatted to simulate 
the prototypic layout of a printed book
 Read 
this text"
pdf_image,MODULE 3_MindChange_part3#page=21#docs\pdf_images\MODULE 3_MindChange_part3\page_21_img1.png,M3-Q08,0.135,"While the brains of the two groups 
showed similar patterns of 
activation during the text reading 
task…
Googling
Read 
this text
…the activation patterns were 
markedly different during the 
Internet search task"
pdf_image,MODULE 3_MindChange_part3#page=21#docs\pdf_images\MODULE 3_MindChange_part3\page_21_img2.png,M3-Q08,0.135,"While the brains of the two groups 
showed similar patterns of 
activation during the text reading 
task…
Googling
Read 
this text
…the activation patterns were 
markedly different during the 
Internet search task"
pdf_image,MODULE 3_MindChange_part3#page=21#docs\pdf_images\MODULE 3_MindChange_part3\page_21_img3.png,M3-Q08,0.135,"While the brains of the two groups 
showed similar patterns of 
activation during the text reading 
task…
Googling
Read 
this text
…the activation patterns were 
markedly different during the 
Internet search task"
pdf_image,MODULE 3_MindChange_part3#page=22#docs\pdf_images\MODULE 3_MindChange_part3\page_22_img1.png,M1-Q20,0.139,"• The brain scans of the Net-naive group 
showed an activation pattern similar to that 
of their text reading task.
• Net-savvy group demonstrated significant 
increases in activity in additional regions 
that control decision making, complex 
reasoning, and vision
• After only five days of spending"
pdf_image,MODULE 3_MindChange_part3#page=22#docs\pdf_images\MODULE 3_MindChange_part3\page_22_img2.png,M1-Q20,0.139,"• The brain scans of the Net-naive group 
showed an activation pattern similar to that 
of their text reading task.
• Net-savvy group demonstrated significant 
increases in activity in additional regions 
that control decision making, complex 
reasoning, and vision
• After only five days of spending"
pdf_image,MODULE 3_MindChange_part3#page=22#docs\pdf_images\MODULE 3_MindChange_part3\page_22_img3.png,M1-Q20,0.139,"• The brain scans of the Net-naive group 
showed an activation pattern similar to that 
of their text reading task.
• Net-savvy group demonstrated significant 
increases in activity in additional regions 
that control decision making, complex 
reasoning, and vision
• After only five days of spending"
pdf_image,MODULE 3_MindChange_part3#page=23#docs\pdf_images\MODULE 3_MindChange_part3\page_23_img1.png,M1-Q12,0.115,"When we search information we organize facts
Connections 
between facts
Highlight 
concepts
Create 
maps
History
Hyperlinks
Key words
VideosAudio"
pdf_image,MODULE 3_MindChange_part3#page=23#docs\pdf_images\MODULE 3_MindChange_part3\page_23_img2.png,M1-Q12,0.115,"When we search information we organize facts
Connections 
between facts
Highlight 
concepts
Create 
maps
History
Hyperlinks
Key words
VideosAudio"
pdf_image,MODULE 3_MindChange_part3#page=23#docs\pdf_images\MODULE 3_MindChange_part3\page_23_img3.png,M1-Q12,0.115,"When we search information we organize facts
Connections 
between facts
Highlight 
concepts
Create 
maps
History
Hyperlinks
Key words
VideosAudio"
pdf_image,MODULE 3_MindChange_part3#page=23#docs\pdf_images\MODULE 3_MindChange_part3\page_23_img4.png,M1-Q12,0.115,"When we search information we organize facts
Connections 
between facts
Highlight 
concepts
Create 
maps
History
Hyperlinks
Key words
VideosAudio"
pdf_image,MODULE 3_MindChange_part3#page=24#docs\pdf_images\MODULE 3_MindChange_part3\page_24_img1.png,M3-Q10,0.127,"Internet 
exploration
• As a type of hypermedia, the Internet combines graphics, 
audio, video, text and hyperlinks in an interactive and 
nonlinear environment. 
• Users must decide how to find information, what 
information to read, which hyperlinks to followand 
when to modify behaviours. 
• Cons"
pdf_image,MODULE 3_MindChange_part3#page=24#docs\pdf_images\MODULE 3_MindChange_part3\page_24_img2.png,M3-Q10,0.127,"Internet 
exploration
• As a type of hypermedia, the Internet combines graphics, 
audio, video, text and hyperlinks in an interactive and 
nonlinear environment. 
• Users must decide how to find information, what 
information to read, which hyperlinks to followand 
when to modify behaviours. 
• Cons"
pdf_image,MODULE 3_MindChange_part3#page=25#docs\pdf_images\MODULE 3_MindChange_part3\page_25_img1.png,M3-Q10,0.106,"Internet 
exploration
• Researchers have identified that learners with low
domain knowledge, on average, have exhibited little or 
no learning gains after studying from hypermedia 
environments, including the Internet
• In general, attention has been regarded as a major 
influence on the information"
pdf_image,MODULE 3_MindChange_part3#page=25#docs\pdf_images\MODULE 3_MindChange_part3\page_25_img2.png,M3-Q10,0.106,"Internet 
exploration
• Researchers have identified that learners with low
domain knowledge, on average, have exhibited little or 
no learning gains after studying from hypermedia 
environments, including the Internet
• In general, attention has been regarded as a major 
influence on the information"
pdf_image,MODULE 3_MindChange_part3#page=26#docs\pdf_images\MODULE 3_MindChange_part3\page_26_img1.png,M4-Q11,0.116,"• Eye-gaze was recorded
• Eye-gaze information was used to 
determine the time spent 
attending to relevant information. 
• Based on the time spent viewing 
relevant look zones the following 
two scores were created: 
(a) the duration of time spent 
within the look-zone during 
the initial visit of "
pdf_image,MODULE 3_MindChange_part3#page=27#docs\pdf_images\MODULE 3_MindChange_part3\page_27_img1.png,M3-Q14,0.115,"Internet 
exploration
• N = 84 undergraduate students with high 
and low levels of sustained attention (65 
females and 19 males, with a mean age 
of 20.46 years)
• Students were tasked with navigating 
the Internet for 20 minutes to learn 
about how tropical cyclones form"
pdf_image,MODULE 3_MindChange_part3#page=27#docs\pdf_images\MODULE 3_MindChange_part3\page_27_img2.png,M3-Q14,0.115,"Internet 
exploration
• N = 84 undergraduate students with high 
and low levels of sustained attention (65 
females and 19 males, with a mean age 
of 20.46 years)
• Students were tasked with navigating 
the Internet for 20 minutes to learn 
about how tropical cyclones form"
pdf_image,MODULE 3_MindChange_part3#page=28#docs\pdf_images\MODULE 3_MindChange_part3\page_28_img1.png,M1-Q12,0.132,"• Students with high level of attention →more frequently guided their 
learning in a linear manner, alternating between search engine results 
and first links. Rarely did these learners select hyperlinks presented 
on the links themselves, and it was these students who performed 
better on the test
"
pdf_image,MODULE 3_MindChange_part3#page=28#docs\pdf_images\MODULE 3_MindChange_part3\page_28_img2.png,M1-Q12,0.132,"• Students with high level of attention →more frequently guided their 
learning in a linear manner, alternating between search engine results 
and first links. Rarely did these learners select hyperlinks presented 
on the links themselves, and it was these students who performed 
better on the test
"
pdf_image,MODULE 3_MindChange_part3#page=29#docs\pdf_images\MODULE 3_MindChange_part3\page_29_img1.png,M3-Q10,0.106,"• Learners with low levels of sustained attention →typically took advantage 
of the opportunity to jump around between sources of information. While 
they alternated between search engine results and first links, the low-
attending learners engaged in far more exploration of the hyperlinks 
presente"
pdf_image,MODULE 3_MindChange_part3#page=29#docs\pdf_images\MODULE 3_MindChange_part3\page_29_img2.png,M3-Q10,0.106,"• Learners with low levels of sustained attention →typically took advantage 
of the opportunity to jump around between sources of information. While 
they alternated between search engine results and first links, the low-
attending learners engaged in far more exploration of the hyperlinks 
presente"
pdf_image,MODULE 3_MindChange_part3#page=30#docs\pdf_images\MODULE 3_MindChange_part3\page_30_img1.png,M1-Q20,0.111,"Internet exploration 
and generations 
• Such variations in 
performance can be even 
more marked when we look 
across age groups
Google generation
(born after 1993)
Generation Y
(1973<born<1994)
Generation X
(born before 1973)
→Younger generations were faster but less confident about 
the answers"
pdf_image,MODULE 3_MindChange_part3#page=31#docs\pdf_images\MODULE 3_MindChange_part3\page_31_img1.png,M1-Q28,0.133,"Reading
from books to 
screens
 Read 
this text"
pdf_image,MODULE 3_MindChange_part3#page=31#docs\pdf_images\MODULE 3_MindChange_part3\page_31_img2.png,M1-Q28,0.133,"Reading
from books to 
screens
 Read 
this text"
pdf_image,MODULE 3_MindChange_part3#page=31#docs\pdf_images\MODULE 3_MindChange_part3\page_31_img3.png,M1-Q28,0.133,"Reading
from books to 
screens
 Read 
this text"
pdf_image,MODULE 3_MindChange_part3#page=31#docs\pdf_images\MODULE 3_MindChange_part3\page_31_img4.png,M1-Q28,0.133,"Reading
from books to 
screens
 Read 
this text"
pdf_image,MODULE 3_MindChange_part3#page=32#docs\pdf_images\MODULE 3_MindChange_part3\page_32_img1.png,M3-Q08,0.117,"Readings
• The authors explored 
effects of the 
technological interface 
on reading 
comprehension in a 
Norwegian school 
context
• N = 72 tenth graders from 
2 different primary 
schools in Norway.
• Students randomized into 2 groups:
Read 
this text
Read the same text as pdf 
on a computer scree"
pdf_image,MODULE 3_MindChange_part3#page=32#docs\pdf_images\MODULE 3_MindChange_part3\page_32_img2.png,M3-Q08,0.117,"Readings
• The authors explored 
effects of the 
technological interface 
on reading 
comprehension in a 
Norwegian school 
context
• N = 72 tenth graders from 
2 different primary 
schools in Norway.
• Students randomized into 2 groups:
Read 
this text
Read the same text as pdf 
on a computer scree"
pdf_image,MODULE 3_MindChange_part3#page=32#docs\pdf_images\MODULE 3_MindChange_part3\page_32_img3.png,M3-Q08,0.117,"Readings
• The authors explored 
effects of the 
technological interface 
on reading 
comprehension in a 
Norwegian school 
context
• N = 72 tenth graders from 
2 different primary 
schools in Norway.
• Students randomized into 2 groups:
Read 
this text
Read the same text as pdf 
on a computer scree"
pdf_image,MODULE 3_MindChange_part3#page=32#docs\pdf_images\MODULE 3_MindChange_part3\page_32_img4.png,M3-Q08,0.117,"Readings
• The authors explored 
effects of the 
technological interface 
on reading 
comprehension in a 
Norwegian school 
context
• N = 72 tenth graders from 
2 different primary 
schools in Norway.
• Students randomized into 2 groups:
Read 
this text
Read the same text as pdf 
on a computer scree"
pdf_image,MODULE 3_MindChange_part3#page=33#docs\pdf_images\MODULE 3_MindChange_part3\page_33_img1.png,M4-Q17,0.116,"Readings
• Regression analysis was 
carried out to investigate to 
what extent reading 
modality would influence 
the students’ scores on the 
reading comprehension 
measure
• RESULTS: students who 
read texts in print scored 
better on the reading 
comprehension test
• Pedagogical implications?
"
pdf_image,MODULE 3_MindChange_part3#page=33#docs\pdf_images\MODULE 3_MindChange_part3\page_33_img2.png,M4-Q17,0.116,"Readings
• Regression analysis was 
carried out to investigate to 
what extent reading 
modality would influence 
the students’ scores on the 
reading comprehension 
measure
• RESULTS: students who 
read texts in print scored 
better on the reading 
comprehension test
• Pedagogical implications?
"
pdf_image,MODULE 3_MindChange_part3#page=33#docs\pdf_images\MODULE 3_MindChange_part3\page_33_img3.png,M4-Q17,0.116,"Readings
• Regression analysis was 
carried out to investigate to 
what extent reading 
modality would influence 
the students’ scores on the 
reading comprehension 
measure
• RESULTS: students who 
read texts in print scored 
better on the reading 
comprehension test
• Pedagogical implications?
"
pdf_image,MODULE 3_MindChange_part3#page=33#docs\pdf_images\MODULE 3_MindChange_part3\page_33_img4.png,M4-Q17,0.116,"Readings
• Regression analysis was 
carried out to investigate to 
what extent reading 
modality would influence 
the students’ scores on the 
reading comprehension 
measure
• RESULTS: students who 
read texts in print scored 
better on the reading 
comprehension test
• Pedagogical implications?
"
pdf_image,MODULE 3_MindChange_part3#page=34#docs\pdf_images\MODULE 3_MindChange_part3\page_34_img1.png,M1-Q29,0.138,"Readings
• This paper aims to assess the 
usability of electronic books (e-
books) and paper books (p-
books) with objective measures, 
including user comprehension, 
eye fatigue, and perception
• N = 56 sixth-year public school 
students participated in this 
study
"
pdf_image,MODULE 3_MindChange_part3#page=35#docs\pdf_images\MODULE 3_MindChange_part3\page_35_img1.png,M3-Q10,0.113,"Readings
• Eye fatigue →Participants’ eye fatigues were measured by critical 
flicker/fusion frequency (CFF) threshold. 
• CFF is defined as the frequency at which a flickering light is in 
distinguishable from steady, non-flickering light
• CFF is widely used as highly sensitive measurement to eval"
pdf_image,MODULE 3_MindChange_part3#page=35#docs\pdf_images\MODULE 3_MindChange_part3\page_35_img2.png,M3-Q10,0.113,"Readings
• Eye fatigue →Participants’ eye fatigues were measured by critical 
flicker/fusion frequency (CFF) threshold. 
• CFF is defined as the frequency at which a flickering light is in 
distinguishable from steady, non-flickering light
• CFF is widely used as highly sensitive measurement to eval"
pdf_image,MODULE 3_MindChange_part3#page=36#docs\pdf_images\MODULE 3_MindChange_part3\page_36_img1.png,M4-Q22,0.131,"Readings
This paper was conducted in the 
following order: 
1) pre-CFF measurement, 
2) p-/e-book reading,
3) post-CFF measurement, 
4) quiz and questionnaire. 
5) exit
"
pdf_image,MODULE 3_MindChange_part3#page=36#docs\pdf_images\MODULE 3_MindChange_part3\page_36_img2.png,M4-Q22,0.131,"Readings
This paper was conducted in the 
following order: 
1) pre-CFF measurement, 
2) p-/e-book reading,
3) post-CFF measurement, 
4) quiz and questionnaire. 
5) exit
"
pdf_image,MODULE 3_MindChange_part3#page=37#docs\pdf_images\MODULE 3_MindChange_part3\page_37_img1.png,M3-Q14,0.107,"Readings
RESULTS: 
1) there is a significant “book 
effect” on quiz scores →
compared to e-books, p-books 
appear to enable better 
reading comprehension
2) Regarding eye fatigue, students 
had significantly greater eye 
fatigue after reading e-books 
than after reading p-books. 
3) Students were sa"
pdf_image,MODULE 3_MindChange_part3#page=37#docs\pdf_images\MODULE 3_MindChange_part3\page_37_img2.png,M3-Q14,0.107,"Readings
RESULTS: 
1) there is a significant “book 
effect” on quiz scores →
compared to e-books, p-books 
appear to enable better 
reading comprehension
2) Regarding eye fatigue, students 
had significantly greater eye 
fatigue after reading e-books 
than after reading p-books. 
3) Students were sa"
pdf_image,MODULE 3_MindChange_part3#page=37#docs\pdf_images\MODULE 3_MindChange_part3\page_37_img3.png,M3-Q14,0.107,"Readings
RESULTS: 
1) there is a significant “book 
effect” on quiz scores →
compared to e-books, p-books 
appear to enable better 
reading comprehension
2) Regarding eye fatigue, students 
had significantly greater eye 
fatigue after reading e-books 
than after reading p-books. 
3) Students were sa"
pdf_image,MODULE 3_MindChange_part3#page=37#docs\pdf_images\MODULE 3_MindChange_part3\page_37_img4.png,M3-Q14,0.107,"Readings
RESULTS: 
1) there is a significant “book 
effect” on quiz scores →
compared to e-books, p-books 
appear to enable better 
reading comprehension
2) Regarding eye fatigue, students 
had significantly greater eye 
fatigue after reading e-books 
than after reading p-books. 
3) Students were sa"
pdf_image,MODULE 3_MindChange_part3#page=38#docs\pdf_images\MODULE 3_MindChange_part3\page_38_img1.png,M3-Q10,0.111,"Multitasking
• A distinguishing feature of 
digital technology is the 
temptation and opportunity it 
offers for multitasking
• In a survey of two thousand children between the ages of eight and 
eighteen, the time spent multitasking between more than one 
technology medium in 1999 was 16 percent bu"
pdf_image,MODULE 3_MindChange_part3#page=39#docs\pdf_images\MODULE 3_MindChange_part3\page_39_img1.png,M3-Q10,0.102,"Multitasking
• In a survey of U.S. college 
students, 38 percent said they 
could not go for more than ten 
minutes while studying without 
checking their laptop, 
smartphone, tablet, or e-reader
• Since media multitasking involves, by definition, shifting attention 
between multiple sources, much r"
pdf_image,MODULE 3_MindChange_part3#page=40#docs\pdf_images\MODULE 3_MindChange_part3\page_40_img1.png,M3-Q10,0.131,"Multitasking
• Chronic media multitasking is quickly becoming ubiquitous, 
although processing multiple incoming streams of information is 
considered a challenge for human cognition. 
• A series of experiments addressed whether there are 
systematic differences in information processing styles betw"
pdf_image,MODULE 3_MindChange_part3#page=41#docs\pdf_images\MODULE 3_MindChange_part3\page_41_img1.png,M1-Q20,0.088,"Multitasking
• A trait media multitasking index was developed to identify 
groups of heavy and light media multitaskers. 
• The questionnaire addressed 12 different media forms: 
print media, television, computer-based video (such as 
YouTube or online television episodes), music, nonmusic
audio, vi"
pdf_image,MODULE 3_MindChange_part3#page=41#docs\pdf_images\MODULE 3_MindChange_part3\page_41_img2.png,M1-Q20,0.088,"Multitasking
• A trait media multitasking index was developed to identify 
groups of heavy and light media multitaskers. 
• The questionnaire addressed 12 different media forms: 
print media, television, computer-based video (such as 
YouTube or online television episodes), music, nonmusic
audio, vi"
pdf_image,MODULE 3_MindChange_part3#page=42#docs\pdf_images\MODULE 3_MindChange_part3\page_42_img1.png,M3-Q10,0.112,"• The goal was to examine whether there is a relationship between 
chronic media multitasking and cognitive control abilities.
• Different hypothesis →
Multitasking
Positive
Light media multitaskers exhibit 
advantages in cognitive control 
This result would motivate future work to 
establish whethe"
pdf_image,MODULE 3_MindChange_part3#page=43#docs\pdf_images\MODULE 3_MindChange_part3\page_43_img1.png,M3-Q10,0.139,"• Three tests in the study involved the subjects looking at shapes, 
numbers, or letters, but the task was to remember something about 
just some of the images on the screen and to ignore the others.
Multitasking
FILTERING TASK, example for shapes"
pdf_image,MODULE 3_MindChange_part3#page=43#docs\pdf_images\MODULE 3_MindChange_part3\page_43_img2.png,M3-Q10,0.139,"• Three tests in the study involved the subjects looking at shapes, 
numbers, or letters, but the task was to remember something about 
just some of the images on the screen and to ignore the others.
Multitasking
FILTERING TASK, example for shapes"
pdf_image,MODULE 3_MindChange_part3#page=44#docs\pdf_images\MODULE 3_MindChange_part3\page_44_img1.png,M4-Q22,0.113,"Multitasking
RESULTS: 
Heavy media multitaskers are more 
susceptible to interference from irrelevant 
environmental stimuli
CONCLUSIONS:
the high multitaskers seemed unable to 
ignore the shapes they were told to ignore, 
and were unable to filter out what wasn’t 
important to that particular task."
pdf_image,MODULE 3_MindChange_part3#page=44#docs\pdf_images\MODULE 3_MindChange_part3\page_44_img2.png,M4-Q22,0.113,"Multitasking
RESULTS: 
Heavy media multitaskers are more 
susceptible to interference from irrelevant 
environmental stimuli
CONCLUSIONS:
the high multitaskers seemed unable to 
ignore the shapes they were told to ignore, 
and were unable to filter out what wasn’t 
important to that particular task."
pdf_image,MODULE 4_1_Neuro_mech-1#page=2#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_2_img1.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=2#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_2_img2.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=2#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_2_img3.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=2#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_2_img4.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=2#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_2_img5.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=2#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_2_img6.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=2#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_2_img7.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=2#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_2_img8.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=2#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_2_img9.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=2#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_2_img10.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=3#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_3_img1.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=3#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_3_img2.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=3#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_3_img3.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=3#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_3_img4.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=4#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_4_img1.png,M3-Q10,0.093,"ISCHEMIC PAIN
DAY1   DAY2    DAY3   DAY4    DAY5
15
20
25
30
MOR MOR PLA
+
NAL
Pain tolerance
(minutes)
NALOXONE
 antagonist
OPIOIDS
Placebo analgesia: Study on 
Ischemic Pain 
(Amanzio & Benedetti J Neurosci 1999; 19:484-94
Benedetti et al. J Neurosci  2007; 27:11934-9)
• Day 1 (baseline): no trea"
pdf_image,MODULE 4_1_Neuro_mech-1#page=4#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_4_img2.png,M3-Q10,0.093,"ISCHEMIC PAIN
DAY1   DAY2    DAY3   DAY4    DAY5
15
20
25
30
MOR MOR PLA
+
NAL
Pain tolerance
(minutes)
NALOXONE
 antagonist
OPIOIDS
Placebo analgesia: Study on 
Ischemic Pain 
(Amanzio & Benedetti J Neurosci 1999; 19:484-94
Benedetti et al. J Neurosci  2007; 27:11934-9)
• Day 1 (baseline): no trea"
pdf_image,MODULE 4_1_Neuro_mech-1#page=4#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_4_img3.png,M3-Q10,0.093,"ISCHEMIC PAIN
DAY1   DAY2    DAY3   DAY4    DAY5
15
20
25
30
MOR MOR PLA
+
NAL
Pain tolerance
(minutes)
NALOXONE
 antagonist
OPIOIDS
Placebo analgesia: Study on 
Ischemic Pain 
(Amanzio & Benedetti J Neurosci 1999; 19:484-94
Benedetti et al. J Neurosci  2007; 27:11934-9)
• Day 1 (baseline): no trea"
pdf_image,MODULE 4_1_Neuro_mech-1#page=4#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_4_img4.png,M3-Q10,0.093,"ISCHEMIC PAIN
DAY1   DAY2    DAY3   DAY4    DAY5
15
20
25
30
MOR MOR PLA
+
NAL
Pain tolerance
(minutes)
NALOXONE
 antagonist
OPIOIDS
Placebo analgesia: Study on 
Ischemic Pain 
(Amanzio & Benedetti J Neurosci 1999; 19:484-94
Benedetti et al. J Neurosci  2007; 27:11934-9)
• Day 1 (baseline): no trea"
pdf_image,MODULE 4_1_Neuro_mech-1#page=4#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_4_img5.png,M3-Q10,0.093,"ISCHEMIC PAIN
DAY1   DAY2    DAY3   DAY4    DAY5
15
20
25
30
MOR MOR PLA
+
NAL
Pain tolerance
(minutes)
NALOXONE
 antagonist
OPIOIDS
Placebo analgesia: Study on 
Ischemic Pain 
(Amanzio & Benedetti J Neurosci 1999; 19:484-94
Benedetti et al. J Neurosci  2007; 27:11934-9)
• Day 1 (baseline): no trea"
pdf_image,MODULE 4_1_Neuro_mech-1#page=4#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_4_img6.png,M3-Q10,0.093,"ISCHEMIC PAIN
DAY1   DAY2    DAY3   DAY4    DAY5
15
20
25
30
MOR MOR PLA
+
NAL
Pain tolerance
(minutes)
NALOXONE
 antagonist
OPIOIDS
Placebo analgesia: Study on 
Ischemic Pain 
(Amanzio & Benedetti J Neurosci 1999; 19:484-94
Benedetti et al. J Neurosci  2007; 27:11934-9)
• Day 1 (baseline): no trea"
pdf_image,MODULE 4_1_Neuro_mech-1#page=4#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_4_img7.png,M3-Q10,0.093,"ISCHEMIC PAIN
DAY1   DAY2    DAY3   DAY4    DAY5
15
20
25
30
MOR MOR PLA
+
NAL
Pain tolerance
(minutes)
NALOXONE
 antagonist
OPIOIDS
Placebo analgesia: Study on 
Ischemic Pain 
(Amanzio & Benedetti J Neurosci 1999; 19:484-94
Benedetti et al. J Neurosci  2007; 27:11934-9)
• Day 1 (baseline): no trea"
pdf_image,MODULE 4_1_Neuro_mech-1#page=4#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_4_img8.png,M3-Q10,0.093,"ISCHEMIC PAIN
DAY1   DAY2    DAY3   DAY4    DAY5
15
20
25
30
MOR MOR PLA
+
NAL
Pain tolerance
(minutes)
NALOXONE
 antagonist
OPIOIDS
Placebo analgesia: Study on 
Ischemic Pain 
(Amanzio & Benedetti J Neurosci 1999; 19:484-94
Benedetti et al. J Neurosci  2007; 27:11934-9)
• Day 1 (baseline): no trea"
pdf_image,MODULE 4_1_Neuro_mech-1#page=4#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_4_img9.png,M3-Q10,0.093,"ISCHEMIC PAIN
DAY1   DAY2    DAY3   DAY4    DAY5
15
20
25
30
MOR MOR PLA
+
NAL
Pain tolerance
(minutes)
NALOXONE
 antagonist
OPIOIDS
Placebo analgesia: Study on 
Ischemic Pain 
(Amanzio & Benedetti J Neurosci 1999; 19:484-94
Benedetti et al. J Neurosci  2007; 27:11934-9)
• Day 1 (baseline): no trea"
pdf_image,MODULE 4_1_Neuro_mech-1#page=4#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_4_img10.png,M3-Q10,0.093,"ISCHEMIC PAIN
DAY1   DAY2    DAY3   DAY4    DAY5
15
20
25
30
MOR MOR PLA
+
NAL
Pain tolerance
(minutes)
NALOXONE
 antagonist
OPIOIDS
Placebo analgesia: Study on 
Ischemic Pain 
(Amanzio & Benedetti J Neurosci 1999; 19:484-94
Benedetti et al. J Neurosci  2007; 27:11934-9)
• Day 1 (baseline): no trea"
pdf_image,MODULE 4_1_Neuro_mech-1#page=5#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_5_img1.png,M3-Q10,0.090,"HOT PLATE TEST
Guo et al. (2010) J. Psychopharmacol. 24: 1561-1567
Drug  (US) + blue light (CS)
OPIOIDS
paw
withdrawal
latency
(seconds)
DAY1   DAY2  DAY3 DAY4 DAY5
15
30
MOR MOR PLAMOR MOR
+
NAL
45
MICE
Placebo analgesia: Animal Study (Mice) 
• Mice reveived morphine paired with blue light 
(condit"
pdf_image,MODULE 4_1_Neuro_mech-1#page=5#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_5_img2.png,M3-Q10,0.090,"HOT PLATE TEST
Guo et al. (2010) J. Psychopharmacol. 24: 1561-1567
Drug  (US) + blue light (CS)
OPIOIDS
paw
withdrawal
latency
(seconds)
DAY1   DAY2  DAY3 DAY4 DAY5
15
30
MOR MOR PLAMOR MOR
+
NAL
45
MICE
Placebo analgesia: Animal Study (Mice) 
• Mice reveived morphine paired with blue light 
(condit"
pdf_image,MODULE 4_1_Neuro_mech-1#page=5#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_5_img3.png,M3-Q10,0.090,"HOT PLATE TEST
Guo et al. (2010) J. Psychopharmacol. 24: 1561-1567
Drug  (US) + blue light (CS)
OPIOIDS
paw
withdrawal
latency
(seconds)
DAY1   DAY2  DAY3 DAY4 DAY5
15
30
MOR MOR PLAMOR MOR
+
NAL
45
MICE
Placebo analgesia: Animal Study (Mice) 
• Mice reveived morphine paired with blue light 
(condit"
pdf_image,MODULE 4_1_Neuro_mech-1#page=5#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_5_img4.png,M3-Q10,0.090,"HOT PLATE TEST
Guo et al. (2010) J. Psychopharmacol. 24: 1561-1567
Drug  (US) + blue light (CS)
OPIOIDS
paw
withdrawal
latency
(seconds)
DAY1   DAY2  DAY3 DAY4 DAY5
15
30
MOR MOR PLAMOR MOR
+
NAL
45
MICE
Placebo analgesia: Animal Study (Mice) 
• Mice reveived morphine paired with blue light 
(condit"
pdf_image,MODULE 4_1_Neuro_mech-1#page=5#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_5_img5.png,M3-Q10,0.090,"HOT PLATE TEST
Guo et al. (2010) J. Psychopharmacol. 24: 1561-1567
Drug  (US) + blue light (CS)
OPIOIDS
paw
withdrawal
latency
(seconds)
DAY1   DAY2  DAY3 DAY4 DAY5
15
30
MOR MOR PLAMOR MOR
+
NAL
45
MICE
Placebo analgesia: Animal Study (Mice) 
• Mice reveived morphine paired with blue light 
(condit"
pdf_image,MODULE 4_1_Neuro_mech-1#page=5#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_5_img6.png,M3-Q10,0.090,"HOT PLATE TEST
Guo et al. (2010) J. Psychopharmacol. 24: 1561-1567
Drug  (US) + blue light (CS)
OPIOIDS
paw
withdrawal
latency
(seconds)
DAY1   DAY2  DAY3 DAY4 DAY5
15
30
MOR MOR PLAMOR MOR
+
NAL
45
MICE
Placebo analgesia: Animal Study (Mice) 
• Mice reveived morphine paired with blue light 
(condit"
pdf_image,MODULE 4_1_Neuro_mech-1#page=5#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_5_img7.png,M3-Q10,0.090,"HOT PLATE TEST
Guo et al. (2010) J. Psychopharmacol. 24: 1561-1567
Drug  (US) + blue light (CS)
OPIOIDS
paw
withdrawal
latency
(seconds)
DAY1   DAY2  DAY3 DAY4 DAY5
15
30
MOR MOR PLAMOR MOR
+
NAL
45
MICE
Placebo analgesia: Animal Study (Mice) 
• Mice reveived morphine paired with blue light 
(condit"
pdf_image,MODULE 4_1_Neuro_mech-1#page=5#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_5_img8.png,M3-Q10,0.090,"HOT PLATE TEST
Guo et al. (2010) J. Psychopharmacol. 24: 1561-1567
Drug  (US) + blue light (CS)
OPIOIDS
paw
withdrawal
latency
(seconds)
DAY1   DAY2  DAY3 DAY4 DAY5
15
30
MOR MOR PLAMOR MOR
+
NAL
45
MICE
Placebo analgesia: Animal Study (Mice) 
• Mice reveived morphine paired with blue light 
(condit"
pdf_image,MODULE 4_1_Neuro_mech-1#page=5#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_5_img9.png,M3-Q10,0.090,"HOT PLATE TEST
Guo et al. (2010) J. Psychopharmacol. 24: 1561-1567
Drug  (US) + blue light (CS)
OPIOIDS
paw
withdrawal
latency
(seconds)
DAY1   DAY2  DAY3 DAY4 DAY5
15
30
MOR MOR PLAMOR MOR
+
NAL
45
MICE
Placebo analgesia: Animal Study (Mice) 
• Mice reveived morphine paired with blue light 
(condit"
pdf_image,MODULE 4_1_Neuro_mech-1#page=5#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_5_img10.png,M3-Q10,0.090,"HOT PLATE TEST
Guo et al. (2010) J. Psychopharmacol. 24: 1561-1567
Drug  (US) + blue light (CS)
OPIOIDS
paw
withdrawal
latency
(seconds)
DAY1   DAY2  DAY3 DAY4 DAY5
15
30
MOR MOR PLAMOR MOR
+
NAL
45
MICE
Placebo analgesia: Animal Study (Mice) 
• Mice reveived morphine paired with blue light 
(condit"
pdf_image,MODULE 4_1_Neuro_mech-1#page=5#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_5_img11.png,M3-Q10,0.090,"HOT PLATE TEST
Guo et al. (2010) J. Psychopharmacol. 24: 1561-1567
Drug  (US) + blue light (CS)
OPIOIDS
paw
withdrawal
latency
(seconds)
DAY1   DAY2  DAY3 DAY4 DAY5
15
30
MOR MOR PLAMOR MOR
+
NAL
45
MICE
Placebo analgesia: Animal Study (Mice) 
• Mice reveived morphine paired with blue light 
(condit"
pdf_image,MODULE 4_1_Neuro_mech-1#page=5#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_5_img12.png,M3-Q10,0.090,"HOT PLATE TEST
Guo et al. (2010) J. Psychopharmacol. 24: 1561-1567
Drug  (US) + blue light (CS)
OPIOIDS
paw
withdrawal
latency
(seconds)
DAY1   DAY2  DAY3 DAY4 DAY5
15
30
MOR MOR PLAMOR MOR
+
NAL
45
MICE
Placebo analgesia: Animal Study (Mice) 
• Mice reveived morphine paired with blue light 
(condit"
pdf_image,MODULE 4_1_Neuro_mech-1#page=6#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_6_img1.png,M4-Q11,0.069,"Benedetti et al. Lancet, 1995; 346:1231. Benedetti et al. Psychopharmacol 2011; 213:791-7
PENTAGASTRIN (CCK agonist) 
MOR MORPLA + PENTAGASTRIN
15
20
25
30
DAY1   DAY2   DAY3   DAY4   DAY5
Pain tolerance
(minutes)
PROGLUMIDE (CCK antagonist)
CCK  (ANTI-OPIOIDS)
3
Proglumide
Placebo
Control
time
10
9"
pdf_image,MODULE 4_1_Neuro_mech-1#page=6#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_6_img2.png,M4-Q11,0.069,"Benedetti et al. Lancet, 1995; 346:1231. Benedetti et al. Psychopharmacol 2011; 213:791-7
PENTAGASTRIN (CCK agonist) 
MOR MORPLA + PENTAGASTRIN
15
20
25
30
DAY1   DAY2   DAY3   DAY4   DAY5
Pain tolerance
(minutes)
PROGLUMIDE (CCK antagonist)
CCK  (ANTI-OPIOIDS)
3
Proglumide
Placebo
Control
time
10
9"
pdf_image,MODULE 4_1_Neuro_mech-1#page=6#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_6_img3.png,M4-Q11,0.069,"Benedetti et al. Lancet, 1995; 346:1231. Benedetti et al. Psychopharmacol 2011; 213:791-7
PENTAGASTRIN (CCK agonist) 
MOR MORPLA + PENTAGASTRIN
15
20
25
30
DAY1   DAY2   DAY3   DAY4   DAY5
Pain tolerance
(minutes)
PROGLUMIDE (CCK antagonist)
CCK  (ANTI-OPIOIDS)
3
Proglumide
Placebo
Control
time
10
9"
pdf_image,MODULE 4_1_Neuro_mech-1#page=6#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_6_img4.png,M4-Q11,0.069,"Benedetti et al. Lancet, 1995; 346:1231. Benedetti et al. Psychopharmacol 2011; 213:791-7
PENTAGASTRIN (CCK agonist) 
MOR MORPLA + PENTAGASTRIN
15
20
25
30
DAY1   DAY2   DAY3   DAY4   DAY5
Pain tolerance
(minutes)
PROGLUMIDE (CCK antagonist)
CCK  (ANTI-OPIOIDS)
3
Proglumide
Placebo
Control
time
10
9"
pdf_image,MODULE 4_1_Neuro_mech-1#page=6#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_6_img5.png,M4-Q11,0.069,"Benedetti et al. Lancet, 1995; 346:1231. Benedetti et al. Psychopharmacol 2011; 213:791-7
PENTAGASTRIN (CCK agonist) 
MOR MORPLA + PENTAGASTRIN
15
20
25
30
DAY1   DAY2   DAY3   DAY4   DAY5
Pain tolerance
(minutes)
PROGLUMIDE (CCK antagonist)
CCK  (ANTI-OPIOIDS)
3
Proglumide
Placebo
Control
time
10
9"
pdf_image,MODULE 4_1_Neuro_mech-1#page=6#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_6_img6.png,M4-Q11,0.069,"Benedetti et al. Lancet, 1995; 346:1231. Benedetti et al. Psychopharmacol 2011; 213:791-7
PENTAGASTRIN (CCK agonist) 
MOR MORPLA + PENTAGASTRIN
15
20
25
30
DAY1   DAY2   DAY3   DAY4   DAY5
Pain tolerance
(minutes)
PROGLUMIDE (CCK antagonist)
CCK  (ANTI-OPIOIDS)
3
Proglumide
Placebo
Control
time
10
9"
pdf_image,MODULE 4_1_Neuro_mech-1#page=7#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_7_img1.png,M4-Q11,0.077,"Amanzio & Benedetti J Neurosci 1999;19:484-94 Benedetti et al. Nature Med 2011;17:12828-30
DAY1    DAY2    DAY3    DAY4    DAY5
10
15
20
KET KET PLA + RIM
Pain tolerance
(minutes)
CANNABINOIDS
25
20
+
NAL
DAY1   DAY2   DAY3  DAY4   DAY5
15
Pain tolerance
(minutes)
KET KET PLA
Activation of 
CB1 rece"
pdf_image,MODULE 4_1_Neuro_mech-1#page=7#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_7_img2.png,M4-Q11,0.077,"Amanzio & Benedetti J Neurosci 1999;19:484-94 Benedetti et al. Nature Med 2011;17:12828-30
DAY1    DAY2    DAY3    DAY4    DAY5
10
15
20
KET KET PLA + RIM
Pain tolerance
(minutes)
CANNABINOIDS
25
20
+
NAL
DAY1   DAY2   DAY3  DAY4   DAY5
15
Pain tolerance
(minutes)
KET KET PLA
Activation of 
CB1 rece"
pdf_image,MODULE 4_1_Neuro_mech-1#page=7#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_7_img3.png,M4-Q11,0.077,"Amanzio & Benedetti J Neurosci 1999;19:484-94 Benedetti et al. Nature Med 2011;17:12828-30
DAY1    DAY2    DAY3    DAY4    DAY5
10
15
20
KET KET PLA + RIM
Pain tolerance
(minutes)
CANNABINOIDS
25
20
+
NAL
DAY1   DAY2   DAY3  DAY4   DAY5
15
Pain tolerance
(minutes)
KET KET PLA
Activation of 
CB1 rece"
pdf_image,MODULE 4_1_Neuro_mech-1#page=7#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_7_img4.png,M4-Q11,0.077,"Amanzio & Benedetti J Neurosci 1999;19:484-94 Benedetti et al. Nature Med 2011;17:12828-30
DAY1    DAY2    DAY3    DAY4    DAY5
10
15
20
KET KET PLA + RIM
Pain tolerance
(minutes)
CANNABINOIDS
25
20
+
NAL
DAY1   DAY2   DAY3  DAY4   DAY5
15
Pain tolerance
(minutes)
KET KET PLA
Activation of 
CB1 rece"
pdf_image,MODULE 4_1_Neuro_mech-1#page=7#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_7_img5.png,M4-Q11,0.077,"Amanzio & Benedetti J Neurosci 1999;19:484-94 Benedetti et al. Nature Med 2011;17:12828-30
DAY1    DAY2    DAY3    DAY4    DAY5
10
15
20
KET KET PLA + RIM
Pain tolerance
(minutes)
CANNABINOIDS
25
20
+
NAL
DAY1   DAY2   DAY3  DAY4   DAY5
15
Pain tolerance
(minutes)
KET KET PLA
Activation of 
CB1 rece"
pdf_image,MODULE 4_1_Neuro_mech-1#page=7#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_7_img6.png,M4-Q11,0.077,"Amanzio & Benedetti J Neurosci 1999;19:484-94 Benedetti et al. Nature Med 2011;17:12828-30
DAY1    DAY2    DAY3    DAY4    DAY5
10
15
20
KET KET PLA + RIM
Pain tolerance
(minutes)
CANNABINOIDS
25
20
+
NAL
DAY1   DAY2   DAY3  DAY4   DAY5
15
Pain tolerance
(minutes)
KET KET PLA
Activation of 
CB1 rece"
pdf_image,MODULE 4_1_Neuro_mech-1#page=7#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_7_img7.png,M4-Q11,0.077,"Amanzio & Benedetti J Neurosci 1999;19:484-94 Benedetti et al. Nature Med 2011;17:12828-30
DAY1    DAY2    DAY3    DAY4    DAY5
10
15
20
KET KET PLA + RIM
Pain tolerance
(minutes)
CANNABINOIDS
25
20
+
NAL
DAY1   DAY2   DAY3  DAY4   DAY5
15
Pain tolerance
(minutes)
KET KET PLA
Activation of 
CB1 rece"
pdf_image,MODULE 4_1_Neuro_mech-1#page=7#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_7_img8.png,M4-Q11,0.077,"Amanzio & Benedetti J Neurosci 1999;19:484-94 Benedetti et al. Nature Med 2011;17:12828-30
DAY1    DAY2    DAY3    DAY4    DAY5
10
15
20
KET KET PLA + RIM
Pain tolerance
(minutes)
CANNABINOIDS
25
20
+
NAL
DAY1   DAY2   DAY3  DAY4   DAY5
15
Pain tolerance
(minutes)
KET KET PLA
Activation of 
CB1 rece"
pdf_image,MODULE 4_1_Neuro_mech-1#page=7#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_7_img9.png,M4-Q11,0.077,"Amanzio & Benedetti J Neurosci 1999;19:484-94 Benedetti et al. Nature Med 2011;17:12828-30
DAY1    DAY2    DAY3    DAY4    DAY5
10
15
20
KET KET PLA + RIM
Pain tolerance
(minutes)
CANNABINOIDS
25
20
+
NAL
DAY1   DAY2   DAY3  DAY4   DAY5
15
Pain tolerance
(minutes)
KET KET PLA
Activation of 
CB1 rece"
pdf_image,MODULE 4_1_Neuro_mech-1#page=7#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_7_img10.png,M4-Q11,0.077,"Amanzio & Benedetti J Neurosci 1999;19:484-94 Benedetti et al. Nature Med 2011;17:12828-30
DAY1    DAY2    DAY3    DAY4    DAY5
10
15
20
KET KET PLA + RIM
Pain tolerance
(minutes)
CANNABINOIDS
25
20
+
NAL
DAY1   DAY2   DAY3  DAY4   DAY5
15
Pain tolerance
(minutes)
KET KET PLA
Activation of 
CB1 rece"
pdf_image,MODULE 4_1_Neuro_mech-1#page=7#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_7_img11.png,M4-Q11,0.077,"Amanzio & Benedetti J Neurosci 1999;19:484-94 Benedetti et al. Nature Med 2011;17:12828-30
DAY1    DAY2    DAY3    DAY4    DAY5
10
15
20
KET KET PLA + RIM
Pain tolerance
(minutes)
CANNABINOIDS
25
20
+
NAL
DAY1   DAY2   DAY3  DAY4   DAY5
15
Pain tolerance
(minutes)
KET KET PLA
Activation of 
CB1 rece"
pdf_image,MODULE 4_1_Neuro_mech-1#page=7#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_7_img12.png,M4-Q11,0.077,"Amanzio & Benedetti J Neurosci 1999;19:484-94 Benedetti et al. Nature Med 2011;17:12828-30
DAY1    DAY2    DAY3    DAY4    DAY5
10
15
20
KET KET PLA + RIM
Pain tolerance
(minutes)
CANNABINOIDS
25
20
+
NAL
DAY1   DAY2   DAY3  DAY4   DAY5
15
Pain tolerance
(minutes)
KET KET PLA
Activation of 
CB1 rece"
pdf_image,MODULE 4_1_Neuro_mech-1#page=7#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_7_img13.png,M4-Q11,0.077,"Amanzio & Benedetti J Neurosci 1999;19:484-94 Benedetti et al. Nature Med 2011;17:12828-30
DAY1    DAY2    DAY3    DAY4    DAY5
10
15
20
KET KET PLA + RIM
Pain tolerance
(minutes)
CANNABINOIDS
25
20
+
NAL
DAY1   DAY2   DAY3  DAY4   DAY5
15
Pain tolerance
(minutes)
KET KET PLA
Activation of 
CB1 rece"
pdf_image,MODULE 4_1_Neuro_mech-1#page=7#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_7_img14.png,M4-Q11,0.077,"Amanzio & Benedetti J Neurosci 1999;19:484-94 Benedetti et al. Nature Med 2011;17:12828-30
DAY1    DAY2    DAY3    DAY4    DAY5
10
15
20
KET KET PLA + RIM
Pain tolerance
(minutes)
CANNABINOIDS
25
20
+
NAL
DAY1   DAY2   DAY3  DAY4   DAY5
15
Pain tolerance
(minutes)
KET KET PLA
Activation of 
CB1 rece"
pdf_image,MODULE 4_1_Neuro_mech-1#page=9#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_9_img1.png,M3-Q15,0.110,"Psychosocial context
Expectation
Previous experiences 
Benedetti et al. (2011) Nature Med, 17: 1228-1230
CB1
cannabinoid
receptor
 opioid
receptor
Analgesia
Previous exposure
to opioids () 
Previous exposure
to NSAIDs (CB1) 
Memory
ON
Memory
ON
and
 and
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=9#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_9_img2.png,M3-Q15,0.110,"Psychosocial context
Expectation
Previous experiences 
Benedetti et al. (2011) Nature Med, 17: 1228-1230
CB1
cannabinoid
receptor
 opioid
receptor
Analgesia
Previous exposure
to opioids () 
Previous exposure
to NSAIDs (CB1) 
Memory
ON
Memory
ON
and
 and
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=9#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_9_img3.png,M3-Q15,0.110,"Psychosocial context
Expectation
Previous experiences 
Benedetti et al. (2011) Nature Med, 17: 1228-1230
CB1
cannabinoid
receptor
 opioid
receptor
Analgesia
Previous exposure
to opioids () 
Previous exposure
to NSAIDs (CB1) 
Memory
ON
Memory
ON
and
 and
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=9#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_9_img4.png,M3-Q15,0.110,"Psychosocial context
Expectation
Previous experiences 
Benedetti et al. (2011) Nature Med, 17: 1228-1230
CB1
cannabinoid
receptor
 opioid
receptor
Analgesia
Previous exposure
to opioids () 
Previous exposure
to NSAIDs (CB1) 
Memory
ON
Memory
ON
and
 and
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=9#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_9_img5.png,M3-Q15,0.110,"Psychosocial context
Expectation
Previous experiences 
Benedetti et al. (2011) Nature Med, 17: 1228-1230
CB1
cannabinoid
receptor
 opioid
receptor
Analgesia
Previous exposure
to opioids () 
Previous exposure
to NSAIDs (CB1) 
Memory
ON
Memory
ON
and
 and
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=9#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_9_img6.png,M3-Q15,0.110,"Psychosocial context
Expectation
Previous experiences 
Benedetti et al. (2011) Nature Med, 17: 1228-1230
CB1
cannabinoid
receptor
 opioid
receptor
Analgesia
Previous exposure
to opioids () 
Previous exposure
to NSAIDs (CB1) 
Memory
ON
Memory
ON
and
 and
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=9#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_9_img7.png,M3-Q15,0.110,"Psychosocial context
Expectation
Previous experiences 
Benedetti et al. (2011) Nature Med, 17: 1228-1230
CB1
cannabinoid
receptor
 opioid
receptor
Analgesia
Previous exposure
to opioids () 
Previous exposure
to NSAIDs (CB1) 
Memory
ON
Memory
ON
and
 and
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=9#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_9_img8.png,M3-Q15,0.110,"Psychosocial context
Expectation
Previous experiences 
Benedetti et al. (2011) Nature Med, 17: 1228-1230
CB1
cannabinoid
receptor
 opioid
receptor
Analgesia
Previous exposure
to opioids () 
Previous exposure
to NSAIDs (CB1) 
Memory
ON
Memory
ON
and
 and
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=9#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_9_img9.png,M3-Q15,0.110,"Psychosocial context
Expectation
Previous experiences 
Benedetti et al. (2011) Nature Med, 17: 1228-1230
CB1
cannabinoid
receptor
 opioid
receptor
Analgesia
Previous exposure
to opioids () 
Previous exposure
to NSAIDs (CB1) 
Memory
ON
Memory
ON
and
 and
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=9#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_9_img10.png,M3-Q15,0.110,"Psychosocial context
Expectation
Previous experiences 
Benedetti et al. (2011) Nature Med, 17: 1228-1230
CB1
cannabinoid
receptor
 opioid
receptor
Analgesia
Previous exposure
to opioids () 
Previous exposure
to NSAIDs (CB1) 
Memory
ON
Memory
ON
and
 and
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=9#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_9_img11.png,M3-Q15,0.110,"Psychosocial context
Expectation
Previous experiences 
Benedetti et al. (2011) Nature Med, 17: 1228-1230
CB1
cannabinoid
receptor
 opioid
receptor
Analgesia
Previous exposure
to opioids () 
Previous exposure
to NSAIDs (CB1) 
Memory
ON
Memory
ON
and
 and
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=9#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_9_img12.png,M3-Q15,0.110,"Psychosocial context
Expectation
Previous experiences 
Benedetti et al. (2011) Nature Med, 17: 1228-1230
CB1
cannabinoid
receptor
 opioid
receptor
Analgesia
Previous exposure
to opioids () 
Previous exposure
to NSAIDs (CB1) 
Memory
ON
Memory
ON
and
 and
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=10#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_10_img1.png,M4-Q22,0.064,"Amanzio & Benedetti J Neurosci 1999 
Benedetti et al. J Neurosci  2007
Benedetti et al. Lancet, 1995
Benedetti et al. Psychopharmacol, 2011
Benedetti et al. Nature Med 2011
Kessner et al., Jama, 2013
CCK
SYSTEM
Nocebo
HYPERALGESIA
Block by anti-CCK 
drugs (e.g. proglumide)
Placebo
OPIOID 
SYSTEM
Opp"
pdf_image,MODULE 4_1_Neuro_mech-1#page=10#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_10_img2.png,M4-Q22,0.064,"Amanzio & Benedetti J Neurosci 1999 
Benedetti et al. J Neurosci  2007
Benedetti et al. Lancet, 1995
Benedetti et al. Psychopharmacol, 2011
Benedetti et al. Nature Med 2011
Kessner et al., Jama, 2013
CCK
SYSTEM
Nocebo
HYPERALGESIA
Block by anti-CCK 
drugs (e.g. proglumide)
Placebo
OPIOID 
SYSTEM
Opp"
pdf_image,MODULE 4_1_Neuro_mech-1#page=10#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_10_img3.png,M4-Q22,0.064,"Amanzio & Benedetti J Neurosci 1999 
Benedetti et al. J Neurosci  2007
Benedetti et al. Lancet, 1995
Benedetti et al. Psychopharmacol, 2011
Benedetti et al. Nature Med 2011
Kessner et al., Jama, 2013
CCK
SYSTEM
Nocebo
HYPERALGESIA
Block by anti-CCK 
drugs (e.g. proglumide)
Placebo
OPIOID 
SYSTEM
Opp"
pdf_image,MODULE 4_1_Neuro_mech-1#page=10#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_10_img4.png,M4-Q22,0.064,"Amanzio & Benedetti J Neurosci 1999 
Benedetti et al. J Neurosci  2007
Benedetti et al. Lancet, 1995
Benedetti et al. Psychopharmacol, 2011
Benedetti et al. Nature Med 2011
Kessner et al., Jama, 2013
CCK
SYSTEM
Nocebo
HYPERALGESIA
Block by anti-CCK 
drugs (e.g. proglumide)
Placebo
OPIOID 
SYSTEM
Opp"
pdf_image,MODULE 4_1_Neuro_mech-1#page=12#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_12_img1.png,M1-Q20,0.118,"Wager et al. 2004 Science 303: 1162-1167.
Zubieta et al. 2005 J. Neurosci. 25: 7754 –7762.Watson et al. 2009 Pain 145: 24-30.
DLPFC
Petrovic et al. 2002 Science 295: 1737-1740.
ACC
Opioid-induced analgesia and placebo analgesia activate the same 
brain areas
PET  AND  fMRI STUDIES
Increased activity"
pdf_image,MODULE 4_1_Neuro_mech-1#page=12#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_12_img2.png,M1-Q20,0.118,"Wager et al. 2004 Science 303: 1162-1167.
Zubieta et al. 2005 J. Neurosci. 25: 7754 –7762.Watson et al. 2009 Pain 145: 24-30.
DLPFC
Petrovic et al. 2002 Science 295: 1737-1740.
ACC
Opioid-induced analgesia and placebo analgesia activate the same 
brain areas
PET  AND  fMRI STUDIES
Increased activity"
pdf_image,MODULE 4_1_Neuro_mech-1#page=12#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_12_img3.png,M1-Q20,0.118,"Wager et al. 2004 Science 303: 1162-1167.
Zubieta et al. 2005 J. Neurosci. 25: 7754 –7762.Watson et al. 2009 Pain 145: 24-30.
DLPFC
Petrovic et al. 2002 Science 295: 1737-1740.
ACC
Opioid-induced analgesia and placebo analgesia activate the same 
brain areas
PET  AND  fMRI STUDIES
Increased activity"
pdf_image,MODULE 4_1_Neuro_mech-1#page=12#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_12_img4.png,M1-Q20,0.118,"Wager et al. 2004 Science 303: 1162-1167.
Zubieta et al. 2005 J. Neurosci. 25: 7754 –7762.Watson et al. 2009 Pain 145: 24-30.
DLPFC
Petrovic et al. 2002 Science 295: 1737-1740.
ACC
Opioid-induced analgesia and placebo analgesia activate the same 
brain areas
PET  AND  fMRI STUDIES
Increased activity"
pdf_image,MODULE 4_1_Neuro_mech-1#page=14#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_14_img1.png,M1-Q20,0.167,"Amanzio, Benedetti et al (2011) Hum Brain Mapp
Placebo - Expectation Pain perception (pain matrix)
Activation
Inhibition
DLPFC
rACC
(Rostral Cingulate 
Anterior Cortex)
PAG
(Periaqueductal 
Gray)
Putamen
Insula
Caudate
Thalamus
pCC
(Posterior cingulate 
Cortex)"
pdf_image,MODULE 4_1_Neuro_mech-1#page=14#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_14_img2.png,M1-Q20,0.167,"Amanzio, Benedetti et al (2011) Hum Brain Mapp
Placebo - Expectation Pain perception (pain matrix)
Activation
Inhibition
DLPFC
rACC
(Rostral Cingulate 
Anterior Cortex)
PAG
(Periaqueductal 
Gray)
Putamen
Insula
Caudate
Thalamus
pCC
(Posterior cingulate 
Cortex)"
pdf_image,MODULE 4_1_Neuro_mech-1#page=14#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_14_img3.png,M1-Q20,0.167,"Amanzio, Benedetti et al (2011) Hum Brain Mapp
Placebo - Expectation Pain perception (pain matrix)
Activation
Inhibition
DLPFC
rACC
(Rostral Cingulate 
Anterior Cortex)
PAG
(Periaqueductal 
Gray)
Putamen
Insula
Caudate
Thalamus
pCC
(Posterior cingulate 
Cortex)"
pdf_image,MODULE 4_1_Neuro_mech-1#page=14#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_14_img4.png,M1-Q20,0.167,"Amanzio, Benedetti et al (2011) Hum Brain Mapp
Placebo - Expectation Pain perception (pain matrix)
Activation
Inhibition
DLPFC
rACC
(Rostral Cingulate 
Anterior Cortex)
PAG
(Periaqueductal 
Gray)
Putamen
Insula
Caudate
Thalamus
pCC
(Posterior cingulate 
Cortex)"
pdf_image,MODULE 4_1_Neuro_mech-1#page=14#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_14_img5.png,M1-Q20,0.167,"Amanzio, Benedetti et al (2011) Hum Brain Mapp
Placebo - Expectation Pain perception (pain matrix)
Activation
Inhibition
DLPFC
rACC
(Rostral Cingulate 
Anterior Cortex)
PAG
(Periaqueductal 
Gray)
Putamen
Insula
Caudate
Thalamus
pCC
(Posterior cingulate 
Cortex)"
pdf_image,MODULE 4_1_Neuro_mech-1#page=14#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_14_img6.png,M1-Q20,0.167,"Amanzio, Benedetti et al (2011) Hum Brain Mapp
Placebo - Expectation Pain perception (pain matrix)
Activation
Inhibition
DLPFC
rACC
(Rostral Cingulate 
Anterior Cortex)
PAG
(Periaqueductal 
Gray)
Putamen
Insula
Caudate
Thalamus
pCC
(Posterior cingulate 
Cortex)"
pdf_image,MODULE 4_1_Neuro_mech-1#page=14#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_14_img7.png,M1-Q20,0.167,"Amanzio, Benedetti et al (2011) Hum Brain Mapp
Placebo - Expectation Pain perception (pain matrix)
Activation
Inhibition
DLPFC
rACC
(Rostral Cingulate 
Anterior Cortex)
PAG
(Periaqueductal 
Gray)
Putamen
Insula
Caudate
Thalamus
pCC
(Posterior cingulate 
Cortex)"
pdf_image,MODULE 4_1_Neuro_mech-1#page=14#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_14_img8.png,M1-Q20,0.167,"Amanzio, Benedetti et al (2011) Hum Brain Mapp
Placebo - Expectation Pain perception (pain matrix)
Activation
Inhibition
DLPFC
rACC
(Rostral Cingulate 
Anterior Cortex)
PAG
(Periaqueductal 
Gray)
Putamen
Insula
Caudate
Thalamus
pCC
(Posterior cingulate 
Cortex)"
pdf_image,MODULE 4_1_Neuro_mech-1#page=14#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_14_img9.png,M1-Q20,0.167,"Amanzio, Benedetti et al (2011) Hum Brain Mapp
Placebo - Expectation Pain perception (pain matrix)
Activation
Inhibition
DLPFC
rACC
(Rostral Cingulate 
Anterior Cortex)
PAG
(Periaqueductal 
Gray)
Putamen
Insula
Caudate
Thalamus
pCC
(Posterior cingulate 
Cortex)"
pdf_image,MODULE 4_1_Neuro_mech-1#page=14#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_14_img10.png,M1-Q20,0.167,"Amanzio, Benedetti et al (2011) Hum Brain Mapp
Placebo - Expectation Pain perception (pain matrix)
Activation
Inhibition
DLPFC
rACC
(Rostral Cingulate 
Anterior Cortex)
PAG
(Periaqueductal 
Gray)
Putamen
Insula
Caudate
Thalamus
pCC
(Posterior cingulate 
Cortex)"
pdf_image,MODULE 4_1_Neuro_mech-1#page=14#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_14_img11.png,M1-Q20,0.167,"Amanzio, Benedetti et al (2011) Hum Brain Mapp
Placebo - Expectation Pain perception (pain matrix)
Activation
Inhibition
DLPFC
rACC
(Rostral Cingulate 
Anterior Cortex)
PAG
(Periaqueductal 
Gray)
Putamen
Insula
Caudate
Thalamus
pCC
(Posterior cingulate 
Cortex)"
pdf_image,MODULE 4_1_Neuro_mech-1#page=14#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_14_img12.png,M1-Q20,0.167,"Amanzio, Benedetti et al (2011) Hum Brain Mapp
Placebo - Expectation Pain perception (pain matrix)
Activation
Inhibition
DLPFC
rACC
(Rostral Cingulate 
Anterior Cortex)
PAG
(Periaqueductal 
Gray)
Putamen
Insula
Caudate
Thalamus
pCC
(Posterior cingulate 
Cortex)"
pdf_image,MODULE 4_1_Neuro_mech-1#page=14#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_14_img13.png,M1-Q20,0.167,"Amanzio, Benedetti et al (2011) Hum Brain Mapp
Placebo - Expectation Pain perception (pain matrix)
Activation
Inhibition
DLPFC
rACC
(Rostral Cingulate 
Anterior Cortex)
PAG
(Periaqueductal 
Gray)
Putamen
Insula
Caudate
Thalamus
pCC
(Posterior cingulate 
Cortex)"
pdf_image,MODULE 4_1_Neuro_mech-1#page=14#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_14_img14.png,M1-Q20,0.167,"Amanzio, Benedetti et al (2011) Hum Brain Mapp
Placebo - Expectation Pain perception (pain matrix)
Activation
Inhibition
DLPFC
rACC
(Rostral Cingulate 
Anterior Cortex)
PAG
(Periaqueductal 
Gray)
Putamen
Insula
Caudate
Thalamus
pCC
(Posterior cingulate 
Cortex)"
pdf_image,MODULE 4_1_Neuro_mech-1#page=15#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_15_img1.png,M4-Q22,0.180,"Krummenacher et al. 2010 Pain 148: 368-374
If the prefrontal area (DLPFC) is inactivated, 
placebo effect is abolished
Analgesia 
expectation
Analgesia 
expectation"
pdf_image,MODULE 4_1_Neuro_mech-1#page=15#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_15_img2.png,M4-Q22,0.180,"Krummenacher et al. 2010 Pain 148: 368-374
If the prefrontal area (DLPFC) is inactivated, 
placebo effect is abolished
Analgesia 
expectation
Analgesia 
expectation"
pdf_image,MODULE 4_1_Neuro_mech-1#page=16#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_16_img1.png,M1-Q17,0.143,"Stein et al (2012) Pain 153: 2210-2217
The matter integrity
by fractional anisotropy
in normal subjects
Lower frontal integrity corresponds to a lower 
placebo response"
pdf_image,MODULE 4_1_Neuro_mech-1#page=17#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_17_img1.png,M3-Q14,0.097,"All participants received remifentanil, at a fixed dose. 
The study aimed to test how expectations modulate the effect of a real drug: 
1. No expectancy: patients received remifentanil without knowing its effect
2. Positive expectancy: participants received remifentanil and, therefore they 
expected"
pdf_image,MODULE 4_1_Neuro_mech-1#page=18#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_18_img1.png,M1-Q20,0.118,"Bingel et al. 2011 Science Trans Med, 3: 70ra14
Gollub  and Kong, 2011 Science Trans Med Com
OPEN ADMINISTRATION: 
• Expecting pain relief enhances 
opioid analgesia 
• Brain activity increases in: 
• Dorsolateral prefrontal 
cortex (DLPFC) 
• ACC (anterior cingulate cortex) 
• Striatum (Caudate, pu"
pdf_image,MODULE 4_1_Neuro_mech-1#page=18#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_18_img2.png,M1-Q20,0.118,"Bingel et al. 2011 Science Trans Med, 3: 70ra14
Gollub  and Kong, 2011 Science Trans Med Com
OPEN ADMINISTRATION: 
• Expecting pain relief enhances 
opioid analgesia 
• Brain activity increases in: 
• Dorsolateral prefrontal 
cortex (DLPFC) 
• ACC (anterior cingulate cortex) 
• Striatum (Caudate, pu"
pdf_image,MODULE 4_1_Neuro_mech-1#page=18#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_18_img3.png,M1-Q20,0.118,"Bingel et al. 2011 Science Trans Med, 3: 70ra14
Gollub  and Kong, 2011 Science Trans Med Com
OPEN ADMINISTRATION: 
• Expecting pain relief enhances 
opioid analgesia 
• Brain activity increases in: 
• Dorsolateral prefrontal 
cortex (DLPFC) 
• ACC (anterior cingulate cortex) 
• Striatum (Caudate, pu"
pdf_image,MODULE 4_1_Neuro_mech-1#page=20#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_20_img1.png,M3-Q03,0.123,"Placebo and Event Related Potentials 
(ERPs)
• STUDY 1: LEP
(Laser-Evoked 
Potentials)
• STUDY 2: CNV
(Contingent Negative 
Variation)
EEG
early nociceptive 
processes
anticipation phase 
during pain-task
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=20#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_20_img2.png,M3-Q03,0.123,"Placebo and Event Related Potentials 
(ERPs)
• STUDY 1: LEP
(Laser-Evoked 
Potentials)
• STUDY 2: CNV
(Contingent Negative 
Variation)
EEG
early nociceptive 
processes
anticipation phase 
during pain-task
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=20#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_20_img3.png,M3-Q03,0.123,"Placebo and Event Related Potentials 
(ERPs)
• STUDY 1: LEP
(Laser-Evoked 
Potentials)
• STUDY 2: CNV
(Contingent Negative 
Variation)
EEG
early nociceptive 
processes
anticipation phase 
during pain-task
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=20#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_20_img4.png,M3-Q03,0.123,"Placebo and Event Related Potentials 
(ERPs)
• STUDY 1: LEP
(Laser-Evoked 
Potentials)
• STUDY 2: CNV
(Contingent Negative 
Variation)
EEG
early nociceptive 
processes
anticipation phase 
during pain-task
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=21#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_21_img1.png,M1-Q20,0.109,"Colloca et al. Pain 139 (2009) 306-314
Wager et al. Brain, Behav Imm 20 (2006) 219-230
Watson et al Pain 126 (2006) 115-122
DECREASE IN N2-P2 
complex during placebo 
analgesia
The N2–P2 complex is a component of laser-
evoked potentials (LEPs) that reflects cortical 
processing of painful stimuli, "
pdf_image,MODULE 4_1_Neuro_mech-1#page=21#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_21_img2.png,M1-Q20,0.109,"Colloca et al. Pain 139 (2009) 306-314
Wager et al. Brain, Behav Imm 20 (2006) 219-230
Watson et al Pain 126 (2006) 115-122
DECREASE IN N2-P2 
complex during placebo 
analgesia
The N2–P2 complex is a component of laser-
evoked potentials (LEPs) that reflects cortical 
processing of painful stimuli, "
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img1.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img2.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img3.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img4.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img5.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img6.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img7.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img8.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img9.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img10.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img11.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img12.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img13.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img14.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img15.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img16.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img17.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img18.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img19.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img20.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img21.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=23#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_23_img22.png,M1-Q20,0.090,"*
+ or −
Fixation (4000ms)
Cue(700ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
C 1
+
P=0.006
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Cond 1
Cond 2
Test
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
Carlino E, EJP, 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         0.6   
E"
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img1.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img2.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img3.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img4.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img5.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img6.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img7.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img8.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img9.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img10.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img11.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img12.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img13.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img14.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img15.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img16.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img17.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img18.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img19.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img20.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img21.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=24#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_24_img22.png,M4-Q11,0.099,"*
+ or −
Fixation (4000ms)
Cue(700 ms)
Mask →FIRE (300ms)
Rating(6000ms)
Rating
NO EFFECT
P = 0.7
C 1
+
6
5
4
3
2
1
0
C 2
+
T
+
C 1
−
C 2
−
T
−
Expectation CONDITIONING
CONSCIOUS UNCONSCIOUS 
?
C 1
C 2
Test
Carlino E, EJP , 2015
8
 
  4
  0
- 4
- 8
N2-P2 (µV)
Time(s)
0        0.2        0.4         "
pdf_image,MODULE 4_1_Neuro_mech-1#page=26#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_26_img1.png,M4-Q22,0.102,"Reaction time recording
Electrical 
shocks
EEG recording
Cue’s 
presentation
ACQUISITION
EVOCATION
COND group
warning
imperative
Piedimonte et al., 2017
Green cue → expected pain reduction (placebo) 
Red cue → expected pain increase (nocebo) 
Measures: 
• RT: reaction time to stop the stimulus 
(if "
pdf_image,MODULE 4_1_Neuro_mech-1#page=26#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_26_img2.png,M4-Q22,0.102,"Reaction time recording
Electrical 
shocks
EEG recording
Cue’s 
presentation
ACQUISITION
EVOCATION
COND group
warning
imperative
Piedimonte et al., 2017
Green cue → expected pain reduction (placebo) 
Red cue → expected pain increase (nocebo) 
Measures: 
• RT: reaction time to stop the stimulus 
(if "
pdf_image,MODULE 4_1_Neuro_mech-1#page=26#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_26_img3.png,M4-Q22,0.102,"Reaction time recording
Electrical 
shocks
EEG recording
Cue’s 
presentation
ACQUISITION
EVOCATION
COND group
warning
imperative
Piedimonte et al., 2017
Green cue → expected pain reduction (placebo) 
Red cue → expected pain increase (nocebo) 
Measures: 
• RT: reaction time to stop the stimulus 
(if "
pdf_image,MODULE 4_1_Neuro_mech-1#page=26#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_26_img4.png,M4-Q22,0.102,"Reaction time recording
Electrical 
shocks
EEG recording
Cue’s 
presentation
ACQUISITION
EVOCATION
COND group
warning
imperative
Piedimonte et al., 2017
Green cue → expected pain reduction (placebo) 
Red cue → expected pain increase (nocebo) 
Measures: 
• RT: reaction time to stop the stimulus 
(if "
pdf_image,MODULE 4_1_Neuro_mech-1#page=26#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_26_img5.png,M4-Q22,0.102,"Reaction time recording
Electrical 
shocks
EEG recording
Cue’s 
presentation
ACQUISITION
EVOCATION
COND group
warning
imperative
Piedimonte et al., 2017
Green cue → expected pain reduction (placebo) 
Red cue → expected pain increase (nocebo) 
Measures: 
• RT: reaction time to stop the stimulus 
(if "
pdf_image,MODULE 4_1_Neuro_mech-1#page=27#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_27_img1.png,M3-Q10,0.059,"Se rosso mi aspetto ‘preparazione’ maggiore per stoppare lo stimolo (onda più gonfia)
Se stimoli rosso e verde stessa intensità → se ti ho condizionato dopo il rosso ti prepari a schivare 
come fosse intenso come prima. 
A livello comportamentale i rossi sono più alti dei verdi, invece i tempi di re"
pdf_image,MODULE 4_1_Neuro_mech-1#page=27#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_27_img2.png,M3-Q10,0.059,"Se rosso mi aspetto ‘preparazione’ maggiore per stoppare lo stimolo (onda più gonfia)
Se stimoli rosso e verde stessa intensità → se ti ho condizionato dopo il rosso ti prepari a schivare 
come fosse intenso come prima. 
A livello comportamentale i rossi sono più alti dei verdi, invece i tempi di re"
pdf_image,MODULE 4_1_Neuro_mech-1#page=28#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_28_img1.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System 
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=28#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_28_img2.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System 
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=28#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_28_img3.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System 
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=28#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_28_img4.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System 
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=29#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_29_img1.png,M4-Q18,0.203,"MOTOR 
SYSTEM
Placebo effect
(caffeine drink)
Nocebo effect
(sham stimulation)
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=29#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_29_img2.png,M4-Q18,0.203,"MOTOR 
SYSTEM
Placebo effect
(caffeine drink)
Nocebo effect
(sham stimulation)
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=29#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_29_img3.png,M4-Q18,0.203,"MOTOR 
SYSTEM
Placebo effect
(caffeine drink)
Nocebo effect
(sham stimulation)
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=29#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_29_img4.png,M4-Q18,0.203,"MOTOR 
SYSTEM
Placebo effect
(caffeine drink)
Nocebo effect
(sham stimulation)
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=29#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_29_img5.png,M4-Q18,0.203,"MOTOR 
SYSTEM
Placebo effect
(caffeine drink)
Nocebo effect
(sham stimulation)
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=29#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_29_img6.png,M4-Q18,0.203,"MOTOR 
SYSTEM
Placebo effect
(caffeine drink)
Nocebo effect
(sham stimulation)
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=29#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_29_img7.png,M4-Q18,0.203,"MOTOR 
SYSTEM
Placebo effect
(caffeine drink)
Nocebo effect
(sham stimulation)
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=29#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_29_img8.png,M4-Q18,0.203,"MOTOR 
SYSTEM
Placebo effect
(caffeine drink)
Nocebo effect
(sham stimulation)
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=29#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_29_img9.png,M4-Q18,0.203,"MOTOR 
SYSTEM
Placebo effect
(caffeine drink)
Nocebo effect
(sham stimulation)
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=29#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_29_img10.png,M4-Q18,0.203,"MOTOR 
SYSTEM
Placebo effect
(caffeine drink)
Nocebo effect
(sham stimulation)
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=30#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_30_img1.png,M4-Q11,0.116,"PROTOCOL 1:
Expectation 
alone
SESSION 1
Baseline
SESSION 2
Evaluation
PROTOCOL 2:
Expectation + 
conditioning
SESSION 1
Baseline
SESSION 4
Evaluation
SESSION 2 and SESSION 3
Conditioning + Expectation
load to lift
Subjects performed different leg extension 
sessions, to exhaustion, in different day"
pdf_image,MODULE 4_1_Neuro_mech-1#page=30#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_30_img2.png,M4-Q11,0.116,"PROTOCOL 1:
Expectation 
alone
SESSION 1
Baseline
SESSION 2
Evaluation
PROTOCOL 2:
Expectation + 
conditioning
SESSION 1
Baseline
SESSION 4
Evaluation
SESSION 2 and SESSION 3
Conditioning + Expectation
load to lift
Subjects performed different leg extension 
sessions, to exhaustion, in different day"
pdf_image,MODULE 4_1_Neuro_mech-1#page=30#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_30_img3.png,M4-Q11,0.116,"PROTOCOL 1:
Expectation 
alone
SESSION 1
Baseline
SESSION 2
Evaluation
PROTOCOL 2:
Expectation + 
conditioning
SESSION 1
Baseline
SESSION 4
Evaluation
SESSION 2 and SESSION 3
Conditioning + Expectation
load to lift
Subjects performed different leg extension 
sessions, to exhaustion, in different day"
pdf_image,MODULE 4_1_Neuro_mech-1#page=30#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_30_img4.png,M4-Q11,0.116,"PROTOCOL 1:
Expectation 
alone
SESSION 1
Baseline
SESSION 2
Evaluation
PROTOCOL 2:
Expectation + 
conditioning
SESSION 1
Baseline
SESSION 4
Evaluation
SESSION 2 and SESSION 3
Conditioning + Expectation
load to lift
Subjects performed different leg extension 
sessions, to exhaustion, in different day"
pdf_image,MODULE 4_1_Neuro_mech-1#page=30#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_30_img5.png,M4-Q11,0.116,"PROTOCOL 1:
Expectation 
alone
SESSION 1
Baseline
SESSION 2
Evaluation
PROTOCOL 2:
Expectation + 
conditioning
SESSION 1
Baseline
SESSION 4
Evaluation
SESSION 2 and SESSION 3
Conditioning + Expectation
load to lift
Subjects performed different leg extension 
sessions, to exhaustion, in different day"
pdf_image,MODULE 4_1_Neuro_mech-1#page=37#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_37_img1.png,M1-Q29,0.097,"First series
(10-min, 60 movements)  
Second series
(10-min, 60 movements)  
Third series
(10-min, 60 movements)  
CONTROL GROUP
PLACEBO  GROUP
A)
B)
administration         → expected effect →“in ten minutes it will 
be effective”
grip handleload
First series
(10-min, 60 movements)  
Second series
("
pdf_image,MODULE 4_1_Neuro_mech-1#page=39#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_39_img1.png,M4-Q08,0.109,"C3 Cz C4 
CONTROL  GROUPPLACEBO  GROUP
A)
B)
FIG. 3 AREA (uVs) Amp  (uV)
**
***
**
***
**
**
 **
***
**
First series Second series Third series
-2000    -1500   - 1000   -500         0 
Time windows (ms)
4
3
2
1
0
- 12
- 6
0
-2000    -1500   - 1000   -500        0 
Time windows (ms)
4
3
2
1
0
- 12
-"
pdf_image,MODULE 4_1_Neuro_mech-1#page=39#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_39_img2.png,M4-Q08,0.109,"C3 Cz C4 
CONTROL  GROUPPLACEBO  GROUP
A)
B)
FIG. 3 AREA (uVs) Amp  (uV)
**
***
**
***
**
**
 **
***
**
First series Second series Third series
-2000    -1500   - 1000   -500         0 
Time windows (ms)
4
3
2
1
0
- 12
- 6
0
-2000    -1500   - 1000   -500        0 
Time windows (ms)
4
3
2
1
0
- 12
-"
pdf_image,MODULE 4_1_Neuro_mech-1#page=39#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_39_img3.png,M4-Q08,0.109,"C3 Cz C4 
CONTROL  GROUPPLACEBO  GROUP
A)
B)
FIG. 3 AREA (uVs) Amp  (uV)
**
***
**
***
**
**
 **
***
**
First series Second series Third series
-2000    -1500   - 1000   -500         0 
Time windows (ms)
4
3
2
1
0
- 12
- 6
0
-2000    -1500   - 1000   -500        0 
Time windows (ms)
4
3
2
1
0
- 12
-"
pdf_image,MODULE 4_1_Neuro_mech-1#page=39#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_39_img4.png,M4-Q08,0.109,"C3 Cz C4 
CONTROL  GROUPPLACEBO  GROUP
A)
B)
FIG. 3 AREA (uVs) Amp  (uV)
**
***
**
***
**
**
 **
***
**
First series Second series Third series
-2000    -1500   - 1000   -500         0 
Time windows (ms)
4
3
2
1
0
- 12
- 6
0
-2000    -1500   - 1000   -500        0 
Time windows (ms)
4
3
2
1
0
- 12
-"
pdf_image,MODULE 4_1_Neuro_mech-1#page=39#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_39_img5.png,M4-Q08,0.109,"C3 Cz C4 
CONTROL  GROUPPLACEBO  GROUP
A)
B)
FIG. 3 AREA (uVs) Amp  (uV)
**
***
**
***
**
**
 **
***
**
First series Second series Third series
-2000    -1500   - 1000   -500         0 
Time windows (ms)
4
3
2
1
0
- 12
- 6
0
-2000    -1500   - 1000   -500        0 
Time windows (ms)
4
3
2
1
0
- 12
-"
pdf_image,MODULE 4_1_Neuro_mech-1#page=39#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_39_img6.png,M4-Q08,0.109,"C3 Cz C4 
CONTROL  GROUPPLACEBO  GROUP
A)
B)
FIG. 3 AREA (uVs) Amp  (uV)
**
***
**
***
**
**
 **
***
**
First series Second series Third series
-2000    -1500   - 1000   -500         0 
Time windows (ms)
4
3
2
1
0
- 12
- 6
0
-2000    -1500   - 1000   -500        0 
Time windows (ms)
4
3
2
1
0
- 12
-"
pdf_image,MODULE 4_1_Neuro_mech-1#page=40#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_40_img1.png,M1-Q27,0.090,"Conclusions
Inhibitory systemFacilitatory system
•Motor cortex
•Orbitofrontal cortex
•Prefrontal cortex
•Anterior Cingulate cortex
•Limbic system
•Thalamus
•Basal ganglia
•Motor cortex
•Anterior Cingulate cortex
•Medial and posterior insular 
cortex
•Secondary somatosensory cortex
•Thalamus
•Spinal "
pdf_image,MODULE 4_1_Neuro_mech-1#page=41#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_41_img1.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System 
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=41#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_41_img2.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System 
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=41#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_41_img3.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System 
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=41#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_41_img4.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System 
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=43#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_43_img1.png,M4-Q09,0.124,"Goebel et al. (2002) FASEB J. 16: 1869-1873.
Strawberry 
milk
Cyclosporin A
(immunosuppressant:
reduction of interleukin-2 and interferon)
Placebo
Strawberry 
milk
CONDITIONED GROUP
ACQUISITION EVOCATION
Control group
Conditioned group
Drug group
IMMUNOSUPPRESSION"
pdf_image,MODULE 4_1_Neuro_mech-1#page=43#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_43_img2.png,M4-Q09,0.124,"Goebel et al. (2002) FASEB J. 16: 1869-1873.
Strawberry 
milk
Cyclosporin A
(immunosuppressant:
reduction of interleukin-2 and interferon)
Placebo
Strawberry 
milk
CONDITIONED GROUP
ACQUISITION EVOCATION
Control group
Conditioned group
Drug group
IMMUNOSUPPRESSION"
pdf_image,MODULE 4_1_Neuro_mech-1#page=43#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_43_img3.png,M4-Q09,0.124,"Goebel et al. (2002) FASEB J. 16: 1869-1873.
Strawberry 
milk
Cyclosporin A
(immunosuppressant:
reduction of interleukin-2 and interferon)
Placebo
Strawberry 
milk
CONDITIONED GROUP
ACQUISITION EVOCATION
Control group
Conditioned group
Drug group
IMMUNOSUPPRESSION"
pdf_image,MODULE 4_1_Neuro_mech-1#page=43#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_43_img4.png,M4-Q09,0.124,"Goebel et al. (2002) FASEB J. 16: 1869-1873.
Strawberry 
milk
Cyclosporin A
(immunosuppressant:
reduction of interleukin-2 and interferon)
Placebo
Strawberry 
milk
CONDITIONED GROUP
ACQUISITION EVOCATION
Control group
Conditioned group
Drug group
IMMUNOSUPPRESSION"
pdf_image,MODULE 4_1_Neuro_mech-1#page=43#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_43_img5.png,M4-Q09,0.124,"Goebel et al. (2002) FASEB J. 16: 1869-1873.
Strawberry 
milk
Cyclosporin A
(immunosuppressant:
reduction of interleukin-2 and interferon)
Placebo
Strawberry 
milk
CONDITIONED GROUP
ACQUISITION EVOCATION
Control group
Conditioned group
Drug group
IMMUNOSUPPRESSION"
pdf_image,MODULE 4_1_Neuro_mech-1#page=44#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_44_img1.png,M4-Q09,0.095,"Water group (water + placebo):
- decreased the subjective symptoms
- attenuated the effects of the skin prick 
test for histamine
Placebo group (novel-tasting drink + 
placebo):
- decreased the subjective symptoms
- attenuated the effects of the skin prick 
test for histamine
- Reduced basophil acti"
pdf_image,MODULE 4_1_Neuro_mech-1#page=44#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_44_img2.png,M4-Q09,0.095,"Water group (water + placebo):
- decreased the subjective symptoms
- attenuated the effects of the skin prick 
test for histamine
Placebo group (novel-tasting drink + 
placebo):
- decreased the subjective symptoms
- attenuated the effects of the skin prick 
test for histamine
- Reduced basophil acti"
pdf_image,MODULE 4_1_Neuro_mech-1#page=44#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_44_img3.png,M4-Q09,0.095,"Water group (water + placebo):
- decreased the subjective symptoms
- attenuated the effects of the skin prick 
test for histamine
Placebo group (novel-tasting drink + 
placebo):
- decreased the subjective symptoms
- attenuated the effects of the skin prick 
test for histamine
- Reduced basophil acti"
pdf_image,MODULE 4_1_Neuro_mech-1#page=44#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_44_img4.png,M4-Q09,0.095,"Water group (water + placebo):
- decreased the subjective symptoms
- attenuated the effects of the skin prick 
test for histamine
Placebo group (novel-tasting drink + 
placebo):
- decreased the subjective symptoms
- attenuated the effects of the skin prick 
test for histamine
- Reduced basophil acti"
pdf_image,MODULE 4_1_Neuro_mech-1#page=45#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_45_img1.png,M4-Q18,0.167,"HORMONAL CHANGES
• Plasma GH 
concentration
• Expectancy does not 
vary GH 
concentration
• Placebo mimics the 
effect of 
sumatriptan (> GH)
Benedetti et al., 2003"
pdf_image,MODULE 4_1_Neuro_mech-1#page=46#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_46_img1.png,M4-Q18,0.163,"HORMONAL CHANGES
• Plasma cortisol 
concentration
• Expectancy does not 
vary cortisol 
concentration
• Placebo mimics the 
effect of sumatriptan 
(< cortisol)
Benedetti et al., 2003
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=47#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_47_img1.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System 
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=47#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_47_img2.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System 
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=47#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_47_img3.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System 
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=47#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_47_img4.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System 
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_1_Neuro_mech-1#page=48#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_48_img1.png,M4-Q06,0.103,"Parkinson’s Disease (PD)
Bradykinesia
Tremor at 
rest
Rigidity
Postural instability
Freezing
Symptoms due to dopaminergic 
impairment at the level of the 
substance nigra and striatum 
(putamen and caudate):
- From initial nigrostriatal 
degeneration
- Possible degeneration of 
several dopaminergic "
pdf_image,MODULE 4_1_Neuro_mech-1#page=48#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_48_img2.png,M4-Q06,0.103,"Parkinson’s Disease (PD)
Bradykinesia
Tremor at 
rest
Rigidity
Postural instability
Freezing
Symptoms due to dopaminergic 
impairment at the level of the 
substance nigra and striatum 
(putamen and caudate):
- From initial nigrostriatal 
degeneration
- Possible degeneration of 
several dopaminergic "
pdf_image,MODULE 4_1_Neuro_mech-1#page=56#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_56_img1.png,M4-Q09,0.140,"Pollo et al., 2002; Benedetti et al., 2003
Improvement in behavioral studies"
pdf_image,MODULE 4_1_Neuro_mech-1#page=56#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_56_img2.png,M4-Q09,0.140,"Pollo et al., 2002; Benedetti et al., 2003
Improvement in behavioral studies"
pdf_image,MODULE 4_1_Neuro_mech-1#page=56#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_56_img3.png,M4-Q09,0.140,"Pollo et al., 2002; Benedetti et al., 2003
Improvement in behavioral studies"
pdf_image,MODULE 4_1_Neuro_mech-1#page=58#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_58_img1.png,M4-Q10,0.137,"De la Fuente-Fernandez et al.  Science  2001
200% increase in
dopamine =
One dose of
amphetamine
Release of 
endogenous 
dopamine at the 
level of the striatum 
in PD.
Improvement in PET studies
Raclopride binding decreased because endogenous 
dopamine increased, showing that placebo induced 
dopami"
pdf_image,MODULE 4_1_Neuro_mech-1#page=58#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_58_img2.png,M4-Q10,0.137,"De la Fuente-Fernandez et al.  Science  2001
200% increase in
dopamine =
One dose of
amphetamine
Release of 
endogenous 
dopamine at the 
level of the striatum 
in PD.
Improvement in PET studies
Raclopride binding decreased because endogenous 
dopamine increased, showing that placebo induced 
dopami"
pdf_image,MODULE 4_1_Neuro_mech-1#page=61#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_61_img1.png,M4-Q11,0.133,"• Double-blind study
• During DBS surgery
• Placebo administered in the operating room 
after several days of preconditioning with 
apomorphine
Improvements in single-neuron 
studies
Benedetti,   Nature Neurosci  2004
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=62#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_62_img1.png,M4-Q22,0.114,"Basal Recording
of the subthalamic nucleus
Experimental registration
of the subthalamic nucleus
placebo
Improvements in single-neuron 
studies
PLACEBO EFFECT
• Reduction of wrist rigidity between pre- and post-treatment
• Increase in the firing rate of the thalamus (in the inhibitory circuit 
of the"
pdf_image,MODULE 4_1_Neuro_mech-1#page=62#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_62_img2.png,M4-Q22,0.114,"Basal Recording
of the subthalamic nucleus
Experimental registration
of the subthalamic nucleus
placebo
Improvements in single-neuron 
studies
PLACEBO EFFECT
• Reduction of wrist rigidity between pre- and post-treatment
• Increase in the firing rate of the thalamus (in the inhibitory circuit 
of the"
pdf_image,MODULE 4_1_Neuro_mech-1#page=62#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_62_img3.png,M4-Q22,0.114,"Basal Recording
of the subthalamic nucleus
Experimental registration
of the subthalamic nucleus
placebo
Improvements in single-neuron 
studies
PLACEBO EFFECT
• Reduction of wrist rigidity between pre- and post-treatment
• Increase in the firing rate of the thalamus (in the inhibitory circuit 
of the"
pdf_image,MODULE 4_1_Neuro_mech-1#page=63#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_63_img1.png,M1-Q20,0.143,"• Extension of previous study
• During DBS surgery
• Analysis of thalamic nuclei (VA, anterior 
ventral and anterior ventral lateral VLA) and 
substance nigra
Improvements in single-neuron 
studies
Benedetti,   J Physiol  2009
"
pdf_image,MODULE 4_1_Neuro_mech-1#page=64#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_64_img1.png,M4-Q06,0.129,"Placebo responder: reduction of 
firing rate in the STN associated with 
reduction in the substance nigra and 
increase in the thalamic nuclei
Placebo non-responder
+ +
- -
+ +
increasedecrease
pre –post 
pre
Neuronal firing rate (Hz)
STN
SNr
Th
STN"
pdf_image,MODULE 4_1_Neuro_mech-1#page=64#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_64_img2.png,M4-Q06,0.129,"Placebo responder: reduction of 
firing rate in the STN associated with 
reduction in the substance nigra and 
increase in the thalamic nuclei
Placebo non-responder
+ +
- -
+ +
increasedecrease
pre –post 
pre
Neuronal firing rate (Hz)
STN
SNr
Th
STN"
pdf_image,MODULE 4_1_Neuro_mech-1#page=64#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_64_img3.png,M4-Q06,0.129,"Placebo responder: reduction of 
firing rate in the STN associated with 
reduction in the substance nigra and 
increase in the thalamic nuclei
Placebo non-responder
+ +
- -
+ +
increasedecrease
pre –post 
pre
Neuronal firing rate (Hz)
STN
SNr
Th
STN"
pdf_image,MODULE 4_1_Neuro_mech-1#page=64#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_64_img4.png,M4-Q06,0.129,"Placebo responder: reduction of 
firing rate in the STN associated with 
reduction in the substance nigra and 
increase in the thalamic nuclei
Placebo non-responder
+ +
- -
+ +
increasedecrease
pre –post 
pre
Neuronal firing rate (Hz)
STN
SNr
Th
STN"
pdf_image,MODULE 4_1_Neuro_mech-1#page=64#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_64_img5.png,M4-Q06,0.129,"Placebo responder: reduction of 
firing rate in the STN associated with 
reduction in the substance nigra and 
increase in the thalamic nuclei
Placebo non-responder
+ +
- -
+ +
increasedecrease
pre –post 
pre
Neuronal firing rate (Hz)
STN
SNr
Th
STN"
pdf_image,MODULE 4_1_Neuro_mech-1#page=64#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_64_img6.png,M4-Q06,0.129,"Placebo responder: reduction of 
firing rate in the STN associated with 
reduction in the substance nigra and 
increase in the thalamic nuclei
Placebo non-responder
+ +
- -
+ +
increasedecrease
pre –post 
pre
Neuronal firing rate (Hz)
STN
SNr
Th
STN"
pdf_image,MODULE 4_1_Neuro_mech-1#page=64#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_64_img7.png,M4-Q06,0.129,"Placebo responder: reduction of 
firing rate in the STN associated with 
reduction in the substance nigra and 
increase in the thalamic nuclei
Placebo non-responder
+ +
- -
+ +
increasedecrease
pre –post 
pre
Neuronal firing rate (Hz)
STN
SNr
Th
STN"
pdf_image,MODULE 4_1_Neuro_mech-1#page=65#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_65_img1.png,M4-Q09,0.135,"• N = 42 PD patients (DBS)
• 6 experimental groups
• OUTCOMES:
– Single Neuron Recording (Thalamus)
– Wrist rigidity
Benedetti et al., J Physiol, 2016
Improvements in single-neuron 
studies"
pdf_image,MODULE 4_1_Neuro_mech-1#page=65#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_65_img2.png,M4-Q09,0.135,"• N = 42 PD patients (DBS)
• 6 experimental groups
• OUTCOMES:
– Single Neuron Recording (Thalamus)
– Wrist rigidity
Benedetti et al., J Physiol, 2016
Improvements in single-neuron 
studies"
pdf_image,MODULE 4_1_Neuro_mech-1#page=65#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_65_img3.png,M4-Q09,0.135,"• N = 42 PD patients (DBS)
• 6 experimental groups
• OUTCOMES:
– Single Neuron Recording (Thalamus)
– Wrist rigidity
Benedetti et al., J Physiol, 2016
Improvements in single-neuron 
studies"
pdf_image,MODULE 4_1_Neuro_mech-1#page=65#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_65_img4.png,M4-Q09,0.135,"• N = 42 PD patients (DBS)
• 6 experimental groups
• OUTCOMES:
– Single Neuron Recording (Thalamus)
– Wrist rigidity
Benedetti et al., J Physiol, 2016
Improvements in single-neuron 
studies"
pdf_image,MODULE 4_1_Neuro_mech-1#page=67#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_67_img1.png,M4-Q01,0.130,EXPERIMENTAL GROUPS
pdf_image,MODULE 4_1_Neuro_mech-1#page=67#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_67_img2.png,M4-Q01,0.130,EXPERIMENTAL GROUPS
pdf_image,MODULE 4_1_Neuro_mech-1#page=67#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_67_img3.png,M4-Q01,0.130,EXPERIMENTAL GROUPS
pdf_image,MODULE 4_1_Neuro_mech-1#page=68#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_68_img1.png,M1-Q20,0.143,"EEG STUDY
It’s my 
standard dose 
of L-dopa
DECEIVE
= HALF DOSE
HALF
= HALF DOSE 
FULL
= FULL DOSE 
It’s my 
standard dose 
of L-dopa
It’s the 50% 
of my dose of 
L-dopa
Carlino et al., Parkinsonisms, 2019"
pdf_image,MODULE 4_1_Neuro_mech-1#page=68#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_68_img2.png,M1-Q20,0.143,"EEG STUDY
It’s my 
standard dose 
of L-dopa
DECEIVE
= HALF DOSE
HALF
= HALF DOSE 
FULL
= FULL DOSE 
It’s my 
standard dose 
of L-dopa
It’s the 50% 
of my dose of 
L-dopa
Carlino et al., Parkinsonisms, 2019"
pdf_image,MODULE 4_1_Neuro_mech-1#page=68#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_68_img3.png,M1-Q20,0.143,"EEG STUDY
It’s my 
standard dose 
of L-dopa
DECEIVE
= HALF DOSE
HALF
= HALF DOSE 
FULL
= FULL DOSE 
It’s my 
standard dose 
of L-dopa
It’s the 50% 
of my dose of 
L-dopa
Carlino et al., Parkinsonisms, 2019"
pdf_image,MODULE 4_1_Neuro_mech-1#page=68#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_68_img4.png,M1-Q20,0.143,"EEG STUDY
It’s my 
standard dose 
of L-dopa
DECEIVE
= HALF DOSE
HALF
= HALF DOSE 
FULL
= FULL DOSE 
It’s my 
standard dose 
of L-dopa
It’s the 50% 
of my dose of 
L-dopa
Carlino et al., Parkinsonisms, 2019"
pdf_image,MODULE 4_1_Neuro_mech-1#page=68#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_68_img5.png,M1-Q20,0.143,"EEG STUDY
It’s my 
standard dose 
of L-dopa
DECEIVE
= HALF DOSE
HALF
= HALF DOSE 
FULL
= FULL DOSE 
It’s my 
standard dose 
of L-dopa
It’s the 50% 
of my dose of 
L-dopa
Carlino et al., Parkinsonisms, 2019"
pdf_image,MODULE 4_1_Neuro_mech-1#page=68#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_68_img6.png,M1-Q20,0.143,"EEG STUDY
It’s my 
standard dose 
of L-dopa
DECEIVE
= HALF DOSE
HALF
= HALF DOSE 
FULL
= FULL DOSE 
It’s my 
standard dose 
of L-dopa
It’s the 50% 
of my dose of 
L-dopa
Carlino et al., Parkinsonisms, 2019"
pdf_image,MODULE 4_1_Neuro_mech-1#page=69#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_69_img1.png,M1-Q20,0.092,"Medication-off condition           Medication-on condition                    
UPDRS
1. Full group (get full dose, told full dose)
2. Half group (get half dose, told half dose)
3. Deceit group (get half dose, told full dose)
Number of 
flexions
Rate of perceived 
exertion
EEG recording
Readiness Pot"
pdf_image,MODULE 4_1_Neuro_mech-1#page=69#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_69_img2.png,M1-Q20,0.092,"Medication-off condition           Medication-on condition                    
UPDRS
1. Full group (get full dose, told full dose)
2. Half group (get half dose, told half dose)
3. Deceit group (get half dose, told full dose)
Number of 
flexions
Rate of perceived 
exertion
EEG recording
Readiness Pot"
pdf_image,MODULE 4_1_Neuro_mech-1#page=70#docs\pdf_images\MODULE 4_1_Neuro_mech-1\page_70_img1.png,M4-Q16,0.135,"0
20
40
60
80
100
-50
0
50
100
% improvement
**
*
Full  Deceit  Half  
% improvement
**
*
Full  Deceit  Half  
UPDRS
(part III)
-50
0
50
100% improvement
***
***
Full  Deceit  Half  
Fatigue
EEG STUDY
Results showed a large difference
between the two half-dose groups: 
those who believedthey receive"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=1#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_1_img1.png,M1-Q20,0.108,"Before starting…
If you are interested in taking part in some of our research studies, 
please scan the QR code and fill out the form. 
A member of our research team will get in touch with you (there is no obligation 
to participate if our free slots are not compatible with your schedule).
https://f"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=5#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_5_img1.png,M3-Q14,0.146,"Pharmacological Treatment
masculine noun
A substance capable of causing functional changes in the body by 
means of a chemical or physical action
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=5#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_5_img2.png,M3-Q14,0.146,"Pharmacological Treatment
masculine noun
A substance capable of causing functional changes in the body by 
means of a chemical or physical action
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=5#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_5_img3.png,M3-Q14,0.146,"Pharmacological Treatment
masculine noun
A substance capable of causing functional changes in the body by 
means of a chemical or physical action
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=5#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_5_img4.png,M3-Q14,0.146,"Pharmacological Treatment
masculine noun
A substance capable of causing functional changes in the body by 
means of a chemical or physical action
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=6#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_6_img1.png,M3-Q12,0.132,"PHARMACOLOGICAL 
TREATMENT
• molecule introduced into the body
• has certain biochemical actions
• has certain biological effects
ex. morphine
pain
μ
μ
First analgesic pathway
Second analgesic pathway"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=6#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_6_img2.png,M3-Q12,0.132,"PHARMACOLOGICAL 
TREATMENT
• molecule introduced into the body
• has certain biochemical actions
• has certain biological effects
ex. morphine
pain
μ
μ
First analgesic pathway
Second analgesic pathway"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=6#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_6_img3.png,M3-Q12,0.132,"PHARMACOLOGICAL 
TREATMENT
• molecule introduced into the body
• has certain biochemical actions
• has certain biological effects
ex. morphine
pain
μ
μ
First analgesic pathway
Second analgesic pathway"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=6#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_6_img4.png,M3-Q12,0.132,"PHARMACOLOGICAL 
TREATMENT
• molecule introduced into the body
• has certain biochemical actions
• has certain biological effects
ex. morphine
pain
μ
μ
First analgesic pathway
Second analgesic pathway"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=7#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_7_img1.png,M3-Q10,0.168,"PHARMACOLOGICAL 
TREATMENT 
• Pharmacodynamics: study of the 
biochemical and physiological 
effects of drugs on the body, and 
their mechanism of action
• Pharmacokinetics:  study of the 
effects that the body's processes 
have on the drug (absorption, 
distribution, metabolism, 
elimination)
pharm"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=7#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_7_img2.png,M3-Q10,0.168,"PHARMACOLOGICAL 
TREATMENT 
• Pharmacodynamics: study of the 
biochemical and physiological 
effects of drugs on the body, and 
their mechanism of action
• Pharmacokinetics:  study of the 
effects that the body's processes 
have on the drug (absorption, 
distribution, metabolism, 
elimination)
pharm"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=8#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_8_img1.png,M4-Q22,0.127,"From pharmacological treatments to other 
treatments
Pharmacological 
treatment 
Surgical 
treatment
Manual therapies
Psychotherapy
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=8#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_8_img2.png,M4-Q22,0.127,"From pharmacological treatments to other 
treatments
Pharmacological 
treatment 
Surgical 
treatment
Manual therapies
Psychotherapy
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=8#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_8_img3.png,M4-Q22,0.127,"From pharmacological treatments to other 
treatments
Pharmacological 
treatment 
Surgical 
treatment
Manual therapies
Psychotherapy
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=8#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_8_img4.png,M4-Q22,0.127,"From pharmacological treatments to other 
treatments
Pharmacological 
treatment 
Surgical 
treatment
Manual therapies
Psychotherapy
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=8#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_8_img5.png,M4-Q22,0.127,"From pharmacological treatments to other 
treatments
Pharmacological 
treatment 
Surgical 
treatment
Manual therapies
Psychotherapy
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=8#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_8_img6.png,M4-Q22,0.127,"From pharmacological treatments to other 
treatments
Pharmacological 
treatment 
Surgical 
treatment
Manual therapies
Psychotherapy
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=9#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_9_img1.png,M4-Q18,0.157,"HOW CAN WE SAY THAT A TREATMENT 
IS EFFECTIVE?
?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=9#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_9_img2.png,M4-Q18,0.157,"HOW CAN WE SAY THAT A TREATMENT 
IS EFFECTIVE?
?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=9#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_9_img3.png,M4-Q18,0.157,"HOW CAN WE SAY THAT A TREATMENT 
IS EFFECTIVE?
?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=9#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_9_img4.png,M4-Q18,0.157,"HOW CAN WE SAY THAT A TREATMENT 
IS EFFECTIVE?
?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=9#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_9_img5.png,M4-Q18,0.157,"HOW CAN WE SAY THAT A TREATMENT 
IS EFFECTIVE?
?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=9#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_9_img6.png,M4-Q18,0.157,"HOW CAN WE SAY THAT A TREATMENT 
IS EFFECTIVE?
?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=10#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_10_img1.png,M4-Q07,0.137,"DEFINITIONS
placebo
/pla·cè·bo/
masculine noun
Inert substance, with no specific effects
??
? ? ?
?
?
PLACEBO ?
? ?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=10#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_10_img2.png,M4-Q07,0.137,"DEFINITIONS
placebo
/pla·cè·bo/
masculine noun
Inert substance, with no specific effects
??
? ? ?
?
?
PLACEBO ?
? ?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=10#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_10_img3.png,M4-Q07,0.137,"DEFINITIONS
placebo
/pla·cè·bo/
masculine noun
Inert substance, with no specific effects
??
? ? ?
?
?
PLACEBO ?
? ?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=10#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_10_img4.png,M4-Q07,0.137,"DEFINITIONS
placebo
/pla·cè·bo/
masculine noun
Inert substance, with no specific effects
??
? ? ?
?
?
PLACEBO ?
? ?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=11#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_11_img1.png,M4-Q22,0.184,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how placebo effect works
• In clinical practice → the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=11#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_11_img2.png,M4-Q22,0.184,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how placebo effect works
• In clinical practice → the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=11#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_11_img3.png,M4-Q22,0.184,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how placebo effect works
• In clinical practice → the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=11#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_11_img4.png,M4-Q22,0.184,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how placebo effect works
• In clinical practice → the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=11#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_11_img5.png,M4-Q22,0.184,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how placebo effect works
• In clinical practice → the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=11#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_11_img6.png,M4-Q22,0.184,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how placebo effect works
• In clinical practice → the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=11#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_11_img7.png,M4-Q22,0.184,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how placebo effect works
• In clinical practice → the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=11#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_11_img8.png,M4-Q22,0.184,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how placebo effect works
• In clinical practice → the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=11#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_11_img9.png,M4-Q22,0.184,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how placebo effect works
• In clinical practice → the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=11#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_11_img10.png,M4-Q22,0.184,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how placebo effect works
• In clinical practice → the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=12#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_12_img1.png,M4-Q22,0.206,"PLACEBO in modern science: 3 contexts
• In clinical trials→ the aim is to REDUCE the placebo effect
Placebo administered to quantify the efficacy of an active 
treatment
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=13#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_13_img1.png,M4-Q01,0.194,"PLACEBO in modern science: 3 contexts
• In clinical trials → REDUCE
PLACEBO
Efficacy"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=13#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_13_img2.png,M4-Q01,0.194,"PLACEBO in modern science: 3 contexts
• In clinical trials → REDUCE
PLACEBO
Efficacy"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=13#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_13_img3.png,M4-Q01,0.194,"PLACEBO in modern science: 3 contexts
• In clinical trials → REDUCE
PLACEBO
Efficacy"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=13#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_13_img4.png,M4-Q01,0.194,"PLACEBO in modern science: 3 contexts
• In clinical trials → REDUCE
PLACEBO
Efficacy"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=14#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_14_img1.png,M3-Q10,0.142,"PLACEBO IN CLINICAL TRIALS
Placebo in modern science: distinguishing 3 contexts
• In clinical trials
→Placebo as a control treatment to evaluate the efficacy of an active treatment
→THE GOAL IS TO FIND TREATMENTS WITH SUPERIOR EFFICACY  
COMPARING TO PLACEBO
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=15#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_15_img1.png,M4-Q16,0.160,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm)
time
pain
Treatment 
administration
PAIN CONDITION
With the active treatment the 
pain decreases over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=15#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_15_img2.png,M4-Q16,0.160,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm)
time
pain
Treatment 
administration
PAIN CONDITION
With the active treatment the 
pain decreases over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=15#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_15_img3.png,M4-Q16,0.160,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm)
time
pain
Treatment 
administration
PAIN CONDITION
With the active treatment the 
pain decreases over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=15#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_15_img4.png,M4-Q16,0.160,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm)
time
pain
Treatment 
administration
PAIN CONDITION
With the active treatment the 
pain decreases over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=15#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_15_img5.png,M4-Q16,0.160,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm)
time
pain
Treatment 
administration
PAIN CONDITION
With the active treatment the 
pain decreases over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=15#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_15_img6.png,M4-Q16,0.160,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm)
time
pain
Treatment 
administration
PAIN CONDITION
With the active treatment the 
pain decreases over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=15#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_15_img7.png,M4-Q16,0.160,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm)
time
pain
Treatment 
administration
PAIN CONDITION
With the active treatment the 
pain decreases over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=15#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_15_img8.png,M4-Q16,0.160,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm)
time
pain
Treatment 
administration
PAIN CONDITION
With the active treatment the 
pain decreases over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=16#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_16_img1.png,M3-Q10,0.148,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(flat line)
In this case, is the drug more 
effective than placebo in reducing 
pain?
Time
pain
Treatment 
administration
PAIN CONDITION
Pain remains the same 
over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=16#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_16_img2.png,M3-Q10,0.148,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(flat line)
In this case, is the drug more 
effective than placebo in reducing 
pain?
Time
pain
Treatment 
administration
PAIN CONDITION
Pain remains the same 
over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=16#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_16_img3.png,M3-Q10,0.148,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(flat line)
In this case, is the drug more 
effective than placebo in reducing 
pain?
Time
pain
Treatment 
administration
PAIN CONDITION
Pain remains the same 
over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=16#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_16_img4.png,M3-Q10,0.148,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(flat line)
In this case, is the drug more 
effective than placebo in reducing 
pain?
Time
pain
Treatment 
administration
PAIN CONDITION
Pain remains the same 
over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=16#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_16_img5.png,M3-Q10,0.148,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(flat line)
In this case, is the drug more 
effective than placebo in reducing 
pain?
Time
pain
Treatment 
administration
PAIN CONDITION
Pain remains the same 
over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=16#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_16_img6.png,M3-Q10,0.148,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(flat line)
In this case, is the drug more 
effective than placebo in reducing 
pain?
Time
pain
Treatment 
administration
PAIN CONDITION
Pain remains the same 
over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=16#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_16_img7.png,M3-Q10,0.148,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(flat line)
In this case, is the drug more 
effective than placebo in reducing 
pain?
Time
pain
Treatment 
administration
PAIN CONDITION
Pain remains the same 
over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=16#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_16_img8.png,M3-Q10,0.148,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(flat line)
In this case, is the drug more 
effective than placebo in reducing 
pain?
Time
pain
Treatment 
administration
PAIN CONDITION
Pain remains the same 
over time"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=17#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_17_img1.png,M4-Q16,0.161,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(sine wave)
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Treatment 
administration
PAIN CONDITION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=17#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_17_img2.png,M4-Q16,0.161,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(sine wave)
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Treatment 
administration
PAIN CONDITION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=17#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_17_img3.png,M4-Q16,0.161,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(sine wave)
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Treatment 
administration
PAIN CONDITION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=17#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_17_img4.png,M4-Q16,0.161,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(sine wave)
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Treatment 
administration
PAIN CONDITION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=17#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_17_img5.png,M4-Q16,0.161,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(sine wave)
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Treatment 
administration
PAIN CONDITION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=17#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_17_img6.png,M4-Q16,0.161,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(sine wave)
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Treatment 
administration
PAIN CONDITION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=17#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_17_img7.png,M4-Q16,0.161,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(sine wave)
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Treatment 
administration
PAIN CONDITION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=17#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_17_img8.png,M4-Q16,0.161,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(sine wave)
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Treatment 
administration
PAIN CONDITION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=17#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_17_img9.png,M4-Q16,0.161,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
(sine wave)
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Treatment 
administration
PAIN CONDITION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=18#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_18_img1.png,M4-Q11,0.148,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Administration
treatment
PAIN CONDITION
Both active treatment and 
placebo lead to a decrease of 
pain over t"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=18#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_18_img2.png,M4-Q11,0.148,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Administration
treatment
PAIN CONDITION
Both active treatment and 
placebo lead to a decrease of 
pain over t"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=18#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_18_img3.png,M4-Q11,0.148,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Administration
treatment
PAIN CONDITION
Both active treatment and 
placebo lead to a decrease of 
pain over t"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=18#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_18_img4.png,M4-Q11,0.148,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Administration
treatment
PAIN CONDITION
Both active treatment and 
placebo lead to a decrease of 
pain over t"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=18#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_18_img5.png,M4-Q11,0.148,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Administration
treatment
PAIN CONDITION
Both active treatment and 
placebo lead to a decrease of 
pain over t"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=18#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_18_img6.png,M4-Q11,0.148,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Administration
treatment
PAIN CONDITION
Both active treatment and 
placebo lead to a decrease of 
pain over t"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=18#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_18_img7.png,M4-Q11,0.148,"PLACEBO IN CLINICAL TRIALS
We administer the ACTIVE treatment (active arm) and ... WE COMPARE WITH PLACEBO
In this case, is the drug more 
effective than placebo in reducing 
pain?
time
pain
Administration
treatment
PAIN CONDITION
Both active treatment and 
placebo lead to a decrease of 
pain over t"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=19#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_19_img1.png,M1-Q20,0.121,"FACTORS THAT LEAD TO IMPROVEMENT
When we administer a treatment, this treatment can lead to an 
improvement due to several factors:
1) Specific factors→related to the treatment→active principle 
2) Methodological factors
3) Non-specific factors
1 +/* 2 +/* 3
time
pain
Treatment efficacyActive princi"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=19#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_19_img2.png,M1-Q20,0.121,"FACTORS THAT LEAD TO IMPROVEMENT
When we administer a treatment, this treatment can lead to an 
improvement due to several factors:
1) Specific factors→related to the treatment→active principle 
2) Methodological factors
3) Non-specific factors
1 +/* 2 +/* 3
time
pain
Treatment efficacyActive princi"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=23#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_23_img1.png,M1-Q29,0.140,"Natural History (NH)
Regression to the mean
Bias
NON-SPECIFIC FACTORS
HOW CAN WE SAY THAT A DRUG (treatment) 
is EFFECTIVE?
• To control methodological factors→we administer a PLACEBO
✓ACTIVE ARM: receives the active treatment
✓PLACEBO ARM: receives the placebo treatment
time
Administration
treatmen"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=23#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_23_img2.png,M1-Q29,0.140,"Natural History (NH)
Regression to the mean
Bias
NON-SPECIFIC FACTORS
HOW CAN WE SAY THAT A DRUG (treatment) 
is EFFECTIVE?
• To control methodological factors→we administer a PLACEBO
✓ACTIVE ARM: receives the active treatment
✓PLACEBO ARM: receives the placebo treatment
time
Administration
treatmen"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=23#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_23_img3.png,M1-Q29,0.140,"Natural History (NH)
Regression to the mean
Bias
NON-SPECIFIC FACTORS
HOW CAN WE SAY THAT A DRUG (treatment) 
is EFFECTIVE?
• To control methodological factors→we administer a PLACEBO
✓ACTIVE ARM: receives the active treatment
✓PLACEBO ARM: receives the placebo treatment
time
Administration
treatmen"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=27#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_27_img1.png,M4-Q01,0.232,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: non-
randomized method"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=27#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_27_img2.png,M4-Q01,0.232,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: non-
randomized method"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=27#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_27_img3.png,M4-Q01,0.232,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: non-
randomized method"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=27#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_27_img4.png,M4-Q01,0.232,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: non-
randomized method"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=27#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_27_img5.png,M4-Q01,0.232,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: non-
randomized method"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=27#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_27_img6.png,M4-Q01,0.232,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: non-
randomized method"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=27#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_27_img7.png,M4-Q01,0.232,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: non-
randomized method"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=27#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_27_img8.png,M4-Q01,0.232,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: non-
randomized method"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=27#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_27_img9.png,M4-Q01,0.232,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: non-
randomized method"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=28#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_28_img1.png,M4-Q17,0.193,"Informations
about
patients
 RANDOM
CLASSIFICATION OF CLINICAL TRIALS: 
randomized method
Experimenter"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=28#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_28_img2.png,M4-Q17,0.193,"Informations
about
patients
 RANDOM
CLASSIFICATION OF CLINICAL TRIALS: 
randomized method
Experimenter"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=28#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_28_img3.png,M4-Q17,0.193,"Informations
about
patients
 RANDOM
CLASSIFICATION OF CLINICAL TRIALS: 
randomized method
Experimenter"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=28#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_28_img4.png,M4-Q17,0.193,"Informations
about
patients
 RANDOM
CLASSIFICATION OF CLINICAL TRIALS: 
randomized method
Experimenter"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=28#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_28_img5.png,M4-Q17,0.193,"Informations
about
patients
 RANDOM
CLASSIFICATION OF CLINICAL TRIALS: 
randomized method
Experimenter"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=28#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_28_img6.png,M4-Q17,0.193,"Informations
about
patients
 RANDOM
CLASSIFICATION OF CLINICAL TRIALS: 
randomized method
Experimenter"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=28#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_28_img7.png,M4-Q17,0.193,"Informations
about
patients
 RANDOM
CLASSIFICATION OF CLINICAL TRIALS: 
randomized method
Experimenter"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=28#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_28_img8.png,M4-Q17,0.193,"Informations
about
patients
 RANDOM
CLASSIFICATION OF CLINICAL TRIALS: 
randomized method
Experimenter"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=28#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_28_img9.png,M4-Q17,0.193,"Informations
about
patients
 RANDOM
CLASSIFICATION OF CLINICAL TRIALS: 
randomized method
Experimenter"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=28#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_28_img10.png,M4-Q17,0.193,"Informations
about
patients
 RANDOM
CLASSIFICATION OF CLINICAL TRIALS: 
randomized method
Experimenter"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=28#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_28_img11.png,M4-Q17,0.193,"Informations
about
patients
 RANDOM
CLASSIFICATION OF CLINICAL TRIALS: 
randomized method
Experimenter"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=29#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_29_img1.png,M4-Q01,0.252,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
SINGLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=29#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_29_img2.png,M4-Q01,0.252,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
SINGLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=29#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_29_img3.png,M4-Q01,0.252,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
SINGLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=29#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_29_img4.png,M4-Q01,0.252,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
SINGLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=29#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_29_img5.png,M4-Q01,0.252,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
SINGLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=29#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_29_img6.png,M4-Q01,0.252,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
SINGLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=29#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_29_img7.png,M4-Q01,0.252,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
SINGLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=29#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_29_img8.png,M4-Q01,0.252,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
SINGLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=29#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_29_img9.png,M4-Q01,0.252,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
SINGLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=30#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_30_img1.png,M4-Q16,0.258,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
DOUBLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=30#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_30_img2.png,M4-Q16,0.258,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
DOUBLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=30#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_30_img3.png,M4-Q16,0.258,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
DOUBLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=30#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_30_img4.png,M4-Q16,0.258,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
DOUBLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=30#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_30_img5.png,M4-Q16,0.258,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
DOUBLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=30#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_30_img6.png,M4-Q16,0.258,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
DOUBLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=30#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_30_img7.png,M4-Q16,0.258,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
DOUBLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=30#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_30_img8.png,M4-Q16,0.258,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
DOUBLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=30#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_30_img9.png,M4-Q16,0.258,"Experimenter
CLASSIFICATION OF CLINICAL TRIALS: 
DOUBLE-BLINDING"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=31#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_31_img1.png,M4-Q16,0.158,"CLINICAL TRIALS
GOLD STANDARD:
1) Randomized
2) Double-blind
3) Placebo controlled
Experimenter
RANDOMIZATION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=31#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_31_img2.png,M4-Q16,0.158,"CLINICAL TRIALS
GOLD STANDARD:
1) Randomized
2) Double-blind
3) Placebo controlled
Experimenter
RANDOMIZATION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=31#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_31_img3.png,M4-Q16,0.158,"CLINICAL TRIALS
GOLD STANDARD:
1) Randomized
2) Double-blind
3) Placebo controlled
Experimenter
RANDOMIZATION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=31#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_31_img4.png,M4-Q16,0.158,"CLINICAL TRIALS
GOLD STANDARD:
1) Randomized
2) Double-blind
3) Placebo controlled
Experimenter
RANDOMIZATION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=31#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_31_img5.png,M4-Q16,0.158,"CLINICAL TRIALS
GOLD STANDARD:
1) Randomized
2) Double-blind
3) Placebo controlled
Experimenter
RANDOMIZATION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=31#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_31_img6.png,M4-Q16,0.158,"CLINICAL TRIALS
GOLD STANDARD:
1) Randomized
2) Double-blind
3) Placebo controlled
Experimenter
RANDOMIZATION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=31#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_31_img7.png,M4-Q16,0.158,"CLINICAL TRIALS
GOLD STANDARD:
1) Randomized
2) Double-blind
3) Placebo controlled
Experimenter
RANDOMIZATION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=31#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_31_img8.png,M4-Q16,0.158,"CLINICAL TRIALS
GOLD STANDARD:
1) Randomized
2) Double-blind
3) Placebo controlled
Experimenter
RANDOMIZATION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=31#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_31_img9.png,M4-Q16,0.158,"CLINICAL TRIALS
GOLD STANDARD:
1) Randomized
2) Double-blind
3) Placebo controlled
Experimenter
RANDOMIZATION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=31#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_31_img10.png,M4-Q16,0.158,"CLINICAL TRIALS
GOLD STANDARD:
1) Randomized
2) Double-blind
3) Placebo controlled
Experimenter
RANDOMIZATION"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=33#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_33_img1.png,M3-Q10,0.135,"PHASE 0 –Discovery and early 
testing 
• Discovery and selection of molecules
• Laboratory analysis on cells and animals
• Administration of extremely small doses of 
the drug under study to obtain preliminary 
data on the pharmacokinetics of the agent 
• Request for authorization of human trials
• "
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=33#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_33_img2.png,M3-Q10,0.135,"PHASE 0 –Discovery and early 
testing 
• Discovery and selection of molecules
• Laboratory analysis on cells and animals
• Administration of extremely small doses of 
the drug under study to obtain preliminary 
data on the pharmacokinetics of the agent 
• Request for authorization of human trials
• "
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=33#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_33_img3.png,M3-Q10,0.135,"PHASE 0 –Discovery and early 
testing 
• Discovery and selection of molecules
• Laboratory analysis on cells and animals
• Administration of extremely small doses of 
the drug under study to obtain preliminary 
data on the pharmacokinetics of the agent 
• Request for authorization of human trials
• "
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=34#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_34_img1.png,M3-Q10,0.153,"PHASE I –Safety and dosage 
• Typically on humans (volunteers) (20-80 
subjects)
• Typically on healthy subjects (sometimes on 
terminal patients in the absence of other 
treatments)
• It is used to test the pharmacokinetics and 
toxicity
• If the safety of the drug has been confirmed, 
we move on t"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=34#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_34_img2.png,M3-Q10,0.153,"PHASE I –Safety and dosage 
• Typically on humans (volunteers) (20-80 
subjects)
• Typically on healthy subjects (sometimes on 
terminal patients in the absence of other 
treatments)
• It is used to test the pharmacokinetics and 
toxicity
• If the safety of the drug has been confirmed, 
we move on t"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=35#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_35_img1.png,M3-Q14,0.169,"PHASE II –Efficacy
• Testing of the molecule on larger groups (300-
400 subjects).
• Patients who have the pathology for which 
the particular molecule is to be tested are 
recruited
Phase III
If benefits are 
observed"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=36#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_36_img1.png,M1-Q29,0.161,"PHASE III –
Approval phase
• Increasing the number of patients 
(multicenter studies with 2000-3000 patients)
• Approval phase
 If few side effects
and good efficacy
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=36#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_36_img2.png,M1-Q29,0.161,"PHASE III –
Approval phase
• Increasing the number of patients 
(multicenter studies with 2000-3000 patients)
• Approval phase
 If few side effects
and good efficacy
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=37#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_37_img1.png,M1-Q20,0.122,"PHASE IV –Post-marketing 
surveillance
• MARKET LAUNCH
• Phase that lasts ""forever“
• The recording of side effects continues.
• Ex: Thalidomide, marketed after animal testing 
(late 50s)
→Lancet study
→administration of thalidomide to pregnant mice 
resulted in the birth of broods with severe limb "
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=37#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_37_img2.png,M1-Q20,0.122,"PHASE IV –Post-marketing 
surveillance
• MARKET LAUNCH
• Phase that lasts ""forever“
• The recording of side effects continues.
• Ex: Thalidomide, marketed after animal testing 
(late 50s)
→Lancet study
→administration of thalidomide to pregnant mice 
resulted in the birth of broods with severe limb "
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=38#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_38_img1.png,M3-Q15,0.142,"• STANDARD TRIALS (Phase I, II and III):
• If active arm > placebo arm →We proceed with the other phases of 
the trial
VERUM GROUP
(active arm)
PLACEBO GROUP
(placebo arm)"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=38#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_38_img2.png,M3-Q15,0.142,"• STANDARD TRIALS (Phase I, II and III):
• If active arm > placebo arm →We proceed with the other phases of 
the trial
VERUM GROUP
(active arm)
PLACEBO GROUP
(placebo arm)"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=39#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_39_img1.png,M4-Q24,0.133,"Gold standard? 
All that glitters is not gold
RCTs Problems"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=40#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_40_img1.png,M4-Q15,0.152,"PLACEBO IN CLINICAL TRIALS: PROBLEMS
We administer the ACTIVE treatment (active arm) and… WE COMPARE WITH PLACEBO
(placebo arm)
pain
Treatment administration
Natural History (NH)
Regression to the mean
Bias
NON-SPECIFIC FACTORS
Treatment efficacy
ACTIVE 
PRINCIPLE
x
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=40#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_40_img2.png,M4-Q15,0.152,"PLACEBO IN CLINICAL TRIALS: PROBLEMS
We administer the ACTIVE treatment (active arm) and… WE COMPARE WITH PLACEBO
(placebo arm)
pain
Treatment administration
Natural History (NH)
Regression to the mean
Bias
NON-SPECIFIC FACTORS
Treatment efficacy
ACTIVE 
PRINCIPLE
x
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=40#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_40_img3.png,M4-Q15,0.152,"PLACEBO IN CLINICAL TRIALS: PROBLEMS
We administer the ACTIVE treatment (active arm) and… WE COMPARE WITH PLACEBO
(placebo arm)
pain
Treatment administration
Natural History (NH)
Regression to the mean
Bias
NON-SPECIFIC FACTORS
Treatment efficacy
ACTIVE 
PRINCIPLE
x
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=40#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_40_img4.png,M4-Q15,0.152,"PLACEBO IN CLINICAL TRIALS: PROBLEMS
We administer the ACTIVE treatment (active arm) and… WE COMPARE WITH PLACEBO
(placebo arm)
pain
Treatment administration
Natural History (NH)
Regression to the mean
Bias
NON-SPECIFIC FACTORS
Treatment efficacy
ACTIVE 
PRINCIPLE
x
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=40#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_40_img5.png,M4-Q15,0.152,"PLACEBO IN CLINICAL TRIALS: PROBLEMS
We administer the ACTIVE treatment (active arm) and… WE COMPARE WITH PLACEBO
(placebo arm)
pain
Treatment administration
Natural History (NH)
Regression to the mean
Bias
NON-SPECIFIC FACTORS
Treatment efficacy
ACTIVE 
PRINCIPLE
x
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=40#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_40_img6.png,M4-Q15,0.152,"PLACEBO IN CLINICAL TRIALS: PROBLEMS
We administer the ACTIVE treatment (active arm) and… WE COMPARE WITH PLACEBO
(placebo arm)
pain
Treatment administration
Natural History (NH)
Regression to the mean
Bias
NON-SPECIFIC FACTORS
Treatment efficacy
ACTIVE 
PRINCIPLE
x
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=40#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_40_img7.png,M4-Q15,0.152,"PLACEBO IN CLINICAL TRIALS: PROBLEMS
We administer the ACTIVE treatment (active arm) and… WE COMPARE WITH PLACEBO
(placebo arm)
pain
Treatment administration
Natural History (NH)
Regression to the mean
Bias
NON-SPECIFIC FACTORS
Treatment efficacy
ACTIVE 
PRINCIPLE
x
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=40#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_40_img8.png,M4-Q15,0.152,"PLACEBO IN CLINICAL TRIALS: PROBLEMS
We administer the ACTIVE treatment (active arm) and… WE COMPARE WITH PLACEBO
(placebo arm)
pain
Treatment administration
Natural History (NH)
Regression to the mean
Bias
NON-SPECIFIC FACTORS
Treatment efficacy
ACTIVE 
PRINCIPLE
x
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=42#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_42_img1.png,M4-Q17,0.095,"PLACEBO IN CLINICAL TRIALS: PROBLEMS
Clinical trial: postoperative pain
Benedetti F, Amanzio M, Maggi G. Potentiation of placebo analgesia by proglumide. Lancet 1995.
Benedetti F, Carlino E, Piedimonte A. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effec"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=43#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_43_img1.png,M4-Q11,0.093,"PLACEBO IN CLINICAL TRIALS: 
ACTIVE ARM PROBLEMS
Clinical trial: postoperative pain
Benedetti F, Amanzio M, Maggi G. Potentiation of placebo analgesia by proglumide. Lancet 1995.
Benedetti F, Carlino E, Piedimonte A. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Haw"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=44#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_44_img1.png,M4-Q17,0.135,"PLACEBO IN CLINICAL TRIALS: 
ACTIVE ARM PROBLEMS
Clinical trial: postoperative pain
Benedetti F, Amanzio M, Maggi G. Potentiation of placebo analgesia by proglumide. Lancet 1995.
Benedetti F, Carlino E, Piedimonte A. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Haw"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=45#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_45_img1.png,M3-Q10,0.117,"PLACEBO IN CLINICAL TRIALS: 
ACTIVE ARM PROBLEMS
Trial of open vs hidden administration of remifentanil (no placebo!)
Benedetti F, Carlino E, Piedimonte A. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects. Lancet 
Neurology 2016.
Bingel U, Wanigaseker"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=46#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_46_img1.png,M4-Q16,0.130,"PLACEBO IN CLINICAL TRIALS: 
ACTIVE ARM PROBLEMS
• Negative RCTs are increasing over time in different therapeutic areas 
(oncology, chronic and musculoskeletal pain, CNS disorders)
• In the majority of trials (52%), the problem is the absence of a 
difference between the treatment and the placebo→
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=47#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_47_img1.png,M4-Q22,0.153,"PLACEBO IN CLINICAL TRIALS: 
ACTIVE ARM PROBLEMS
• Is the placebo effect therefore increasing?
• The effect of the psychosocial context that accompanies the 
administration of medical treatment is increasing
Carlino E, Vase L. Can knowledge of Placebo and Nocebo Mechanisms Help Improve Randomized Cl"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=48#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_48_img1.png,M4-Q18,0.168,"PLACEBO EFFECT = CONTEXT EFFECT
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=48#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_48_img2.png,M4-Q18,0.168,"PLACEBO EFFECT = CONTEXT EFFECT
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=48#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_48_img3.png,M4-Q18,0.168,"PLACEBO EFFECT = CONTEXT EFFECT
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=48#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_48_img4.png,M4-Q18,0.168,"PLACEBO EFFECT = CONTEXT EFFECT
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=48#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_48_img5.png,M4-Q18,0.168,"PLACEBO EFFECT = CONTEXT EFFECT
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=48#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_48_img6.png,M4-Q18,0.168,"PLACEBO EFFECT = CONTEXT EFFECT
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=48#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_48_img7.png,M4-Q18,0.168,"PLACEBO EFFECT = CONTEXT EFFECT
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=48#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_48_img8.png,M4-Q18,0.168,"PLACEBO EFFECT = CONTEXT EFFECT
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=49#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_49_img1.png,M4-Q18,0.166,"PLACEBO EFFECT = CONTEXT EFFECT
The placebo effect is the effect of the context
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT
PLACEBO"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=49#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_49_img2.png,M4-Q18,0.166,"PLACEBO EFFECT = CONTEXT EFFECT
The placebo effect is the effect of the context
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT
PLACEBO"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=49#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_49_img3.png,M4-Q18,0.166,"PLACEBO EFFECT = CONTEXT EFFECT
The placebo effect is the effect of the context
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT
PLACEBO"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=49#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_49_img4.png,M4-Q18,0.166,"PLACEBO EFFECT = CONTEXT EFFECT
The placebo effect is the effect of the context
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT
PLACEBO"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=49#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_49_img5.png,M4-Q18,0.166,"PLACEBO EFFECT = CONTEXT EFFECT
The placebo effect is the effect of the context
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT
PLACEBO"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=49#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_49_img6.png,M4-Q18,0.166,"PLACEBO EFFECT = CONTEXT EFFECT
The placebo effect is the effect of the context
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT
PLACEBO"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=49#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_49_img7.png,M4-Q18,0.166,"PLACEBO EFFECT = CONTEXT EFFECT
The placebo effect is the effect of the context
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT
PLACEBO"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=49#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_49_img8.png,M4-Q18,0.166,"PLACEBO EFFECT = CONTEXT EFFECT
The placebo effect is the effect of the context
Expectation
Previous 
experience
• VERBAL 
INFORMATION
• DOCTOR-PATIENT 
RELATIONSHIP
Patient 
characteristics
• PHYSICAL CONTEXT
• PHYSICALITY OF THE 
TREATMENT
PLACEBO"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=50#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_50_img1.png,M4-Q18,0.174,"+ CONTEXT
PLACEBO
Placebo effect Nocebo effect
Placebo effect ≠ placebo response (RCTs)
Inert treatment administered 
within a psychosocial 
setting (context effect)"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=50#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_50_img2.png,M4-Q18,0.174,"+ CONTEXT
PLACEBO
Placebo effect Nocebo effect
Placebo effect ≠ placebo response (RCTs)
Inert treatment administered 
within a psychosocial 
setting (context effect)"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=50#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_50_img3.png,M4-Q18,0.174,"+ CONTEXT
PLACEBO
Placebo effect Nocebo effect
Placebo effect ≠ placebo response (RCTs)
Inert treatment administered 
within a psychosocial 
setting (context effect)"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=51#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_51_img1.png,M4-Q22,0.124,"Benedetti F, Carlino E, Pollo A. Neuropsychopharmacology 2011;36:339-54
Benedetti F, Carlino E, Pollo A. Neuropsychopharmacology 2011;36:339-54
Clinical trialist
Neurobiologist
Our interest
/TREATMENT
PLACEBO EFFECT"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=52#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_52_img1.png,M4-Q17,0.141,"CONTEXTUAL FACTORS: 
what are they and how have they been studied? 
Testa & Rossettini, 2016, Manual Therapy
Rossettini, Carlino, Testa, 2018, BMC Musculoskeletal Disorders"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=55#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_55_img1.png,M1-Q20,0.071,"→fMRI study on the biological 
effect of holding hands 
→Married women were exposed 
to the threat of an electric 
shock under three conditions: 
→ not holding hands/spouse 
hand/stranger hand 
2
No hand     spouse    unknown
unpleasantness
When they held their spouse’s hand, they reported 
less unp"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=55#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_55_img2.png,M1-Q20,0.071,"→fMRI study on the biological 
effect of holding hands 
→Married women were exposed 
to the threat of an electric 
shock under three conditions: 
→ not holding hands/spouse 
hand/stranger hand 
2
No hand     spouse    unknown
unpleasantness
When they held their spouse’s hand, they reported 
less unp"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=55#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_55_img3.png,M1-Q20,0.071,"→fMRI study on the biological 
effect of holding hands 
→Married women were exposed 
to the threat of an electric 
shock under three conditions: 
→ not holding hands/spouse 
hand/stranger hand 
2
No hand     spouse    unknown
unpleasantness
When they held their spouse’s hand, they reported 
less unp"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=55#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_55_img4.png,M1-Q20,0.071,"→fMRI study on the biological 
effect of holding hands 
→Married women were exposed 
to the threat of an electric 
shock under three conditions: 
→ not holding hands/spouse 
hand/stranger hand 
2
No hand     spouse    unknown
unpleasantness
When they held their spouse’s hand, they reported 
less unp"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=55#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_55_img5.png,M1-Q20,0.071,"→fMRI study on the biological 
effect of holding hands 
→Married women were exposed 
to the threat of an electric 
shock under three conditions: 
→ not holding hands/spouse 
hand/stranger hand 
2
No hand     spouse    unknown
unpleasantness
When they held their spouse’s hand, they reported 
less unp"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=55#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_55_img6.png,M1-Q20,0.071,"→fMRI study on the biological 
effect of holding hands 
→Married women were exposed 
to the threat of an electric 
shock under three conditions: 
→ not holding hands/spouse 
hand/stranger hand 
2
No hand     spouse    unknown
unpleasantness
When they held their spouse’s hand, they reported 
less unp"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=55#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_55_img7.png,M1-Q20,0.071,"→fMRI study on the biological 
effect of holding hands 
→Married women were exposed 
to the threat of an electric 
shock under three conditions: 
→ not holding hands/spouse 
hand/stranger hand 
2
No hand     spouse    unknown
unpleasantness
When they held their spouse’s hand, they reported 
less unp"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=55#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_55_img8.png,M1-Q20,0.071,"→fMRI study on the biological 
effect of holding hands 
→Married women were exposed 
to the threat of an electric 
shock under three conditions: 
→ not holding hands/spouse 
hand/stranger hand 
2
No hand     spouse    unknown
unpleasantness
When they held their spouse’s hand, they reported 
less unp"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=55#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_55_img9.png,M1-Q20,0.071,"→fMRI study on the biological 
effect of holding hands 
→Married women were exposed 
to the threat of an electric 
shock under three conditions: 
→ not holding hands/spouse 
hand/stranger hand 
2
No hand     spouse    unknown
unpleasantness
When they held their spouse’s hand, they reported 
less unp"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=55#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_55_img10.png,M1-Q20,0.071,"→fMRI study on the biological 
effect of holding hands 
→Married women were exposed 
to the threat of an electric 
shock under three conditions: 
→ not holding hands/spouse 
hand/stranger hand 
2
No hand     spouse    unknown
unpleasantness
When they held their spouse’s hand, they reported 
less unp"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=55#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_55_img11.png,M1-Q20,0.071,"→fMRI study on the biological 
effect of holding hands 
→Married women were exposed 
to the threat of an electric 
shock under three conditions: 
→ not holding hands/spouse 
hand/stranger hand 
2
No hand     spouse    unknown
unpleasantness
When they held their spouse’s hand, they reported 
less unp"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=55#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_55_img12.png,M1-Q20,0.071,"→fMRI study on the biological 
effect of holding hands 
→Married women were exposed 
to the threat of an electric 
shock under three conditions: 
→ not holding hands/spouse 
hand/stranger hand 
2
No hand     spouse    unknown
unpleasantness
When they held their spouse’s hand, they reported 
less unp"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=58#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_58_img1.png,M1-Q29,0.154,"HOW TO GIVE INFORMATION
• IBS patients
• Placebo acupuncture 
Kelley et al., Psychosom Med. 2009
Augmented group:
Treated with an empathetic approach Control group
Limited group:
Treated with a neutral approach
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=58#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_58_img2.png,M1-Q29,0.154,"HOW TO GIVE INFORMATION
• IBS patients
• Placebo acupuncture 
Kelley et al., Psychosom Med. 2009
Augmented group:
Treated with an empathetic approach Control group
Limited group:
Treated with a neutral approach
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=58#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_58_img3.png,M1-Q29,0.154,"HOW TO GIVE INFORMATION
• IBS patients
• Placebo acupuncture 
Kelley et al., Psychosom Med. 2009
Augmented group:
Treated with an empathetic approach Control group
Limited group:
Treated with a neutral approach
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=58#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_58_img4.png,M1-Q29,0.154,"HOW TO GIVE INFORMATION
• IBS patients
• Placebo acupuncture 
Kelley et al., Psychosom Med. 2009
Augmented group:
Treated with an empathetic approach Control group
Limited group:
Treated with a neutral approach
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=59#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_59_img1.png,M3-Q10,0.147,"Testa & Rossettini, 2016, Manual Therapy
Rossettini, Carlino, Testa, 2018, BMC Musculoskeletal Disorders
CONTEXTUAL FACTORS: 
what are they and how have they been studied?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=60#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_60_img1.png,M4-Q19,0.119,"TYPES OF CLINICAL TRIAL 
Placebo run-in 
→EXCLUDING PLACEBO 
RESPONDERS
P non-responder
P responder
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Administration of 
a placebo
Placebo administration"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=60#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_60_img2.png,M4-Q19,0.119,"TYPES OF CLINICAL TRIAL 
Placebo run-in 
→EXCLUDING PLACEBO 
RESPONDERS
P non-responder
P responder
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Administration of 
a placebo
Placebo administration"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=60#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_60_img3.png,M4-Q19,0.119,"TYPES OF CLINICAL TRIAL 
Placebo run-in 
→EXCLUDING PLACEBO 
RESPONDERS
P non-responder
P responder
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Administration of 
a placebo
Placebo administration"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=60#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_60_img4.png,M4-Q19,0.119,"TYPES OF CLINICAL TRIAL 
Placebo run-in 
→EXCLUDING PLACEBO 
RESPONDERS
P non-responder
P responder
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Administration of 
a placebo
Placebo administration"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=61#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_61_img1.png,M3-Q10,0.132,"Active run-in →
EXCLUDE SUBJECTS WHO DO NOT 
RESPOND TO THE DRUG
• F responder
• Few side effects
• F non-responder o 
• Marked collateral effect
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Administration of 
a drug
Placebo administration"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=61#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_61_img2.png,M3-Q10,0.132,"Active run-in →
EXCLUDE SUBJECTS WHO DO NOT 
RESPOND TO THE DRUG
• F responder
• Few side effects
• F non-responder o 
• Marked collateral effect
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Administration of 
a drug
Placebo administration"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=61#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_61_img3.png,M3-Q10,0.132,"Active run-in →
EXCLUDE SUBJECTS WHO DO NOT 
RESPOND TO THE DRUG
• F responder
• Few side effects
• F non-responder o 
• Marked collateral effect
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Administration of 
a drug
Placebo administration"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=61#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_61_img4.png,M3-Q10,0.132,"Active run-in →
EXCLUDE SUBJECTS WHO DO NOT 
RESPOND TO THE DRUG
• F responder
• Few side effects
• F non-responder o 
• Marked collateral effect
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Administration of 
a drug
Placebo administration"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=62#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_62_img1.png,M4-Q20,0.190,"CROSS-OVER DESIGN
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Placebo administration
 Placebo administration
Drug administration"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=62#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_62_img2.png,M4-Q20,0.190,"CROSS-OVER DESIGN
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Placebo administration
 Placebo administration
Drug administration"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=63#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_63_img1.png,M4-Q22,0.112,"TRIAL BASED ON ASSIGNMENT
(real or perceived)
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Placebo administration
REAL ASSIGNMENT ASSIGNMENT RECEIVED
Drug administration
Placebo administration
""What group 
do you think 
you belong to?""
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=63#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_63_img2.png,M4-Q22,0.112,"TRIAL BASED ON ASSIGNMENT
(real or perceived)
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Placebo administration
REAL ASSIGNMENT ASSIGNMENT RECEIVED
Drug administration
Placebo administration
""What group 
do you think 
you belong to?""
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=63#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_63_img3.png,M4-Q22,0.112,"TRIAL BASED ON ASSIGNMENT
(real or perceived)
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Placebo administration
REAL ASSIGNMENT ASSIGNMENT RECEIVED
Drug administration
Placebo administration
""What group 
do you think 
you belong to?""
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=63#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_63_img4.png,M4-Q22,0.112,"TRIAL BASED ON ASSIGNMENT
(real or perceived)
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Placebo administration
REAL ASSIGNMENT ASSIGNMENT RECEIVED
Drug administration
Placebo administration
""What group 
do you think 
you belong to?""
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=63#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_63_img5.png,M4-Q22,0.112,"TRIAL BASED ON ASSIGNMENT
(real or perceived)
R
A
N
D
O
M
I
Z
A
T
I
O
N
Drug administration
Placebo administration
REAL ASSIGNMENT ASSIGNMENT RECEIVED
Drug administration
Placebo administration
""What group 
do you think 
you belong to?""
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=64#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_64_img1.png,M4-Q18,0.192,"BALANCED DESIGN
GET
TOLD
MEDICATION PLACEBO
ACTIVE 
EFFECT
PLACEBO
EFFECT
BASELINE
MEDICATION
PLACEBO
ACTIVE + 
Placebo"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=64#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_64_img2.png,M4-Q18,0.192,"BALANCED DESIGN
GET
TOLD
MEDICATION PLACEBO
ACTIVE 
EFFECT
PLACEBO
EFFECT
BASELINE
MEDICATION
PLACEBO
ACTIVE + 
Placebo"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=64#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_64_img3.png,M4-Q18,0.192,"BALANCED DESIGN
GET
TOLD
MEDICATION PLACEBO
ACTIVE 
EFFECT
PLACEBO
EFFECT
BASELINE
MEDICATION
PLACEBO
ACTIVE + 
Placebo"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=66#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_66_img1.png,M4-Q22,0.118,"OPEN-HIDDEN
OPEN
 HIDDEN
Enck et al, 2013, Nature 12:191-204.
Benedetti F, Carlino E, Pollo A. 2011 Clin Pharm Ther 90: 651-661.
• Participants know they 
are receiving the 
tratment 
• Allows both 
pharmacological effects 
and 
psychological/placebo 
effects to occur 
• Participants don’t know 
whe"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=66#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_66_img2.png,M4-Q22,0.118,"OPEN-HIDDEN
OPEN
 HIDDEN
Enck et al, 2013, Nature 12:191-204.
Benedetti F, Carlino E, Pollo A. 2011 Clin Pharm Ther 90: 651-661.
• Participants know they 
are receiving the 
tratment 
• Allows both 
pharmacological effects 
and 
psychological/placebo 
effects to occur 
• Participants don’t know 
whe"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=67#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_67_img1.png,M4-Q16,0.110,"Colloca and Benedetti, Nature Rev Neurosci 6: 545-552, 2005 
OPEN-HIDDEN
Is metamizol (300 mg) effective in post-
operative pain? 
Double blind
Informed consent ""You will 
receive a dose of metamizole
but you will not know when""
Open group (N=10) Hidden group (N=10)"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=67#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_67_img2.png,M4-Q16,0.110,"Colloca and Benedetti, Nature Rev Neurosci 6: 545-552, 2005 
OPEN-HIDDEN
Is metamizol (300 mg) effective in post-
operative pain? 
Double blind
Informed consent ""You will 
receive a dose of metamizole
but you will not know when""
Open group (N=10) Hidden group (N=10)"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=68#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_68_img1.png,M4-Q09,0.110,"OPEN-HIDDEN
-3
0
BUPRENORPHINE
OPEN
-1
-2
PAIN REDUCTION
TRAMADOL
OPEN
KETOROLAC
OPEN
METAMIZOLO
OPEN
HIDDEN HIDDENHIDDEN HIDDEN
EFFECT of the
DRUG
CONTEXT
Benedetti et al. 1995 Lancet 346: 1231;  
Amanzio et al.  2001 Pain 90: 205-15;
Colloca et al. 2004 Lancet Neurol 3: 679-684"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=68#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_68_img2.png,M4-Q09,0.110,"OPEN-HIDDEN
-3
0
BUPRENORPHINE
OPEN
-1
-2
PAIN REDUCTION
TRAMADOL
OPEN
KETOROLAC
OPEN
METAMIZOLO
OPEN
HIDDEN HIDDENHIDDEN HIDDEN
EFFECT of the
DRUG
CONTEXT
Benedetti et al. 1995 Lancet 346: 1231;  
Amanzio et al.  2001 Pain 90: 205-15;
Colloca et al. 2004 Lancet Neurol 3: 679-684"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=68#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_68_img3.png,M4-Q09,0.110,"OPEN-HIDDEN
-3
0
BUPRENORPHINE
OPEN
-1
-2
PAIN REDUCTION
TRAMADOL
OPEN
KETOROLAC
OPEN
METAMIZOLO
OPEN
HIDDEN HIDDENHIDDEN HIDDEN
EFFECT of the
DRUG
CONTEXT
Benedetti et al. 1995 Lancet 346: 1231;  
Amanzio et al.  2001 Pain 90: 205-15;
Colloca et al. 2004 Lancet Neurol 3: 679-684"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=68#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_68_img4.png,M4-Q09,0.110,"OPEN-HIDDEN
-3
0
BUPRENORPHINE
OPEN
-1
-2
PAIN REDUCTION
TRAMADOL
OPEN
KETOROLAC
OPEN
METAMIZOLO
OPEN
HIDDEN HIDDENHIDDEN HIDDEN
EFFECT of the
DRUG
CONTEXT
Benedetti et al. 1995 Lancet 346: 1231;  
Amanzio et al.  2001 Pain 90: 205-15;
Colloca et al. 2004 Lancet Neurol 3: 679-684"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=68#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_68_img5.png,M4-Q09,0.110,"OPEN-HIDDEN
-3
0
BUPRENORPHINE
OPEN
-1
-2
PAIN REDUCTION
TRAMADOL
OPEN
KETOROLAC
OPEN
METAMIZOLO
OPEN
HIDDEN HIDDENHIDDEN HIDDEN
EFFECT of the
DRUG
CONTEXT
Benedetti et al. 1995 Lancet 346: 1231;  
Amanzio et al.  2001 Pain 90: 205-15;
Colloca et al. 2004 Lancet Neurol 3: 679-684"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=68#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_68_img6.png,M4-Q09,0.110,"OPEN-HIDDEN
-3
0
BUPRENORPHINE
OPEN
-1
-2
PAIN REDUCTION
TRAMADOL
OPEN
KETOROLAC
OPEN
METAMIZOLO
OPEN
HIDDEN HIDDENHIDDEN HIDDEN
EFFECT of the
DRUG
CONTEXT
Benedetti et al. 1995 Lancet 346: 1231;  
Amanzio et al.  2001 Pain 90: 205-15;
Colloca et al. 2004 Lancet Neurol 3: 679-684"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=68#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_68_img7.png,M4-Q09,0.110,"OPEN-HIDDEN
-3
0
BUPRENORPHINE
OPEN
-1
-2
PAIN REDUCTION
TRAMADOL
OPEN
KETOROLAC
OPEN
METAMIZOLO
OPEN
HIDDEN HIDDENHIDDEN HIDDEN
EFFECT of the
DRUG
CONTEXT
Benedetti et al. 1995 Lancet 346: 1231;  
Amanzio et al.  2001 Pain 90: 205-15;
Colloca et al. 2004 Lancet Neurol 3: 679-684"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=68#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_68_img8.png,M4-Q09,0.110,"OPEN-HIDDEN
-3
0
BUPRENORPHINE
OPEN
-1
-2
PAIN REDUCTION
TRAMADOL
OPEN
KETOROLAC
OPEN
METAMIZOLO
OPEN
HIDDEN HIDDENHIDDEN HIDDEN
EFFECT of the
DRUG
CONTEXT
Benedetti et al. 1995 Lancet 346: 1231;  
Amanzio et al.  2001 Pain 90: 205-15;
Colloca et al. 2004 Lancet Neurol 3: 679-684"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=70#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_70_img1.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=70#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_70_img2.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=70#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_70_img3.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=70#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_70_img4.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=70#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_70_img5.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=70#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_70_img6.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=70#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_70_img7.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=70#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_70_img8.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=70#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_70_img9.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=70#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_70_img10.png,M4-Q22,0.190,"PLACEBO in modern science: 3 contexts
• In clinical trials → the aim is to REDUCE the placebo effect
• In scientific research → the aim is to UNDERSTAND how the placebo effect works
• In clinical practice →the aim is to INCREASE the placebo effect
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=71#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_71_img1.png,M4-Q22,0.187,"PLACEBO in modern science: SCIENTIFIC 
RESEARCH
• In research→ UNDERSTAND
How does that work:
1) Psychological mechanisms
2) Neurobiological mechanisms
How can it be studied?
How much does it work?
Who does it work on?
On what population?
Under what conditions does it work?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=71#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_71_img2.png,M4-Q22,0.187,"PLACEBO in modern science: SCIENTIFIC 
RESEARCH
• In research→ UNDERSTAND
How does that work:
1) Psychological mechanisms
2) Neurobiological mechanisms
How can it be studied?
How much does it work?
Who does it work on?
On what population?
Under what conditions does it work?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=71#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_71_img3.png,M4-Q22,0.187,"PLACEBO in modern science: SCIENTIFIC 
RESEARCH
• In research→ UNDERSTAND
How does that work:
1) Psychological mechanisms
2) Neurobiological mechanisms
How can it be studied?
How much does it work?
Who does it work on?
On what population?
Under what conditions does it work?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=72#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_72_img1.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=72#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_72_img2.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=72#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_72_img3.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=72#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_72_img4.png,M1-Q17,0.103,"Finniss et al. Lancet 2010;375:686-95
Pain
Motor performance
Parkinson's disease
Alzheimer's disease
Cardiovascular system
Respiratory system
Gastrointestinal System
Immune system
Endocrine system
Depression
Anxiety
PLACEBO
Under what conditions does it work?
?"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=73#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_73_img1.png,M4-Q14,0.141,"BEHAVIORAL STUDIES
EEGPHARMACOLOGY
How can it be studied?
fMRI / PET
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=73#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_73_img2.png,M4-Q14,0.141,"BEHAVIORAL STUDIES
EEGPHARMACOLOGY
How can it be studied?
fMRI / PET
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=73#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_73_img3.png,M4-Q14,0.141,"BEHAVIORAL STUDIES
EEGPHARMACOLOGY
How can it be studied?
fMRI / PET
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=73#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_73_img4.png,M4-Q14,0.141,"BEHAVIORAL STUDIES
EEGPHARMACOLOGY
How can it be studied?
fMRI / PET
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=74#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_74_img1.png,M4-Q22,0.118,"Magnitude of the placebo effect
• Several studies have measured and quantified the magnitude of the 
placebo/nocebo effect induced by contextual factors under different 
conditions.
E.g. Musculoskeletal pain, fibromyalgia, osteoarthritis (effect size > 0.5) 
Rossettini, Carlino, Testa, 2015, BMC Mus"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=79#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_79_img1.png,M1-Q12,0.084,"Expectation: Peirce's theory
Signs are anything that elicits an interpretation of an 
object. They are classified into 3 categories:
1. Indexes →signs that are dynamically connected with 
objects and with the senses and memories of the 
individuals to whom they serve as signs. They refer to 
a given"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=79#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_79_img2.png,M1-Q12,0.084,"Expectation: Peirce's theory
Signs are anything that elicits an interpretation of an 
object. They are classified into 3 categories:
1. Indexes →signs that are dynamically connected with 
objects and with the senses and memories of the 
individuals to whom they serve as signs. They refer to 
a given"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=85#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_85_img1.png,M1-Q29,0.085,"1)
2)
3)4)
5)
6)
ViolEx-model
Rief and Petrie, 2016
When we receive medical treatment:
1) Generalized pre-existing expectations→may amplify the effects 
of the treatment or worsen them (nocebo effects)
2) The interaction between generalized pre-existing expectations 
and the medical context leads to"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=87#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_87_img1.png,M1-Q29,0.102,"Rief and Petrie, 2016
tre
7) The development of expectations is determined by at 
least three different factors: 
• previous experience (associative learning)
• social influences (direct or indirect social learning via 
social media)
• cognitive processes specific to the individual patient
8) Finall"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=89#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_89_img1.png,M4-Q09,0.115,"Bayesian Perspective
• Prior has different levels of accuracy
• High accuracy → Reliable
• Low accuracy→ Unreliable
PE
Expect A Get B
prior update
prior sensory imput
(Brown et al., 2013;Buchel et al., 2014;Seth and Friston, 2016)
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=89#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_89_img2.png,M4-Q09,0.115,"Bayesian Perspective
• Prior has different levels of accuracy
• High accuracy → Reliable
• Low accuracy→ Unreliable
PE
Expect A Get B
prior update
prior sensory imput
(Brown et al., 2013;Buchel et al., 2014;Seth and Friston, 2016)
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=89#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_89_img3.png,M4-Q09,0.115,"Bayesian Perspective
• Prior has different levels of accuracy
• High accuracy → Reliable
• Low accuracy→ Unreliable
PE
Expect A Get B
prior update
prior sensory imput
(Brown et al., 2013;Buchel et al., 2014;Seth and Friston, 2016)
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=90#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_90_img1.png,M1-Q12,0.105,"Bayesian Perspective
PE
Expect A
A gets closer 
to B
Get B
prior update
A remains 
close to A
Prior with low 
certainty
Prior with high  
certainty
prior sensory imput
posterior
PE
Expect A Get B
minimal prior update
prior sensory imput
posterior
Rossettini et al., 2022 (under review)"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=90#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_90_img2.png,M1-Q12,0.105,"Bayesian Perspective
PE
Expect A
A gets closer 
to B
Get B
prior update
A remains 
close to A
Prior with low 
certainty
Prior with high  
certainty
prior sensory imput
posterior
PE
Expect A Get B
minimal prior update
prior sensory imput
posterior
Rossettini et al., 2022 (under review)"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=90#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_90_img3.png,M1-Q12,0.105,"Bayesian Perspective
PE
Expect A
A gets closer 
to B
Get B
prior update
A remains 
close to A
Prior with low 
certainty
Prior with high  
certainty
prior sensory imput
posterior
PE
Expect A Get B
minimal prior update
prior sensory imput
posterior
Rossettini et al., 2022 (under review)"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=90#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_90_img4.png,M1-Q12,0.105,"Bayesian Perspective
PE
Expect A
A gets closer 
to B
Get B
prior update
A remains 
close to A
Prior with low 
certainty
Prior with high  
certainty
prior sensory imput
posterior
PE
Expect A Get B
minimal prior update
prior sensory imput
posterior
Rossettini et al., 2022 (under review)"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=92#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_92_img1.png,M3-Q07,0.166,"Clinical scenario
Rossettini et al., 2022 (under review)"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=94#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_94_img1.png,M4-Q24,0.167,"Conditioning
• Behavioral psychology: different types of Learning 
"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=95#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_95_img1.png,M4-Q11,0.089,"ACQUISITION PHASE
Sound + food Salivation
(UR)
BEFORE CONDITIONING
Food
(US)
Unconditioned 
Stimulus
Salivation
(UR)
Unconditioned 
Response
Sound
(NS)
Neutral 
Stimulus 
No salivation
(no UR)
Unconditioned 
Response
RECALL PHASE
Sound
(CS)
Conditioned Stimulus
Salivation
(CR)
Conditioned response
S"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=95#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_95_img2.png,M4-Q11,0.089,"ACQUISITION PHASE
Sound + food Salivation
(UR)
BEFORE CONDITIONING
Food
(US)
Unconditioned 
Stimulus
Salivation
(UR)
Unconditioned 
Response
Sound
(NS)
Neutral 
Stimulus 
No salivation
(no UR)
Unconditioned 
Response
RECALL PHASE
Sound
(CS)
Conditioned Stimulus
Salivation
(CR)
Conditioned response
S"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=95#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_95_img3.png,M4-Q11,0.089,"ACQUISITION PHASE
Sound + food Salivation
(UR)
BEFORE CONDITIONING
Food
(US)
Unconditioned 
Stimulus
Salivation
(UR)
Unconditioned 
Response
Sound
(NS)
Neutral 
Stimulus 
No salivation
(no UR)
Unconditioned 
Response
RECALL PHASE
Sound
(CS)
Conditioned Stimulus
Salivation
(CR)
Conditioned response
S"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=95#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_95_img4.png,M4-Q11,0.089,"ACQUISITION PHASE
Sound + food Salivation
(UR)
BEFORE CONDITIONING
Food
(US)
Unconditioned 
Stimulus
Salivation
(UR)
Unconditioned 
Response
Sound
(NS)
Neutral 
Stimulus 
No salivation
(no UR)
Unconditioned 
Response
RECALL PHASE
Sound
(CS)
Conditioned Stimulus
Salivation
(CR)
Conditioned response
S"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=96#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_96_img1.png,M1-Q29,0.113,"CLASSICAL CONDITIONING
ACQUISITION PHASE
co-occurrence of… 
THERAPEUTIC 
BENEFIT
(pain reduction)
RE-RECALL PHASE
Schedlowski et al. (2010) Brain Behav Imm 24: 176-185
Vits et al. (2011) Phil. Trans. R. Soc. B 366: 1799-1807
+
MEDICATION / 
TREATMENT CONTEXT CONTEXT
+ EFFECT EFFECT
Chemotherapy +
 N"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=96#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_96_img2.png,M1-Q29,0.113,"CLASSICAL CONDITIONING
ACQUISITION PHASE
co-occurrence of… 
THERAPEUTIC 
BENEFIT
(pain reduction)
RE-RECALL PHASE
Schedlowski et al. (2010) Brain Behav Imm 24: 176-185
Vits et al. (2011) Phil. Trans. R. Soc. B 366: 1799-1807
+
MEDICATION / 
TREATMENT CONTEXT CONTEXT
+ EFFECT EFFECT
Chemotherapy +
 N"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=99#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_99_img1.png,M4-Q22,0.113,"Role of time expectation
Camerone et al., Psychosom Med, 2021
Temporal expectations play a crucial role in modulating when and how pain is 
perceived
(study with a inert cream) 
• Placebo effects emerge at the expected time and remain stable 
• Nocebo effects emerge at the expected time and increase"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=100#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_100_img1.png,M3-Q10,0.143,"Colloca L, Benedetti F (2009) Pain 144:28–34.
Social Learning vs Classical 
Conditioning vs Expectation
Learning from a model: 
it can be observed that
another subject experiences
a reduction in pain following the activation of two 
electrodes (sham placebo)
NO DIFFERENCE BETWEEN SOCIAL LEARNING
AND"
pdf_image,MODULE 4_2_RCT_PSYCH_MECHANISMS#page=101#docs\pdf_images\MODULE 4_2_RCT_PSYCH_MECHANISMS\page_101_img1.png,M4-Q22,0.108,"Au Yeung et al. (2014) Pain 155:1110–1117.
During the
Acquisition phase, 
the placebo
is always paired with 
the
Pain reduction
During the
Acquisition phase, the placebo
is paired with the
Pain reduction in 62% of trials
The placebo effect does not 
extinguish after partial 
reinforcement
Partial vs"
rtf_qid,RTF:Q1.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q2.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q2.2,M4-Q02,0.375,Module 1 - General
rtf_qid,RTF:Q3.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q4.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q4.2,M4-Q09,0.375,Module 1 - General
rtf_qid,RTF:Q5.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q5.2,M4-Q05,0.364,Module 1 - General
rtf_qid,RTF:Q6.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q6.2,M1-Q26,0.250,Module 1 - General
rtf_qid,RTF:Q7.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q7.2,M4-Q07,0.250,Module 1 - General
rtf_qid,RTF:Q8.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q9.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q9.2,M4-Q09,0.263,Module 1 - General
rtf_qid,RTF:Q10.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q10.2,M4-Q21,0.250,Module 1 - General
rtf_qid,RTF:Q11.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q11.2,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q12.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q13.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q14.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q14.2,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q15.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q15.2,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q16.1,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q16.2,M1-Q24,0.129,Module 1 - General
rtf_qid,RTF:Q1.1,M1-Q01,0.156,Part 2 - Specific Studies
rtf_qid,RTF:Q2.1,M1-Q01,0.156,Part 2 - Specific Studies
rtf_qid,RTF:Q2.2,M4-Q02,0.375,Part 2 - Specific Studies
rtf_qid,RTF:Q3.1,M1-Q01,0.156,Part 2 - Specific Studies
rtf_qid,RTF:Q4.1,M1-Q01,0.156,Part 2 - Specific Studies
rtf_qid,RTF:Q4.2,M4-Q09,0.375,Part 2 - Specific Studies
rtf_qid,RTF:Q4.3,M1-Q20,0.308,Part 2 - Specific Studies
rtf_qid,RTF:Q1.1,M1-Q02,0.150,Part 3 - Circuitry
rtf_qid,RTF:Q2.1,M1-Q02,0.150,Part 3 - Circuitry
rtf_qid,RTF:Q2.2,M4-Q02,0.375,Part 3 - Circuitry
rtf_qid,RTF:Q3.1,M1-Q02,0.150,Part 3 - Circuitry
rtf_qid,RTF:Q4.1,M1-Q02,0.150,Part 3 - Circuitry
rtf_qid,RTF:Q4.2,M4-Q09,0.375,Part 3 - Circuitry
rtf_qid,RTF:Q5.1,M1-Q02,0.150,Part 3 - Circuitry
rtf_qid,RTF:Q5.2,M4-Q05,0.364,Part 3 - Circuitry
rtf_qid,RTF:Q6.1,M1-Q02,0.150,Part 3 - Circuitry
rtf_qid,RTF:Q6.2,M1-Q26,0.250,Part 3 - Circuitry
rtf_qid,RTF:Q7.1,M1-Q02,0.150,Part 3 - Circuitry
rtf_qid,RTF:Q7.2,M4-Q07,0.250,Part 3 - Circuitry
rtf_qid,RTF:Q8.1,M1-Q02,0.150,Part 3 - Circuitry
rtf_qid,RTF:Q9.1,M1-Q02,0.150,Part 3 - Circuitry
rtf_qid,RTF:Q10.1,M1-Q02,0.150,Part 3 - Circuitry
rtf_qid,RTF:Q10.2,M4-Q21,0.250,Part 3 - Circuitry
rtf_qid,RTF:Q11.1,M1-Q02,0.150,Part 3 - Circuitry
rtf_qid,RTF:Q11.2,M1-Q02,0.150,Part 3 - Circuitry
rtf_qid,RTF:Q12.1,M1-Q02,0.150,Part 3 - Circuitry
rtf_qid,RTF:Q1.1,M4-Q21,0.111,Module 3 - Mind Change
rtf_qid,RTF:Q2.1,M4-Q21,0.111,Module 3 - Mind Change
rtf_qid,RTF:Q2.2,M4-Q02,0.375,Module 3 - Mind Change
rtf_qid,RTF:Q3.1,M4-Q21,0.111,Module 3 - Mind Change
rtf_qid,RTF:Q4.1,M4-Q21,0.111,Module 3 - Mind Change
rtf_qid,RTF:Q4.2,M4-Q09,0.375,Module 3 - Mind Change
rtf_qid,RTF:Q5.1,M4-Q21,0.111,Module 3 - Mind Change
rtf_qid,RTF:Q5.2,M4-Q05,0.364,Module 3 - Mind Change
rtf_qid,RTF:Q6.1,M4-Q21,0.111,Module 3 - Mind Change
rtf_qid,RTF:Q6.2,M1-Q26,0.250,Module 3 - Mind Change
rtf_qid,RTF:Q7.1,M4-Q21,0.111,Module 3 - Mind Change
rtf_qid,RTF:Q7.2,M4-Q07,0.250,Module 3 - Mind Change
